-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 U1Wd7m2+1SHi4msj2oS9dhl4eLcL7NlOXFp3rUdyi+Jd3xeqzMtmIdQQaM2m+6UE
 Vji2NBZwZ3LWUaqTnnqh3Q==

<SEC-DOCUMENT>0001104659-06-079475.txt : 20061205
<SEC-HEADER>0001104659-06-079475.hdr.sgml : 20061205
<ACCEPTANCE-DATETIME>20061205153644
ACCESSION NUMBER:		0001104659-06-079475
CONFORMED SUBMISSION TYPE:	N-CSR
PUBLIC DOCUMENT COUNT:		9
CONFORMED PERIOD OF REPORT:	20060930
FILED AS OF DATE:		20061205
DATE AS OF CHANGE:		20061205
EFFECTIVENESS DATE:		20061205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			H&Q LIFE SCIENCES INVESTORS
		CENTRAL INDEX KEY:			0000884121
		IRS NUMBER:				043147016
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		N-CSR
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-06565
		FILM NUMBER:		061257311

	BUSINESS ADDRESS:	
		STREET 1:		30 ROWES WHARF
		STREET 2:		HAMBRECHT & QUIST FOURTH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		6175740500

	MAIL ADDRESS:	
		STREET 1:		30 ROWES WHARF
		STREET 2:		HAMBRECHT & QUIST 4TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-CSR
<SEQUENCE>1
<FILENAME>a06-22409_1ncsr.htm
<DESCRIPTION>CERTIFIED ANNUAL SHAREHOLDER REPORT
<TEXT>
<html>

<head>






</head>

<body lang="EN-US">

<div>
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">UNITED STATES</font></p>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">SECURITIES AND EXCHANGE COMMISSION</font></p>

<p align="center" style="margin:2.0pt 0pt .0001pt;text-align:center;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">Washington, D.C. 20549</font></p>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="4" face="Times New Roman" style="font-size:14.0pt;font-weight:bold;">FORM N-CSR</font></b></p>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CERTIFIED SHAREHOLDER REPORT OF REGISTERED<br>
MANAGEMENT INVESTMENT COMPANIES</font></b></p>

<p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="31%" colspan="2" valign="top" style="padding:0pt 0pt 0pt 0pt;width:31.54%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investment
  Company Act file number</font></p>
  </td>
  <td width="68%" colspan="7" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:68.46%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">811-06565</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="9" valign="top" style="padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="9" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">H&amp;Q Life
  Sciences Investors</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="9" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as specified in charter)</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="9" valign="top" style="padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="66%" colspan="7" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:66.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30 Rowes Wharf,
  Fourth Floor, Boston, MA</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:2.0%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="32%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:32.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">02110-3328</font></p>
  </td>
 </tr>
 <tr>
  <td width="66%" colspan="7" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:66.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive offices)</font></p>
  </td>
  <td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:2.0%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="32%" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:32.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Zip code)</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="9" valign="top" style="padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="9" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30 Rowes Wharf,
  Fourth Floor, Boston, MA 02110-3328</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="9" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Name and address of agent for service)</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="9" valign="top" style="padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="42%" colspan="4" valign="top" style="padding:0pt 0pt 0pt 0pt;width:42.5%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Registrant&#146;s
  telephone number, including area code:</font></p>
  </td>
  <td width="20%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:20.02%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">617-772-8500</font></p>
  </td>
  <td width="37%" colspan="3" valign="top" style="padding:0pt 0pt 0pt 0pt;width:37.5%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="9" valign="top" style="padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="21%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:21.2%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of fiscal year end:</font></p>
  </td>
  <td width="15%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:15.84%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">September 30</font></p>
  </td>
  <td width="62%" colspan="6" valign="top" style="padding:0pt 0pt 0pt 0pt;width:62.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="9" valign="top" style="padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="21%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:21.2%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of reporting period:</font></p>
  </td>
  <td width="32%" colspan="4" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:32.7%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">October 1, 2005 to September 30, 2006</font></p>
  </td>
  <td width="46%" colspan="4" valign="top" style="padding:0pt 0pt 0pt 0pt;width:46.1%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="159" style="border:none;"></td>
  <td width="77" style="border:none;"></td>
  <td width="41" style="border:none;"></td>
  <td width="41" style="border:none;"></td>
  <td width="85" style="border:none;"></td>
  <td width="64" style="border:none;"></td>
  <td width="26" style="border:none;"></td>
  <td width="15" style="border:none;"></td>
  <td width="239" style="border:none;"></td>
 </tr>
</table>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">Form N-CSR is to be used by management investment companies to file
reports</font>  with the Commission not
later than 10 days after the transmission to  stockholders of any report that is required to be transmitted to
stockholders  under Rule 30e-1 under
the Investment Company Act of 1940 (17 CFR 270.30e-1).  The Commission may use the information provided
on Form N-CSR in its regulatory,  disclosure
review, inspection, and policymaking roles.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">A registrant is required to disclose the information specified by Form</font>
N-CSR, and the Commission will make this
information public. A registrant is not  required to respond to the collection of information contained in Form
N-CSR  unless the Form displays a
currently valid Office of Management and Budget  (&#147;OMB&#148;) control number. Please direct comments concerning the accuracy of
the  information collection burden
estimate and any suggestions for reducing the  burden to Secretary, Securities and Exchange Commission, 450 Fifth
Street, NW,  Washington, DC
20549-0609. The OMB has reviewed this collection of information  under the clearance requirements of 44 U.S.C.
Section 3507.</font></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\pnellai\06-22409-1\task1536167\22409-1-ba.htm',USER='105276',CD='Dec  5 22:05 2006' -->



<br clear="all" style="page-break-before:always;">

<div>
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 1.
REPORTS TO STOCKHOLDERS.</font></b></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(See
Annual Report 9/30/06)</font></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\pnellai\06-22409-1\task1536167\22409-1-bg.htm',USER='105276',CD='Dec  5 22:05 2006' -->



<br clear="all" style="page-break-before:always;">
<!-- Document name: 06-22409-2.aa-->
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="3"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p><img src="j06224092_aa001.jpg"></p>
<p><img src="j06224092_aa002.jpg"></p>
<p><img src="j06224092_aa003.jpg"></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="5"><b><i>Annual Report</i></b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">&nbsp;&nbsp;2&nbsp;&nbsp;0&nbsp;&nbsp;0&nbsp;&nbsp;6</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=1,FOLIO='',FILE='06-22409-2.aa',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 06-22409-2.ba-->
<p><font face="Times New Roman PS, Times New Roman, Times" size="6">T</font><font face="Times New Roman PS, Times New Roman, Times" size="2">o our Shareholders:</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">On September 30, 2006, the net asset value ("NAV") per share of the Fund was $13.94. During the twelve-month period ended September 30, 2006, total return at net asset value of your Fund was -12.50%. During the most recent six-month period ended September 30, 2006, total return at net asset value of your Fund was -15.88%. The total investment return at market was -9.95% during the twelve-month period ended September 30, 2006 and was -18.68% during the six-month period ended September 30, 2006. Comparisons to relevant indices are listed below:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="138" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Investment Returns</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="92" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Six months<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Ended <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>9/30/06</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="89" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Fiscal Year<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Ended <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>9/30/06</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="138" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Investment Return at Market</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">- 18.68</font></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="58" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">- 9.95</font></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="138" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net Asset Value</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">- 15.88</font></td>
<td colspan="1" width="23" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="58" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">- 12.50</font></td>
<td colspan="1" width="23" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="138" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">NASDAQ Biotech Index (NBI)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">- 10.33</font></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="58" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">- 3.90</font></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="138" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">S&amp;P 500 Index</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">+ 4.14</font></td>
<td colspan="1" width="23" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="58" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">+10.79</font></td>
<td colspan="1" width="23" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">The fiscal year ending September 30, 2006 has been a volatile one in the biotech and healthcare sectors as evidenced by the behavior of the NASDAQ Biotechnology Index (NBI). During the first five months of the fiscal year this index advanced notably. However, the index declined significantly in the following five months. This decrease was followed by a general upward trend in the index through year end. For the twelve-month period ended September 30, 2006, the index declined 3.9%. The market value and the NAV of your Fund declined more than the NBI. Furthermore, the Fund and the NBI Index trailed the broader S&amp;P Index by a considerable amount.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">We believe that the volatility of the NBI index (and your Fund's Stock and NAV performance) resulted from a combination of favorable and unfavorable events in the biotechnology and healthcare sectors. On a macro level, positive factors affecting the biotechnology/healthcare sectors included the appointment of a permanent FDA head and a warm reception to the Medicare Part D (prescription drug) benefit and Medicare Advantage (MA) programs by eligible beneficiaries. The healthcare information technology sub-sector has benefited from the appointment of a healthcare IT "czar."</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">Product related developments were among the most encouraging events in the biotechnology sector during the Fund's fiscal year. Sales growth of key products at Gilead Sciences, Inc. ("Gilead"), Celgene Corp. and Genentech, Inc., three of the sector's leading companies, were very impressive and were, in our opinion, drivers for the sector. The Fund maintains positions in these companies. Merger and acquisition activity was also an important factor for the Fund. Specifically, Gilead proposed to acquire two companies in which the Fund maintained significant positions. Gilead first acquired Corus Pharma, Inc., one of the Fund's venture holdings, in the fourth fiscal quarter and then announced its intention to acquire Myogen, Inc., a holding in HQL's public portfolio, just a few days after the completion </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">1</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=3,FOLIO='1',FILE='06-22409-2.ba',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">of the fiscal year. In November 2006, Gilead completed its acquisition of Myogen, Inc. Merger and acquisition activity has continued as the 2007 fiscal year has commenced.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">During the fiscal year, significant positive contributors to return included long term holdings Gilead Sciences, Inc. and IDEXX Laboratories, Inc. as well as several more recent acqusitions including Align Technology, Inc., Medarex, Inc. and Nuvelo, Inc. The significant underperformance of HQL relative to the NBI was in no small part due to the poor performance of six holdings. Four of the six, Critical Therapeutics, Inc., EPIX Pharmaceuticals, Inc., Nitromed, Inc. and Zix Corp. each had products that either failed to obtain FDA approval or failed to reach expected adoption/market penetration during the fiscal year. In addition, Rigel Pharmaceuticals, Inc., a development stage biotech company, had an unsuccessful clinical trial for its asthma drug. Impax Laboratories, Inc., a manufacturer of differentiated generics, has been beset with auditing/accounting problems.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">The Fund's recent rights offering was successfully completed with approximately 5.6 million shares issued at a subscription price of $12.82 leading to proceeds of over $71 million. However, this issuance had a dilutive impact on existing shares.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">During the twelve-month period ended September 30, 2006, within the public portfolio, the Fund established positions in several companies including Amgen, Inc., Genetech, Inc., Medarex, Inc., Nektar Therapeutics, and United Therapeutics Corp. During the same twelve-month period the Fund exited its position in several companies including Affymetrix, Inc., Applera Corporation &#150; Celera Genomics Group, Intralase Corporation, Molecular Devices Corporation, and Nuvelo, Inc.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">During the same twelve-month period, within the venture portfolio, the Fund established a position in Cougar biotechnology, Inc. and Matritech, Inc. and made a follow-on investment in Xanthus Life Sciences, Inc. The Fund increased its position in Ceres, Inc. by participating in a cashless exercise of warrants. The Fund also exited its venture position in Corus Pharma, Inc. when it was acquired by Gilead Sciences, Inc.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">We continue to believe that the healthcare sector provides significant opportunity for investment. As the population continues to age, healthcare expenditures increase as patients get older. In addition, increased incidence of diabetes, obesity and other disease continues to demand more therapies in which the Fund should be able to continue to invest.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">As always, if you have questions, please feel free to call us at 617-772-8500. Thank you.</font></p>
<p align="left"><img src="j06224092_ba004.jpg">
</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="2">Daniel R. Omstead<BR>President</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">2</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=4,FOLIO='2',FILE='06-22409-2.ba',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>LARGEST HOLDINGS BY ISSUER</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>As of September 30, 2006</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="145" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="125" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>% of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="145" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Gilead Sciences, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3.0</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="145" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Concentric Medical, Inc.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2.5</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="145" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Conor Medsystems, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2.3</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="145" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cubist Pharmaceuticals, Inc.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2.0</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="145" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Genzyme Corp.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2.0</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="145" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Align Technology, Inc.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1.7</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="145" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cardionet, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1.5</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="145" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">MedImmune, Inc.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1.3</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="145" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">PHT Corp.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1.3</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="145" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Raven Biotechnologies, Inc.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1.3</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>PORTFOLIO</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>As of September 30, 2006</i></font></p>
<p align="center"><img src="j06224092_ba005.jpg" height="228 pt" width="247 pt">
</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">3</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=5,FOLIO='3',FILE='06-22409-2.ba',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 06-22409-2.ca-->
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2006</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="93" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>CONVERTIBLE SECURITIES AND WARRANTS</b><b> - 13.3% of Net Assets</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>SHARES</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="239" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Convertible Preferred (Restricted) </b><b><sup>(d)</sup></b><b> - 12.2% </b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="355" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><i>Drug Discovery Technologies - 1.3%</i></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,587,302</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Agilix Corporation Series B <sup>(a)</sup> <sup>(b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">94,540</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">250,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Ceres, Inc. Series C <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,500,000</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">21,462</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Ceres, Inc. Series C-1 <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">128,772</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">175,540</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Ceres, Inc. Series D <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,053,240</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">174,848</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cougar Biotechnology Inc. Series A <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">787,498</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">932,488</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Galileo Pharmaceuticals, Inc. Series F-1 <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">93</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">200,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Zyomyx, Inc. Series A New <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">20,000</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">200</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Zyomyx, Inc. Series B New <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">20</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><i>Emerging Biopharmaceuticals - 3.4%</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">744,921</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Agensys, Inc. Series C <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,200,201</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,212,121</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Raven biotechnologies, Inc. Series B <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,006,060</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,872,772</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Raven biotechnologies, Inc. Series C <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,554,401</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,722,014</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Raven biotechnologies, Inc. Series D <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">800,000</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,415,385</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">TargeGen, Inc. Series C <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,840,001</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">30,920</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Therion Biologics Corporation Series A <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">309</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">160,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Therion Biologics Corporation Series B <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,600</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">271,808</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Therion Biologics Corporation Series C <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,718</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">22,224</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Therion Biologics Corporation Series C-2 <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">222</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">16,668</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Therion Biologics Corp. warrants <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(expiration 8/18/08) <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">28,991</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Therion Biologics Corporation Sinking <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">Fund <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">290</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,645,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Xanthus Life Sciences, Inc. Series B <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,645,000</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="355" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><i>Healthcare Services - 2.8%</i></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,051,429</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CardioNet, Inc. Series C <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,680,001</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">35,254</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CardioNet Inc. warrants <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(expiration 5/01/11) <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,390</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CardioNet, Inc. warrants <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(expiration 8/29/11) <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">322,168</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CytoLogix Corporation Series A <sup>(a)</sup> <sup>(b)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">265,789</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">151,420</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CytoLogix Corporation Series B <sup>(a)</sup> <sup>(b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">124,922</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,589,744</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">PHT Corporation Series D <sup>(a)</sup> <sup>(b)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,800,000</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">802,996</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">PHT Corporation Series E <sup>(a)</sup> <sup>(b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">626,337</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="355" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><i>Medical Devices and Diagnostics - 4.7%</i></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,235,293</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Concentric Medical, Inc. Series B <sup>(a)</sup> <sup>(b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,529,410</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,162,790</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Concentric Medical, Inc. Series C <sup>(a)</sup> <sup>(b)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,627,906</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">455,333</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Concentric Medical, Inc. Series D <sup>(a)</sup> <sup>(b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">637,466</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">177,778</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">EPR, Inc. Series A <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,778</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,446,016</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Labcyte, Inc. Series C <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,280,000</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">130,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Masimo Corporation Series D</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,430,000</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,088,436</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">OmniSonics Medical Technologies, Inc. <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">Series B <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,308,518</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">The accompanying notes are an integral part of these financial statements.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">4</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=6,FOLIO='4',FILE='06-22409-2.ca',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SCHEDULE OF INVESTMENTS, continued</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2006</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="93" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>SHARES</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="239" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Convertible Preferred (Restricted) </b><b><sup>(d)</sup></b><b> - continued </b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,031,992</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">OmniSonics Medical Technologies, Inc. <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">Series C <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,077,400</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">43,478</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">TherOx, Inc. Series H <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">167,868</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">99,646</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">TherOx, Inc. Series I <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">384,733</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,813</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">TherOx warrants (expiration 1/26/10) <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,427</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">TherOx warrants (expiration 6/09/09) <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="340" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">32,577,093</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>PRINCIPAL<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>AMOUNT</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="239" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Convertible Notes (Restricted) </b><b><sup>(d)</sup></b><b> - 1.1%</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b> </b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><i>Drug Discovery Technologies - 1.0%</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,000,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Matritech Inc., 15.00% due 2009</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,625,846</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><i>Healthcare Services - 0.1%</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">216,219</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CardioNet, Inc. Cvt. Note, 8.00% due 2007</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">216,219</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">112,224</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CytoLogix Corporation Cvt. Note, 6.75% <sup>(b)</sup> <sup>(c)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">112,224</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="340" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,954,289</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>TOTAL CONVERTIBLE SECURITIES<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>AND WARRANTS<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(Cost $42,461,588)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">35,531,382</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>SHARES</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="239" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>COMMON STOCKS AND WARRANTS - 55.2%</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b> </b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Biopharmaceuticals - 19.3%</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">175,880</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Advancis Pharmaceutical Corp. <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">warrants (expiration 4/29/10) <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">214,574</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">363,111</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Akorn, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,310,831</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">108,889</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Akorn Inc. warrants (expiration 3/07/11) <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">201,250</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Alexza Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,636,162</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">39,300</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Amgen, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,811,129</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">53,900</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Amylin Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,375,373</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">351,500</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Bioenvision, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,936,765</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">534,805</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Critical Therapeutics, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,283,532</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">159,672</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Critical Therapeutics, Inc. warrants <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(expiration 6/06/10) <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">247,653</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cubist Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,383,976</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">33,570</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Genentech, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,776,239</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">78,982</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Genzyme Corporation <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,328,916</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">115,475</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Gilead Sciences, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">7,933,132</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">263,325</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Idenix Pharmaceuticals Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,554,252</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">540,559</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Inspire Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,751,445</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">257,600</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Solexa, Inc. warrants (expiration <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">4</font><font face="Times New Roman PS, Times New Roman, Times" size="2">/29/07) <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">264,050</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Medarex, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,835,897</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">The accompanying notes are an integral part of these financial statements.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">5</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=7,FOLIO='5',FILE='06-22409-2.ca',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SCHEDULE OF INVESTMENTS, continued</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2006</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="93" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>SHARES</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="239" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Biopharmaceuticals - continued </b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">121,060</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">MedImmune, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,536,163</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">82,740</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Myriad Genetics Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,039,541</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">181,300</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Nektar Therapeutics <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,612,533</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">337,700</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Point Therapeutics, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">506,550</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">374,334</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Tercica, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,995,200</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="340" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">51,822,210</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Drug Delivery - 1.5%</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">526,855</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">DepoMed, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,149,568</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">30,480</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Noven Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">735,178</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">70,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Penwest Pharmaceuticals Co. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,165,500</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="340" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,050,246</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="355" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Drug Discovery Technologies - 5.8%</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">184,848</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Avalon Pharmaceuticals, Inc. <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">424,226</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">48,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Celgene Corp. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,078,400</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">19,428</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cougar Biotechnology Inc. (Restricted) <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">87,502</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">598,232</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">deCODE Genetics, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,290,276</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,846,154</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Matritech Inc. warrants <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(expiration 1/17/11) <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">582,700</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Pharmacopeia Drug Discovery, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,208,433</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">120,737</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Senomyx, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,855,728</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">54,700</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">United Therapeutics Corp. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,873,938</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">156,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">ZymoGenetics, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,631,720</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">200,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Zyomyx, Inc. (Restricted) <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,000</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="340" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">15,452,223</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="355" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Emerging Biopharmaceuticals - 10.5%</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">309,420</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">ACADIA Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,673,389</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">424,254</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Ariad Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,849,747</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">229,973</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Barrier Therapeutics, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,485,626</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">84,629</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cytokinetics, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">544,164</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">82,320</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">DOV Pharmaceutical, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">74,088</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">319,380</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Exelixis, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,781,800</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">157,511</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Kosan Biosciences, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">760,778</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">654,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Lexicon Genetics, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,465,580</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">32,109</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Momenta Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">434,114</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">41,707</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Myogen, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,463,082</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">51,080</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Myogen, Inc. warrants <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(expiration 9/29/09) <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,393,462</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">222,050</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Neurogen Corporation <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,496,617</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">242,522</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Nitromed, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">768,795</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">153,300</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Rigel Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,574,391</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">365,700</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Sangamo BioSciences, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,033,292</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">455,320</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Seattle Genetics, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,212,855</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">66,404</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Telik, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,181,327</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">The accompanying notes are an integral part of these financial statements.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">6</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=8,FOLIO='6',FILE='06-22409-2.ca',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SCHEDULE OF INVESTMENTS, continued</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2006</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="93" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>SHARES</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="239" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Emerging Biopharmaceuticals - continued </b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">113,389</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Theravance, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,066,039</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">146,982</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Therion Biologics Corporation <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(Restricted) <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,470</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="340" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">28,260,616</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="355" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Generic Pharmaceuticals - 3.2%</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">330,100</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Caraco Pharmaceutical Laboratories, Ltd. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,353,816</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">325,462</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Impax Laboratories, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,138,285</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">90,908</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Teva Pharmaceutical Industries, Ltd. <sup>(e)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,099,054</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="340" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">8,591,155</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Healthcare Services - 2.9%</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">148,148</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Aveta, Inc. (Restricted) <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,999,998</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">17,416</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Dako A/S (Restricted) <sup>(d)</sup> <sup>(f)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">181,301</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">212,990</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Emageon, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,320,514</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">51,015</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">National Medical Health Card <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">Systems, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">793,283</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">204,139</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Syntiro Healthcare Services (Restricted) <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">204</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,475,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Zix Corp. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,534,500</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,485,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Zix Corp. warrrants <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(expiration 10/05/11) <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="340" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">7,829,800</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="93" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="355" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Medical Devices and Diagnostics - 12.0%</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">100,970</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Adeza Biomedical Corporation <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,656,918</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">402,850</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Align Technology, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,584,433</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">258,177</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Conor Medsystems, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,085,232</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">77,100</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cytyc Corp. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,887,408</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">482,533</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">EPIX Pharmaceuticals Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,997,687</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">124,557</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Genomic Health Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,801,094</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">30,365</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">IDEXX Laboratories, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,767,466</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">130,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Masimo Corporation (Restricted)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,300</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">447,080</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Medwave, Inc. <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">611,829</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">111,770</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Medwave Inc. warrants <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(expiration 8/21/11) <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">196,100</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Natus Medical, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,676,765</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">662,755</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Orthovita, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,313,015</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">139,019</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Songbird Hearing, Inc. (Restricted) <sup>(a)</sup> <sup>(d)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,390</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">708,973</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Third Wave Technologies, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,176,199</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">382,583</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">VNUS Medical Technologies, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,544,177</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="340" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">32,104,913</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>TOTAL COMMON STOCKS <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>AND WARRANTS <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(Cost $136,793,385)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">148,111,163</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">The accompanying notes are an integral part of these financial statements.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">7</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=9,FOLIO='7',FILE='06-22409-2.ca',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SCHEDULE OF INVESTMENTS, continued</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2006</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="93" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>PRINCIPAL<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>AMOUNT</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="239" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>SHORT-TERM INVESTMENTS - 32.0% </b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">35,000,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Abbey National NA LLC; 5.23% <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">due 10/30/06</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">34,852,543</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,950,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">American Express Corp.; 5.12% <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">due 10/05/06</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,947,753</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">12,000,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Intesa Funding LLC; 5.24% <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">due 10/20/06</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">11,966,813</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">24,900,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">UBS Financial Development LLC; <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">5.24% - 5.25% due 10/02/06 - 10/12/06</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">24,865,809</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">10,117,000<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2"> <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2"> <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2"> <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2"> <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2"> </font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Repurchase Agreement, State Street Bank <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">and Trust Co. (collateralized by <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">U.S. Treasury Bond 8.75%, 5/15/17, <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">market value $10,320,707); <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">3.40</font><font face="Times New Roman PS, Times New Roman, Times" size="2">% due 10/02/06 <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(Cost $10,117,000)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">10,117,000</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>TOTAL SHORT-TERM INVESTMENTS<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(Cost $85,749,918)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">85,749,918</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>TOTAL INVESTMENTS - 100.5%<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(Cost $265,004,891)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">269,392,463</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="239" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>OTHER LIABILITIES IN EXCESS <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>OF ASSETS - (0.5)%</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(1,273,694</font></td>
<td colspan="1" width="20" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="239" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NET ASSETS - 100%</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">268,118,769</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(a)&nbsp;&nbsp;Non-income producing security.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(b)&nbsp;&nbsp;Affiliated issuers in which the Fund holds 5% or more of the voting securities (Total Market Value of $10,818,594).</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(c)&nbsp;&nbsp;Variable maturity.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(d)&nbsp;&nbsp;Security fair valued by the Valuation Committee of the Board of Trustees.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(e)&nbsp;&nbsp;American Depository Receipt.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(f)&nbsp;&nbsp;Foreign Security.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">The accompanying notes are an integral part of these financial statements.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">8</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=10,FOLIO='8',FILE='06-22409-2.ca',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES</b></font><font face="Times New Roman PS, Times New Roman, Times" size="3"><b> </b></font><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>STATEMENT OF ASSETS AND LIABILITIES</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2006</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="371" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">AS</font><font face="Times New Roman PS, Times New Roman, Times" size="2">SETS:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Investments in non affiliated issuers, at value <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(identified cost $254,355,169; see Schedule of &nbsp;</font><BR><font face="Times New Roman PS, Times New Roman, Times" size="2">Investments)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">258,573,869</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Investments in affiliated issuers, at value <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(identified cost $10,649,722; see Schedule of &nbsp;</font><BR><font face="Times New Roman PS, Times New Roman, Times" size="2">Investments)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">10,818,594</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cash</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,447</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Interest receivable</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">254,851</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Receivable for investments sold</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,119,279</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Prepaid expenses</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">45,966</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Total assets</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="78" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">270,814,006</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="371" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">LIABILITIES:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Payable for investments purchased</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,058,484</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accrued advisory fee</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">246,435</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accrued offering costs</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">204,100</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accrued audit fee</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">59,453</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accrued shareholder reporting fees</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">38,790</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accrued legal fees</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">13,410</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accrued other</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">74,565</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Total liabilities</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,695,237</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">NET ASSETS</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="78" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">268,118,769</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="371" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">SOURCES OF NET ASSETS:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Shares of beneficial interest, par value $.01 per <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">share, unlimited number of shares authorized, <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">amount paid in on 19,227,702 shares issued and <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">outstanding</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">262,946,065</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accumulated net realized gain on investments</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">785,125</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net unrealized gain on investments</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,387,579</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Total net assets (equivalent to $13.94 per <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">share based on 19,227,702 shares issued and<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">outstanding)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">268,118,769</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">The accompanying notes are an integral part of these financial statements.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">9</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=11,FOLIO='9',FILE='06-22409-2.ca',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES</b></font><font face="Times New Roman PS, Times New Roman, Times" size="3"><b> </b></font><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>STATEMENT OF OPERATIONS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>FOR THE YEAR ENDED SEPTEMBER 30, 2006</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="11" width="435" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">INVESTMENT INCOME:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Dividend income (net of foreign tax &nbsp;</font><BR><font face="Times New Roman PS, Times New Roman, Times" size="2">of $3,712)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">18,956</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"> </font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Special dividend</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,312,446</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Interest income from non affiliated issuers</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">963,646</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Interest income from affiliated issuers</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">7,575</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Total investment income</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"> </font></td>
<td colspan="1" width="8" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="66" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,302,623</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="435" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">EXPENSES:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Advisory fees</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,758,714</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Trustees' fees and expenses</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">170,351</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accounting, administration and auditing fees</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">150,723</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Legal fees</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">119,154</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Custodian fees</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">109,853</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Shareholder reporting</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">82,334</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Transfer agent fees</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">64,364</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Stock exchange listing fee</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">26,426</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Other (see note (2))</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">159,429</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Total expenses</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"> </font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,641,348</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net investment loss</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"> </font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="66" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,338,725</font></td>
<td colspan="1" width="20" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="435" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">NET REALIZED AND UNREALIZED LOSS<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">ON INVESTMENTS:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net realized gain on investments</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"> </font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="66" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">13,733,052</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Decrease in net unrealized gain on investments</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"> </font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(33,840,281</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net realized and unrealized loss <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">on investments</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"> </font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="66" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">20,107,229</font></td>
<td colspan="1" width="20" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="230" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net decrease in net assets <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">resulting from operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"> </font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">21,445,954</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">The accompanying notes are an integral part of these financial statements.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">10</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=12,FOLIO='10',FILE='06-22409-2.ca',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>STATEMENTS OF CHANGES IN NET ASSETS</b></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="209" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="117" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">For the <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">year ended<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">September 30,<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">2006</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="117" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">For the <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">year ended<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">September 30,<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">2005</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="451" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">NET DECREASE IN NET ASSETS<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">RESULTING FROM OPERATIONS:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="209" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net investment loss</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="72" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,338,725</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="72" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,587,561</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="209" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net realized gain on investments</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">13,733,052</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">26,035,268</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="209" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Decrease/increase in net unrealized<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">gain on investments</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="72" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(33,840,281</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="72" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">21,315,662</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="209" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net decrease/increase in net <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">assets resulting from operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">21,445,954</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">44,763,369</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="451" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">DISTRIBUTIONS TO SHAREHOLDERS<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">FROM:</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="209" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net realized capial gains</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">26,482,790</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">15,828,633</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="451" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CAPITAL SHARE TRANSACTIONS:</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="209" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Value of shares issued in<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">reinvestment of distributions&nbsp;</font><BR><font face="Times New Roman PS, Times New Roman, Times" size="2">(1,016,450 and 538,795 shares, &nbsp;</font><BR><font face="Times New Roman PS, Times New Roman, Times" size="2">respectively)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">15,348,652</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">8,518,606</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="209" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Value of 5,606,048 shares issued <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">in rights offering</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="72" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">71,869,535</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="72" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">&#151;</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="209" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Offering costs charged to paid-in-capital</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(462,000</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">&#151;</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="209" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net increase in net assets resulting <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">from capital share transactions</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="72" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">86,756,187</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="72" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">8,518,606</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="209" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net increase in net assets</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">38,827,443</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">37,453,342</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="451" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">NET ASSETS:</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="209" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Beginning of period</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">229,291,326</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">191,837,984</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="209" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">End of period</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="72" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">268,118,769</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="72" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">229,291,326</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="209" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accumulated net investment loss<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">included in net assets at end &nbsp;</font><BR><font face="Times New Roman PS, Times New Roman, Times" size="2">of the period</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(14</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">The accompanying notes are an integral part of these financial statements.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">11</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=13,FOLIO='11',FILE='06-22409-2.ca',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES</b></font><font face="Times New Roman PS, Times New Roman, Times" size="3"><b> </b></font><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>STATEMENT OF CASH FLOWS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>FOR THE YEAR ENDED SEPTEMBER 30, 2006</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="371" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CASH FLOWS USED IN OPERATING ACTIVITIES:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Purchases of portfolio securities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($97,501,807)</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net purchases of short-term investments</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(69,784,079</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Sales of portfolio securities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">109,053,427</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Interest income received</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">36,476</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Dividends received</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,331,402</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Operating expenses paid</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(3,428,664</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net cash used for operating activities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($60,293,245)</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="371" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CASH FLOWS PROVIDED FROM FINANCING ACTIVITIES:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cash distributions paid, net</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($11,134,138)</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cash received in rights offering, net of offering costs</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">71,407,535</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net cash provided from financing activities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="78" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">60,273,397</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">NET DECREASE IN CASH</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($19,848)</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CASH AT BEGINNING OF PERIOD</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">21,295</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CASH AT END OF PERIOD</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,447</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="371" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">RECONCILIATION OF NET DECREASE IN NET ASSETS<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">RESULTING FROM OPERATIONS TO NET CASH<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">USED FOR OPERATING ACTIVITIES:</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net decrease in net assets resulting from operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($21,445,954)</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Purchases of portfolio securities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($97,501,807)</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net purchases of short-term investments</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(69,784,079</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Sales of portfolio securities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">109,053,427</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accretion of discount</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(715,602</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net realized gain on investments</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(13,733,052</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Decrease in net unrealized gain on investments</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">33,840,281</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Increase in dividends and interest receivable</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(219,143</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Increase in accrued expenses</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">209,273</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Increase in prepaid expenses</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,411</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net cash used for operating activities</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($60,293,245)</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">Noncash financing activities not included herein consist of reinvested distributions of $15,348,652</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">Noncash investing activities not included herein consist of one conversion of restricted preferred stock and convertible note with a total cost of $2,145,319 to restricted common stock of the same issuer and one reverse stock split of an issuer with a cost of $4,521,886.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">The accompanying notes are an integral part of these financial statements.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">12</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=14,FOLIO='12',FILE='06-22409-2.ca',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 06-22409-2.da-->
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>FINANCIAL HIGHLIGHTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>(Selected data for each share of beneficial interest outstanding throughout the period indicated)</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="111" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="19" width="526" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">For the year ended September 30,</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2006</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2005</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2004</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2003</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2002 (1)</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net asset value per share:<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Beginning of period</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">18.19</font></td>
<td colspan="1" width="33" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">15.90</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">16.68</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">15.14</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">23.09</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net investment loss (2)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.10</font></td>
<td colspan="1" width="33" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>(3)</sup></font>&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.21</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.26</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.21</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.26</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net realized and unrealized<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">gain (loss) on investments</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(2.10</font></td>
<td colspan="1" width="33" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.79</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.86</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.55</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(4.83</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Total increase (decrease)<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">from investment operations</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2.20</font></td>
<td colspan="1" width="33" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.58</font></td>
<td colspan="1" width="24" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.60</font></td>
<td colspan="1" width="24" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.34</font></td>
<td colspan="1" width="24" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5.09</font></td>
<td colspan="1" width="24" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Capital gains distributions<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">to shareholders</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2.05</font></td>
<td colspan="1" width="33" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.29</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.38</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.80</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2.86</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net asset value per share:<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">End of period</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">13.94</font></td>
<td colspan="1" width="33" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">18.19</font></td>
<td colspan="1" width="24" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">15.90</font></td>
<td colspan="1" width="24" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">16.68</font></td>
<td colspan="1" width="24" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">15.14</font></td>
<td colspan="1" width="24" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Per share market value:<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">End of period</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">13.29</font></td>
<td colspan="1" width="33" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">16.85</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">16.20</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">15.28</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11.79</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Total investment return<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">at market value</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(9.95</font></td>
<td colspan="1" width="33" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12.77</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">15.52</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">47.65</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(25.82</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="637" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>RATIOS AND SUPPLEMENTAL DATA:</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net assets at end of period</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">268,118,769</font></td>
<td colspan="1" width="33" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">229,291,326</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">191,837,984</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">190,352,471</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">157,585,450</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Ratio of operating expenses<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">to average net assets</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.74</font></td>
<td colspan="1" width="33" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.74</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.73</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.74</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.71</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Ratio of net investment loss<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">to average net assets</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(0.64</font></td>
<td colspan="1" width="33" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%)(3)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(1.29</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(1.56</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(1.38</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(1.25</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Portfolio turnover rate</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">49.90</font></td>
<td colspan="1" width="33" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">73.79</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">34.93</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">32.36</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">17.36</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="111" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Number of shares outstanding<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">at end of period</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">19,227,702</font></td>
<td colspan="1" width="33" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12,605,204</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12,066,409</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11,412,475</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">10,409,622</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(1) In 2002, the Fund adopted the provisions of the AICPA Audit and Accounting Guide for Investment Companies and began accreting discounts and amortizing premiums on all debt securities. The effect of this change for the year ended September 30, 2002 was a decrease in net investment loss per share of $.006, an increase in net realized and unrealized loss on investments per share of $.006, and a decrease in the ratio of net investment loss to average net assets from (1.28%) to (1.25%).</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(2) Net investment income/(loss) per share has been computed using average shares outstanding.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(3) Includes a special dividend from an issuer in the amount of $0.10 per share. Excluding the special dividend, the ratio of net investment income/(loss) to average net assets would have been (1.27%).</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">The accompanying notes are an integral part of these financial statements.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">13</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=15,FOLIO='13',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2006</i></font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>(1)&nbsp;&nbsp;Significant Accounting Policies</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">H&amp;Q Life Sciences Investors (the Fund) is a Massachusetts business trust registered under the Investment Company Act of 1940 as a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in life science companies (including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies) agriculture and environmental management. The Fund invests primarily in securities of public and private companies that are believed to have significant potential for above-average growth. The Fund was organized on February 20, 1992 and commenced operations on May 8, 1992.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The preparation of these financial statements requires the use of certain estimates by management in determining the Fund's assets, liabilities, revenues and expenses. Actual results could differ from these estimates. The following is a summary of significant accounting policies consistently followed by the Fund, which are in conformity with accounting principles generally accepted in the United States of America.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">In July 2006, Financial Accounting Standards Board Interpretation No. 48, Accounting for Uncertainty in Income Taxes &#151; an interpretation of FASB Statement 109 (FIN 48), was issued and is effective for fiscal years beginning after December 15, 2006. FIN 48 sets forth a threshold for financial statement recognition, measurement and disclosure of a tax position taken or expected to be taken on a tax return. Management is currently evaluating the impact, if any, the adoption of FIN 48 will have on the Fund's net assets, results of operations and financial statement disclosures.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">In addition, in September 2006, Statement of Financial Accounting Standards No. 157, Fair Value Measurements (SFAS 157), was issued and is effective for fiscal years beginning after November 15, 2007. SFAS 157 defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. Management is currently evaluating the impact the adoption of SFAS 157 will have on the Fund's financial statements.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Investment Securities &amp; Investment Income</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Investments traded on national securities exchanges or in the over-the-counter market that are National Market System securities are valued at the last sale price or, lacking any sales, at the mean between the last bid and asked prices. Other over-the-counter securities are valued at the most recent bid prices as obtained from one or more dealers that make markets in the securities. Exchange traded investments for which market quotations are not readily available are valued at fair value as determined in good faith by the Trustees of the Fund. The fair value of venture capital and other restricted securities is determined in good faith by the Trustees. However, because of the uncertainty of fair valuations these estimated values may differ significantly from the values that would have been used had a ready market for these securities existed, and the differences could be material. Each such fair value determination is based on a consideratio
n of relevant factors. Factors the Trustees consider may include (i) the existence of any contractual restrictions on the disposition of securities; (ii) information obtained from the issuer which may include an analysis of the company's financial statements, the company's products or intended markets or the company's technologies; and (iii) the price of a security negotiated at arm's length in an issuer's completed subsequent round of financing. See note 3. Short-term investments with maturity of 60 days or less are valued at amortized cost.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Investment transactions are recorded on a trade date basis. Gains and losses from sales of investments are recorded using the "identified cost" method. Interest income is recorded on </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">14</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=16,FOLIO='14',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS, continued</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2006</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">the accrual basis, adjusted for amortization of premiums and accretion of discounts. Dividend income is recorded on the ex-dividend date.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The aggregate cost of purchases and proceeds from sales of investment securities (other that short-term investments) for the year ended September 30, 2006 totaled $99,002,918 and $106,648,924 respectively.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Repurchase Agreements</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">In managing short-term investments the Fund may from time to time enter into transactions in repurchase agreements. In a repurchase agreement, the Fund's custodian takes possession of the underlying collateral securities, the market value of which is at least equal to the principal, including accrued interest, of the repurchase transaction at all times. In the event of default or bankruptcy by the other party to the agreement, realization and/or retention of the collateral by the Fund may be delayed or limited.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Distribution Policy</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Distributions will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. Pursuant to an SEC exceptive order, the Fund has implemented a fixed distribution policy that permits the Fund to make quarterly distributions at a rate of 2% of the Fund's net assets to shareholders of record. The Fund intends to use net realized capital gains when making quarterly distributions. This could result in a return of capital to shareholders if the amount of the distribution exceeds the Fund's net investment income and realized capital gains. It is anticipated that net realized capital gains in excess of the total distributed under this policy would be included in the December distribution. The Fund's distribution policy has been established by the Board of Trustees. The distribution policy may be changed by the Board of Trustees without Shareholder approval.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The current distribution policy is to declare distributions in stock. Distributions will automatically be paid in newly-issued full Shares of the Trust plus cash in lieu of any fraction of a Share, unless otherwise instructed by the Shareholder. The Fund's transfer agent delivers an election card and instructions to each registered Shareholder in connection with each distribution. For shareholders other than registered shareholders with book entry accounts at the Trust's transfer agent, fractional shares will generally be settled in cash. The number of Shares issued will be determined by dividing the dollar amount of the distribution by the lower of net asset value or market value on the pricing date. If a Shareholder elects to receive a distribution in cash, rather than in Shares, the Shareholder's relative ownership in the Trust will be reduced. The shares will be valued at the lower of the net asset value or market price on the pricing da
te. Distributions in stock will not relieve shareholders of any federal, state or local income taxes that may be payable on such distributions.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Federal Income Taxes</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">It is the Fund's policy to comply with the requirements of the Internal Revenue Code applicable to regulated investment companies and to distribute to its shareholders substantially all of its taxable income and its net realized capital gains, if any. Therefore, no Federal income or excise tax provision is required.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Distributions</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund records all distributions to shareholders from net investment income, if any, and realized gains on the ex-dividend date. Such distributions are determined in conformity with </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">15</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=17,FOLIO='15',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS, continued</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2006</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">income tax regulations. Due to permanent book/tax differences in accounting for certain transactions, certain distributions may be treated as distributions from capital as opposed to distributions of net investment income or realized capital gains.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">At September 30, 2006, the cost and related gross unrealized appreciation and depreciation are as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="188" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Cost of investments for tax purposes </font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">265,406,148</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="188" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Gross tax unrealized appreciation </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="56" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">42,427,625</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="188" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Gross tax unrealized depreciation </font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">38,441,310</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="188" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net tax unrealized appreciation on investments </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="56" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,986,315</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">As of September 30, 2006, the components of distributable earnings on a tax basis were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="188" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Long-term capital gain </font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,186,383</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="188" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net unrealized appreciation </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="56" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,986,322</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The tax character of distributions paid during the years ended September 30, 2006 and September 30, 2005 were as follows;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Distributions paid from</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2006</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2005</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Ordinary income</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">79,690</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Long-term capital gain</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">26,403,100</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">15,828,633</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Net realized gains and losses may differ for financial and tax reporting purposes primarily as a result of the deferral of losses relating to wash sale transactions.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Pursuant to Section 852 of the Internal Revenue Code, the Fund has designated $26,482,790 as long-term capital gain distributions for its taxable year ended September 30, 2006.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Statement of Cash Flows</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The cash amount shown in the Statement of Cash Flows is the amount included in the Fund's Statement of Assets and Liabilities and represents cash on hand at its custodian and does not include short-term investments at September 30, 2006.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Indemnifications</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Under the Fund's organizational documents, its officers and Trustees may be indemnified against certain liabilities and expenses arising out of the performance of their duties to the Fund. Additionally, in the normal course of business, the Fund enters into agreements with service providers that may contain indemnification clauses. The Fund's maximum exposure under these agreements is unknown as this would involve future claims that may be made against the fund that have not yet occurred. However, based on experience, the Fund expects the risk of loss to be remote.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>(2)&nbsp;&nbsp;Investment Advisory Fees and Other Transactions with Affiliates</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund has entered into an Investment Advisory Agreement (the Advisory Agreement) with Hambrecht &amp; Quist Capital Management, LLC (the Adviser). Starting July 1, 2006, pursuant to the terms of the Advisory Agreement, the Fund pays the Adviser a monthly fee at the rate when annualized of (i) 2.5% of the average net assets for the month of its venture capital and </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">16</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=18,FOLIO='16',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS, continued</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2006</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">other restricted securities up to 25% of net assets and (ii) for the month, for all other assets, 0.98% of the average net assets up to $250 million, 0.88% of the average net assets for the next $250 million, 0.8% of the average net assets for the next $500 million and 0.7% of the average net assets thereafter. The aggregate fee may not exceed a rate when annualized of 1.375%. Prior to July 1, 2006, the Fund paid a monthly fee at the rate when annualized of (i) 2.5% of the average net assets for the month of its venture capital and other restricted securities up to 25% of net assets and (ii) for the month, for all other assets, 1.0% of the average net assets up to $250 million, 0.9% of the average net assets for the next $250 million, 0.8% of the average net assets for the next $500 million and 0.7% of the average net assets thereafter. The aggregate fee could not exceed a rate when annualized of 1.375%.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund has entered into a Services Agreement (the "Agreement") with the Adviser. Pursuant to the terms of the Agreement, the Fund reimburses the Adviser for certain services related to a portion of the payment of salary and provision of benefits to the Fund's Chief Compliance Officer. During the year ended September 30, 2006 these payments amounted to $60,160 and are included in the "other" category in the Statement of Operations, together with insurance expenses of $45,979 incurred to unaffiliated entities. Such expenses are the major components of "other" in the Statement of Operations. Expenses incurred pursuant to the Agreement as well as certain expenses paid for by the Adviser are allocated in an equitable fashion to the Fund.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Certain officers and Trustees of the Fund are also officers of the Adviser. Trustees who are not affiliates of the Adviser receive an annual fee of $20,000 plus $500 for each Committee on which they serve and $500 for each meeting attended.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">An affiliate company is a company in which the Fund holds 5% or more of the voting securities. Transactions with such companies during the year ended September 30, 2006 were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="57" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Issuer</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="91" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Value on <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">October 1, 2005</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="74" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Purchases</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="58" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Sales</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="66" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Income</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="103" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Value on <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">September 30, 2006</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="57" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Agilix <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">380,952</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="39" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">94,540</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="57" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Concentric <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Medical, Inc.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6,794,782</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="39" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6,794,782</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="57" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">CytoLogix <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">502,935</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="39" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">7,575</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">502,935</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="57" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">PHT <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Corporation</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,426,337</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="39" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,426,337</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11,105,006</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="39" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">7,575</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">10,818,594</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>(3)&nbsp;&nbsp;Venture Capital and Other Restricted Securities</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund may invest in venture capital and other restricted securities if these securities would currently comprise 40% or less of net assets. The value of these securities represents 14% of the Fund's net assets at September 30, 2006.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">During the year ended September 30, 2006, restricted securities from one issuer were exchanged for cash in connection with a corporate action, a portion of which has been retained by the issuer in an escrow account pending resolution of certain contingencies and whose estimated value of $278,876 at September 30, 2006 has been determined by the Trustees. The value of the escrow account is included in the Receivable for Investments Sold in the Statement of Assets and Liabilities.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">17</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=19,FOLIO='17',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS, continued</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2006</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The following table details the acquisition date, cost, carrying value per unit, and value of the Fund's venture capital and other restricted securities at September 30, 2006, as determined by the Trustees of the Fund. The Fund may invest up to 40% of its net assets in venture capital and other restricted securities. The values of these securities represent 14% of the Fund's net assets at September 30, 2006. The Fund does not have the right to demand that such securities be registered.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="108" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Security </font><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>(f)</sup></font>&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Acquisition<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="75" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Cost</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="90" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Carrying Value<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">per Unit</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="93" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Value</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Agensys, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/14/02, 9/27/05</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,204,684</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2.95</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,200,201</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Agilix Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/8/01</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,663,667</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.06</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">94,540</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Aveta, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/21/05</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,999,998</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">13.50</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,999,998</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">CardioNet, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/3/01 - 3/25/03</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,701,714</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.50</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,680,001</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Warrants (expiration 5/01/11)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/1/06</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.00</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Warrants (expiration 8/29/11)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">8</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/29/06</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.00</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Convertible Note</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">8</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/15/05</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">211,310</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.00</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">216,219</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Ceres, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/23/98</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,000,875</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6.00</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,500,000</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C-1 Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/31/01</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">74,339</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6.00</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">128,772</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series D Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/14/01</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,046,887</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6.00</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,053,240</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Concentric Medical, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/7/02, 1/24/03</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,219,473</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.40</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">4,529,410</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/19/03</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">999,999</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.40</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,627,906</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series D Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">9</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/30/05</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">638,511</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.40</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">637,466</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Cougar Biotechnology Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series A Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/30/06</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">788,030</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">4.50</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">787,498</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/30/06</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">87,559</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">4.50</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">87,502</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">CytoLogix Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series A Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/13/98 - 7/21/99</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,077,912</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.83</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">265,789</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/11/01</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">506,622</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.83</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">124,922</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Convertible Note</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/29/02</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">112,224</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.00</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">112,224</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Dako A/S</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/14/04</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">734,913</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">10.41</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">181,301</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">EPR, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series A Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/9/94</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">800,331</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,778</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Galileo Pharmaceuticals, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series F-1 Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">8</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/18/00</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,002,559</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.00</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">93</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Labcyte, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">7</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/18/05</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,282,337</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.52</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,280,000</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Masimo Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series D Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">8</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/14/96</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">910,530</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11.00</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,430,000</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/31/98</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,300</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Matritech, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Convertible Note</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/17/06</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,013,664</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.31</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,625,846</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Omnisonics Medical Technologies, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/24/01</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,606,312</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.20</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,308,518</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">10</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/1/03</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,200,224</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.04</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,077,400</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">PHT Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series D Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">7</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/23/01</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,803,841</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.78</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,800,000</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series E Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">9</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/12/03 - 12/17/03</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">627,472</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.78</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">626,337</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Raven biotechnologies, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/12/00</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,001,150</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.83</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,006,060</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/26/02</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,554,400</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.83</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,554,401</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series D Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/23/05</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">803,610</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.29</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">800,000</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">18</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=20,FOLIO='18',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS, continued</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2006</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="108" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Security </font><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>(f)</sup></font>&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Acquisition<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="75" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Cost</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="90" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Carrying Value<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">per Unit</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="93" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Value</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Songbird Hearing, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/14/00</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,003,239</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,390</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Syntiro Healthcare Services</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/5/97</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">800,325</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.001</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">204</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">TargeGen, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">8</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/30/05</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,842,331</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.30</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,840,001</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Therion Biologics Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series A Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">8</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/20/96 - 10/16/96</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">289,847</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">309</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/22/99</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">600,929</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,600</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">9</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/26/01 - 10/15/01</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,019,568</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,718</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C-2 Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">8</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/13/03</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">40,003</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">222</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Warrants (expiration 8/18/08)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">8</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/18/03</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.00</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Sinking Fund Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">10</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/18/94 - 4/3/96</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">582,505</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">290</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/30/93</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">251,642</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,470</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">TherOx, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series H Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">9</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/11/00</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,001,626</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.86</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">167,868</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series I Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">7</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/8/05</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">386,273</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.86</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">384,733</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Warrants (expiration 1/26/10)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/26/05</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.00</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Warrants (expiration 6/09/09)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/9/04</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.00</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Xanthus Life Sciences, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/5/03 - 3/23/06</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,645,917</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.00</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,645,000</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="453" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Zyomyx, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series A New Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/19/99 - 1/12/04</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">199,800</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.10</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">20,000</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B New Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/31/04</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">112</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.10</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">20</font></td>
<td colspan="1" width="26" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">New Restricted Common</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/19/99 - 7/22/02</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,401,101</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,000</font></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">50,740,365</font></td>
<td colspan="1" width="8" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">37,806,547</font></td>
<td colspan="1" width="26" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>(g)</sup></font>&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">(f) See Schedule of Investments and corresponding footnotes for more information on each issuer.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">(g) Represents 14% of the Fund's net assets as of September 30, 2006.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>(4)&nbsp;&nbsp;Capital</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">On August 18, 2006, the Fund distributed one non transferable right for each of the 13,454,515 shares outstanding to shareholders of record on that date. Each three rights entitled shareholders to purchase one additional share of the Fund at the subscription price of $12.82 per share. The subscription period expired on September 21, 2006. The rights offering resulted in the issuance of 5,606,048 shares and proceeds of $71,869,535 prior to the deduction of costs of $462,000.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">19</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=21,FOLIO='19',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS, continued</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2006</i></font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>(5)&nbsp;&nbsp;Sources of Net Assets</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The changes in the sources of net assets for the period from October 1, 2005 through September 30, 2006 are as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="102" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="94" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Capital Paid <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">in on Shares <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">of Beneficial <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Interest</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Accumulated <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Net<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Investment <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">(loss) </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="94" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Accumulated<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Net Realized<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Gain on<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Investments</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="90" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Unrealized<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Gain on<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Investments</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="88" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Total Net<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Assets</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="102" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">As of October 1, 2005:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">177,528,617</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(14</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">13,534,863</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">38,227,860</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">229,291,326</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="102" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">For the period from <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">October 1, 2005 through <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">September 30, 2006:</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="60" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="53" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="102" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net investment loss</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(1,338,725</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(1,338,725</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="102" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net realized gains</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="60" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">13,733,052</font></td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="53" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">13,733,052</font></td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="102" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Distributions</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(26,482,790</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(26,482,790</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="102" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Value of shares issued in <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">reinvestment of <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">dividends and rights <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">offering, net of <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">expenses</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">86,756,187</font></td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="60" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="53" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">86,756,187</font></td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="102" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Decrease in net unrealized <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">gain on investments</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(33,840,281</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(33,840,281</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="102" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Reclassification for Federal <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">income purposes</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(1,338,739</font></td>
<td colspan="1" width="18" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,338,739</font></td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="53" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="102" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">As of September 30, 2006:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">262,946,065</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">785,125</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">4,387,579</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">268,118,769</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt; padding:0in 0in 0in 0in;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">20</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=22,FOLIO='20',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>To the Trustees and Shareholders of H&amp;Q Life Sciences Investors:</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">We have audited the accompanying statement of assets and liabilities of H&amp;Q Life Sciences Investors (the "Fund"), including the schedule of investments, as of September 30, 2006, and the related statements of operations and cash flows for the year then ended, the statements of changes in net assets for each of the two years in the period then ended and financial highlights for each of the three years in the period then ended. These financial statements and financial highlights are the responsibility of the Fund's management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits. The financial highlights for the years ended September 30, 2003 and 2002 were audited by other auditors whose report, dated November 23, 2003, expressed an unqualified opinion on the financial highlights.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant e
stimates made by management, as well as evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of September 30, 2006, by correspondence with the custodian and brokers; where replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">In our opinion, the financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of H&amp;Q Life Sciences Investors as of September 30, 2006, the results of its operations and its cash flows for the year then ended, the changes in its net assets for each of the two years in the period then ended, and the financial highlights for each of the three years in the period then ended, in conformity with accounting principles generally accepted in the United States of America.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="2">DELOITTE &amp; TOUCHE LLP<BR>Boston, Massachusetts<BR>November 17, 2006</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">21</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=23,FOLIO='21',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>TRUSTEES</b></font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>H &amp; Q Life Sciences Investors<BR>30 Rowes Wharf, Suite 430<BR>Boston, Massachusetts 02110<BR>(617) 772-8500</b></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="159" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Name, Address</b><b><sup>1<BR></sup></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>and Date of Birth</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Position(s) Held with <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Fund, Term of Office</b><b><sup>2</sup></b><b> and<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1638" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Principal Occupation(s)<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>During Past 5 Years and<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Other Directorships Held</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Number of <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Portfolios in Fund<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Complex Overseen<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>by Trustee</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Independent Trustees:</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1638" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="92" valign="top">
&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="159" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Lawrence S. Lewin 4/1938</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 1992) and Chairman (since 2000)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1638" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Self-employed Executive Consultant (since 1999); Director (since 2003) of Medco Health Solutions, Inc.; Director (since 2001) of CardioNet, Inc.; Director (since 2005) of Care Fusion (provides solutions for patient care providers); and Director (since 1984) of Intermountain Healthcare (non-profit organization).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="92" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="159" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Robert P. Mack 8/1935</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 1992)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1638" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Orthopedic Surgeon at Orthopedic Associates of Aspen (since 2000).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="92" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="159" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Eric Oddleifson 4/1935</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 1992)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1638" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Self-employed Consultant (since 2005); Investment Committee Chair (from 2003-2005) and Partner (from 1997-2003) of GMO Renewable Resources LLC (timber investment management).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="92" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="159" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Oleg M. Pohotsky 3/1947</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 2000)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1638" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Self-employed Financial Consultant (since 2002); Senior Vice President (from 1991-2001) of FAC/Equities, a division of First Albany Corporation (investment bank).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="92" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="159" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Uwe E. Reinhardt, Ph.D. <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">9</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/1937</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 1992)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1638" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Professor of Economics (since 1968) at Princeton University; Director (since 2000) of Triad Hospitals, Inc.; Director of Boston Scientific (since 2002); Director of Amerigroup, Inc. (since 2002); Director of Duke University (since 2001); Director of The Duke University Health System (since 2001); and Director of the National Bureau of Economic Research (since 2002).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="92" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">22</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=24,FOLIO='22',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>TRUSTEES</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Name, Address</b><b><sup>1<BR></sup></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>and Date of Birth</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Position(s) Held with <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Fund, Term of Office</b><b><sup>2</sup></b><b> and<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1638" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Principal Occupation(s)<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>During Past 5 Years and<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Other Directorships Held</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Number of <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Portfolios in Fund<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Complex Overseen<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>by Trustee</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Independent Trustees: </b></font><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1638" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="92" valign="top">
&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="159" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Lucinda H.</font><font size="1"> </font><font face="Times New Roman PS, Times New Roman, Times" size="1">Stebbins, <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">CP</font><font face="Times New Roman PS, Times New Roman, Times" size="1">A <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">11</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/1945 </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 2006)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1638" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Self-employed Financial Consultant (since 2004); Director of Deutsche Asset Management (from 2002-2004); Senior Vice President of Scudder Investments (from 2000-2002).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="92" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="159" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Henri A. Termeer 2/1946</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 1992)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1638" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Chairman (since 1988), Chief Executive Officer (since 1985) and Director (since 1983) of Genzyme Corporation; Director (from 1987-2006) of ABIOMED, Inc.; Director (from 1992-2003) of AutoImmune, Inc.; Director (from 1993-2002) of Genzyme Transgenics; and Director (from 1996-2002) of Diacrin, Inc.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="92" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="159" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Interested Trustees:</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1638" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="92" valign="top">
&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="159" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Daniel R</font><font size="1"> </font><font face="Times New Roman PS, Times New Roman, Times" size="1">Omstead, Ph.D. <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">7</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/1953</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">President (since 2001); Trustee (since 2003)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1638" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">President of HQH and of HQL (since 2001); Trustee of HQH and HQL (since 2003); President, Chief Executive Officer and Managing Member of Hambrecht &amp; Quist Capital Management LLC (since 2002); President and Chief Executive Officer (from 2001 to 2002) and Managing Director (from 2000 to 2002) of Hambrecht &amp; Quist Capital Management Inc.; Director (since 2003) of Concentric Medical, Inc.; Director (since 2001) of Agilix Corporation.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="92" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
</table>

<p>&nbsp;</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>1&nbsp;&nbsp;</sup>The address for each Trustee is c/o the Fund at the Fund's address as set forth above.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>2</sup>&nbsp;&nbsp;Each Trustee currently is serving a three year term.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>3</sup>&nbsp;&nbsp;Trustee considered to be an "interested person" within the meaning of the Investment Company Act of 1940, as amended (the "1940 Act") through position or affiliation with Hambrecht &amp; Quist Capital Management LLC, the Fund's investment adviser.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">23</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=25,FOLIO='23',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>OFFICERS</b></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="108" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Name, Address</b><b><sup>1</sup></b><b> <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>and Age</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="290" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Position(s) Held with<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Fund, Term of Office</b><b><sup>2</sup></b><b> and <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1646" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Principal Occupation(s) During Past 5 Years</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Officers:</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="290" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1646" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="12" height="8"></td></tr>
<tr>
<td colspan="3" width="108" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Daniel R.</font><font size="1"> </font><font face="Times New Roman PS, Times New Roman, Times" size="1">Omstead, Ph.D. <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">7</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/1953</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="290" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">President (since 2001); Trustee (since 2003)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1646" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">President of HQH and of HQL (since 2001); Trustee of HQH and HQL (since 2003); President, Chief Executive Officer and Managing Member of Hambrecht &amp; Quist Capital Management LLC (since 2002); President and Chief Executive Officer (from 2001 to 2002) and Managing Director (from 2000 to 2002) of Hambrecht &amp; Quist Capital Management Inc.; Director (since 2003) of Concentric Medical, Inc.; Director (since 2001) of Agilix Corporation.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="12" height="8"></td></tr>
<tr>
<td colspan="3" width="108" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Kathleen Eckert 12/1966</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="290" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Chief Compliance Officer (since 2004); Treasurer and Secretary (since 2005)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1646" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Chief Compliance Officer of Hambrecht &amp; Quist Capital Management LLC (since October 2004); Chief Compliance Officer of HQH and HQL (since October 2004); Senior Vice President of Ivy Mackenzie Services Corp., from June 2002 to January 2004. Chief Compliance Officer of Mackenzie Investment Management, Inc. from June 2002 to June 2003. Director of Fund Administration of Mackenzie Investment Management, Inc. from 1999 to June 2003.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="12" height="8"></td></tr>
</table>

<p>&nbsp;</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>1</sup>&nbsp;&nbsp;The address for each officer is c/o the Fund at the Fund's address as set forth above.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>2</sup>&nbsp;&nbsp;Each officer serves in such capacity for an indefinite period of time at the pleasure of the Trustees.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund's Statement of Additional Information includes additional information about the fund Directors and is available without charge, upon request by calling (617) 772-8500 or writing to Hambrecht &amp; Quist Capital Management LLC at 30 Rowes Wharf, Boston, MA 02110-3328.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">24</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=26,FOLIO='24',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>INVESTMENT ADVISORY AGREEMENT APPROVAL</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Investment Advisory Agreement (Advisory Agreement) between the Fund and the Adviser provides that the Advisory Agreement will continue in effect so long as its continuance is approved at least annually by (i) by the Trustees of the Fund or the shareholders by affirmative vote of a majority of the outstanding shares and (ii) a majority of the Trustees of the Fund who are not interested persons, by vote cast in person at a meeting called for the purpose of voting on such approval.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">On April 20, 2006, the Board, and the independent Trustees voting separately, determined that the terms of the Advisory Agreement are fair and reasonable and approved the continuance of the Advisory Agreement as being in the best interests of the Fund and its shareholders. In making its determination, the Board considered materials that were specifically prepared by the Adviser at the request of the Board and Fund counsel for purposes of the contract review process, including comparisons of (i) the Fund's performance to its benchmark and to other investment companies, (ii) the Fund's expenses and expense ratios to those of a peer group of other investment companies, and (iii) the Adviser's profitability with respect to its services for the Fund to the profitability of other investment managers, as described below. The Trustees took into account that the Adviser presently provides investment management services only to the Fund and to H&amp;Q
 Healthcare Investors and does not derive any benefit from its relationship with the Fund other than receipt of advisory fees pursuant to the Advisory Agreement. The Board also received and reviewed information throughout the year about portfolio performance, investment strategy, the portfolio management team and fees and expenses of the Fund.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">In approving the Advisory Agreement, the Board considered, among other things, the nature, extent, and quality of the services to be provided by the Adviser, the investment performance of the Fund and the Adviser, the costs of services provided and profits realized by the investment Adviser and its affiliates, and whether fee levels reflected economies of scale for the benefit of Fund investors and the extent to which economies of scale would be realized as the Fund grows. The Board reviewed information about the foregoing factors and considered changes, if any, in such information since its previous approval. The Board also discussed the financial strength of the Adviser and the capability of the personnel of the Adviser, and specifically the strength and background of its investment analysts. The Board, together with its counsel, reviewed the statutory and regulatory requirements for approval and disclosure of investment advisory agreement
s. The Board, including the independent Trustees, evaluated all of the foregoing and, considering all factors together, determined in the exercise of its business judgment that the continuance of the Advisory Agreement is in the best interests of the Fund and its shareholders. The following provides more detail on certain factors considered by the Trustees and the Board's conclusions with respect to each such factor:</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1"><u>The nature, extent and quality of the services to be provided by the investment adviser.</u> On a regular basis the Board considers the roles and responsibilities of the Adviser as a whole and for those specific portfolio management, support and trading functions servicing the Fund. The Trustees considered the nature, extent and quality of the services provided by the Adviser to the Fund and concluded that they continue to be satisfied with the quality and value of the investment advisory services provided to the Fund by the Adviser. In particular, the Trustees noted the management style and discipline followed by the Adviser and the quality of the Adviser's research, trading, portfolio management and administrative personnel.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1"><u>The investment performance of the Fund and Adviser.</u> On a regular basis the Board reviews performance information on the Fund. The Trustees reviewed performance information for the </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">25</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=27,FOLIO='25',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>INVESTMENT ADVISORY AGREEMENT APPROVAL</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Fund over the past three-month period and the one-, three-, five-, and ten-year periods ended March 31 and discussed the Fund's strategy with the Adviser and concluded that they continue to be satisfied with the performance of the Fund and the Adviser. In particular the Trustees noted that although during the periods under review the annualized returns of the Fund's stock price and net asset value fluctuated relative to the performance of its benchmark (the NBI), in the majority of cases the Fund outperformed its benchmark.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1"><u>The costs of services to be provided and profits to be realized by the investment adviser from the relationship with the Fund.</u> The Trustees considered the various services provided by the Adviser to the Fund and comparative information regarding the expenses and expense ratios of the Fund and a peer group of other investment companies. The Trustees also noted that the Adviser agreed to reduce the investment advisory fee effective July 1, 2006 to the levels described in financial statement footnote (2). The Trustees noted that the Adviser's fees are within the range of fees presented in the comparative information and noted that a portion of the Fund's investment portfolio is invested in venture and restricted securities, a portfolio management service which can command higher management fees than those charged by the Adviser pursuant to the investment advisory agreement. The Trustees also noted the satisfactory nature, extent and qual
ity of the services provided by the Adviser to the Fund. Based on the information provided to and evaluated by the Trustees, the Board determined that the fees charged by the Adviser are within a reasonable range of fees as compared to fees charged by competitors and that the services provided by the Adviser and the amounts paid under the agreement are sufficiently favorable in comparison to the services rendered and fees charged by others for similar services to warrant a finding by the Trustees that the fees to be paid by the Fund are fair. The Trustees also considered financial information provided by the Adviser, including financial statements of the Adviser and a comparison of the Adviser's profitability with respect to its services for the Fund to the profitability of other investment managers. After such review, the Trustees concluded that the fees charged by the Adviser are fair and reasonable in light of the quality and nature of the services provided by the Adviser and that the profitability of the
 Adviser's relationship with the Fund has not been excessive.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1"><u>Whether fee levels reflect economies of scale and the extent to which economies of scale would be realized as the Fund grows.</u> The Trustees noted that the investment advisory agreement provides for breakpoints in the advisory fees (adjusted as noted above) so that the Fund will share the benefits of the economies of scale that would inure to the Advisor as the Fund's assets increase. In addition, the Trustees also considered the assets of the Fund over the last five years, the recent investment performance of the Fund, and the management fees and breakpoints of other funds with similar objectives. The Board concluded that economies of scale are still modest at current asset levels and that the breakpoint schedule (adjusted as noted above) for the Fund is satisfactory and fair given the asset size of the Fund and the investment strategies being pursued by the Adviser for the Fund.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">26</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=28,FOLIO='26',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>CERTIFICATIONS</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund's President has certified to the New York Stock Exchange ("NYSE") that as of July 12, 2006, he was not aware of any violation by the Fund of applicable NYSE corporate governance listing standards. In addition, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and applicable Securities and Exchange Commission ("SEC") rules, the Fund's President and Treasurer made quarterly certifications during the fiscal year that were filed with the SEC as exhibits to Form N-CSR and Form N-Q filings and related to the Fund's disclosure in such reports, disclosure controls and procedures and internal control over financial reporting, as required.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>ANNUAL MEETING REPORT</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">An Annual Meeting of Shareholders was held on June 15, 2006 at 10:00am. The Shareholders voted to elect three Trustees of the Fund to hold office for a term of three years or until their respective successors shall have been duly elected and qualified. The following votes were cast with respect to each of the nominees.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="125" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">For</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="64" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Withheld</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="125" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Daniel R. Omstead, Ph.D.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11,705,815</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">197,343</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="125" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Henri A. Termeer</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11,401,979</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">501,179</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="125" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Lucinda H. Stebbins, CPA</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11,615,644</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">287,514</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The nominees were elected to serve until the 2009 Annual Meeting. Lawrence S. Lewin and Uwe E. Reinhardt, Ph.D. will serve until the 2007 Annual Meeting. Trustees serving until the 2008 Annual Meeting are Robert P. Mack, M.D., Eric Oddleifson and Oleg M. Pohotsky.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Shareholders ratified the appointment of Deloitte &amp; Touche LLP as the independent registered public accountants of the Fund for the fiscal year ending September 30, 2006 by the following votes.</font></p>
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td colspan="3" width="125" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">For</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Against</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="64" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt; padding:0in 0in 0in 0in;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Abstain</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="109" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11,789,921</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">56,896</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">56,341</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">27</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=29,FOLIO='27',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>FOR MORE INFORMATION</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">A description of the Fund's proxy voting policies and procedures and information on how the Fund voted proxies and relating to portfolio securities during the most recent 12-month period ended June 30, is available (i) without charge, upon request by calling 1-800-451-2597; (ii) by writing to Hambrecht &amp; Quist Capital management LLC at 30 Rowes Wharf, Boston, MA 02110-3328; (iii) on the Fund's website at www.hqcm.com; and (iv) on the Securities and Exchange Commission's website at www.sec.gov.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund's complete Schedule of Investments for the first and third quarters of its fiscal year will be filed quarterly with the Securities and Exchange Commission ("SEC") on Form N-Q. This Schedule of Investments will also be available on the Fund's website at www.hqcm.com, or the SEC's website at www.sec.gov. The Fund's Form N-Q may be reviewed and copied at the SEC's Public Reference Room in Washington, DC or by calling 1-800-SEC-0330.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>DISTRIBUTION POLICY</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund has a fixed distribution policy as described in the Notes to Financial Statements. For more information contact your financial adviser.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">28</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=30,FOLIO='28',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">This page has been intentionally left blank.</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=31,FOLIO='',FILE='06-22409-2.da',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 06-22409-2.za-->
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="3"><b>H&amp;Q LIFE SCIENCES INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">New York Stock Exchange Symbol: HQL</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">30 Rowes Wharf, 4th Floor<BR>Boston, Massachusetts 02110-3328<BR>(617) 772-8500 <BR>www.hqcm.com</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Officers</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Daniel R. Omstead, Ph.D., President<BR>Kathleen Eckert, Secretary, Treasurer and <BR>Chief Compliance Officer</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Trustees</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Lawrence S. Lewin<BR>Robert P. Mack, M.D.<BR>Eric Oddleifson<BR>Daniel R. Omstead, Ph.D.<BR>Oleg M. Pohotsky<BR>Uwe E. Reinhardt, Ph.D.<BR>Lucinda H. Stebbins, CPA<BR>Henri A. Termeer</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Investment Adviser</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Hambrecht &amp; Quist Capital Management LLC</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Administrator &amp; Custodian</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">State Street Bank and Trust Company</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Transfer Agent</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Computershare Shareholder Services, Inc.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Legal Counsel</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Dechert LLP</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Shareholders with questions regarding share transfers may call</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>1-800-426-5523</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Daily net asset value may be obtained from</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">our website <i>(www.hqcm.com)</i> or by calling</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>1-800-451-2597</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">3702-AR-06</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=32,FOLIO='',FILE='06-22409-2.za',USER='105021',CD='Nov 26 16:58 2006' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">

<div>
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item
2.&#160; CODE OF ETHICS.</font></b></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 108.0pt;text-indent:-72.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>As of the end of the period covered by this
report, the Registrant has adopted a code of ethics that applies to the
Registrant&#146;s principal executive officer, principal financial officer,
principal accounting officer or controller, or persons performing similar
functions, regardless of whether these individuals are employed by the
Registrant or a third party.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 108.0pt;text-indent:-72.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No disclosures are required by this Item.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 108.0pt;text-indent:-72.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>During the period covered by this report, the
Registrant did not make any substantive amendment to the code of ethics.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 108.0pt;text-indent:-72.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>During the period covered by this report, the
Registrant did not grant any waiver, including any implicit waiver, from any
provision of the code of ethics.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 108.0pt;text-indent:-72.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Not applicable.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 108.0pt;text-indent:-72.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A copy of the Registrant&#146;s Code of Ethics is
filed as Exhibit 1 to this Form N-CSR.&#160;
Copies of the code will also be made available, free of charge, upon
request, by writing or calling Hambrecht &amp; Quist Capital Management, LLC at
30 Rowes Wharf, Boston, MA&#160; 02110,
1-800-451-2597.</p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 3.
AUDIT COMMITTEE FINANCIAL EXPERT.</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Registrant&#146;s Board of Trustees has determined that the Registrant has
at least one audit committee financial expert serving on its audit
committee.&#160; The audit committee financial
expert is Oleg M. Pohotsky.&#160; He is &#147;independent&#148;
for the purposes of Item 3.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 4.
PRINCIPAL ACCOUNTANT FEES AND SERVICES.</font></b></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 54.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Audit Fees.&#160;
The aggregate fees in each of the last two fiscal years for professional
services rendered by the principal accountant for the audit of the Registrant&#146;s
financial statements or services that are normally provided by the accountant
in connection with statutory and regulatory filings or engagements for those
fiscal years were $74,000 for the fiscal year ended September 30, 2006 and
$67,000 for the fiscal year ended September 30, 2005.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 54.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Audit Related Fees.&#160; The Registrant was not billed any fees by the
principal accountant for the last two fiscal years ended September 30 for the
Fund for assurance and related services that were reasonably related to the
performance of the audit of the Registrant&#146;s financial statements and not
otherwise included above.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 54.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Tax Fees.&#160;
The aggregate fees billed in each of the last two fiscal years for
professional services rendered by the principal accountant for tax compliance,
tax advice, and tax planning were $4,000 for the fiscal year ended September
30, 2006 and $5,500 for the fiscal year ended September 30, 2005.&#160; The nature of the services comprising the
fees disclosed under this category was tax compliance.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 54.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All Other Fees.&#160;
The aggregate fees billed in each of the last two fiscal years for
products and services provided by the principal accountant, other than the
services reported in paragraphs (a) through (c) of this Item were $8,680&#160; for the fiscal year ended September 30, 2006
and $0 for the fiscal year ended September 30, 2005.&#160; The nature of the services comprising the
fees disclosed for the fiscal year ended September 30, 2006 was a review of
investment valuation policies and procedures for publicly traded securities.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 54.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Pre-approval Policies and Procedures.</p>

<p style="margin:0pt 0pt 12.0pt 54.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the Registrant&#146;s Audit Committee
Charter (&#147;Charter&#148;), the Audit Committee is responsible for approving in
advance the firm to be employed as the Registrant&#146;s independent auditor.&#160; In addition, the Charter provides that the
Audit Committee is responsible for approving any and all proposals by the
Registrant, its investment adviser or their affiliated persons or any entity
controlling, controlled by, or under common control with the adviser that
provides services to the Registrant to employ the independent auditor to render
permissible non-audit services related directly to the operations and financial
reporting of the Registrant.&#160; In
determining whether to pre-approve non-audit services, the Audit Committee
considers whether such services are consistent with the independent auditor&#146;s
independence.&#160; The </font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\sethu\06-22409-1\task1536668\22409-1-ga.htm',USER='105167',CD='Dec  6 01:07 2006' -->
<br clear="all" style="page-break-before:always;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>


<p style="margin:0pt 0pt 12.0pt 54.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Charter further permits the Audit Committee to
delegate to one or more of its members authority to pre-approve permissible
non-audit services to the registrant, provided that any pre-approval
determination of a delegate is for services with an estimated budget of less
than $15,000.</font></p>

<p style="margin:0pt 0pt 12.0pt 54.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)&#160;&#160; &#160; All of the services
described in each of paragraphs (b) through (d) of this Item were approved by
the Audit Committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of
Regulation S-X.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 54.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>N/A.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 54.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>None.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 54.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>None.</p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM
5.&#160; AUDIT COMMITTEE OF LISTED
REGISTRANTS.</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Registrant has a separately-designated standing Audit Committee
established in accordance with Section 3(a)(58)(A) of the Securities Exchange
Act of 1934.&#160; The members of the Audit
Committee are Eric Oddleifson, Oleg M. Pohotsky, Uwe E. Reinhardt and Lucinda
H. Stebbins.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM
6.&#160; SCHEDULE OF INVESTMENTS.</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Registrant&#146;s Schedule of Investments is included as part of the
Report to Shareholders filed under Item 1 of this form.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM
7.&#160; DISCLOSURE OF PROXY VOTING POLICIES
AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Registrant has adopted the following proxy voting policies and procedures.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 12.0pt;text-align:center;text-transform:uppercase;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;text-transform:none;">PROXY VOTING POLICIES AND PROCEDURES</font></b></p>

<p style="font-weight:bold;margin:12.0pt 0pt;page-break-after:avoid;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Policy</font></u></b></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following are the policies and procedures adopted and implemented by
Hambrecht &amp; Quist Capital Mangement LLC (the &#147;Adviser&#148;) for voting proxies
with respect to portfolio securities held by H&amp;Q Healthcare Investors and
H&amp;Q Life Sciences Investors (each a &#147;Fund&#148; and collectively the &#147;Funds&#148;).
The policies and procedures are reasonably designed to ensure that proxies are
voted in the best interest of the Funds and the Funds&#146; shareholders, in
accordance with the Adviser&#146;s fiduciary duties and Rule 206(4)-6 under the
Investment Advisers Act of 1940 (the &#147;Investment Advisers Act&#148;). The Adviser
considers the &#147;best interests&#148; of the Funds and their shareholders to mean
their best long-term economic interests.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Adviser shall vote proxies for the exclusive
benefit, and in the best economic interest, of the Funds and their
shareholders. Such exercise of voting rights shall be subject to the same
standard of care as is generally applicable to the Adviser&#146;s performance of its
duties, as set forth in the advisory agreements with the Funds. The policies
and procedures contained herein are designed to be guidelines, however each
vote is ultimately cast on a case-by-case basis, taking into consideration the
relevant facts and circumstances at the time of the vote. Any material
conflicts that may arise will be resolved in the best interests of the Funds
and their shareholders.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A proxy committee has been designated and is
responsible for administering and overseeing the proxy voting process. The
committee consists of the President of the Adviser, the Treasurer of the
Adviser, and the analyst responsible for oversight of the company that is the
subject of the proxy.&#160; The committee considers
proxy questions and determines the vote on behalf of the Funds.</font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\sethu\06-22409-1\task1536668\22409-1-ga.htm',USER='105167',CD='Dec  6 01:07 2006' -->
<br clear="all" style="page-break-before:always;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>


<p style="font-weight:bold;margin:12.0pt 0pt;page-break-after:avoid;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Procedures</font></u></b></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Logistics</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Treasurer shall be responsible for maintaining
the proxy log, monitoring corporate actions and confirming the timely voting of
proxies. The proxy log shall contain the following information, in accordance
with Form N-PX:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the
name of the issuer;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the
exchange ticker symbol, if available;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the
CUSIP number, if available;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the
shareholder meeting date;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a
brief identification of the matter voted on;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>whether
the matter was proposed by the issuer or a security holder;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>whether
the Adviser cast its vote on the matter;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>how the Adviser cast its vote on the matter
(for, against, abstain; for or withhold regarding the election of directors);
and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>whether the Adviser cast its vote for or
against management;</p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Treasurer shall also record whether any conflicts
of interest have been identified and, if so, what action was taken to resolve
the conflict with respect to each vote cast and each abstention.</font></p>

<p style="margin:12.0pt 0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Substantive Voting
Decisions</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Adviser&#146;s substantive voting decisions turn on
the particular facts and circumstances of each proxy vote. The following is a
list of common proxy vote issues and the Adviser&#146;s standard considerations when
determining how to vote such proxies.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Routine Matters/Corporate Administrative Items. After
an initial review, the Adviser generally votes with management on routine
matters related to the operation of the issuer that are not expected to have a
significant economic impact on the issuer and/or its shareholders.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Potential for Major Economic Impact. The Adviser
reviews and analyzes on a case-by-case basis, non-routine proposals that are
more likely to affect the structure and operation of the issuer and to have a
greater impact on the value of the investment.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Corporate Governance. The Adviser reviews and
considers corporate governance issues related to proxy matters and generally
supports proposals that foster good corporate governance practices.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Special Interest Issues. The Adviser considers:
(i)&nbsp;the long-term benefit to shareholders of promoting corporate
accountability and responsibility on social issues; (ii)&nbsp;management&#146;s
responsibility with respect to special interest issues; (iii)&nbsp;any economic
costs and restrictions on management; and (iv)&nbsp;the responsibility of the
Adviser to vote proxies for the greatest long-term shareholder value.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Limitations on Director Tenure and Retirement. The
Adviser considers: (i)&nbsp;a reasonable retirement age for directors, <i>e.g.</i> 70 or 72; (ii)&nbsp;the introduction of new
perspectives on the board; and (iii)&nbsp;the arbitrary nature of such
limitations and the possibility of detracting from the board&#146;s stability and
continuity.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Directors&#146; Minimum Stock Ownership. The Adviser
considers: (i)&nbsp;the benefits of additional vested interest; (ii)&nbsp;the
ability of a director to serve a company well regardless of the extent of his
or her share ownership; and (iii)&nbsp;the impact of limiting the number of
persons qualified to be directors.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">D&amp;O Indemnification and Liability Protection. The
Adviser considers: (i)&nbsp;indemnifying directors for acts conducted in the
normal course of business; (ii)&nbsp;limiting liability for monetary damages
for violating the duty of care; (iii)&nbsp;expanding coverage beyond legal
expenses to acts that represent more serious violations of fiduciary obligation
than carelessness (<i>e.g.</i>
negligence); and (iv)&nbsp;providing expanded coverage in cases when a director&#146;s
legal defense was unsuccessful if the director was found to have acted in good
faith and in a manner that he or she reasonably believed was in the best
interests of the issuer.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Director Nominations in Contested Elections. The
Adviser considers: (i)&nbsp;long-term financial performance of the issuer
relative to its industry; (ii)&nbsp;management&#146;s track record;
(iii)&nbsp;background to proxy contest; (iv)&nbsp;qualifications of both slates
of nominees; (v)&nbsp;evaluations of what each side is offering shareholders as
well as the likelihood that the proposed objectives and goals can be met; and
(vi)&nbsp;stock ownership positions.</font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\sethu\06-22409-1\task1536668\22409-1-ga.htm',USER='105167',CD='Dec  6 01:07 2006' -->
<br clear="all" style="page-break-before:always;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>


<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cumulative Voting. The Adviser considers:
(i)&nbsp;the ability of significant stockholders to elect a director of their
choosing; (ii)&nbsp;the ability of minority shareholders to concentrate their
support in favor of a director or directors of their choosing; and
(iii)&nbsp;the potential to limit the ability of directors to work for all
shareholders.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Classified Boards.&#160;
The Adviser considers: (i)&nbsp;providing continuity;
(ii)&nbsp;promoting long-term planning; and (iii)&nbsp;guarding against
unwanted takeovers.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Poison Pills. The Adviser considers: (i)&nbsp;the
Adviser&#146;s position on supporting proposals to require a shareholder vote on
other shareholder rights plans; (ii)&nbsp;ratifying or redeeming a poison pill
in the interest of protecting the value of the issuer; and (iii)&nbsp;other
alternatives to prevent a takeover at a price demonstrably below the true value
of the issuer.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fair Price Provisions. The Adviser considers:
(i)&nbsp;the vote required to approve the proposed acquisition; (ii)&nbsp;the
vote required to repeal the fair price provision; (iii)&nbsp;the mechanism for
determining fair price; and (iv)&nbsp;whether these provisions are bundled with
other anti-takeover measures (<i>e.g.</i>,
supermajority voting requirements) that may entrench management and discourage
attractive tender offers.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Equal Access. The Adviser considers: (i)&nbsp;the
opportunity for significant shareholders of the issuer to evaluate and propose
voting recommendations on proxy proposals and director nominees, and to
nominate candidates to the board; and (ii)&nbsp;the added complexity and
burden.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Charitable Contributions. The Adviser considers:
(i)&nbsp;the potential benefits to shareholders; (ii)&nbsp;the potential to
detract the issuer&#146;s resources from more direct uses of increasing shareholder
value; and (iii)&nbsp;the responsibility of shareholders to make individual
contributions.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stock Authorizations: The Adviser considers: (i)&nbsp;the
need for the increase; (ii)&nbsp;the percentage increase with respect to the
existing authorization; (iii)&nbsp;voting rights of the stock; and
(iv)&nbsp;overall capitalization structures.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preferred Stock. The Adviser considers:
(i)&nbsp;whether the new class of preferred stock has unspecified voting,
conversion, dividend distribution, and other rights; (ii)&nbsp;whether the
issuer expressly states that the stock will not be used as a takeover defense
or carry superior voting rights; (iii)&nbsp;whether the issuer specifies the
voting, dividend, conversion, and other rights of such stock and the terms of
the preferred stock appear reasonable; and (iv)&nbsp;whether the stated purpose
is to raise capital or make acquisitions in the normal course of business.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Director Compensation. The Adviser considers:
(i)&nbsp;whether director shares are at the same market risk as those of the
shareholders; and (ii)&nbsp;how option programs for outside directors compare
with the standards of internal programs.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Golden and Tin Parachutes. The Adviser considers:
(i)&nbsp;whether they will be submitted for shareholder approval; and
(ii)&nbsp;the employees covered by the plan and the quality of management.</font></p>

<p style="margin:12.0pt 0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Limitations</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Adviser may abstain from voting a proxy if it
concludes that the effect on shareholders&#146; economic interests or the value of
the portfolio holding is indeterminable or insignificant. The Adviser may
abstain from voting a proxy if it concludes that the cost of voting is
disproportionate to the economic impact the vote would have on the portfolio
holdings.</font></p>

<p style="margin:12.0pt 0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Conflicts of Interest</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Proxy Committee identifies any potential
conflicts of interest.&#160; Each potential
conflict must be addressed in a manner which will be in the best interest of
the Funds and their shareholders. If any potential conflict is identified the
Proxy Committee consults with the Adviser&#146;s CCO.&#160; Where conflicts of interest arise between
clients and the Adviser, the Adviser may convene an ad-hoc committee to debate
the conflict and to give a ruling on a preferred course of action. If the
ad-hoc committee determines that the Adviser has a conflict of interest in any
instance, the Adviser&#146;s CCO shall disclose the conflict to the Board and seek
voting instructions.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Adviser may cause the proxies to be voted in
accordance with the recommendations of an independent third party service
provider that the Adviser may use to assist in voting proxies.</font></p>

<p style="margin:12.0pt 0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Disclosure</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following disclosure shall be provided in
connection with these policies and procedures:</font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\sethu\06-22409-1\task1536668\22409-1-ga.htm',USER='105167',CD='Dec  6 01:07 2006' -->
<br clear="all" style="page-break-before:always;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>


<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Adviser shall provide a description or a
copy of these policies and procedures to the Boards of Trustees of the Funds
annually and upon request.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Adviser shall make available to the Funds
its proxy voting records, for inclusion on the Funds&#146; Form N-PX.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Adviser shall include its proxy voting
policies and procedures in its annual filing on Form N-CSR.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Adviser shall cause the Funds&#146; shareholder
reports to include a statement that a copy of these policies and procedures is
available upon request (i) by calling a toll-free number; (ii) on the Funds&#146;
website, (if the Funds choose); and (iii) on the SEC&#146;s website.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-18.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Adviser shall cause the Funds&#146; annual and
semi-annual reports to include a statement that information is available
regarding how the Funds voted proxies during the most recent twelve-month
period (i) without charge, upon request, either by calling a toll-free number
or on or through the Funds&#146; website, or both; and (ii) on the SEC&#146;s website.</p>

<p style="margin:12.0pt 0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Recordkeeping</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Adviser shall maintain records of proxies voted
in accordance with Section 204-2 of the Advisers Act, including proxy
statements, a record of each vote cast, and a copy of any document created by
the Adviser that was material to making a decision of how to vote the proxy, or
that memorializes the basis for the Adviser&#146;s decision on how to vote the
proxy. The Adviser shall also maintain a copy of its policies and procedures
and each written request from a client for proxy voting records and the Adviser&#146;s
written response to any client request, either written or oral, for such
records. Proxy statements that are filed on EDGAR shall be considered
maintained by the Adviser. All such records shall be maintained for a period of
five years in an easily accessible place, the first two year in the offices of
the Adviser.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM
8.&#160; PORTFOLIO MANAGERS OF CLOSED-END
MANAGEMENT INVESTMENT COMPANIES</font></b></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)(1)&#160;&#160;&#160;&#160;&#160;&#160; As of December 5, 2006, Daniel R.
Omstead, Ph.D., Christopher F. Brinzey, M.B.A., Frank T. Gentile, Ph.D., and
Jason C. Akus, M.D./M.B.A., are members of a team that makes investments on
behalf of the Registrant.&#160; Dr. Omstead
oversees investments made by other team members.&#160; Dr. Omstead also performs other duties
including management of the investment adviser and makes investments on behalf
of H&amp;Q Healthcare Investors (&#147;HQH&#148;).&#160;
The date each team member joined the portfolio management team and each
team member&#146;s business experience for at least the last five years is included
below.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead, Ph.D., is President and Chief Executive Officer of
the investment adviser and has been employed by the investment adviser of the
Registrant since 2000. He is also President of the Registrant, HQH and the
investment adviser. Dr.&nbsp;Omstead holds Doctoral and Master&#146;s Degrees in
Chemical Engineering and Applied Chemistry from Columbia University and a B.S.
degree in Civil Engineering from Lehigh University.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christopher F. Brinzey is Senior Vice President, Research of the
investment adviser. Mr.&nbsp;Brinzey joined the investment adviser of the
Registrant in February&nbsp;of 2001 and is responsible for investment research
and venture investment due diligence in the following areas: specialty
pharmaceuticals and life sciences information technology and services.
Mr.&nbsp;Brinzey received a B.A. in psychology from Hobart College and an MBA
from Northeastern University.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Frank T. Gentile, Ph.D., is Senior Vice President, Research of the
investment adviser. Dr.&nbsp;Gentile joined the investment adviser of the
Registrant in September&nbsp;2002. His emphasis is on the analysis of private
and public companies in the fields of Functional Genomics and Proteomics, as
well as Cell and Gene Therapy. From March 2001 to August 2002, Dr.&nbsp;Gentile
was Vice President, Technology Program Management at Millennium
Pharmaceuticals. At Millennium, Dr.&nbsp;Gentile was responsible for management
of all technology platform development programs. Dr.&nbsp;Gentile received a
B.E. degree in Chemical Engineering from The Cooper Union and a Ph.D. in
Chemical </font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\sethu\06-22409-1\task1536668\22409-1-ga.htm',USER='105167',CD='Dec  6 01:07 2006' -->
<br clear="all" style="page-break-before:always;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>


<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Engineering
from MIT. Before working in industry, he was a post-doctoral fellow at the
Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jason C. Akus, M.D./M.B.A., is Vice President, Research of the
investment adviser and is responsible for investment research and due diligence
in the biotechnology, medical device, and diagnostic areas. Dr.&nbsp;Akus
joined the investment adviser of the Registrant in July&nbsp;of 2001 after
graduating from Tufts with an M.D. and M.B.A. Dr.&nbsp;Akus also graduated from
Tufts with a B.S. in Mathematics. During medical school, Dr.&nbsp;Akus
consulted for a variety of life sciences information technology companies.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)(2)&#160;&#160;&#160;&#160;&#160;&#160; The following table lists the number and
types of other accounts and assets under management in those accounts advised
by the Registrant&#146;s portfolio management team as of the end of the Registrant&#146;s
fiscal year.</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="20%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:20.7%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">REGISTERED</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="20%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:20.7%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">INVESTMENT</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="20%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:20.7%;">
  <p align="left" style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">PORTFOLIO</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">COMPANY</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">ASSETS</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">POOLED</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">ASSETS</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">OTHER</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">ASSETS</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="20%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:20.7%;">
  <p align="left" style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">MANAGER</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">ACCOUNTS</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">MANAGED</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">ACCOUNTS</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">MANAGED</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">ACCOUNTS</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">MANAGED</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid;">
  <td width="20%" valign="top" style="border:none;padding:0pt .7pt 0pt 0pt;width:20.7%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel
  R. Omstead</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:.98%;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="9%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:9.8%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">385 million</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="20%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:20.7%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christopher
  F. Brinzey</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:.98%;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="9%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:9.8%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">385 million</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid;">
  <td width="20%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:20.7%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Frank
  T. Gentile</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:.98%;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="9%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:9.8%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">385 million</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="20%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:20.7%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jason C. Akus</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:.98%;">
  <p align="left" style="margin:0pt 0pt .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="9%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:9.8%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">385
  million</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.78%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">None of the funds or other accounts are subject to a performance-based
advisory fee.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Each member of the portfolio management team may perform investment
management services for other accounts similar to those provided to the
Registrant and the investment action for each account may differ. The portfolio
management team may discover an investment opportunity that may be suitable for
more than one account. However, the investment opportunity may be limited so
that all accounts may not be able to fully participate or an investment
opportunity or&nbsp;investment allocation&nbsp;may be allocated to just one account or may be allocated between accounts at
different levels based on an investment decision made by the investment team.&nbsp;
The investment team may subsequently
make investment decisions that result in&nbsp;investment levels that make the
accounts&nbsp;more differentiated or, conversely, more closely&nbsp;or
completely aligned.&nbsp;&nbsp;Such
investment decisions may occur within a day or two.&nbsp;&nbsp;In
addition, the investment adviser may receive different compensation from each
account. In that case, the portfolio management team may have an incentive to
direct investments to an account that could result in higher fees for the
investment adviser. The registrant has adopted procedures designed to allocate
investments fairly across multiple accounts.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Additionally, a portfolio manager may be perceived to have a conflict of
interest if he has other executive management responsibilities.&#160; In addition to managing the Registrant and
HQH, Dr. Omstead is the President of the investment adviser of the
Registrant.&#160; Dr. Omstead periodically
discusses the amount of time he allocates to each of his responsibilities with
the Registrant&#146;s Board of Trustees.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The portfolio management team&#146;s management of personal accounts may also
present certain conflicts of interest.&#160;
The Registrant has adopted a code of ethics designed to address these
potential conflicts.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)(3)&#160;&#160;&#160;&#160;&#160;&#160; As of September 30, 2006, portfolio
manager compensation is comprised of a base salary and discretionary
compensation as described below.</font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\sethu\06-22409-1\task1536668\22409-1-ga.htm',USER='105167',CD='Dec  6 01:07 2006' -->
<br clear="all" style="page-break-before:always;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>


<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Base Salary Compensation</font></i>.&#160; The
team members receive a base salary compensation linked to individual experience
and responsibilities. The amount of base salary is reviewed annually.</p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;<i>Discretionary
Compensation</i>.&#160; Discretionary
Compensation is in the form of a cash bonus, paid annually, which may be up to
60% of the team member&#146;s base salary. Several factors affect discretionary
compensation, which can vary by team member and circumstances. The
discretionary compensation component is determined based on four factors
including investment performance of accounts managed by the team relative to an
appropriate benchmark and/or peer funds, performance of specific investments
proposed by the individual, financial performance of the investment adviser and
a qualitative assessment of the individual overall contribution to the
investment team and to the investment adviser. Discretionary compensation is
evaluated annually after the completion of the Registrant&#146;s fiscal year.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)(4)&#160;&#160;&#160;&#160;&#160;&#160; As of September 30, 2006, the dollar
range of Registrant&#146;s shares beneficially owned by the portfolio managers are
as follows as of the end of the Registrant&#146;s fiscal year:</font></p>

<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;font-family:Times New Roman;">
 <tr style="page-break-inside:avoid;">
  <td width="159" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:119.4pt;">
  <p align="left" style="font-size:8.0pt;font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;text-align:left;"><!-- SET mrlHTMLTableLeft -->PORTFOLIO MANAGER</p>
  </td>
  <td width="31" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:23.4pt;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="308" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:231.0pt;">
  <p style="font-weight:bold;line-height:10.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">DOLLAR RANGE OF SHARES BENEFICIALLY OWNED</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid;">
  <td width="159" valign="top" style="border:none;padding:0pt .7pt 0pt 0pt;width:119.4pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead</font></p>
  </td>
  <td width="31" valign="top" style="padding:0pt .7pt 0pt 0pt;width:23.4pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="308" valign="top" style="padding:0pt .7pt 0pt 0pt;width:231.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$50,000-$100,000</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="159" valign="top" style="padding:0pt .7pt 0pt 0pt;width:119.4pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christopher F. Brinzey</font></p>
  </td>
  <td width="31" valign="top" style="padding:0pt .7pt 0pt 0pt;width:23.4pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="308" valign="top" style="padding:0pt .7pt 0pt 0pt;width:231.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid;">
  <td width="159" valign="top" style="padding:0pt .7pt 0pt 0pt;width:119.4pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Frank T. Gentile</font></p>
  </td>
  <td width="31" valign="top" style="padding:0pt .7pt 0pt 0pt;width:23.4pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="308" valign="top" style="padding:0pt .7pt 0pt 0pt;width:231.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="159" valign="top" style="padding:0pt .7pt 0pt 0pt;width:119.4pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jason C. Akus</font></p>
  </td>
  <td width="31" valign="top" style="padding:0pt .7pt 0pt 0pt;width:23.4pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="308" valign="top" style="padding:0pt .7pt 0pt 0pt;width:231.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>
  </td>
 </tr>
</table>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM
9.&#160; PURCHASES OF EQUITY SECURITIES BY
CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.</font></b></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="40%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:40.9%;">
  <p align="left" style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><b><font size="1" face="Times New Roman"><font style="font-size:8.0pt;">Period</font><br>
  (12&nbsp;months)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">(a)&nbsp;Total&nbsp;No.<br>
  of&nbsp;Shares<br>
  Purchased</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">(b)&nbsp;Average<br>
  Price&nbsp;Paid&nbsp;per<br>
  Share</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">(c)&nbsp;Total&nbsp;No.<br>
  of&nbsp;Shares<br>
  Purchased&nbsp;as<br>
  Part&nbsp;of<br>
  Publicly<br>
  Announced&nbsp;Plans<br>
  or&nbsp;Programs</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">(d)&nbsp;Maximum&nbsp;No.<br>
  of&nbsp;Shares&nbsp;that<br>
  May&nbsp;Yet&nbsp;Be<br>
  Purchased&nbsp;Under<br>
  the&nbsp;Plans&nbsp;or<br>
  Programs</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid;">
  <td width="40%" valign="top" style="border:none;padding:0pt .7pt 0pt 0pt;width:40.9%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #1 (Oct. 1, 2005-Oct. 31, 2005)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="40%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:40.9%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #2 (Nov. 1, 2005 &#150; Nov. 30, 2005)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid;">
  <td width="40%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:40.9%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #3 (Dec. 1, 2005 &#150; Dec. 31, 2005)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="40%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:40.9%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #4 (Jan. 1, 2006 &#150; Jan. 31, 2006)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid;">
  <td width="40%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:40.9%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #5 (Feb. 1, 2006 &#150; Feb. 28, 2006)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="40%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:40.9%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #6 (Mar. 1, 2006 &#150; Mar. 31, 2006)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid;">
  <td width="40%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:40.9%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #7 (Apr. 1, 2006 &#150; Apr. 30, 2006)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="40%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:40.9%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #8 (May 1, 2006 &#150; May 31, 2006)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid;">
  <td width="40%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:40.9%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #9 (June 1, 2006 &#150; June 30, 2006)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="40%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:40.9%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #10 (Jul. 1, 2006 &#150; Jul. 31, 2006)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid;">
  <td width="40%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:40.9%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #11 (Aug. 1, 2006 &#150; Aug. 31, 2006)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="40%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:40.9%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #12
  (Sep. 1, 2006 &#150; Sep. 30, 2006)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.3%;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
</table>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\sethu\06-22409-1\task1536668\22409-1-ga.htm',USER='105167',CD='Dec  6 01:07 2006' -->
<br clear="all" style="page-break-before:always;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>


<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 10.
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">There have been no material changes to the procedures by which the
shareholders may recommend nominees to the registrant&#146;s Board of Trustees,
where those changes were implemented after the registrant last provided
disclosure in response to the requirements of Item 7(d)(2)(ii)(G) of Schedule
14A, or this Item.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 11.
CONTROLS AND PROCEDURES.</font></b></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 57.0pt;text-indent:-21.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In the opinion of the principal executive officer
and principal financial officer, based on their evaluation which took place
within 90 days of this filing, the Registrant&#146;s disclosure controls and
procedures are adequately designed and are operating effectively to ensure (i)
that material information relating to the Registrant, including its
consolidated subsidiaries, is made known to them by others within those
entities, particularly during the period in which this report is being
prepared; and (ii) that information required to be disclosed by the registrant
on Form N-CSR is recorded, processed, summarized and reported within the time
period specified in the Securities and Exchange Commission&#146;s rules and forms.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 58.5pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font>There were no changes in the Registrant&#146;s
internal control over financial reporting that occurred during the Registrant&#146;s
most recent fiscal half-year that have materially affected or that are
reasonably likely to materially affect the Registrant&#146;s internal control.</p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 12.
EXHIBITS</font></b></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)(1)&#160;&#160;&#160;&#160;&#160; </font></b>The Code of Ethics that is the subject of the
disclosure required by Item 2 is attached hereto (Exhibit 1).</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)(2)&#160;&#160;&#160;&#160;&#160; </font></b>Separate certifications of the Principal
Executive and Financial Officers pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002 are attached hereto (Exhibit 2).</p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Certifications
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 are attached hereto
(Exhibit 3).</font></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\sethu\06-22409-1\task1536668\22409-1-ga.htm',USER='105167',CD='Dec  6 01:07 2006' -->



<br clear="all" style="page-break-before:always;">

<div style="font-family:Times New Roman;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934 and the
Investment Company Act of 1940, the registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly authorized.</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="10%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:10.46%;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt;"><!-- SET mrlNoTableShading -->(Registrant)</p>
  </td>
  <td width="87%" colspan="4" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:87.54%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">H&amp;Q LIFE SCIENCES INVESTORS</font></p>
  </td>
  <td width="1%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:1.98%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="30%" colspan="5" valign="top" style="padding:0pt .7pt 0pt 0pt;width:30.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="69%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:69.66%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="20%" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:20.82%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By (Signature and Title)*</font></p>
  </td>
  <td width="77%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:77.2%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Daniel R. Omstead</font></p>
  </td>
  <td width="1%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:1.98%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="20%" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:20.82%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="79%" colspan="4" valign="top" style="padding:0pt .7pt 0pt 0pt;width:79.18%;">
  <p style="margin:0pt 0pt .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead, President</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="5%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:5.7%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>
  </td>
  <td width="15%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:15.22%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">December 5, 2006</font></p>
  </td>
  <td width="79%" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:79.06%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="43" style="border:none;"></td>
  <td width="36" style="border:none;"></td>
  <td width="77" style="border:none;"></td>
  <td width="1" style="border:none;"></td>
  <td width="70" style="border:none;"></td>
  <td width="506" style="border:none;"></td>
  <td width="15" style="border:none;"></td>
 </tr>
</table>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934 and the
Investment Company Act of 1940, this report has been signed below by the following
persons on behalf of the registrant and in the capacities and on the dates
indicated.</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="20%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:20.8%;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt;"><!-- SET mrlNoTableShading -->By (Signature and Title)*</p>
  </td>
  <td width="77%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:77.02%;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;/s/ Kathleen
  Eckert</font></p>
  </td>
  <td width="2%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:2.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="20%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:20.8%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="77%" colspan="2" valign="top" style="border:none;padding:0pt .7pt 0pt 0pt;width:77.02%;">
  <p style="margin:0pt 0pt .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Kathleen Eckert, Treasurer</font></p>
  </td>
  <td width="2%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:2.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="20%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:20.8%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="79%" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:79.2%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="5%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:5.7%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>
  </td>
  <td width="15%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:15.22%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">December 5, 2006</font></p>
  </td>
  <td width="79%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:79.08%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="43" style="border:none;"></td>
  <td width="113" style="border:none;"></td>
  <td width="1" style="border:none;"></td>
  <td width="575" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
 </tr>
</table>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><hr size="1" width="160" noshade color="black" align="left" style="width:120.0pt;"></div>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*
Print the name and title of each signing officer under his or her signature.</font></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\sethu\06-22409-1\task1536702\22409-1-jc.htm',USER='105167',CD='Dec  6 01:18 2006' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.CODEETH
<SEQUENCE>2
<FILENAME>a06-22409_1ex99dcodeeth.htm
<DESCRIPTION>EX-99.CODEETH
<TEXT>
<html>

<head>






</head>

<body lang="EN-US">

<div>
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>

<p align="right" style="margin:0pt 0pt 12.0pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT 99.CODE.ETH</font></b></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT 1: Sarbanes-Oxley Code of Ethics</font></b></p>

<p style="font-weight:bold;margin:12.0pt 0pt;page-break-after:avoid;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-variant:normal !important;">Introduction</font></u></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Trustees of H&amp;Q Life Sciences
Investors and H&amp;Q Healthcare Investors (each, a &#147;Fund&#148;) has established
this Code of Ethics (&#147;Code&#148;) in accordance with the Sarbanes-Oxley Act of 2002
and the rules promulgated thereunder. This Code does not supersede or otherwise
affect the separate code of ethics that the Fund and its investment adviser
have adopted pursuant to Rule 17j-1 under the Investment Company Act of 1940,
as amended (&#147;1940 Act&#148;).</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Code is designed to deter wrongdoing and
promote: (i) honest and ethical conduct, including the ethical handling of
actual or apparent conflicts of interest between personal and professional
relationships; (ii) full, fair, accurate, timely, and understandable disclosure
in reports and documents that the Fund files with, or submits to, the
Securities and Exchange Commission (&#147;SEC&#148;) and in other public communications
made by the Fund; (iii) compliance with applicable governmental laws, rules,
and regulations; (iv) the prompt internal reporting of violations of the Code
to an appropriate person or persons; and (v) accountability for adherence to
the Code. The Code applies to the Fund&#146;s President and Treasurer and Secretary
(collectively, &#147;Covered Officers,&#148; each of whom is set forth in Exhibit A).</font></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Principles of Honest and Ethical Conduct</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1<i>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </i>General
Objectives</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Fund expects all Covered Officers to adhere to the highest possible
standards of honest and ethical conduct. All Covered Officers are expected to
handle actual or apparent conflicts of interest between personal and
professional relationships in a manner that is above reproach, and to place the
interests of the Fund above their own personal interests.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Conflicts of
Interest</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All Covered Officers should be scrupulous in
avoiding a conflict of interest with regard to the Fund&#146;s interests. A conflict
of interest occurs when an individual&#146;s private interest interferes in any way
with the interests of the Fund. This includes any specific situation or
transaction that the Trustees of the Fund who are not interested persons as
defined in the 1940 Act, would consider to create the appearance of a conflict
of interest. A conflict situation can arise when a Covered Officer takes
actions or has interests that may make it difficult to perform his or her work
for the Fund objectively and effectively.&#160;
Conflicts of interest also arise when a Covered Officer, or a member of
his or her family, receives improper benefits as a result of his or her position
with the Fund, whether such benefits are received from the Fund or a third
party.&#160; Any conflict of interest that
arises in a specific situation or transaction must be disclosed by the Covered
Officer and resolved before taking any action.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conflicts of interest may not always be evident,
and Covered Officers should consult with the Funds&#146; Chief Compliance Officer or
the Fund&#146;s legal counsel if they are uncertain about any situation.</font></p>

<p style="margin:0pt 0pt 12.0pt;page-break-after:avoid;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Examples of possible conflicts
of interest include:</font></p>

<h5 style="font-family:Times New Roman;font-size:10.0pt;font-weight:normal;margin:0pt 0pt 12.0pt 54.0pt;page-break-after:avoid;text-indent:-18.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Outside
Employment or Activities</i>.&#160; Covered
Officers may not engage in any outside employment or activity that interferes
with their performance or responsibilities to the Fund or is otherwise in
conflict with or prejudicial to the Fund.&#160;
A Covered Officer must disclose to the Funds&#146; Chief Compliance Officer
any outside employment or activity that may constitute a conflict of interest
and obtain the Funds&#146; Chief Compliance Officer&#146;s approval before engaging in
any such employment or activity.</h5>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rsomuga\06-22409-1\task1536300\22409-1-ma.htm',USER='105157',CD='Dec  5 23:03 2006' -->
<br clear="all" style="page-break-before:always;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>


<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 54.0pt;text-indent:-18.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Gifts.</i>&#160; Covered Officers may not accept gifts or other
items of more than small value, consistent with industry standards from any
person or entity that does business with or on behalf of the Fund.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 54.0pt;text-indent:-18.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Other Situations.</i>&#160; Because
other conflicts of interest may arise, it would be impractical to attempt to
list all possible situations in this Code. If a proposed transaction or
situation raises questions or doubts, a Covered Officer should consult with the
Funds&#146; Chief Compliance Officer before engaging in the transaction or activity.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;page-break-after:avoid;text-indent:-18.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Corporate Opportunities</p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Officers may not exploit for their own
personal gain, or for the personal gain or their family members or relatives,
opportunities that are discovered through the use of Fund property,
information, or position, unless the opportunity is first disclosed fully in
writing to the Board of Trustees and the Board of Trustees declines to pursue
such opportunity.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Full, Fair, Accurate, Timely, and Understandable
Disclosure in Fund Disclosure and Reporting Documents</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As a registered investment company, it is of critical importance that
the Fund&#146;s public communications, reports, and filings contain full, fair,
accurate, timely, and understandable disclosure. Accordingly, Covered Officers
are expected to consider it central to their roles as officers of the Fund to
promote full, fair, accurate, timely, and understandable disclosure in the Fund&#146;s
public communications and reports, and in the documents that the Fund files
with, or submits to, the Securities and Exchange Commission (the &#147;SEC&#148;).</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Depending on his or her position with the Fund, a Covered Officer may be
called upon to provide necessary information to make the Fund&#146;s public reports,
communications, and SEC filings and submissions complete, fair, and
understandable. The Fund expects Covered Officers to take this responsibility
very seriously and to provide prompt and accurate answers to inquiries related
to the Fund&#146;s public disclosure requirements. Covered Officers may be asked to
certify the accuracy of all responses and information provided for inclusion in
the Fund&#146;s public reports, communications, and SEC filings and submissions.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">C. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Compliance with Applicable Governmental Rules and
Regulations</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As a registered investment company, the Fund is subject to regulation by
the SEC and must comply with Federal securities laws and regulations, as well
as other applicable laws.&#160; The Fund
insists on strict compliance with the spirit and the letter of these laws and
regulations. Each Covered Officer shall cooperate with Fund counsel, the Fund&#146;s
independent accountants, and the Fund&#146;s other service providers with the goal
of maintaining the Fund&#146;s material compliance with applicable governmental
rules and regulations.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Fund expects its Covered Officers to comply with all laws, rules, and
regulations applicable to the Fund&#146;s operations and business. Covered Officers
should seek guidance whenever they are in doubt as to the applicability of any
law, rule, or regulation, or regarding any contemplated course of action.
Covered Officers should also make use of the various guidelines which the Fund
and its service providers have prepared on specific laws and regulations.&#160; If in doubt on a course of action, a good
guideline is &#147;always ask first, act later&#148; &#150; if you are unsure of what to do in
any situation, seek guidance before you act.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Officers are encouraged to attend courses and seminars for the
purpose of keeping themselves apprised of developments relating to those
governmental statutes, rules, and regulations applicable to the Fund.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Upon obtaining knowledge of any material violation of any applicable
law, rule, or regulation by the Fund or a person acting with or on behalf of
the Fund, a Covered Officer shall report such violation to the Funds&#146;
Compliance Officer, Fund counsel, or both. (See Section VI of the Code for a
discussion of reporting Code violations.) Each</font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rsomuga\06-22409-1\task1536300\22409-1-ma.htm',USER='105157',CD='Dec  5 23:03 2006' -->
<br clear="all" style="page-break-before:always;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>


<p style="margin:0pt 0pt 12.0pt;text-indent:0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered
Officer shall cooperate or take such steps as may be necessary or appropriate
to remedy any such material violation.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Confidentiality</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Officers must maintain the confidentiality of information
entrusted to them by the Fund, except when disclosure is authorized by Fund
counsel or required by laws or regulations. Whenever possible, Covered Officers
should consult with Fund counsel if they believe they have a legal obligation
to disclose confidential information. Confidential information includes all
non-public information that might be of use to competitors, or harmful to the
Fund or its shareholders, if disclosed. The obligation to preserve confidential
information continues even after employment as a Covered Officer ends.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-36.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">E.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Prompt
Internal Reporting of Violations of the Code; Evaluation of Possible
Violations; Determination of Sanctions</b></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 63.0pt;text-indent:-18.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Reporting to the Funds&#146; Chief Compliance
Officer</p>

<p style="margin:0pt 0pt 12.0pt 45.0pt;text-indent:27.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A
Covered Officer shall promptly report knowledge of, or information concerning,
any material violation of this Code to the Funds&#146; Chief Compliance Officer. Any
such report shall preferably be in writing, and shall describe in reasonable
detail the conduct that such Covered Officer believes to have violated this
Code. The Funds&#146; Chief Compliance Officer shall also have the authority to
draft a report of a suspected material violation of the Code, if no written
report is made by a Covered Officer.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 63.0pt;text-indent:-18.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Evaluation of Reports</p>

<p style="margin:0pt 0pt 12.0pt 45.0pt;text-indent:27.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Funds&#146; Chief Compliance Officer shall then consult with Fund counsel to the
extent necessary to determine whether the reported conduct actually violates
the Code. If it is determined that there has been a violation of the Code, the
Funds&#146; Chief Compliance Officer will determine (in consultation with Fund
counsel) whether the violation has had or may have, in the reasonable judgment
of the Funds&#146; Chief Compliance Officer, a material adverse impact upon the
Fund.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-9.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">i</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>No Material Adverse Impact on the
Fund.</i>&#160; If the Funds&#146; Chief Compliance Officer
determines that the violation has not caused a material adverse impact upon the
Fund, the Funds&#146; Chief Compliance Officer shall determine what sanctions, if
any, may be appropriate for the violation. (See G of this Code for a discussion
of possible sanctions.)</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-9.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ii</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160; </font><i>Material Adverse Impact on the
Fund</i>.&#160; If the Funds&#146; Chief Compliance Officer
determines that the violation has caused a material adverse impact upon the
Fund, the Funds&#146; Chief Compliance Officer shall promptly notify the Board of
such violation. The Board shall be entitled to consult with independent legal
counsel to determine whether the violation actually has had a material adverse
impact upon the Fund; to formulate sanctions, if any, appropriate for the violation;
or for any other purpose that the Board, in its business judgment, determines
to be necessary or advisable. (See G of this Code for a discussion of possible
sanctions.)</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 63.0pt;text-indent:-18.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Periodic Reports by the Funds&#146; Chief
Compliance Officer to Board of Trustees.</p>

<p style="margin:0pt 0pt 12.0pt 45.0pt;text-indent:27.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Funds&#146; Chief Compliance Officer shall report to the Board at each regularly
scheduled Board meeting all violations of this Code (whether or not they caused
a material adverse impact upon the Fund) and all sanctions imposed.</font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rsomuga\06-22409-1\task1536300\22409-1-ma.htm',USER='105157',CD='Dec  5 23:03 2006' -->
<br clear="all" style="page-break-before:always;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>


<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">F.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>WAIVERS
OF PROVISIONS OF THE CODE</b></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 90.0pt;text-indent:-18.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Waivers.</p>

<p style="margin:0pt 0pt 12.0pt 72.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A
Covered Officer may request a waiver of a provision of this Code if there is a
reasonable likelihood that a contemplated action would be a material departure
from a provision of the Code. Waivers will not be granted except under extraordinary
or special circumstances.</font></p>

<p style="margin:0pt 0pt 12.0pt 72.0pt;text-indent:72.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The process of requesting a waiver shall consist
of the following steps:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 128.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">i.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Covered Officer
shall set forth a request for waiver in writing and submit such request to the
Funds&#146; Chief Compliance Officer. The request shall describe the conduct,
activity, or transaction for which the Covered Officer seeks a waiver, and
shall briefly explain the reason for engaging in the conduct, activity, or
transaction.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 128.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ii.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The determination with
respect to the waiver shall be made in a timely fashion by the Funds&#146; Chief
Compliance Officer, in consultation with Fund counsel, and submitted to the
Board for ratification.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 128.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">iii.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The decision with
respect to the waiver request shall be documented and kept in the Fund&#146;s
records for the appropriate period mandated by applicable law or regulation.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 90.0pt;text-indent:-18.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Disclosure of Waivers.</p>

<p style="margin:0pt 0pt 12.0pt 72.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To
the extent required by applicable law, waivers (including &#147;implicit waivers&#148;)
shall be publicly disclosed on a timely basis. An &#147;implicit waiver&#148; is defined
as the Fund&#146;s failure to take action within a reasonable period of time
regarding a material departure from a provision of the Code that has been made
known to an &#147;executive officer&#148; of the Fund. For this purpose, an &#147;executive
officer&#148; is a Fund&#146;s President or Chief Executive Officer, Vice President (who
is in charge of a principal policymaking function), or any other person who
performs similar policymaking functions for the Fund. For the purpose of
determining whether an &#147;implicit waiver&#148; has occurred, if a material departure
from a provision of the Code is known only by the Covered Officer who has
caused the material departure, the material departure will not be considered to
have been made known to an executive officer of the Fund.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">G.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Accountability
for Adherence to the Code</b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The matters covered in this Code are of the utmost
importance to the Fund and its shareholders, and are essential to the Fund&#146;s
ability to conduct its business in accordance with its stated values. Covered
Officers are expected to adhere to these rules in carrying out their duties for
the Fund.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Fund will, if appropriate, take action against
any Covered Officer whose actions are found to violate this Code. Sanctions for
violations of the Code may include, among other things, a requirement that the
violator undergo training related to the violation, a letter of sanction, the
imposition of a monetary penalty, and/or suspension or termination of the
employment of the violator. Where the Fund has suffered a loss because of
violations of this Code or applicable laws, regulations, or rules, it may
pursue its remedies against the individuals or entities responsible.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">H.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Recordkeeping</b></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-18.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>General.</p>

<p style="margin:0pt 0pt 12.0pt 36.0pt;text-indent:18.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Fund requires accurate recording and reporting of information in order to make
responsible business decisions. All of the Fund&#146;s books, records, accounts and
financial statements must be maintained in reasonable detail, must
appropriately reflect the Fund&#146;s transactions and must conform both to applicable legal requirements and to the
Fund&#146;s system of internal controls.</font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rsomuga\06-22409-1\task1536300\22409-1-ma.htm',USER='105157',CD='Dec  5 23:03 2006' -->
<br clear="all" style="page-break-before:always;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>


<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-18.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Code of Ethics Records.</p>

<p style="margin:0pt 0pt 12.0pt 36.0pt;text-indent:18.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A copy of this Code, any amendments hereto, and any
reports or other records created in relation to waivers of or amendments to
provisions of this Code shall be kept as records of the Fund for six years from
the end of the fiscal year in which such document was created. Such records
shall be furnished to the SEC or its staff upon request.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">I.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Amendments
to the Code</b></p>

<p style="margin:0pt 0pt 24.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Covered Officers and the
Funds&#146; Chief Compliance Officer are encouraged to recommend improvements to this
Code to the Board, and the Board may amend the Code in its discretion. In
connection with any amendment to the Code, the Funds&#146; Chief Compliance Officer
shall prepare a brief description of the amendment, in order that this
description may be disclosed in accordance with applicable law and regulations.</font></p>

<p style="margin:6.0pt 0pt 12.0pt;text-align:center;text-autospace:none;text-decoration:underline;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A:
Covered Officers</font></u></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:72.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead, President</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:72.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Kathleen Eckert, Treasurer</font></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rsomuga\06-22409-1\task1536300\22409-1-ma.htm',USER='105157',CD='Dec  5 23:03 2006' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.CERT
<SEQUENCE>3
<FILENAME>a06-22409_1ex99dcert.htm
<DESCRIPTION>EX-99.CERT
<TEXT>
<html>

<head>






</head>

<body lang="EN-US">

<div>
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>

<p align="right" style="margin:0pt 0pt 12.0pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT 99.CERT </font></b></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT 2: CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></b></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I,
Daniel R. Omstead, certify that:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I have reviewed this report on Form N-CSR of
H&amp;Q LIFE SCIENCES INVESTORS;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, this report does not
contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under
which such statements were made, not misleading with respect to the period
covered by this report;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, the financial statements,
and other financial information included in this report, fairly present in all
material respects the financial condition, results of operations, changes in
net assets, and cash flows (if the financial statements are required to include
a statement of cash flows) of the registrant as of, and for, the periods
presented in this report;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer(s) and
I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Rule 30a-3(c) under the Investment Company Act of
1940) and internal control over financial reporting (as defined in Rule
30a-3(d) under the Investment Company Act of 1940) for the Registrant and have:</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed such internal control over financial
reporting, or caused such internal control over financial reporting to be
designed under supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting
principles; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Evaluated the effectiveness of the registrant&#146;s
disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of a date
within 90 days prior to the filing date of this report based on such
evaluation; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Disclosed in this report any change in the
registrant&#146;s internal control over financial reporting that occurred during the
second fiscal quarter of the period covered by this report that has materially
affected, or is reasonably likely to materially affect, the registrant&#146;s
internal control over financial reporting; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer(s) and
I have disclosed to the registrant&#146;s auditors and the audit committee of the
registrant&#146;s board of directors (or persons performing the equivalent
functions):</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All significant deficiencies and material
weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant&#146;s
ability to record, process, summarize, and report financial information; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant&#146;s internal
control over financial reporting.</p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;font-family:Times New Roman;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="4%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:4.64%;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt;"><!-- SET mrlNoTableShading -->Date: <a name="DateDecember52006_220828"></a></p>
  </td>
  <td width="14%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:14.74%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">December 5, 2006</font></p>
  </td>
  <td width="39%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:39.36%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="23%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:23.78%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Daniel R.
  Omstead</font></p>
  </td>
  <td width="17%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:17.48%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="58%" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:58.74%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="41%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:41.26%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:&nbsp;&nbsp;Daniel R.
  Omstead</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="58%" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:58.74%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="41%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:41.26%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:&nbsp;&nbsp;&nbsp;&nbsp;President</font></p>
  </td>
 </tr>
</table>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\sethu\06-22409-1\task1536668\22409-1-mc.htm',USER='105167',CD='Dec  6 01:09 2006' -->
<br clear="all" style="page-break-before:always;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>


<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT 2: CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></b></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I,
Kathleen Eckert, certify that:</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; I have reviewed this report on Form
N-CSR of H&amp;Q LIFE SCIENCES INVESTORS;</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, this report does not contain
any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under
which such statements were made, not misleading with respect to the period
covered by this report;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, the financial statements,
and other financial information included in this report, fairly present in all
material respects the financial condition, results of operations, changes in
net assets, and cash flows (if the financial statements are required to include
a statement of cash flows) of the registrant as of, and for, the periods
presented in this report;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer(s) and
I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and
internal control over financial reporting (as defined in Rule 30a-3(d) under
the Investment Company Act of 1940) for the registrant and have:</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed such internal control over financial
reporting, or caused such internal control over financial reporting to be
designed under supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting
principles; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Evaluated the effectiveness of the registrant&#146;s
disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of a date
within 90 days prior to the filing date of this report based on such
evaluation; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Disclosed in this report any change in the
registrant&#146;s internal control over financial reporting that occurred during the
second fiscal quarter of the period covered by this report that has materially
affected, or is reasonably likely to materially affect, the registrant&#146;s internal
control over financial reporting; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer(s) and
I have disclosed to the registrant&#146;s auditors and the audit committee of the
registrant&#146;s board of directors (or persons performing the equivalent
functions):</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All significant deficiencies and material
weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant&#146;s
ability to record, process, summarize, and report financial information; and </p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 72.0pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant&#146;s internal
control over financial reporting.</p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;font-family:Times New Roman;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="6%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:6.06%;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt;"><!-- SET mrlNoTableShading -->Date: </p>
  </td>
  <td width="15%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:15.22%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">December 5, 2006</font></p>
  </td>
  <td width="41%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:41.14%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="22%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:22.12%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Kathleen
  Eckert</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:15.44%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="62%" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:62.44%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="37%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:37.56%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name: &nbsp;Kathleen Eckert</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="62%" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:62.44%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="37%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:37.56%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:&nbsp;&nbsp;&nbsp;&nbsp;Treasurer</font></p>
  </td>
 </tr>
</table>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\sethu\06-22409-1\task1536668\22409-1-mc.htm',USER='105167',CD='Dec  6 01:09 2006' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.906CERT
<SEQUENCE>4
<FILENAME>a06-22409_1ex99d906cert.htm
<DESCRIPTION>EX-99.906CERT
<TEXT>
<html>

<head>






</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">
 <p style="margin:0pt 0pt .0001pt;text-align:center;"></p>

<p align="right" style="margin:0pt 0pt 12.0pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT 99.906CERT </font></b></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EHIBIT 3: CERTIFICATION PUSUANT TO SECTION 906 OF THE SARBANES-OXLEY
ACT</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the
undersigned officers of H&amp;Q LIFE SCIENCES INVESTORS, do hereby certify, to
such officer&#146;s knowledge, that the report on Form N-CSR of H&amp;Q LIFE
SCIENCES INVESTORS for the period ended September 30, 2006 fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934, as applicable, and information contained in the Form N-CSR fairly
presents, in all material respects, the financial condition and results of
operations of H&amp;Q LIFE SCIENCES INVESTORS for the stated period.</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="6%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:6.42%;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt;"><!-- SET mrlNoTableShading -->Dated: </p>
  </td>
  <td width="15%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:15.32%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">December 5, 2006</font></p>
  </td>
  <td width="45%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:45.3%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="32%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:32.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="6%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:6.42%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="15%" colspan="2" valign="top" style="border:none;padding:0pt .7pt 0pt 0pt;width:15.32%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="45%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:45.3%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="32%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:32.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="8%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:8.08%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:29.48%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Daniel R. Omstead</font></p>
  </td>
  <td width="29%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:29.48%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="32%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:32.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Kathleen
  Eckert</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="8%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:8.08%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="58%" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:58.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;Name:&nbsp;&nbsp;&nbsp;Daniel
  R. Omstead</font></p>
  </td>
  <td width="32%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:32.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;Name:&nbsp;&nbsp;Kathleen
  Eckert</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="8%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:8.08%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="58%" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:58.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;President</font></p>
  </td>
  <td width="32%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:32.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;Title:&nbsp;&nbsp;&nbsp;&nbsp;Treasurer</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="48" style="border:none;"></td>
  <td width="12" style="border:none;"></td>
  <td width="102" style="border:none;"></td>
  <td width="118" style="border:none;"></td>
  <td width="221" style="border:none;"></td>
  <td width="247" style="border:none;"></td>
 </tr>
</table>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A
signed original of this written statement required by Section 906 has been provided
to H&amp;Q LIFE SCIENCES INVESTORS and will be retained by H&amp;Q LIFE
SCIENCES INVESTORS and furnished to the SEC or its staff upon request. This
statement accompanies this report on Form N-CSR pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not be deemed as filed by H&amp;Q LIFE
SCIENCES INVESTORS for purposes of the Securities and Exchange Act of 1934.</font></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\sethu\06-22409-1\task1536668\22409-1-me.htm',USER='105167',CD='Dec  6 01:10 2006' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>j06224092_aa001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j06224092_aa001.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`90!E`P$1``(1`0,1`?_$`:(````&`@,!````````
M``````<(!@4$"0,*`@$`"P$```8#`0$!````````````!@4$`P<""`$)``H+
M$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M``P#`0`"$0,1`#\`W]/?NO=>]^Z]TR[CW)MW9V!RVZ=W9_"[6VQ@*"HRF=W'
MN/*T.#P.%QE)&9:K(Y;+Y.>EQ^-H*:)2TDTTB1HHN2![J[I$ADD(6,"I)-`!
MZDG`Z9N+BWM(&N;ITBMD4EG=@JJ!Q+,2``/,DTZJ,WS_`#2<]VG0[C3X#=1X
M_MO:FUYZNBWE\N^^MP'HWX9==O1$QY"OJ=[;D.*W)V6,'.`*VDPD,++#(DT4
M\L;7]AV7?GN`W[HC$D:\9I#HA7_;&A:GF%_;U%E[[DS[FD@Y'M5NK:,D27UR
MWT]A%3B3(^EYM/XEC`P00Q'5-O??\RK8M+/74_R`_F9_(3O7.K+.QZC_`):6
MS,/\=^I,#6$(6P=;W_N](M\[XVU+)&RFLH:BME:&10MCY![#5WOD0)%Y?32O
M_!;*(T'R\0]S#Y@GJ)M\]P[)69=]YBO[V;/Z&TQK:P*?X3<R?J2)_24L:'[>
MJYMS_P`QWX85=2DV-_EHXOL&MB<O+N?Y)_+7O/O#/96>43+55U51Y;^'8K'5
M,\;(%6G&B-E=A=I#I)9-ZVPFJV(<^LLSN3^W`_+H`7/N!RBS5CY=6=_X[N]N
M;AF/F2&HH)^7#)\^F.B_F._$R&JAEJOY3OQ=C@0DM)M[?G:&VLW$=#>.7&9Z
MDJZBJQ55%)9EFC7R+;TE39A0;UMP.=O@I\F8'\CY=,)[@<KA@6Y7VVG]&29&
M_)@25/S&>C,=2_S,/AI!6PKBO^'&?@O6M(C05W0GRYSOR(Z\2KBC\-/4[IV%
MWM$%RV)CBC0&%(*JH5`$5C8L5UOOFV`]OUMH?6.8R+^:R<1^T]"+:_<3E)7`
MB_?^RO7!MKYKJ*OD7BN?B7Y48^0ZO,^-OSZ^0FX<;_%>H>XN@_YI?7V.I5K,
MWA-C4M'\6?F]MK&)9ZO*Y#I+=<T6QM]18Z"FG18J5=ORY&=0].2KB-159;O>
M.NJVDAOX0,A?TIP/4H>UO/AIKY=3/R_SQOT\?B[5=V/,MBHJRQ@6>X(/-C;O
M^G)0`X7PBYRO&@M/^.WS$Z)^3HS.+Z\W'D,3V'M)47?_`$OV)A,AL#NGKJJ9
MEC>FWGUQN*.ESN/C29Q&*R%:C'3/Q%42>S^RW*TOJK"Q$R_$C#2Z_P"F4Y_/
M(^?4E[!S9LO,>N.PD9;^+^UMY5,5Q$?22)J,/34*H?)CT:'VOZ$G7O?NO=>]
M^Z]U[W[KW0)?(?Y#]4?%OJC<G<O<NY(]N;.VY''&JQQ_>9S<><K-:8;:6TL,
MCI4Y_=6?J4\5)21<L=3NT<,<LJ);R\M["W:YN6TQ+^TGR`'F3Y#_`"=$^_;]
MMG+6V2;ON\GAVD?YL['X41>+.QPJC[30`D:NGS[^7DL:X;L_^8135F1.72CW
MK\9_Y3^V=PR8K&8W%22";:O;'SOW%0Q?<UU6?`*JGVOXV(G'VRQQQMDT0![O
MN/"?>:FO=%:`TQY/.?YZ?R_BZQMYXYJ(T;ESV"VNDEILJ-I`7\$^Y,,D^8AI
MQ[0`/$`I7_F$]A_.WL+'=';Q^6T<G7^P.RMI5F[_`(^=$X"DIME=?[$Z[QU3
M!BL76[>ZIQ3K2;6I:ZGF6.BGR0DS570Q1O*YIS3,P8WB;=IEBDW'LA=:QQCM
M55X"B#A\J]Q'RIU$'/=_SK?QV5WS36"QN(B]K;*!'%'$"%4K"N$!&%+UD90"
M3ITUK-]D?4=]>]^Z]U[W[KW7O?NO=.^`W!GMJ9K&;DVOF\OMO<6%K(<AAL]@
M,E6X?-8FOIVUP5V,RF.FIJZ@K(&Y26*1'4_0CW9'>-@\9*N#@@T(^PCIV">>
MUF6XMG>.X0U5E)5E(X$,*$'Y@]79=!_S0]O]PY'8^S?G_5;EI]Y;,6FH>F/Y
MA'4<+8'Y2]#Y")9*7%U&\,AM^*GG[AZZIQ52#)T-7%4UL]/+42/'7U4JL@HL
M]^2Y*1;OJ\5?@N$Q+'Z5I\:^H-32O$]3#L?N1!NTD-ISR9!=PT%OND';>6QX
M`R%:&>(5.M6!8@L2'8@C:Z^+?S8W-BMW;'^.'RXW)LC);\[$Q<67^,GR@V$T
M-/T?\SMF2():+);8GIFGP^RNX*:BE@_BNV#4O'--.DN->6&>%/<@6&Z2+(EE
MN+(97%8I5^"9?4>2OZK7_2U!'63G+?.%Q%=P\O\`-,D+7MPNJSO(J"WOX_(H
M158YP*:X:T)(,9(8#JT_V?\`4E]>]^Z]TU9[.X;:V#S6YMQY.BPFWMNXG(YW
M/9G)5$=)CL1AL11S9#*9.OJI2L5-14%#3O++(Q"I&A)X'NKNL:&1R`B@DD\`
M!Q/34\\-M"]S<,$@C4LS$T"JHJ23Y``$D^G6IG\R_G91T-/1?S$.PZ*'/UF9
MK-Q;2_E/?'#=](SX?`X7'/'CMU?.SM+:=6M%45.4S=3"C[8I:N(-2PRTJ()"
M5KZ:/=SW8*!O,PJ346D9X`<#.X]3^$'AC[1C!S;SJB*.?;\!W<NFRVCCM51A
M]RF0T)+',*L.T%0*X=:Q?@=F?CE1[VI/FQ\G>TMF?);Y(5&]NP]^5/QZW]-V
M3+F*/&;0V/OK=^0[AW7G*7KG=6V]S;GQ^=VY3U]/C)9GIJ'!135,$60R[8_%
MQD>TM9"4;I?R+/>ZV;PVU5H%8ZR=)!-0"!P"U(#-I7J.>29>7TO!SAS'<P[C
MS`9I9#:R^+J`CCDD,[L(G1W#(&"$T6,%E$DOAQBX[Y(?&WKG^=#\1MH_)WX_
M=F?Z0.[MGU&4INP<?F=MT>"W=C)S1T<\G6F"VI'F\Y+U]3;%?RUN(P<>1KJ'
M<M-D:B:HK:S)U%+EH!)>V4/,VW+?6<FNZ4G544(_H@5.G3Q"U(8$DDL0PECF
M#E[;_=WE:+F/8KGQ]XB)$H9`K@T'Z*IJ;PA'EDC#LLH9BSO(RRKIS[YV3G^N
M]TY?:.YJ44V5P]5+3R-$9&I*R))&2*NH)98H))J*J5=2%D1QRKHDBLBQM+$\
M,AC?XAUB=>V<]A<O:W`I*AI\C\Q\C^WR(!J.DE[;Z2]>]^Z]U[W[KW7O?NO=
M>]^Z]U;3_+P^;.TMF8;*_#'Y8Y+,U_P_[<S-+5X[<U#65";L^+7;8K$J-I]\
M=7Y1"];MQMO9[159*.CL=/DJ5CG/W-)7"'9MTCB4[9N!)VV0X/G$_E(I\J')
MI]N<@RCR%SC:VD+<H\T,[<J73@AP3KLYZU2YA;BFENYPOS8`]RONL_!KY"]B
M[AJMY?%CY*9+&9'Y,=%XS$Y<;UQ$44&V_D7T5GIY:3K;Y$[,>"HJ:.IBW%!`
M*3/P4SLF.S:,K+"*B.%)/VJ\F<M87I!OH@#J'"2,_#(OV\&IP;[>LO\`DS?K
M^=IN6N865N8K)5;Q%PEU;,:174="0==-,H'P2>FH`6(>SGH>]5)?S,=SR]J;
MAZ5^"U%N*3:FT.Y8]T]T?+3>D%=4XZ/8_P`-^BOX=G.PZ?)Y.C*56%@[3ST]
M)@(:L%H`GW$-0OAF-P]ODAN'BVH-ICEJ\K?PPQY:I\M9HM?M!ZBWW$N3N<]G
MR6DGA6MV'N+V0$CP["VHTH)&5$S%8@W"FH-@]:*_SF^4-?\`+?Y'[X[2AI_X
M+U[131[&Z1V3!14V)QG7G26SY)\7UQL[&86@_P!QV(2AP2K/50TX$)KZB=U`
M#`"*-UOSN-Z]P,0CM1>`5!A0!P&./SKUA=SIS(_-/,$VY`:+`'P[>,`*(K>/
M$48486BY(&-18CCT5+$Y7)8+*8[-8:NJL7E\36TV1QF2H9GIZR@KZ*9*BDJZ
M6>,K)#/3SQJRL"""/9>K,C!U-&!J#T&8I9()%FA8K*A!!&"",@@^HZMS_EZ?
M)[O#I#N[%=U?$S!C*Y?)55%0?)[XQXV>#%;*WCL:"JA>L[)P-+*\&-VCMO'B
MLJ9ZBL512[$K=4Y=<#7/04XCV>_NK6Z%UMPJQ_M8AA67^(>0'SX1G/P&@E/D
M/F/>=FWA=XY735*Q`O+,$+')&#F91PC05)+<+9JM40.479_R_P`"/BU_,D[I
MP/RBKNG$VQTAA,ID]SX3/5='68;*_*[>&0AQT:;SK=L2S)#B.B*2:A-0C&*G
MK-]Y*5\A^SCB:G/#IMHL-[NA?F+3:@D@\#*<=U/*/^<ASA<OD?+R1RU[@[NG
M,CVGA[.C%U8@JU[(:?J%/PVPI48#7+DR8C[I]7/^9C_+>[%^*O8V\-PTFVL1
M0;7#MN'(XC:L%;3;;&!J\A08V3L?K;'UU1D*J+JZHS^7I:.NQ<E759'9&6K(
M<=6M-056$R^8`>^;)-M\S.%`CXT'"F!J4?P5(!%24)"FH*,V-ON+[?7_`"SN
M$MPD:+;?$50$)I)`\6($D^"68*R%F>W=A&Y*-#++43[#O45]>]^Z]U[W[KW7
MO?NO=>]^Z]ULT?R[/F#O;>GQTV_OZEJ\IG?D3_*HA7>^)Q]/+!59CNSX`;RK
ML;M[O?J>O2=X#.G4F&HZ;)XFIJ&J4QSTF.BIXE<F11SLNY2RV0F!)O-O[AZO
M;MB1/]H*$<:46@ZR*Y"YKO+S8([Y2S[_`,LCQ%`RUQMDA"W,!KQ\!0'0FNG3
M&%%<];EO^D_8G^B__3/_`'CH/]&7]PO])_\`>[4W\,_N)_=[^]?]X]>G7]A_
M=_\`RJ^F_C_'N2_'B\#ZG4/`T:J^6FE:_LSUEK^\;+]V_O?Q%_=W@>-K\O#T
MZ]?V:<_9UJ9_S*OD5D(^NOYEWR$QF1T9#N?O?8O\L/J&I6M\F0PG4_0^&R>]
MOD-+B1&-#;<W_O6IR%%4,6:-TK`%53:62/-[O3X-]>`]TLJVJ?)(QJDI\F:H
M/V]8O^X>_N-OYBWZ-OU+N]CV>`URL%LIDNM/]"60LI\N[\SJ;>X^ZQ@Z][]U
M[H<?C7O?K'KCO;K/>_<FQ$[)ZTV[N..MW5M"1(:E*RE>DJJ:BRAQ55)#CMQ_
MW8RL\&4_A%8Z4&9-%]C5LM-42D*K&6""[CEN4UP*V1_EIYT.:'#4H<'HYY=O
M-NV_>[:\W>#ZC;HY*NG&HH0#I.'T,0_AMVR:=#=K'K:K^`_\T#M+XQ=X8[XX
M?.3N&G[KZ,^0=8=_?&+YER9`C:];A]T92LHZ:+)UN2-(,!L&7-4LF.J<94+3
MU6P<W3SXZHB6@56HA_M&^W%A="RW63Q;2;NBFKBA/G7@M<$&AC:JG'#)GDCW
M(W+ES>5Y?YSNQ>;+?GQ;._KV%7)`J333%J!0H:&VD#1L-%"FQY\@_CUL'Y([
M'7:^[84ILGC7K,GLC>E'18S(9?9^9R&*K,-5UE%3Y6FK<3F\%G\'D:C&YO#5
M\-1B-P8:KJ,?7P3TM1)&1K>6<-[%X<GQ#*M@E32GG@@@T93AE)!!!ZR`WW8;
M'F"R^FNA21:F.0`%HV*E20&!5E924DC8%)8V:-U96(ZT!OYDW\NC?'Q0["WC
MF\-MJFHMF8^LHZS<NV\"<Y6XW95%FYZ>CPN]MJU.<\^5RW2&\\Q.:7&UDU16
MU>V<QKV[EZB:JCQ^3SD0[WLLNWS,ZK2('(%:+7@PKDHQP#DJ>QB3I9\'/<+D
M"]Y8OY9H8P+12"Z+J(C#$!9$+59K>1CI1B6:&2MO*Q81R350>P_U&'7O?NO=
M>]^Z]U[W[KW5@G\K3O1>@/G=\>]T9+[*79F\=YTG3W95!EI`N"KNO.X".O\`
M<DF=B,<J56,P,><CRQA92DDN/C#`BX]G&P7?T>[0R-3PF;0U>&E^TU^0K7\N
MAU[:[U^XN=;"YDH;.6803!OA,4_Z3ZO4+J#T\RHZVA8]R9V7X.5?\MV+-O)N
MB@^?N._EN5M8M=D#F:7X^9?=&4[6Q>2GKA)]Q'35_P`7L)68J*<IH>.FD@"^
M92WL=ZW_`'4=DK^H+P6WS\,DN#_SB!'Y=9("XF/)I]O@_P#C*[X-I)J=0M6=
MI@2>-#9JR`_(CB.J,/YC&X:__AOS^6?2U$E?_$.XMP?,[Y*;UGK12F3-YWL7
MM_%9#;62JI:6LJE?)4F`S$T,M[65TN0Q=$"N].?W/8@UK(9I6^99P0?MH>H8
MY_G?^HO+JMJ\2[DO[N2M.YI9U*$T)R%8@_EYU`I%]A;J'.O>_=>Z5VQ-@;Y[
M1W7A]B=;;/W-OW>FX*G[3![4VAA,CN+<&5J-+2-'0XG%4]56U'CB5G<JA6-%
M+,0H)#D,,MQ((H%9Y3P`!)/Y#I596-[N5TEEM\4D]Y(:*D:EV8_)5!)_R#/6
MVU_*R_D_?(B;;[[5_F&;"V__`++1B,UCNUNM^B=U9C![FW51]KB1*-\F9L#6
M9238^SL[M^YW%A4K8&SM33X]*Z#32RQM(>P\MWI3P]Y0?0@ZUC)!.OUQ72I'
MQ+7N-*C'64GMK[4[\8/IN?((_P"KJ.)HK9V5W$_"O:3X<;+_`&L88>(1&'6B
MD':8Q7777^"I\92X+8VT,)3X6FIJ/"PX;;>'Q4>&I:)!'14^)6@HZ?\`AD-&
MB@0K!XQ$`--K>QZL,*`!$4`<*`"GV>G62D5A8P*JPPQ(J`!=**ND#@%H!2GE
M2E/+H#._N@=K_)WK_=.PMPRTM%NC;E1EL'MW>=5AZ7,)2KN#!8JMRV!W%@F;
M'4NZNO=[[=R<6+W/@GEAI\M1:C')2U<5'5TB6[M([Z%H7Q(M0&I7B!4$8JK`
MT9>!'H:$$N^;';<QV,MC.0+F,LJR%0U-2J65UP'BD0A)HZ@.O`JX1ET8?E5_
M*AW9UCV1W1C]B;[ZCQ4/673>[._\[U;G.P:R7/8;;^S=X5&V][;9V+N:NQ'\
M,WQBMNQO2UF.K\I48FLJX*V/%S1G<%)7T4<5;AR_)!/*L3Q@)$9"I;("FC!3
M2C`8()()KI/>".L,.9O;&ZV[<+R.RGM5%M:/<M"TIU*L<A21(W*TD5.UD9RC
M,&$9'CJZ"G#V&NHFZ<*/$Y7(BM./QF0KAC<?)ELB:.CJ:D8_%1-`DN3K3#&_
MVN/C>IC#32:8P9%!/J%]A6:ND$T%3]GK]G3B12R5\-6;2NHT!-%]3Z#(R<9Z
M;_>NF^N<<DD4B2Q.\4L3K)')&S))'(C!D='4AD=&`((-P??N&1QZV"0:C!'6
M\1MG<<*?-KNSM2<0O!4]4?%[YXXS540#$4^XJ+^7Q\ONJLYNJ"O$'\)>DK&K
M\=Y<@8?MEJX(W$'D9I!*:/\`[M);@\/#BG'I7Z>9"?3S&>%?+K,JWN`.<;S<
MC2AM;/<AGM#C:[Z%G!^&AJM6I34`=-<]4%?S'L=5'X/?RAL\9:\4,G0O=>RF
MH:G5%3T.XM@=D8.@W/$E+(PDAKXJW)1P5#%%#K!'8MIX".]*?W5MSYIX+K^:
ML*_X>H/]P(V_J;RK/5M'T-Q'0\`\4JA\>M2`?L'5-/L-=1)TN^KNM=X]R=C[
M&ZHZ^Q,F<WOV+NK![-VMBHSH%7FMP9"#&T*SSD%*2BBFJ`]1.]HJ>!7D<A$8
MAV""6YF2WA%978`#YG'2W;=NN]VW"':[!==Y<2K&B^K,0!7T&:D\`*DX'7T;
MOY=_\N[I/^7!TD:&D;!97M#)86/-=V]VY9*:DFRE70T9K,E18W)Y!*>3;G6V
MV]$AI*9FB7QH:FJU3O(_N:=FV:UV6UH*&<BKN?/UH3P4>0_,YZS^Y"Y"V?V_
MV?0FAMR9-5Q<-0:B!4@$TT1)G2,8[F[B3T)N1^66TNQNH,UV=UWV%MCIOJ/)
M8SL'#[=^4_=:T&T=@T.Z\(^UZ?8VYML[4W]4[3B[-ZXWB^5RLU-E%R>+I*F+
M!R?;R2QU5/4!\[A'-;&>%UBMR&`E?"U%-)`:FI34T-0#IQQ!Z,9.:+7<-J?<
M;">.TVIEE5+RXHD0==`C=$E*>-%)J<A]:*1&=)(96Z(/O'^8A687;E'G>]_F
MK_+FVKTSB)7_`+\YKXD]Q[V[A[R[BH:*&9<AM'K79F-./RG4%5N-GBAGR%!E
MMS9/#Q3,]-7TE0L5?&42[R50/=W5DMJ/B,+L\C^H4#*5]06(\B#GH$7?/KPV
MXGWO>-@BVA#^HUE/)/<3@<4AC%#`7P"RO,\8/:Z-1PK-A_.FB[$F[(VT.R^O
M]@;[[@RE9W3L';^V,CG.RZA>I?X-UGU/UWL^;?\`U-1[QV[2;O[*S6(5JC(X
MBIED&1RW\!VXU?F*6JK\<Y#NHFUIXB)-(=:@5;LHJ*-2:A5B.(/$Z$JP)558
M\Z)?FXM_J((+V[8W$2H6F/@:888H_%@$B!YF7+(2=;^!;ZY59XP?^=_\OGJ;
M>GQZ[Y[,R/7V.V%D>V=Q[6;<.4H]_966+H'%[<H7V]M_L+?<F+RF9PF\\=UW
MNNBH*;.[=H9&VYM/;4V5EPT<M=#45V23;ML]O+9S3L@1I&%3J/Z8&`S4)#:3
M0,H[475IR"6*>=>1=KO-AOMQD@6"2ZD34PE;_%@@TK+)I++((G"B2)3X4$1E
M,(+AGDUQ^C/Y7NY*^IZ/RO>.V]U;7Q=%/\L.Y_D?AJ=)JO<&#Z!^*V:V7M"L
MVQ08*EBCJJ??F^NRL7N/`8Z2&:H6J:LI9H$=:>0."[787)B:Z5E4>*\@\Q'$
M5%`/XF8,H]:@CAU`&R^V]P[64N\QRQQ*;VXNU&66VLFCC*!1D223++$I!.K4
MI`.DUQ?/CK_=/QMZZS/7F6V8]'WEWUO'!]V?,_<.U\74/LGI9]_3YS?/0OPY
MHLI0T4>$P#X?$TTVY\CC5D6.MFI<9]MY:;%0NGMWADLH3"RTNIF#S$#M355H
MX:\!0=Q'GVTPHZUSQ8W/+VWO82PTWF^F6XOV0'P[?Q2TEM8!@-*Z5!F=*T8B
M/358@13E[#743=>]^Z]UNQ[=P3U/97<6WEJ!_%,/_*2^-O2$\HA=L.=V;D^+
M'RLWC2ROD+BIAHAB-J3,@^V,TEV.@!#JE!$K/(E>X;=&GRJ8I3_@'IUF%;P%
MMQNX`?U$Y6M+<_PZWL[V09XTTH?*I],=5G_S*.GZ_%?`ZLVC2122_P"R(?S)
M?DYTM)C5A:2NQ75GR`K9^Y]A;LR++$B4N)R_\1QT"2A8H9:NM6-0S(2"/>[8
MKM)C'_$2]E2GHLG>I^PU'YGJ._<+:7BY)-J@)_<G,-Y;T\UANB;B)SZ*U4%<
M`LU/+K7,]@OJ`>M@#_A-[U/B=^_/[)[YR\<,K=*])[VWGM]77R.NY]Q9+;O7
M-/,J&RJD6W=XY0Z^2DFBPN=2B_DJW6;=S*W^A1,P^TD+_@)ZG+[OVUQ7W/+7
MLM#]'9R2+_IW*Q#_`(Q(^?6GY;4'SSI,CW+V_P##3X7U4_V_5_R"WKV3V+WS
M315%335&[^H_C=@=M[KK>LIY*>2!WV_V'O?=N#H\M'')'/+CEE0$Q-,K#[=@
M;FYMML/]A,S-)\TC`.G[&8J#\OSZR7YV23=]UVCE%C3;;Z:66Y%2"\%HJ.83
M3\,LCQJX!!*5'"O6BO\`S%?F=V1\QOD7OO<&?SF0I>K-H[GS>UND^L:2H>DV
M=U]U_@:V?#;>I\3M^F9,33YO(XFCBFR58D8EJ*ARH*T\<$,44[UN<^Y7KNY/
MTZL0B_A51@4'"I'$_P"2@ZPNY^YNW#FS?YYYW8;9%(R6\(-(XHE.E0JCM#%0
M"[4J3CX0H!!_91T!^K8/C]_,$^4F9[C9MD=71[OW)OC8V5V;N;%?'CK@8GN'
M)9K+;;IMF9+O7964P.%W36X?OG%;71J+&Y1*";%XJEK:Z&BH*09*L>406>\7
M[7/Z4>IW0J1&M')(TF12`:2`8!I05-`-1K)^Q<]<RS;M_B=MXMQ-"T;K:Q:9
MRS((S<QE5<K<JG:CZ2B!G"(GB.3L7?R>OB'\U.D-L=M;-WENC<&'^-W;R)EJ
M':?<^P\CB.SMCY;+IX]Y5<FQ-WPY+"TV]]RXN;[*=%FS>V9'5<A4-4RP-BZH
M:<M[=NEK')%*S"RDR`ZT92?B[34:B,?B7\1K329\]J.5>;]FMKJTNY9$Y?N^
MX)<1E9HV;^T/AR542..TBLD)Q(VHJ8FL9^0G?."Z=5>H?CG@:/<7;GV$6S]P
M;RCAQ^\LEL!,91U^]J;'93);JS%-#O/MLIG)]QR09W*08W`T57-N7<]73T<E
M-'ESJ]NTMO\`%[)0US2A;#::=V23W/G5W&B@EY"!35(&_;W#M(_=6P()-TT^
M&TF)#%0&0`EV'B3]QE(D<)$K&XN75"HET]?GQ\[-M9S%;@Z&Z9K<-OULO'64
M_;'=U3/+O+&Y7(9NNI\OO+;O4F8W3A:+,9B3<V;H*.?=W8U93TN=WI74$$./
MAP^VJ+&8I8WW?=D=3:6Q#U^-^().6"$BIJ::Y#1G(``6,*O6*//'.MM-$^R;
M0R3ZZB>X)\0,6(:1(&=0S:V"F>Z8+)<,JA!%;I'$*8O89ZB+H4>D.K\MW;W-
MU1T[@A,<OVEV-LSK^@>"/R/3S[NW#C\$*QELRK#0K7&:1V]"1HS,0H)]OVL#
M75S';)\4CJO[33HRV;;9=YW>UVF"OBW-Q'$*>1=@M?RK4^@'6Z9B=PT&-^4&
M_N^A@:;_`$9[S_FO=1_"&2%8T%.=D=9_#+NWXLPSRY05`R#4`[>[9DI4F:<N
MM47C6P+`R<KA;][NGZ#;@D'^U6%XN/'XWI]O67L5PD?,D^]Z!^[IN9X-N^7A
MPV%Q9UK6M/'G*UK6M1T+GSH^/.WMR_([MWI?=59!BNO?YIOQXAV%@LS5QVQ^
MV?FC\5T3<72V3R56YA@HZ?=>RJU%CC1C59&;;"TO*M&8E&ZV:27LEK(:0W\.
MD'TFBRG[5_,Z:=&G.FPV]QS!=;1<D+8<RV'A*QX)N%EWVY)\@\9P.+F'3P(I
MH2;JVON#8^Z-R;+W9BJK!;JVAG\QM?<V#KE5*W#;@V_D:C$YG%5BHSHM5CLC
M220R`,0'0V)]Q+)&\4C12"DBD@CT(P1^1ZPCN;:>SN9+.Z4I<Q.R.IXJRDJR
MGY@@@]7F?\)S^XL%UE_,$;:.XLI!C:?N_I[>?6^"^[>*"EJ=XT>7VOO["TS5
M4K1K#55F/V;7TM,A;_**FICA56EDC'L5<F7*0;QX;F@EC91]M0P_XZ0/F:=3
M/[!;M#MW/7TMPP5;RTDB6O`R!DE45]2(V`]20!DCK:M_F%-G>F]\_%#YTXW#
M9K<^T?BGO+L/`]Y8+`4]579.A^/_`']MK$;3W]V#38NBBJ*S+_Z+\[MK!YJH
MIXXR?L*:HE9HXXI'`_WC7;2V^ZJ"T=NS!P./AR`!FIYZ2%8CT!ZR9Y[\?:;W
M:^=(T>2UVR65;A5!)%K<HJ2R@"I;P62.0@#X0QP`3UI=_P`RC^7KV5\;.T-S
M]O;`Q-3V?\1>V\I7]E=.]X[$@DW+L9-H;RJWSV*V_N/-XC[VBPF5Q$&16GAF
MJ7B@RL$:U-,QO+%!&6][-/93M<PCQ-ND.I'7*T;(!(X$5^P\1Y@8B>X?(>X\
MO;E)NMBIN>5KIC+!<1]\>B0ZE5V6H4J#0$T#@:E\PM5GL@ZC/JQ_X:Y?XK[!
MAQN\?D!N#XW5$E-65&4CP>Z>D_D=\@.TG@IZF"%,)+L>CWUU9\:#09*$/)!-
MD<C75<&DF:&Q6-SK;6L(0);PP>M"DDC_`&:=219^9)]1U('*4O+5B%N]]DV\
MD$MI>WN[J;!^'PQ)#:4.2"[,P\QP!V?.@/YBU%V?TQ3]<?$GIS>/4.PY,7N"
MHC[NWSM[H/H2G@V_M:*$[^W7M+8^P\;FNM>N^O\`9D=3%%6[SS"5F,PK2"F@
MILYG#2XFI'=GO0N+;P-NC:.&A[V$<>!\1"J"JJOFYJ%X`.]%.1^Q\_)N6T#;
M^5[2:TL2K'ZB1;:V`5/[5TCC#0Q11U`:X?4D==*K--IB;7=^='\P.'=R[KZ*
M^-^<KTZYK7R>`[+[FAAJ<)N'O''2Y23*5VU]NTM1+5;AVCT74;AFGKWH<AD,
MEN'>F1F;-[IK\ADIRL`-W;>!)JM+(GP#4,_`OFM!YB.M30DLY[I"6.($YTYZ
M%UXNR\ONW[O-5FN,JUP-6HH@-62V+5;2S/+<.3-<O)(V*AO8<ZBOKWOW7NKF
M_P"3SL^AZ_W1W_\`/K=F&7,;<^%G5E=D^O<-54]0]-O3Y'=KQ5O7_3>SX!X3
M#625>1R4ZVB9JFEKJB@E1"2I`FY;C$,DV[R"J6L=5'\4C]J+_/[02.I<]J+1
M+&YON>+I-=OL]L3$I!I)=SUB@C]#4D\,ABA`ZVTO]D0WC_PU=_LJ_P#%D_T_
M_P!S?]+G]ZO\D\W^S5_W]_V8;^(_Q+S^+[;_`$R?Y#]UY-/\,].GP_L^Y"_=
M,O[@^@K_`(YIUU_X;J\2M?\`3XKZ?+'64/\`4J[_`-;3^K6K_=YX7CZ\?[F^
M)]56M>'C]NJOP?+'1ROE[\=:;Y/=';AZZI<PNTM^XS(8;L#IGL2.(/7]8]T[
M$K4SW7&_,=((*B:%L1G:=8ZL1H7J,;45-/8K,P)GN-D+ZU,(.F8$,C?PNN58
M?8>/RJ//H6\U;`O,>S26"OX5\K++;R^<-Q&=44@P?A84:G%"R^?6EO\`S4NA
M)^\MLY#YX;)V-2[*[2V5N6/I+^8WTQBT5:WJCY%X!H\0G:5'CJ::NCJ.M.U&
MC'VN6CE--5/]K-Y*BIJJUX8RW^T-VAW:)`LZ-HN4'X)!C7_I7\CP.#DDTQ$]
MS-D;>;9N=K.$0[E#)]/NMN.,-TO;XP`K6&;R<&A[35F9R*.-C[TW/UOO/:?8
M.R<O4X#>&Q]QX7=FULW2>,U.)W!M[(T^5Q&0A69)(9'I*ZE1]+JR/:S*5)!"
ML4LD$JS1&DJ,"#Z$9'4,V5Y<[?=Q7]FY2[AD5T8<592&4_D0...OHX_RV?YE
M?3G\P[J.BEAK<!MSO;!8.*'M_IBHJ2U705&J2@JMQ;9ILDD<FXMAYUD$R20F
MI./^Y2DK'$NEI9HV3?+;>;8$$+=@=Z?Y17BI_.G`]9_>WON'M//FU`JR1[TB
M?KVY.0>!=`?BC;B"*Z:A7->(E;.^!FUNFM[4FY/C3W+W3\=]E2[@&=W-T)L[
M,[8W7T%GFJ<A_$<W!B>N^SMJ[UBZT?/R%DJ'VI4X151R8T1PCH_%M,=M*'L9
M988M53&I!C/K16#::_T"O1C:<DVVTW@N.7KN\L+,R:GMHV1[9JFK!8IDD\'5
MY^"8_D`:$2NQ.@OF?NG<+5NR/G[6]7[:DQ^"I'P&*^+W3>Z,E%5T-!1T^=RE
M)N#=M1DTCJL]70S5"1RT4]/1^81K&ZH-6YK3<Y'K%>%$H,")"?F:FO'CPQU:
M_P!CYNN9]=GOAMK?2HTK9P.:@`,0SDY8U-"I"UI0TZ3^+^,/S5H)I)*O^9EV
M5FT>/0M/E/C'\5XH8FU*WFC;"]>8B<R6!6SNR6)]-[$46QW0'-\Y^V*+_(HZ
M8BY<YOC-6YBN''HUG9_\^Q*?Y]"+\B/AUL3Y(?'/N'I#?$U'-NCNGKS;^UMX
M]LP[?Q=%N3+[KV52451L?>&0I<>M-"U-MS=>-BR<.*A>*BB:2>.(1B>1F>O-
MMBO;*2UEIXDJ`,]!4E?A8T]"*TX<?7I?OW*=ES!L%WLUX0;F\@5))](#L\8!
MCD(%,(X#A!115@*:B>M`/>'\K?Y1[-R^3P-7F/C%7Y?#9?)83*XZG^97Q6P]
M?C:[%54M'615^/WAV[MBOH9HJF!HW@FB2JB<%98D8$"(I-AOXF*$P%@2"/&B
M%*?:X_S]8.7?MKS+:2M"S[:TJ.58"_LU(*FAJ))T(SBA%1Y@=('+?R]_DOA,
M5D\S71=`/18C'UN3K$QOS+^&^;R+TM!32550N/PV&[[K\QEZUHHB(J6D@GJ:
MB2R11N[*I9;9KY5+'P:`5Q-"3^P25/V#/2&7D3F*&)IG%CH1232_L&-`*FBK
M<EF/H%!).`">BV=1=3[_`.]>S=D=/]6[>K-U=@=A;@H=M;8P=$!KJLA6N=4]
M3.]H*#%XZE22IK:N9DIZ.CAEGF=(HW8(;:WFNYTMH%+3.U`/]7D.)/D,GH/;
M5M=]O6XP[5ML9EOIY`B*/,GS)\E`J68X506)`!/6Z7\&/A[L[(]C=4?&[8-1
M'N7XQ?R[=[5'87>/8M&GAP7R<_F+U^-H#XJ:!R[5VU?C?CY(_`Q*O3UJ4E+*
M*@1F9I.VK;8C-'8P]UC9/J=O*6X(_P`$?\C09X]9><F<IVDE_:\O6)\3ES8)
MC+<2CX;S=2!P'FEH*4]&T*=5*];(7L:]9`]>]^Z]U6-\R/BWO"'?-3\M_CGL
M_`;W['DV35=<?)/X\9Q::EVG\R^A)*:2EKMAYF2J63%T?:>V,9--_=C+5,,J
MR!ACJLR43+$I%N5A()?WC9*'GTZ98SPFC_A/EK`^$G_2G'4<\V\MW:WIYIV"
M*.;</!,5W:M0)?VU*&-JX$R"O@N0:_V;50TZTW_FO_+SP&'V=F?F!\))-P=A
M?$RHR]?2;^V-EZ'(0=Q_$3>=*U,<_P!7]T[8KP^<HJ';M;6>&#)2^;Q0A!52
MR(U-D*^-MTV9%B.Y;75]OKW*?CA;S5QQQZ_M\B<3><.0X(K1^:^3O$GY7+D2
MQL#X]C(*:H;A#W`(30.:T%-1(TR/5'MG=&YME9_$[KV;N+.[2W3@:R/(8/<N
MV<OD,#G\-7PW\5=B<SBJBDR..K(M1TRPR(ZWX/L/QR/$XDB8K(#@@T(^PC(Z
MC"VN;BSG6ZM)'BN4-5=&*LI]592"#\P>K8]I_P`]_P#F?;3P-!M^/Y!TFX(,
M;"E-39'=G676.>SST\2)'&E?G*K:0R.6F73=JBKDGJI&8EY&XL((^;-]C0)X
MP8#S*J3^VF?SSU*%K[U^X]K`L`OA(JB@+PPLU/FQ2K?:Q)/F3TH_^@@+^9__
M`,_HVC_Z)SJW_P"Q;VY_6_??]^K_`+PO^;I1_KY^X_\`REQ?\X(?^@.GO%_\
M*%_YF&/ADBJ^P>M<X[R:UJ,IU'M&*:)=*KX8UPM/B*<QW!:[HSW)]5K`67G'
M?!Q=#]J#_)3IZ/WX]Q$%&GMW/J8$_P"?0HZ<_P#H(F_F3?\`/3]1?^BIQ7_U
M=[M_7/>_XH_]X'3G^OW[A?[\M?\`G"O^?KW_`$$3?S)O^>GZB_\`14XK_P"K
MO?OZY[W_`!1_[P.O?Z_?N%_ORU_YPK_GZ$'JW^>%_-Q^0&^<'U'U%0[![!W]
MO2=L5A-L[<Z:PM?75+3(5J*JH^ZJSC,?B<?3EIJRLKFCH*.G1Y:F1(4=@];\
MT\Q7DHMK8(\S8`"#_B@/4G`&3CI?MOO)[I[[>IM6U+!/?3'2J);J2?4FIH%`
MRS-15%2Q`!Z.W\&_@]N3HJOW+\;OB_G<!NOY?[HI8MN_,?YK8JAFRG6_PGV-
M614;;CZ%Z/W)]K54FZ/D=EZ>:05#PF`T<RQM4BF^W#4QIM6U/:%K*P(;<FQ-
M.,K`OG&A\Y#_`"\Z4P,.3.3;C97DY>Y;=)>:Y!HO]P45BV^,TUVUN]"'NV%:
MTII--6G3V[1?1O1W67QQZOVMT]U#MJFVKL;:-&U/CZ&)Y*FMKJRIE>JRF>SN
M3J"];F]QYW(2R55=6U#O/4U$C.[<V`\M+6"R@6VMETQ*/^+)/F2<D^9ZR2V;
M9MNY?VV+:=JC$5E$*`<22<LS$Y9V-2S'))J>A:]J.C3KWOW7NO>_=>ZK^^0G
MP=&[^Q*CY)?&??T_QT^5"T5/1YC=N.H6RO6'=^(Q].T%-LOY$];++!C=]X.>
MFTT\>33Q9S'(D3P3M]M!&I/>;5XDWUMB_@W],GBKC^&1>##Y_$/(X'0&WWDS
MZN_/,/+LYV_F6@#.!JAN%`H([J+`D6F`XI(F"K=J@:Z7RT_E]_&WL3<%4_R/
MZ_JOY5OR*RT_V5+V)MZ@_O[_`"[>Z]R5$DLD>0P.\L?!CH.H,MFBHDDH,I/@
MA00OS3Y"H#LP,W#9[*9_\=3]WWI_$.ZW<_)L:"?0Z:>A/4!<T<B\O7\Y/,$!
MY9W]C02J/$VNX<^:R``0,W$JYCT@_#(U3U4[W;_)T^>_3=&NX\5U`_??757"
MU9A.S?C9DHNY-K9[&JTELI08[;D1WO!C3"@D\]5B*>'0?U'2^D/77+>[VPUK
M'XT)X-$=8(]:#NI]H'48;Q[3\[[2GU$5I]=8$56:T/CHP]0$_4IYU*`?/CU6
MON#;>XMIY.?";IP&:VUF:6WW.(W!BZ[#9.GN64>>@R,%-5179"/4@Y!]DCH\
M;:)`5;T(H?Y]1[/;W%K(8;E'CF'%64J1]H(!Z9?=>F>ANZE^-/R&[YJZ>BZ7
MZ0[4[0DJ9C`E1LC8NY-PXV%EE\,DE=E\?CIL5C::"7B2:HFBBB(];+[56]C>
M79I:Q22?Z521^T"G1SM?+N_;VX3:+.YN23QCC=A^;`:0!YDD`>?5I.Q_Y->;
MZWBV_NO^83W_`-;?$+;69>EFQ75M%DJ3MGY+[YCG9_!B]E]7;%FS35%?E&58
M(VA?)55-/(!+0LZF(GT7+3P`2;Q,ELAX)77*WR55KQ_,CTZDFR]I9MO$=USW
M?6^U6[TTP@B>[D^4<,>JI/`4+L"<I7'5^?Q.^#&^J_:K]=_&_J;>W\N[XK;B
MI4I^Q>Y=\U./G_F-?)C$K9#0?=-354?QMVOD&C+O&\<62IW59*2@I!42@"[;
M]JE,?@V,;66WL.YV_P!R91_UC'\QY`5ZG#ECDR]>V^@Y?M9M@Y9D%)9Y"#NM
MVOI6A^D0^F''%$74>KVNG>F>K^@.OL#U9T]LS$;$V)MN%X\;A,1'*?)43MY*
M[+9;(U<M3E,_N#+5),]=D:Z>HKJZH9I9Y9)&9B++:V@LX1;VRA(EX`?X3YDG
MS)R?/J:MIVC;=CL$VS:84@LHQA5]?-F)JS,QRSL2S'+$GH3O;_1CU[W[KW7O
M?NO=>]^Z]U[W[KW2=W?_`'2_NMN'^_O]W/[D_P`(K_[U_P![_P"&?W6_@'V\
MG\4_O#_&?]Q/\(^TU?<?<_L^.^OTW]TD\/PSXVGPJ9K2E/.M<4^WI/=_2_32
M?7>']'H.OQ*:--,ZM7;IIQKBG'K7^W;_`,-D_P!Y]P_[([_LW_\`I1_B)_C_
M`/PU/_I:_NK]QKJ-/\1\7_.&_P!G]UJU?=?M:M'E]&CV$)/W'K;]U?4^/7/T
MFNGY_P"@_MZ@VZ_UNOJ9/ZF_O7]Y:N[]R^/HKGC_`,0*5]<<*XIT[R;;_F!U
MN&IY,KW/\DMM]?"FJVI*3YL_&7^6'O6!Z/[?-'(QY3([:^6VP-X1H8&B%4]=
M2O((E4JA@9U2VC>"O=+.L/\`P^*U;UK6DRG[:C^73IM^>GA!EO-PCL:&@W"T
MVB04HU:E+Z*3A2I85IP%*T0.`VI\L):QEV_WU\2*++_;9,XV?KGXD_!/*;N%
M8*>I^X7#TF1^:^'QYJ6B\OD::81JNKR`KJ]LI'N%>R:V#9IIA@)_*LX'2&"V
MYH+T@O=J66AH8K+;F>M#72#N"BO&M33C7I4[PQWR;Q\]$GREWA_.0W;LXN!-
M4_%WK?X?=>;#7":W*-D:+XB=J]G]SMM\46E2M+4#(&/U$Z+K[<D6^!_Q]MR:
M+_A2PJM/GX+L]/LSTINX^8XV`YEEYMEM/6SBL8HM/S%C--<::?PG73Y='3^"
M?_#6_P#'LK_LI/\`HV_TTZ&_O=_?O^\W^S4:_M8/O?[U?Z<?^,Y?;:-/EU?Y
M!>VCTZ?9GM/[AUG]W:/JO/57Q?S\3]3_`"=##DK_`%MO';^JWT_[W_'XFOZW
AAG7]1_C-/7\/IU:=[/\`J2NO>_=>Z][]U[KWOW7NO__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>j06224092_aa002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j06224092_aa002.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`8P!C`P$1``(1`0,1`?_$`:(````&`@,!````````
M``````<(!@4$"0,*`@$`"P$```8#`0$!````````````!@4$`P<""`$)``H+
M$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M``P#`0`"$0,1`#\`W]/?NO=>]^Z]TU9W/8/:V&R>X]S9K$[=V]A**HR69SV=
MR-'B,-B,=21F6JK\GE,A-3T-!14T2EI)972-%%R0/=7=(U+R$*@%22:`#YGI
MJ>>&VA:XN76.!`2S,0JJ!Q))H`!YDFG53&_?YH62W[C]U3_";JG$]H[*VA(U
M)NSY<=];THN@/AKM"H2K%'42TG86Z5I\WVDV-J$=*J'!4ZQQJT<J5,D;"X>F
MWYIE8[7&)(EXS2-X<(_VQR]//3^WJ+[WW(DODE/)]JMS9Q&CWUS(+:P0UH:2
MO1IJ'XA&*#!#$'JD?OC^:O@Y:G)8GNK^8AW]VW7J)%EZX_EL=<;;^.75.&RR
MF1:G'#Y']H_?=N[MP;<(*J@I9(G0*T3:B\A"]WS`A)6ZO)I#_#;*(T!]/$?O
M(^8'V=0[O?N;"6:+>-^OKJ3_`'UM,26L*MYCZN:L[K_24$4X>9Z-U\5/C!\3
M>Y^J\U\I/FS\1:CX_P#0HHJ&OV?V7\NOF_WEO?LG=U=7Y6EAP^[LKAMQUFPM
MG[-P&9-?(,=4N5R5=4U(-,DM+4)*YCM]AMUS;F_W2V\&TIAIIW9C4X)!TJH/
MEYDG&#T*N6>6^5]WVQ^9><-J-CLFD&.:^W&XDE<EAI=E<QQQJU3I/QL3V@JP
M))NQ^&._.W,MB/A__**_TW]-X'<>"VYENS.K_F3N3`=AY.&MR#/+48[`===L
M9*;#_P`6AHVFQ.-R64@J*_P*TZ4S%HX"W_=9-<%=NV[Q;8,`628ACGR"OBOD
M"03YT\@D?ZHWNZ-%RIRK]9M"2*C30W[K*:GB%BG.G52J([@M3N"G"VH_(SIW
MKCX3=:X3N#K'Y=_S#N@:8X:+>#['H=X#Y+;:Z^VI?#8[+[W[`^/G>%9N/,5F
MTMG9O=F*H,Z^,JI'H*K)4PJ0%:.:(^O;:#:X!<P7%Y"*5TZO%"C%6:-ZF@)`
M:AP2*^O4E[_M.W\G[>FZ[=NN_6*Z/$\,2?5I$G:&DEM;@NQ2-G19-#$J775B
MA$7X^?S,_D3D,>^9Q\'2W\R3J3%H*O/[X^'-16]>_*?9FWSHT9W?_P`.NRZF
MCW!E*FHFE$:0X.HAB%C9F:-U]ZL]\O2-2^%>VXXM#VRJ/5H6R?\`:]5V+W$W
M^1/&C%GS#M2Y:2P)BO(U_BEL)B&)/"D9`^T@]6]_'KY1=%_*;:M5NOI/?N-W
M7#B*E,;NO;TL55A=[;$SA5_+M[?FRLS#1;EVEFH)8I$,-931"0QLT32(-1$=
MG?VE_'XEJX:F".#*?1E.0?M'4J;#S)LO,ML;K9YUE"&CKE9(V_ADC:CHPSA@
M*T-*C/1@/:SH]Z][]U[KWOW7NO>_=>Z`_P"0_P`BNJ/BWU?F.W.X]PG!;7QD
M]+B\?245)-E=R;MW1E/*F!V7LS;](&KMQ[MW#41&.DI(1<Z7ED:."*66-+>7
MMO80&XN6I&,#S))X*H\R?(?Y.B;?M_VOEK;7W7=I-%LI```U.[GX8XU&7=CA
M5'S)HH)&K?\`S!?FL,;5XW=WSUP\^Z=T5PI=W="_RK]O;E%/L'K_`!C3B?:G
M9OSNW9A7\F[]VU45.M;2;0166F#+#+!3QU%4R`/>-TTD2;N-4AS':@]JCR:<
MCB?,)Y>@J>L;.>N<!&RW7.Z&2Y:CVVS*](HA^";<G7XW--2P>7`JH9J:YWR:
M^8_R`^6^?HLKW'O62MP.`'VVQNM-MTL6V.J>M\3%%]K18386P<68\'@:*@QZ
MI3)+HEK98(U$\\K#5[!=]N5YN+AKEJH/A4811Z*HP/3U]3U`7,7-N^\TSK+N
MTU8(\1PH-$,2\`L42]J@#%<L0!5CU<]_*S^!/1_5?1V2_FF?/QJ:EZ1V!Y<U
MTQUGEZ*.MAW_`)G'5_\`#L/NC*X:5BVX$R&YT%%M_#.@BR-8OW54?LD3S";8
M-HM;>T._[O\`[BIE%/XB#0$CSSA5\SDXXR[[:\D;-MFS-[E<\4&S0=UO"PKX
MK`T5V7\57[8H^#-W-V`5K^^??\SGLOY^=E1;DW]3[MVOUOM#-U-=U)U5M3>]
M%B\!LNG`6&CS61D.SJNJW%O^>GCU5.6FD!C:1XZ..EISXO9/N^^S[O/KFU+`
MI[$#4"_/X<MZG]E!CH"\\>XVX\\;@+B^$L>WQ.3!"D@58QY,?TR6E(XN3BI"
M!5QTA^KNU/BQDMDTB_([L[YWS[CH,SEJ?;&V^I.P=EY_`;<VRU#@D$U9-V'C
M<%'1Y/,UU,ZF''":'[:CA,K!]**U!<6#1#ZV2[U@F@1E(`Q_$!D_+T'2/;=S
MY:DLQ^_[G>S<*[!$@EC942B\3*%H6(X)4445SCJR+X2?+O\`EY_%K/=MY+IG
M'?(KMSMWY#=39KI7";8^35-UKD=C5F;W:U(,'M_>U?A4V]$FV-Q[DH<=0YIY
M,JM(,<&9I`(U=#O:]QV>P>0VPFDN)HR@$NG34\`Q%,$T#9I3J0>3N:N0^6I[
MJ3:%O[K=;^U:W5+L1&,L]-*R%=/8[A%D)?3HK4XJ*Z?GMT+G/Y?'S?WUM#I[
M?U;A,?@<Y+O?IW>.P-YUB;AVSMO*Y/*TE-@'W-AJFCRU%NC8>9QM=@:YF,%1
M)48YY'1!)I!+N]H^S[J\=LY`!U(5;(!)Q49JI!4^>.@#SOLDW(G.4UKM,Y2-
M'\2"2*0ZD1BP"ZU(8/&P:-N!)0D@5IT<?X^?S)L#W-O':E7\F]Z93X[?*O;T
M,.'ZP_F,=08BBQV?DM'!38_:GRYZXQE'#@.Z>N:MH(H:JN:%:N"GC431R1O5
M3L9V>]I<R*;YC#?C"W""A^0F48=?4\:?F>A9L7N%!N]W$W,<S6',T8TP[K`H
M#>0"7T2C3<1'`+4U`#((+-UMM?#WYLYKL?=]7\9/DQB=L=??*S;6VZ'=6'FV
MIE?XIU+\F>LJFC6;'=Y_'K<4JQQYW:^8@1JBJQ@>6LQ8U!RPCJ!32'MNZ--(
M;&^"IN"K44-4E7RDC/F#YCB/VTRCY4YQFW"[/+G,2QP<S1QAUT-6"[A(Q<VK
M_B1N+)ED\ZT;38_[.NI`Z][]U[IDW-N7`;,VYGMW[KS&/V]M?:V&R>X=Q9[+
M5,='B\+@\-1S9#*Y7(U<Q6*FHJ"AIWEE=B`J*2?=)'2)#)(0L:@DD\`!DD],
MW%Q!:6[W5TZQVT2%G9C0*JBK,3Y``$D]:B'S*^?>0P]-C?G[OB)9>Q=_0YC$
M?RM/CMNNC@K<?U#U;3SSXK+_`#B[.V?6I5XNK[`WG.)#M6*LB9(XVA:%JR"`
MRT\=[EN[*!N\O]L]1:QG\"\#.PX:F_!7Y4J!48K\V\\21*O/-[F_G#+LUJXJ
M((02K;C-&:@RR?Z"&%`*4UJ*KJJ[IW3N3?&Y,[O'>.=RVZ-U[HRU?G=Q[CSM
M?49/,YO,Y.HDJ\AD\GD*N26IK*VLJ96>21V+,QN?8`DD>5S+*2TC&I)R23Q)
M/6,]S<W%Y</=W;M)=2,6=V)+,Q-223DDG))Z8?=.F.MC>@R7:W\QSX,?%;IW
MH/:'96_LA\2L3@]D[BZ?VML_8.:V!4;SQ^)W'CZSL'M^HW=V;L-J>ES>RJ^B
M39E12+5Z<C29^.I6.2IIS&-%:XWK:K>VM%=S;@*4`4KJH>YZLO%::"*Y#UXC
MJ?XY-SY_Y+VS:=DBN)WVM5C:!(XFB,@5P99_$FBH&C*_3E=7>LX:A9:5"]I=
M?]F]6]C9?:^Z</U/L#+[3W%-MW.X*FJ/CO)NS;&?P4_V^8I\CML;^W+D<7EL
M;D89$T39"-2\8(:,DJ`[<0SP3F.01HRM0C].H(XU&HD$'Y]17N5CN.V[@]M<
MI:P2Q2:&4?2ZT931@4\5RK`U&7'#RZL#Z<^1>^.L.G\)B<)_.#CZ"?*RY3/9
M+IC;G2G8&=S>$R&3R$N*EK<INOJ#:V[NO*S(9/'8FGK(_#N":JIJ22))4IZD
M24\9O;7LL%L%3<O!K4E`C$@G&2@*U(%?BJ!3@<=#K:=_O=MVI(H>:_H2Q9C;
MI;RLRDG34O`CQ$D*&%)20I`(5JJ#0?&G'_-WYF;DW7L/XN_SE>T>Q]^[6V?6
M;PGQ&8Q/R6V+@5HX*^@Q5-'E-W9W%-C,0*O(9*-1=)IFC61HH96305]B-UW-
MVBL-RD>95K0B11Z9)%!QZ$?+J<Y<W7$MERWS;<W%]%$9"K+=QK2H45=EHM21
MZFE:`TIU7)_-7PG5?77=6T>D]@]B0]T;_P"M-K9VN^4/=:)12R=E_*;L7?.X
M]Y]LY(Y"F\TE5#AY*ZBH1"TSBAE@EIW454=5+,2\P);PW2VL+^+,BGQ7_BE9
MBSY^6!\N'&M0![FP[9M^\1;/8W`O+ZWB8WEQC]:\ED>2<U''355I7M(*GN#$
MU=>R'J-NK@OY?ORNH=S_`-R/B-W[V/E]AXN@W?0;A^''R<2=*G=?P[[X:>G3
M;[TN1R'E$G0^_P#(PT]#N;!S,,8@9:K_`"8">IC$>S[@)-&W7CE%#5AE\X9/
M+)_T-N#+P\\9/4K<B\SI<^#RMOEP\$:RAK"\K5["YQIH3_Q&E-%FC/9P;M[F
M&[Q\(/E/D_D9L7<^U^T,+1;$^4'0VXO]&?R5ZPI]<46WM\TD)DH=U[:AJ9IZ
MJLZX[(QD8RN!K0\L,U.\D*S3-3O(92VN_:]B:.<!+^%M,J^C>H_HL,J?R\NL
MQ^3>99-_LI+;<D$',EC)X-W"/P2#@Z5))BE'?&V014`G23T=CV:=##JG;^:#
MV!@NPMR]4?";,[I?:G6>\MN;P^3?S/W/1U<U-5;6^'/0GAR^?Q%3+1O%D,=%
MV]O:*FPL59`Q*1TM3&R.)0K!O?9DF>/:V;3`RF68^D,>2/4:VHM?D>HG]R+Z
M&_N+7D^67PMNFCDO+]P:%+"V[F4TR/'DI&&'#2PH:TZT4_F'\E]P_+7Y![\[
MGS-+_!<-E:R'!]<[+@$<6+ZZZKVU'_">OMA8:BIC_#Z"CV]MV")9EIDCAGKG
MGJ-`>9[Q1N5\^XWCW+84FBKY*@PJCR%!Z>=3Y]86\V<Q3\T[[/N\PT0L=,48
M^&*%.V*)0,`*M*TH"VIJ5)Z+%[0]!SKWOW7NC*_%#Y:]V_"_M[#]S]%;F&"W
M+01_P[,XJO@.0VQO/;4U53561VGNW$&2'^(X/)-2)J\<D-53R*LU--!.D<JK
MMOW&ZVRY%S:-1Q@CR8>8(\P?V^8(/0AY8YHWCE#=4W?99-%PN&4BJ2)4$HZ^
M:F@X$$&A4A@"-CCK#8G\O7^<]O'?_:.9[P[/Z=^96[L<M3%T9V)6]-9K9^-K
M\;A:2FHZ'9.?W%U-/OCLOK^#)12N*>ESE#F<;CW\"4M)3T].[#2"+9N9I7N&
MEDCW)A_9MH(&/PDIJ9:^C`@8H`!UD!MMER)[NW<^Y37ES:<VRK7Z:4V[("%`
M`C9X#)-$#7`D61%[0JJJGH._@_\`%/Y-=N=K;AV1/TO_`"X:#XH]$9/*;2WW
M\G:CXO=$=M;*WG#M?(1U6?KNM^S=W;6DW-V9NJ:DDF6HR%5518/#"&5*M*>:
M&&BD9VO;[ZXN#$8K(;?$2&E\*-U:G'2Q%6/S/:OG0@#HOY-Y9YBW7<Y+-K/E
M]>6+)F22\-G;3QR:#5C%,Z:YGI6K$B..A#!2`A07S?\`YJ72?Q[P_87Q6_E+
M;7VKU+LS=V?W+7]T?(78^$@P^6WKN',U%3][1]0Y&DE@.$VUC5KJFGH\A3T]
M-!00%(=OPT-'%#/,SNN_VMFK[?R\JQQ,3KD44+$_P'R`R`1@<$`%"47.7N9L
M^PQ3\L^UT45K:2NYN+J-0K2,Q-1`1\*"I"N``HH(`B`,=;1F9V9W8LS$LS,2
MS,S&Y9B;DDD\GV">L>^.3QZZ]^Z]U[W[KW6UU_+_`/F['-0?'KYL;BRSQ;OZ
MGS6Q_@5\_JZHGE--N7HK?^J+XL?);=D@UT])DMA[MQ'\"RN6G6:OR"0R(SHL
MB:I`VC=:K#NCG]2,K!<'UC;^RE/^E(TD\3UDYR-SD&2PYPN&I=VKQ[;N9)P]
MM+_N'=OY`QNOANYJS`$$BHZW&/<D]98]:4?\T+Y`9+*;`^>_<]/754.2^2'R
MPV]\$>N5D<Z\;\>?ASB3N7M*IV[4B0S4V&["[GK:.2KBX\ZO,ITQNR21AOUX
MS0W=R#W3W`@7Y1PBK4^3/2O6'_N1OLDECOF[JQ$FX;HNVQ?*UL%US%#Q"RW!
M4L///`&AUB?8%ZQRZ][]U[KWOW7NO>_=>ZV*_A-_*!V-L/J>'YT?S0=SOTK\
M==M0T.YL/U#D3E<7OG?]+*ROA4W9'CA'N3`T>XJIHHZ#!XZ-]Q94.?\`@$OC
M:<9[7RY%#;_O7?F\*R7(3(9O2M,BODH[C\O.?.3O:JRLML'.GN1)]'L$8#K`
M=2R2C\.NG>H<T"QH/%?^AC5;U\/?YQ7Q3[NRG96P^Q\I\8OC3\/X\)D^INF^
MC-_T]9@>PJW;V"PF`7*9/>N,I,75]&XWK/?.!W15X^GQ"5L4M+/BWI46O222
M=1'MO,FWW3/%.8(-NH42-L-0`5+"F@*P)`%<4IGCU*O*GNQRQO,EQ9;@VV[=
MRIH,$%M*"LI156ID`!MQ#(KLH0,""A4:P2>J&?YA?\O?JS^XFY_G/_+\EK-Y
M?$1=_9W:6]=O4=6F=?J[+4=31M2[GVW74]9DJZNZEST.6I-"9!H\M@*N<4M;
M&!<4X2WG9H/";==GJVW:R&''2?4<>PU''*G!^4)<^<B;9]%)SIR*3-RKX[)(
MH.KP6!%'0@DF!M2_%1XF.EQ_#2!["W4-]>]^Z]U[W[KW5I'\IS/T>X>^.P?B
MCN2J\.ROF[T=V5\=ZTU$C&@P^_LE@:K<_4&\/M>8ILOM_?\`@*:"C=PRPG(2
M%@4+`GW+SA[M]O?^RNHFC^QB*H?M#`4^WJ2?;"=)][GY8N#2SWFRFM37@LI4
MO!)3S995`7TU'RKU>#_L]7;G^CO_`$C?=Y7^$_\`#'?]V--GU?[-[_LT?^RK
M>?5Y?^+U_?;U_;V\FGC7^?8J_>UQX/C5.G]U4_YO>+X7[=74R_UTW7Z#]X5;
MPOZFZ/\`J.^L^BK_`*;Q/+^?5*OSLW559#X7_P`M'$S2PBHW3MSY;=\[@6*I
M9IZS<G;GR0SD#U5?"UB[T&)V=3T<,UE23PRE$0M)J"^[2$[98J>++-(?M>0_
MY%IU$'.MRS\H<NQ&FJ6.^N6SDO/=MD_8L84'SH:`9ZJ@]A_J,.O>_=>Z][]U
M[K9%_E*?"OI?J#I3=/\`-9^<M+1KTSUC#59'HO8^7HX*T[RW1A,LV-IMWKAZ
MV2&GS.1DW;2IB=L4$I\55E#)52F.*""5QKR]M=K;6K<P;K3Z9,QJ?Q$&E:>9
MKA1YG/D.L@O:[E#:-JV>3W-YS`_=%L";:-@#XCJU!)I.&.L:(5."]6-`JDDZ
M^=/S?^2/S1[KF['KOD)L3KO9F`-;2]5=<[&[8S>(Q.PL!DXJ;[F">OHL;AZK
M/;MR,<$:Y?)RH!4SQE*=8Z-*>%"[==TO=SNO',R)$/@57("@_D*D^9\_+%!T
M$^=.<>8.;]X.X/?P6]I'40Q1SLJQ*:5%0%+.:#6YXD46B!0&7^7M7_(G(IVQ
MAN@=G?#7M7=V3JMN;KWOGOE'B^M,KFL)04[YO%TU%@<[WLV%PDL>8R.1:>K7
M&U-5/(\43264"]-F-Z?$6S6VDD-"QE"D@9&#)09/&A/37(C[_(+J+8XMHN;I
MBCR->+$S*!J`"M<Z5[B:MH))H">KN_C%OSYY'L[;V*^9N,^+.Q?A3U/UY\@L
MIV5L7HS=?Q]RF!W_`-?Y;JG><^Y]D1]*=*]H9S);JI,OEUI<UZL`U53S8YRC
M1I45<<XIL9MV\<+N8MTVR-)"RQF,AE*-5=".:U-&^&HI\S68^7+WG;]XQQ<W
M+ML/)]K!=-+';/:LLL30R:X_I[>9BX9J2?V6H%32@9@VIMWQM;9FR>Z^U]J=
M;9N3<W6V"[!W90]<;EEI\C3/N3KU,W6/L?<!BRM%CJXKF]K/250=X4$BRATU
M(RL8]NXXHKJ2.`ZH`YTGU6O:<^HH>L7][MK.SWBZM=O<R;>D[B)Z$:XM1\-N
MX`]R:3PS6HQT$_M/T5]>]^Z]T/7Q7WC4==_)WXZ;^I:E*.HV7WIU+NJ.IEE2
M&&$X'?N`RC-422QS0K3::8B36CH4)#*RW!5[?*8;Z&88*RH?V,#T=\LW;6',
M>WWRFC0WL#U_TLJG/RQGY=;3O]T]M?W6_P!'G]V>?^@A?_96O!]RWVW^A#_3
M)_LT7]V=?\5\?\(\?^4:='D^[]/BU_O>Q]X:>'X.G_EL^%_M-?BTX\//[>LE
MOI;?Z;Z#P_\`G?/H^./I_'^LT?%\/GP^+%*YZH6^;&+(^*7\K_<`%8@G^.?<
M&S:FGJJ"IH_M<ML7Y0]LTV9I&-5'%(:RDR&7>&:,J-'C5@2LBGV$MT7_`'7V
M#Y_L77\UE>O^'J$N<8_^0QRW/G.WSQD$$4:.\F##/F"U"/E\^JT?9'U'?7O?
MNO=>]^Z]UM&?S1N\7WKT#\,>O=A[<K)_A9U+T;T-N7/]@[3&Z\5L_'=R;JV6
M]/L/;TTFTL=/44N2VGLK%RR4,-2:&)*K*5$;O]S#&BCW?KKQ+2UAB4_NR.*,
MEA4*'*]HP.(48K3)/GUDG[D[S]9L>T6%E&3RA:V5L[2IK6,3O'2)>P$@I&I*
M@Z15V!.H`=4;U_9/7T=7*F,S=964(T>"HK^S>\L=5R7C0R^6BI]N92&'1,65
M;3R:E`8Z22H"IGAKVDD?Z:0?Y#U#+[C8!B(W)3R)FN0?V!&_PGH=.J^P?Y?V
M5V;5TOR7Q/R&W!N:?-//0T'6?=F>H]JTN"2AQYHDR5/OCJK=%56;@3)FK\CP
MM'3I%X@FIM;>U5O-L[1$7PF+UX*YI3''4AS6O1UME_R++:%>8EOY+@O4"&X<
M(%H*5$D+DM756E!2E*YZLO\`B#_+8^$/S-FH.[.M\+WUTI\7^G,OF,QWIV+V
M]V1B:_;^_L#AL/)69/K[:F738'7<F$BBIRTNX<NDM5#0XLO"?%4SPNIYMVR;
M5N=+J`316$1)D9V%&`&5!TK3^D<T&.)'4A\J^WO)O-Q7>-O2^L^6[1V:YEGE
M!6556IB1O"BTXS*X)"I489@>J0_G%V]LWOGY<=_=K]<8^FQ?7>ZNP\K_`*/Z
M.DQ,&"@78V"CI]M[0J%PU-!31XUZW;V'IIWA*"1'D(D+/J8A;=;F*[W&:X@%
M(6<Z<4[1@8\L`=0WSGNMIO?--]N>WJ%L);AO"`4*/#6B(=(`I55!IQSG/15/
M9?T&>O>_=>Z$SI7!3;H[DZEVS3B<S[B[-V'@H!2T[5=49LONG%8^,4U*A#U,
M^NH&B,<NU@/K[?M4,ES&@XM(H_:1T8[/";G=[6W6NJ2YB44%3W.HP/,YX=;=
MWW3_`,6_O%]E6?PO_H*9^U\NFGUZ/[E_Z+?O?']Q?[/^^'[-_P#.>/UZ+>Y%
MKW:Z'3^_O^?='^'K*C4?%^HH?#_URJ>7^^_!KQX>)CUIFG587\R7J&LP'QBW
M[UY'0Z:WX'?S%>_M@18^")4J,3T7\N,=B^Y>J-SY"G15>GQV9R.WI*:-WU()
MG18W8/92+>[8I8O#3-I>R+]D<P#H3\B13J./<+:F@Y<GL`O?LF_W,5!Q6VO@
M+B%R/(,5('SI0YZH"]A#J#>O>_=>Z][]U[JP;X@_)/I/`X67X[?,G;G8^\OB
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MJ@[DFE<ER>"JP9624X587C#,32H-`3F?RUMJ?+?XB_&2'<WSV[,V%\0?@QLG
M;FZX\1T)G=OXBG[+W9+ORMR^9R/]XL[ECF^Q-JS9;+[BJ&IL-3UC[EJ:IA3Q
M4M$JQ^0RV2/<=NL?$W9TMMJ132,@:CJJ<DU85)P`=1.`!T+?;VUYIY5Y<%SS
MO<P;5R7#&^FV95$S^(68ZV;5*FIF-(PWC$]H5,5H\_F/_P`V+*?*';N*^,OQ
MGVF_Q[^%.PH:?#;?ZXP<5'@\EV'18:H#86NWI184+18K;]$84GI-OP2U%.E7
M_E57-55"TYI0MO7,+7Z"QL5\':TP%&"U.&JG`>B^N22:4AKW`]SY.9+=>7>7
M8OH.3X`%6):*90I[3(%PJCBL0)&KN8LVG33'[#/41]>]^Z]U[W[KW5BO\I_K
MC&=B?/GX_P!5N4-!L;J?<60[_P!_YB2)Y<;@-J]%87(=GRY/-E0RQXF7,;;H
MZ.36"DCU21D'78G/+\*S;O"9/[*-O$8^0$8+5/RJ`/SZ'WMAM\=_SQ8M<8LK
M60W,K>2I;*9JM_1U(JGR.H#SZMW_`-('8'^@K[3^';I_OC_H)_X>H^WO0_\`
M%V_X<:_C/\;MX_)_'?\`01_E7EM]I^;Z/5[$?C3?24HWB^#];^?U-:_;X>?3
MJ5/KK[]RZ=,OU?T7]8*8^+]ZZM7^F^FS7X?RSU9I_,?^-^'J/E)G<5N.2DPG
M3G\SSHNF^+.XMR58<8G:/S+ZHJWWI\4=[;BD6"5Y/XVF-3"4<$6EI?M)@734
MNH\WJR4WY5Z"VOHO")\A,G=$Q^VFD?8>I%]P.7XFYE>*XHFT\QV0LW<_"E_"
M?$LI'Q^*GAJ!QTG(ZT8-W;4W%L/=6Y=D;OQ%;@-U[/SV7VON;!9*!Z;(8;/X
M&OJ,7E\76T\@5X:JAKZ62*12+AE(]Q5)&\,C12`B1200?(C!'6%]U:W%E=26
M=VACNHG9'4X*LI(8$>H((/2>]TZ8Z][]U[JU'^7U_*-^3/S_`*F/<VW:>FZK
MZ,I:\T>7[IWKCJR7&5LD,QAK:'K[;D4M#7=@9>B9'$HBGI,;!)&T51702E(W
M/]GY=OMW.M/T[2N788_VH_$?V#U(/4E\B^UG,7/+?4P`6VRAJ-<2`T/J(DP9
M6'G0J@(HSJ:`WCT7:W\LS^3D*_K/XP87;'RH^:]'C*NGW9V1O+?^P\#C-K5H
M:&ER%-F^P]S9K"[*VC+2MD'C3;.V3+F98H7@R51&RM5>Q4+C8^6ZP6(6XW0#
M+%E`'K5B0H_TJ]WDQ\^IF3<_;KVGU;=RVD>Y\X!2'EDEC4(>!#2NRQI2M/!A
MK(0"LC#+=+KJ_P#FC?R[4R_8N7^;GR,V3\LNP\IF]P8/;F8IOBGVA%UYLKKO
M(TD&,RFQ-E;.W(_8&U*7!Y:2F<560H52LSM)X1D:FN\43H[!OVS:G;=)EN)B
M2`?";2J\"J@ZA0^9&6%-1..ENV^Y/(0EN)><;^'=+]G94864WA1Q$`-''&_B
MH%:G<R]TBT\1GH""0=W_`,G[K7YG_'_'?-?^69%A<3)GWW))NKXOP[Q?<&!.
M4VWN+*X#*#J;=FX<?MO,8>;(?PP9&DPFXZ/%RRT-5&43'R>/'$KNN6X-SLQN
MFQT!-:Q:JBH)!T$@$<*A6`P?P_#T#=Y]J=NYNV)></;L(IDUZ[/Q-2U1F5O`
M=@C+6FI8Y50E2*",TCZUHL]@<WM;-Y?;6Y<1D]O[BV_DZ["YW!9JAJ<9F,-F
M,94R461Q>4QU;'#5T&0H*N%XIH9462.12K`$$>P.Z/&Y1P0X-"#@@CB"/7K'
MB>":VF>WN$:.XC8JRL"&5@:%6!R"#@@Y!Z:?=>FNO>_=>ZO2_E[]&;HH?C%N
M2+;E/)0]V_S-^Q*#X1]&5?VYDK<!\>\%D:7=7R][<^U75+E-F4F,QU-A*LQF
M-X)J2=B'53I%>SVD@L6T8NKY_`C^48S,_P`UH`I^P]31R)LMRG+D@MQIWCF.
MX&WVQIE;52'OIZ><8`$;4I0J>(ZW9/\`9/NA?^>.A_[)B_V3[]4/_,A?^>._
MX#_YG_']'^T>Y/\`W;:?P_Z!X/\`S;].LPOZJ;)_OH?\D[Z'R_W&_P!]\/\`
M8^77#YD_&+;WS`^.O871.=RU3MBLW+1T.3V9O?'QR-E=@]A[8R%-N#8^],6U
M/4458LV#W#CX7G2"HII:FC::G$L8F+#VYV";E9/:.=)855O-6!JK#[#^T5'6
MN;>7(.:]@GV6=C&\@!CD'Q12H0T<@H0>U@*T()6JU%>M)O\`F3?&[>_:^'WK
M\I)MM4N&^2W0V3P/4?\`,@ZMQ+*\N+W[1XZAQFP_E5M.CA@IXJ[JSO;;L=)4
MU-13PP1TN0=9=$J35-1'&&]V4MPK7^FE]"0ERH\FI191_0D%"?0Y\R>L/O<+
ME^\W2&;F4QA.8K%E@W6%?*4`".]0"E8;E-))``5LT(+,*,/84ZA?JWO^3_\`
M!+K?Y@=M=A=A_(+<F/VS\8OB]MW#]@]S2Y#+I@*;.)E&SL^W-MY//23TW\`V
MQ60[4R-5E:Q)$F6BHG@B>&6H2HA$?+FTP;E</->,%L8%#/FE:UH"?(8))]!0
M4K42K[4\E;?S7ND]_OLBQ\N;;&LMQ5M(;5J*(S5&E"$=G:M=*E006#`ZWSJ_
MG#]K]A91>A/AMUSO+J+X=;(HJ7:VWGV!M&'9NY^S,'AX$HZ)5CR^Q]T8?:75
M-3!$J4V!BQD<U=0"U>X2=Z&$TW;F2XF;Z3;4>/;4%!I&DL!]JD!/1:9''C0#
M#G7W7W2_E_<G*5O-:\IP@(OA1^&\RJ*#XHW5(2.$82K+\9HQ05(0U/9,\,4Z
M=+[55)HTE19ME?$^GF"R*'42T]1T5%/!(`?4CJKJ>"`01[#H\<BOA+_O,7_6
MOJ+@=P8!A9Q4/_"[(?R-M4?GU9;L/,?,'>^`V_DNM/Y'_P`/NP]H5\$>/P&^
MZSXH[NW.=R+BY7PU5E<SO39O8VS>OLAEI<C0S#(3X_'8K'I6+*L=-3(HB0\B
M;<I4#0;5;/&<!O")K3%2RLJUKQH`*^0ZD*REYKO((Y-NY-VF>T8460V3OKIV
MEFDCECB+5!U%410U:*H%`<+H/L[^;E\=!N&'J[^4OUQUE0[UJJ&7>]#TSUQ3
M=8Q[AIL2V57#4_W,>XMQ5]//B*?,U,=/422U$T?F=E(9N#&SGYBLJB#;D0,>
MX(NFM*T\SPJ<YZ%>Q[C[I[!X@VWE>WMTF(\06\0AU!:Z176Y!4,0"22*GH@_
M\S[K:CW/\;.D>_M\;.WQL[Y==<;LP/QY^8Z[TP>2QU?E]Y;SVIO+LOJ*ER^?
MR.7W"^_MV;7ZJVC`L^<DR-=E:_#Y'%R95XZIEAC*=^@$EC%>2JZ[BC".;4.)
M8,R5-3J(0?%4D@KJSCH$>X^WI<\O6>^7L4T7-5O*MK?^(I!:21))H`S%F\5T
MA05D+,[1M&92&H!1-["?4*]&M^'?Q8W#\L.W*?9L.5@V5UKM3&5>_.\^W,NN
MC;/474>W%^\W;O/-53C[?[J.AC:#&TK,IKLC+%%=$,DL9AMM@^X7'A`Z8%&J
M1SP1!Q8_Y!YGH3\I\M7'-&ZBT#"';XE,ES.WP00)EY&/"M,(/Q,0,"I&[A_+
M-^/W]^]ZP?-G-;)K.N.IL#UA1_'_`/E\]-9>E\&1Z_\`C%C9XYYNVMR4]1KJ
M5[#[UK(?X@]1+>L7&U$@:HJJ>KA9)1V.S\:7]Z,A2W$?AVZ'BL0_&?Z4G'UI
MYD$=9B>W>Q?6W@YQFA-OM:6PMMKMV%#%9CC.X.?%N3W5/=H)[F5A2[7V*.IB
MZ][]U[JM#YN_#/=O8>[MJ_*KXQ)M/$_*GK;$5NU<OMS>,4*]:?)_I7+H\6[?
MC_W)`T4E-5XK,4<C_P`*KJE)$H:EM+Z`T551$>Z;9)-(NX6.D;@@H0?AE0\8
MW^1\CY']HCSG'E*ZO[J+F;ESPEYFMT*,DG]C>6[?':SC@58?`QKI/&F&33W^
M7'\OS$[W7L;O3X7;*W5AH-C9"I/R5^#^Z*6K/R!^).Y+)/DS1X"2(9'L7I&=
MIUJ,5G<>DWAHIHQ*&6*=J>.-QV=9==WMBL`A_5@/]I"?/'XD]&'E^=,4>:>1
M8KP7&]<H0RHL+'ZO;G!^JL7XFB\9;<UJDBUHI%>#%5+_`"3M][,JMY_(SXY;
MTVID^QY.W^K*KLKKGJ&AR.*Q5)W;W#\>=G]G9_8G5>6K<UC\EBXUR,.\LAF<
M:U7']I3Y[!T%3+K,"0RWY7FB,LUE*I?Q(]2I4#6\88JAK49U$BN-2@^5.E/L
M]>VC7>X;!>1-<&[MC-%`"JBXGM8YFCA8L"N?$:1-0TB2-&-=(!`[MGXI9KJK
M?>YMI=^=D87JKL;%PXW-9K:O877/Q%&ZA2;@PU)N+&5+T&#^0.9E9ZG%5\++
M%I24,WC\8=2BI;C;WMY6CO'$<XH2&6&N14<)#Y=$VZ<L3;9>R6N^7"6NX*`S
M)+%8ZZ,H8&BW3<5(QQ\J5QT6*?JSIMJO*UN7[?Q>51IFEI9L(=E[/'VL,>D:
M]O8ZJW%2Q5,BH#XZ9[:K@:V.HH?I[6I+2@_9I'\L_P`N@X=LV@LSRW:L*XT^
M''C_`$H+BOR'\^C&;)V[\'9L1M?`[P^=_P`E-O5M/1U]/2XW8/4M?NC8.S\4
M,MF<@F-7-;UWYU!D:>IJZB6:OEIJ'"24HEKQHFEJ))D1;$FU%522[G4^BI50
M*G%69/MH%IGC6O1_9P<F&**"ZWO<8W`(`B@+Q1KJ8TU220$$FK$+&15L$L2!
M;#\1?Y>?7?SUP6;W'\7?GS\WUVSUQV-M3;'8.<[9PF9V;B<IMJNI<CD,RO65
M7B]T9O'YK=*45#"HIJJ>`XI*Z"HK(2KP05(@V[9H=V0O87EUH1P&+@J",DZ:
M$@GY$XJ"?(&3N5>0[#G>![CEO?-Y^FM[A$E:=6C5D();P2'8,]`,$C1J5G&5
M5@._G??+7X]S;2ZQ_EW?%=8<YU]\?-Z-O#LW?BY6?<7\=[5Q6W\SL^#&/NNM
MEJ<AO/<>*H\_DGS^6FGG^XR%0D"OJI9`$G-.XV9CCV:PS#"VIFK6K@%:5XL1
M4ZCZX\NB;WDYIV$VMMR%RU1[&PF\2:347U3*K1A=9J9'4,YE<DU8A:]IZI\^
M+7P^[7^5F?RZ;33$;-ZQV13+F.W>]^PJU=M=/]0[:2SU&8WGN^L"4$57)#?[
M/&PM)D*YP?%%XTEEC#EAMMQN#GPZ+`F7D;"(/5C_`(!Q/44<M<J;IS/.XM=$
M.W0C5/<RG1!`GFTCG%?X4%6;R%`2-K#X&?`;8'>6Q,+U_P!?;;WAM'^7+MW=
M6+WENS>.]:"LVQVK_,U[#P$E/6[=W3N["U%'09#9_P`5=HU09\'A6_XN@82N
M/NGGFIA_M.T0W4(AA5EV56#%FP]RPX$C%(A^%?/[:D9-<D\D6.\V26%A'+%R
M!'*)'DD!2;=Y5H4=U(!CLD/]G'^/B>XL5V<X88:>&*GIXHX(((TA@@A18H88
M8E"1Q11H%2..-%`50``!8>QT``*#AUD8`%`5111UD]^ZWU[W[KW7O?NO=$9^
M5GP/Z[^2F=VYVQMW=.Z>@OD_U]3>#K3Y*=62I0[XP$".\@V_NC'/+!B^Q-BU
M?EDBJL/D]44M///%')"L\NLJW#:8;UUN$9H;]/AD3XA\B.#+ZJ?*O"O0,YFY
M*L.89X]TMY9+'F2`?HW<.)%'\+C"RQG(,;X()`(J:T*_)'XC9#K[?>"[A^6?
M2NYNA.Y=A[CQ&[=L?S*/Y>^R9M^=3Y/.;=K8,I1;U^2?Q=IZ:'<&T,O3RP&L
MRV3Q=*M/E*R8PK*\">-@E>[<891<[A$T-RC`BYMUU(2,ZI(N(/F2!D_+J$N8
M.5GL+U-VYHLY+'=X)%=-VVN/Q("R$,)+NS`U1L/B=T6CL:5*BG1A/EW\,>A?
MYD.V=X_*OXA_)+;W?7RNCV-L.`['P/;L^W^J]V4NP*..ER6UWZ_PFY\;O[JF
MMW(M34S44.2SBP4M=6?OR(*F6L"S<=LM-Z1MPVZ=9MPT+VAZ(=/$:00R5S2K
M8)SQKT>\U<H[)[@6TO,W*NX1WW,_@Q#PUG*PN(A0IX2N)82]25#R45FR1J+]
M:RVZ.N_G]TVZ;?R_Q=^1O5NWZ"04]!MFCQ/RPQ&RX899)99:7"U";\GHJFBK
M9Q,[-3U<@>1I-+`@V`TD.[VW8UO-&@\J2A?R[O\``>L=;FPYYVD^!+MNX6T"
MX"!;U8_L4^*0037@QS7/5LW\IO='\PKN;O';'3%'US2]9]);>SQ[2[@WAVCM
M#N/<U8NW8JG`8_([<P&X>X-];BKI\YNJ/'046.QD,YHJ0R560-*X2K,HAY?D
MWBZNEM@@2U4ZG9PYQC`+L<FE`.`R:<>I0]L+GGO=]YCVA;<6^SQOXT\DT<[G
M15045IY')9Z!40'2M6DTFCUM_P#YG?7_`,N:/J+$?$WX!]=;+Z-Z2W/B-Q[A
M[[^0.8WSLCJC9NV,3N7-9&?*;.HLKE,Y3[F3*;OKYZO(;DR=-05-1-!5Q1"=
MC45@02;[#N(MQM^T(L5JP)DD+*@`)R*DUJ<EB`3GCD]2M[C6/-*[4G*_(]O#
M9;/(CM<W321PQHKL2T88L'K(2S2N%)(8#5W/2@+X\_RUOC%1[KEP0W'OK^9S
MW-AW,3]+?#6DK]L_&G$9I51J:'M[YC;K_@NW,?M.K8LKRXHTE9&?&1K\@0A"
MSV2P$FC4]]<C\$.(@?Z<QH*?90]0;L/M[RXET8?$GYCW=/\`B/8`I:*WEX]^
M^E`A]4TL,<:TZV*ND?Y8&0WYB-GS?-2GZ\INL]CU])F>K/@7T'1U.V_BKUU5
M1)+(F4[+4"FR_P`@NP&F>.2IK<P30"H%0H2JIZEU]C*UV)IE4[IH\!#5+>/$
M2_-O.1OF<5KQ!ZGS9O;B2^BB/-XMQMT+!H=MM@4LHCZS<&NI>!+/VUU896/5
MS='1TF.I*7'X^EIJ&@H::"CHJ*C@BIJ2CI*:)8::EI::%4AIZ:GA141$4*B@
M```>Q,`%%!@#J6T1(T$<8"HH```H`!P`'D!Y#J1[WU;KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>ZU-OGA_HR_P!F&R/^DO\`X9>^P_O-5_;_`-S/]FZ_V<W5IEU?
MWC_V4O\`W\O]Z[VT?=>G]>GB_N/=V\#ZP^/^[*:OP^-XWY^#FOV]8P<[?N[]
M_-^\?ZHZ/$-/#^N^O_V_T7?K^WY]*7:/]V?[N)_HZ_Z""[>%/'_LN/\`I<_T
M5?;?<+?^Y_\`LTWK\.C1;R?Y7]IX[>KR^W(]&C]']\?\V]>C\O%_XNGY]*+3
MZ?Z?_$/Z]</^(OC^#2OX/K/RX]VFGG7I7X?^)>6K_O-_T$[?PG[3]_\`C']T
M_%_P+I+_`&G^B/\`W^WW?CU?\!O]U>2W[FCVXNK\?[]TT\]/_/G=^SI7%XE3
M]1_KC>%3.KP_4</`_4K]GE7SIT2[>W^@K_2KMO\`@/\`LF_][O\`+;?\/-_\
M.-?WOT?:[>\7V_\`I)_XP?\`9^75]U?]SQ^#R?MZ/99+])]0NCZ;Q,_[F_4U
M\OXNS[?RZ"%Y^Y?WG'X'[I^JS_R7_P!Z^)P7AXO^+T_B\_AKBG6V]\>?^9.;
M%_YDO_Q9X_\`LGG_`)DY^M_^/%_ZL_\`J?\`:K^Y#L_]QD_LN'^A_!_M?EUE
J)L/_`"28/]Q/@_XB_P!A_P`V_P"CT-'M5T;]>]^Z]U[W[KW7O?NO=?_9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>j06224092_aa003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j06224092_aa003.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`8P!E`P$1``(1`0,1`?_$`:(````&`@,!````````
M``````<(!@4$"0,*`@$`"P$```8#`0$!````````````!@4$`P<""`$)``H+
M$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M``P#`0`"$0,1`#\`W]/?NO=>]^Z]TW9C,8C;V)R6>S^4QV#P>%H*O*9C,YBN
MIL9B<3C*"!ZJNR.2R-;+!1T-!14T322S2ND<:*68@`GW5F5%+N0$`J2<`#U)
MZ;EEB@B:>=E2%%+,S$!5`%223@`#))P!U7/F?G?N?MJFS)^%O6&-['V7@OX@
M-Q_*_NW/5G3_`,2=LT^+-LGD<%N>JQU5O7N2'&F.3R2;?Q\>#95UC,*O/LF;
M=I+@']V1AXAQE<Z(A3B0::GI_1&G^ET`9>=;G=%?^J%LMQ9I77>W#&"R0#B5
M<@R3TS4Q*(_/Q:=52;^^=_6.].R<+U)NSY[?*/Y@=O[OST>"V_T5_+%V9@>B
M>K(LUD2I&&I.V*C,2;\W9A:>)=<F4I]_54%/30S3S)$@=5#\V[02SBWDNY[F
MY8T$=J!&E?37741\Q(:"I-.HQON==NN]P3:[K?-RW7=97TK;;1&MM#J/X1.6
M\1U'FXN6``+$`5ZM)VA_++^&&:V5A]T]U_&.DK-VR4$>>W+B.V^Y^T/D97X.
MKI'K:M4RFZ-\[KS-#E<I!25+&M^SB>B6:26""2HIU260^CV/;&B$EU`#)2I#
MNTE/M+$U/K3'$"HZDJU]NN49K-+G>-N!NM.IUGN)KHJ14Y>1V#$`]VD::DA2
MRT)H?Q_S#_E8_(#Y#;$^,_Q6_E@=';JS/8>]Z3:.U>R^W,G@/CSM3^)A:B:G
MRJ2[,V;V%N]J"MGI?'14]J>OK))8D6F\[K`0F-RV"\O$L=OL(F9WH&<B,5]<
M*Q^SS/I7'4)Q\U^VF^;]!R[RSRW92S3S!$FG*VJ5S1OTXY9*&E%&&8D#3J(7
MJX+OGX[_`!+^(.R,+V'DOF'W=_+XEKX$AHL3L+Y-[VWEUSDMTTU##55^-V_U
M%W%0[]PV^Z+$NUC%CMO4$S4I#F*E,K#V([NRV[;HA,US+9D^2RL5)]`CZ@U/
MDHQZ=2OO>P<K\JV:7\F[7FQ%AA8KR22(N!4A8)Q*L@7T2)3IS1:](+HOYV?(
M>J:9^K.XOC-_-0V'C(#7Y:@Z@R6%^.OS.P6&$7W<^<K>EMQ9,[!WQ2T-*GC$
M-&-N5-35,RQI<>&-JUW:\/\`N/)!?Q#CH(CF`]=!.EORTDG]G2'9>=-^:IVR
M[V[F:R4580%;6_5>.HV['PI`!BB^$2>`\A9S\=?E_P!&_)Z'-T/76X,CB]_[
M/T1]A],]A82OV#W1UM5LT<9IM[]<;ACIL]BX?/((TK8DGQM1)<05,MC8]LMR
MM;\$0DB9?B1AI=?],IR/MX>AZD;8.:]FYC#I82,M]%_:V\JF*XB/I)$U&&<:
MA5">#'HSOM=T(^O>_=>Z][]U[KWOW7N@<[X[XZV^-W6V8[2[2S$V-V_C9J/&
M8W&XRCER^Z=X[IR\OVFW-C;&VY27R&Z-Z;HR!6FH*"F4R32$LQ2)))$37=W!
M90&XN#1!@`9))X*HXEB<`#HIWO>]OY?V]]RW)RL"D``#4\CMA(XT&7D<X51D
MGT`)%?F(P6-^7/=&W=H_-O/;<V]EI=IOW)U/_+BI]QQ9.+%;&P>>Q=%2=I_*
M-L8_V'9^^FR]?3"EVU*[;5PICF$4.7J8*BOIR=47<;I8]T95;3K2VK6B@CNE
MI\35I1?@7-`Q!(`L4$?-.[QVO.+QQRF+QX-J#UTQJP`FO*8FDU$:8C^C'0T$
MK*SJG?YVWQ1VG\@?@7V7GJG/YG:.9^-NTMQ=O[*I\9N*JPVSLDFT\0E;E]K[
MDVH*N#;F>&2P6+:GQ#R0_?8_(-&*.14GJJ>JIS1M\=YM$CDE6@4NM#0&@R".
M!J!CS!X<2"Q[Q<L6N^\D7$[2/%+M\3SQ@.5C.A:LCI4(U5%$J-2M300&96T_
MOY/G8QZC^:.T^Q<9O;JS:^[MN[>W%'M7;G=&=EV/L#M6?/TR;9S/6S=H)39.
MGZRWAE<'F)ZS!9.LHJG'RY&A2DJ`%J55XXY;F^GW-9@T:R!30.=*O7!75G22
M#520144/'K%/VHW#]U\WQ7\<UM%=1QOH2X;PXIM0T-%XU"(9&5BT;LI4NH1O
MBSNM9+^9EM7K.BCJ_DS\9_E?\>J"/QG(;WJ^J)>ZNGHH9@)H*_']J?'S)=G8
M>NQT]$WF1I8*6H=4?1"P2YD]M\C@%;Z"XA7S;1K3_>XRPI^S[.LOY/<2VVY-
M?,6W;G8)YR&'ZB"GD1-:F92",Y"GC08ZINWQ_*?_`)9O\P7,Y_L[^73\L=M]
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MF8H\SM9J&16BSL.8P9CKL&:.6Q6J62+QM:S`^PS$95;Q(=0=<U6M1\ZCA]O4
M169O8IA=6!E6>+O#QZ@R4_%J7*T]:BGKUM*_RN.[^V_YI%7ENK^__P!_M_X\
M8+%9_J?YP=;;OP'7?RMZM_BC9:BQ\&7I`]"_<?6T]31FDS4,D-13L];3KD:>
MJEK(:RF'NPW5QOQ,%Y_N3"`4G4A95K6E?XU\FXC(U`D@C)3VVWG=/<EGVW?,
M[K8(K0;C$ZQ7L.K4`&&/'B)&F0$$591(K%PZW]=#_*3LK8W9^$^(OS:@P>![
MVS%+D9NF>Y]NT0P_4GRLV[@DA6JR.VXI)&@V3W)10-Y\YL]V/B#"IQ[RTDJ+
M&+K2_GBG&W;I079KH<824#T_A?\`B3\QCJ<=DYEW"RW).5><0B;TX/T]P@TP
M7JK2I3RCG'&2#R^*,E"*6+>SKH?=>]^Z]TUYS.8?;.%S&Y-Q92@PFW]OXO(9
MS.YK*54-#C,1A\3235^3RF1K:AXZ>CH,?14[RS2NRI'&A9B`#[J[K&I=R`@%
M23P`'$GIJ::*VA>XN&5((U+,S&@55%223@``$D^0ZUI/F-\^,;U'M3$?/SL_
M#_QS?V^H<UA?Y87Q@WE3E<;LC9[QBAS?S$[2Q"&"8;HWQB*J"KQL=Q58W"UU
M)C*:9)*_)5E*"-RW=;:,;O.*S/46L1X*/.9QZL,CS"D*#EB,>>;.>(]JM4YY
MW)-=].&79[.08CCX-?S+COD4AD'Q)&RQJ07D==:'XK]E_/SN'YK4_=?QMRF]
M^S/EWD:_<>_*_+Q2XFNJ,OCG@,&YX=QT^X9Z/:\>RY,=6+0_8SF&A@A>"GIE
MB9:=5`^WS[O<[I]59%Y-Q)+$XR/.M<::8IPX`>76._+.X\\;MS@-XY>::YYJ
M9GD+=I+"E'UAR$\.ATZ310-*J!1>C'?.W^<-\\ODWLC=7Q9[QPW7W4&-PFYY
MMO=K;1Z\VANC:FY,WGMDYAZ>MVMOJ7=6]-X5-/'B-S8L/4T5&*&-JNF42*R)
MH]K=VYDW:^B:PN@D:AJ.%!!)4\&JQX$9`ID="#G7W7YVYCLY>6MY2"TC233,
MD2.CLT;4*2:Y)"-+C*KI&H9P*=$$V'\0^^.ROCKVW\JMH[4HJ_I3I',XK`]@
M[EGW)MZ@K,=D\M+A8H8*'`5N2@S>5$!W%1-*T$#JJU`TZBKA2B';KN>RDW"-
M0;6(@,:C!-/*M3Q'0'L>5=[W'8+KF:UB#;/9NJROK4$%M.`I.IJ:UK0>?VTA
M=4?+[Y4]%Q4E)T]\B^Z>N<916^WP6U.R-UXK;04,7$<VV8,H-OU4.LDZ):9T
MOS:_O5ON.X6@`MII44>08@?LK3^75-KYJYFV4!=IW"\MXQP5)75/]XKI/YCH
M<=U_/GL'?4&S^S<YCL1MKY@=7]@83=&R/E!UAMW;W7&\-T;=^US(W'M_N"@V
MA1X3!;ZRJY'^&28[*RT1K&I$K:.N-7#5*8E4F[S2A9W`7<HW!650%)&:AZ4#
M&M*&E:5!J#T=77/%_>B+<9E2/FNVG5X[R%%BD=*-K6<1A5D-=!5RNK3K1]0;
M&W]\O/YFW\KWO'X<]R;!WG\@^MNQ*S>/4N[J;';/P6&WH^6K>Q,;MS(5VV)=
ML4N6VJM?M_+TF\\?3S8>NKDITAJ%@D9PIN9'W'?-ANMMEAEF1RT9P`U=0&*5
M&#J^$GY=95\U>XOMOO/*=W8W=_;W#S6K@1JLFHRA"4T!DJK"0`QLU*'2:]:L
M?P4_FX]T?R_MDR=?=0=5=,9W`[DWM7;T[.R.]<-N*KW9OJ6JH:##4.$ASV&W
M%AH-O8/;F'H#_#H%I:I(*ZKJJB02I.T``.T\Q76SQ>#;1Q%&?4Q8&K<!2H(H
M`.&#DD^=.L:>2_=/=^1K/Z#:K6S>"28R3&17+R5`4+J5UTJBCL&D@,S,:AM/
M6P;T!TQ\1?YF-!C/FI_+\WQ7?`3YO;`J4_TA8G85#A\GB,3N#(PU'W%%V#U>
M!AMM[PV;O0),(<U104D&6B:89&EJ*F&:CA&-G;;=O@&Z;.YL]T3X@M"`3_$F
M`5;^(4KG4"00)VV/:.5?<2-><.19FV/G&`_JK$%*JQK42P]J21R9I(H4.*^(
MK,"@L?VW\._DWWIUQW'U_P#S!^XNLNQCG,AU[EN@MP]!;4R>PMR=&[RV#!G)
M(.XMKY[+0C)X/LJLS-5CZR,4CO2TCTDT2LU-5R0`Z3;;ZZAEAWB6-ZE3&8P5
M*,M>\$\&K0XP*'R-.I`M^4^8MZV^[L>>[NVN-;1-;/;(8GMI(@U)T9LK,6*L
M-.%TD5*N5Z&#X7]\]@;N'8?QP^1`HZ;Y1?&JLP^`W]DJ.*.CP_<.Q<U32R]<
M?(+9U&KNL>"[$QE'(,A2H6.)SE-5TDBQ6C3VIVR[FDUV5Y3Z^`@,?)U/PR+\
MF'$>3`CHUY1WN^NO'Y?WZ@YDVXJLI&%GC8?I748_AE`.I?P2!E-,#H]'LUZ&
MG5:?SPW-A>P]R]>_%3-YF'#]89+;^Y?DK\PLO.TD=%BOB?TE-35^3VKEJA1'
MX:3N/?K46*J%CD$LVW\?FAI*J?9'NSI.Z;>YI`099CZ1)Q!_T[4'^E#=1YSK
M<0W]Q!RS,X3;6C>[OF/!;*WH2C'R$\NE#0U,2S=:$/SV^76Y?FU\G.P>\<PE
M3C=MUM8-M]6[2FT)%LCJO;TL]+LS;<5-#+-24U8*%C69#P'PRY2KJ94"JX41
M)N^XONE\]VV$)HH_A0?"/\I^9/6$7._-5QSCS'/O,M5MR=$*?[[A7$:4X`T[
MFI@NS$8/0:?&SY/=W?$7LVG[@^/^]'V+OZGPN7VZ<M_!L#N&EJL)G(XDR.-K
M\-N;&9C#5U-+)30RJ)8&,<\,<B%712&+&_NMNG^ILVT34(K0'!XBA!'1=R]S
M'O/*NXC==BF\&^",FK2K`JW$%7#*1@'(P0",CH0/CW\I,+UQ\HJGY*?(3I79
M?R\;<68WSN3?VP^U#CH<+O/=&_VR-5F=SU@J=M;EP,>:CRV4FJX3-B*NGBG?
M6D*NL;QO6=^L%_\`77D2W.HL65Z48M6IX$5J:\"/ETNV+F6';^9#S#OMG#NO
MB/(\L<U-,CRU+.:HZZM1+"J,`<@`@$-6WJGL_<^\MV=*XS?K_%?JSNZLR'8F
M2Z^W[V!O[871R[?CP^0[&V%!N.EJ$R/]YJ&3%T=)2;:K:ZBK7K*B6C991Y?,
M*H9Y)6M5?Z>WEJQ5F94I0LM?7%`I(-<=-V[;E<W<NSQS_NS;+PF4Q2RRQ6^G
M298@X-=8TA5B9E8L2E#FO15_:#H,];??\@_+[#^2?QK[?Z4R'Q/^+6Y.POC9
M/LNHVSV=V'UIA,S)OK'=M;I[`SU31=D9>KQ.>W%-G,)'M^MIZ"JI08/LA30M
M`@IBU1(W*+17MC):FWMVF@TT9E!U!RQ[C0FHH0"/*@IC.5?LA+9<P\O7>SR;
M7MLE_MYC*32PJWB"=Y6(E8JSZETL%88TZ10:>XZ7S+QG:OPXZNW1W]D?Y;7\
MMOM_J?958)=VXK8&W)J#L';^VJZICH*#<M53YWIE,55XO'5M5%_$GIO+)31-
MY?%X%GGIS3<UN-MMVO#964ENO$*.X#URE*#SIP^RI`OYMCW/E/;9-\DY>Y?N
M]KA/>L2$2JA-`Y#6^DJ"1KI4@9IIJRTP_P`Y#Y*=:9+HWXE=6;'^(?QWZ;W#
M\C/CQU#\PMU[RV'LS;T&?VWB.PJC<@VAL#:VX\3MK:5>AAIL-,^:FGIWCG,D
M<,("H\KACF6^@:TM[>*WAC>:%)BRJ*@-6B@@#T[OY=1%[M<P[=)LNU[99[58
M6D^X6$%\\D<:ZD64OHB1U1#P4^(2*&H`X$FE[XI?)[M+XB=U[6[IZFW3E]L9
MS#/+09<8MJ::GS^V<CHCR^!S&)R"38C.8VI5$F6FJXVB%3!#*ICEBCE0,[??
MS[==+=6[%7'&GF#Q!!P1\CYT\^HBY8YCW+E7>(MWVN5XYDPU*49#\2LI[6!X
MT84J`10@$;GW57\^38TG4E)OKN/H7MG*I58F1MN]A_'W;#]A=7;[W#34B/+L
MZN%?D\=GNGNS16MXJK;F;^YCI05J(,G74$U)6U,F6_-D7TPFN89#C#1C4C'T
MR04;U5JTXAB""<N=L][+([6+W=K&Z8%>V6U3Q89&`_LS4AH)JX,4E0/B61XR
MKL#FT_GCDNP\G2?+#-[8GV?\C/Y?R]8;1^8NU*22&3+=A_$3Y![=VOD^SZ;*
MX"BQ>$JJ3?/QO[3D?(UV(:"-,1D=O52-XI,C)2PIH]V:9OW@ZZ;VSTB8>;0R
M`%JC'=&^2/PE3ZT!5:\[27\@YGFC,6_[%X*7Z#XI;&Z1#,&4!2)+2:KLE`(W
MB88,A4;+'\8Q'\(_C_\`%,=_`?X=_&/XW]]3?PC^$?;?>_Q3^)>7[/\`AWV?
M[WGU^+Q>K5IY]C?4NG74:*5KY4]:^G60OBQ>%X^I?`TZM51ITTKJKPI3->%,
M]:F7\S[OF;"?&C^8-W71Y.ICW/\`*WY98#X+=>.K^5\5T+\4,?7TV_7P%3,%
M,>"WAV=B]VQ9$0ZX9QF(K:CI:./M]NRMC>70/?<7`@7Y1Q5U4^18/7[>L7_<
M?>VAY=WW>$8BYW/=%VZ+^C;60(ETG^&299PU,'Q!]HU"_<<]8K=>]^Z]T;CX
MD_!KY*?.#/[NVW\<=CT6\:_8F)QV:W5)D=U[6VI1XJBR]7/18O54[FR^+6KG
MKJBDF"1P"5@(F+:18DQV[:K[=79+)`Q0`FI`I7AQ(Z%/*W)G,/.4\MOR_")7
M@4,]71`H8D+EV%22#@5X9ZM'W5_)._F=[XV!AL-O'H2DW7VE@\U04>/[=W/\
MJ-K[AK:3J/`;1Q>V=H].X_:>7W?5X?&;?VC48]JB@J()$>""44B1K!$@!])R
MOOLL(66$-<`_&90>P``)0F@`I@_EPZDJY]GO<:]L4BN[$2[DC@"=[U&(@5`B
M0!&<J%0BJD'`.@`*!U4I\J/B-WU\+^R*/JCY#[-AV9O')[6QN]<32TFX-O[F
MH,IMC*UV5Q5)E:/*;;R64H2G\6P593/&[I,DM,UTT%&</;AMUWMDXM[Q=,I4
M,,@U!J*U!/F"/RZBWF;E;>^4-P&V;]"(;MHA(H#*X9&+*&!0D?$K"AH:CA2A
M.RK_`,)7/^Y[?_+8?_GA_8VY!_XE_P#-K_K)UD+]VC_EM?\`4'_VM=;2G>VU
M,3OSI'N+9&>@2IP>\.K=_P"V,O3R)K2;&YW:F6Q=:A2ZWU4]4UN0;_0CZ^Q[
M=QK+:RQ/\+1L#]A!'62F]6L5[L]W9SBL,MM*C#Y,C`_R/7S]OYMO_=,G_P`9
M%?##_P":3[B#F+_B#_TKH?\`G[K!CW2_YUS_`,56P_ZR]59[PV3N[K_+Q8#>
M^W,OM3.S87;VXDPV>HIL;E%PF[<%C]S[9R4U!4K'4T]-G=NY:EKJ4R*IEI:B
M.504=22&2*2%M$JE7H#0X-"*@_F""/D>HUN[.ZL91!>1O%,41]+"ATNH=#0Y
M`9&#"O%2#P/2EZR[K[EZ5K\EE>F^V^S>I<GF:6.AS&2ZRWYNK8=?E:*%I&BH
M\E6;5RN*J*ZEB:9RL<K.BES8<GW>"ZN;4EK:22-CQ*L5K]M".E&W;QN^SNTN
MTW5S:R.*,897C+#T)1E)'R/5AO\`)X[9Q^W/GAM+8W8U9-E.O?EKM_??QA[:
MILC4_<2[IQG=V*GQF+HJR>N:45-7ENPH\2KR2:Y'$L@]3.03GENX";LL4YK#
M<!HGKYAQ0?M:G0\]J-T2WYVBLMP):PW2.2SG!-=8N%HH)/$M+HR<FI]>MH'_
M`$L[_P#^&<_]"_\`%JC_`$__`-ZO^&Q?->H_B?\`I`_TT?[*U]]Y_-]U_%?]
M''^YKS>3R>3U:M?J]COZB;^K?TM?\<U?2_[;7X5?MT]W62'[TO\`_6G_`'1J
M/[\\7]T5S7Q?J/HZUXZO"_4K6M<\>M?G^:AN^M?X5_RK=HN5ADWCUKWE\DMS
M11-',M?N/O??V)WG]W4U2T&/6:MI:S*9+7HBC774O?4`C>P?O\A_=>WQ_P`2
M/(?MD8-_E/[>H+]R[ISR?RS:G!EM[F[?YO<RK)4F@R"S\`.)^75%7L*=0MU;
MS\;/CKM#+],14OR2VU0Y_P"*78N7)VI\W>C:?^^&;^(?<57!BJ"HQ?=F,BIL
M9NC%];9!!21YK![EHJ.`"6/*8*IURSRU0CL;*-K6E\H.WN<3Q]QA?&'&"%.-
M2L!_$AR295Y>V"UEVC3S#&LG+%P_9N-L/$:QG(4$7`H'$1[1)',JC(D@:I8M
M8Y_*>^(/?OP7_FQ4/3/9N0CBP?8?0/9^7VQO/8.X_OMC=M["5,?4X3=&%J::
M16FIZ;*4:3)3UT$=325,:R!"C12R'7+^W7>U<P"UG/8\+$,I[77%"/S]<@]#
M_P!L.5=\Y+]SUVC<6I#<6,S))$]8YX\%74CR#"M&`*D`TI0FV#^;ELCY#?&_
MXI]B_*WHOYM?)G:VX^JJW83U6QLGE-AYS9.X,+NOL/;.Q9::.DIMBX?*X_)X
MVJW8E:*N>JKDE@IGIY(2'CE@$',45Y9;>^X6EU.KQE>TE2I!8+_"""*UK4\*
M4])/]T[/?N7^6;CF?9=XW&*XMFBK&3&T;*\J1TH(U8$%]6HE@0"I&05U%?YH
M>\]Z[[^6M3GM^[OSN]MP57Q_^'V0JLWN">F>KEK-S?$SI;>F>DAI<?2X_$XV
M');JW-D*]X*.FIZ85-9*ZQJ7:\=[]+++N)>9BS^##D_.)&/"@%22<`"IZQ8]
MR+N\O>:3-?2O-.;&Q)9B*U>RMY&P`%%7=F(4`58FF>K]_P#A+)M[/4F!^;&Z
M:K#9.FVWG<G\>\+A<]/15$6)RN6VW3]V5>X,;CJ]XQ35E;A:;<F/DJHXV9H%
MK82X`D6XNY"1PEU(0=!,8!\B1KJ!]E17[1U.'W:K>=(-XN61A;NUJJL0=+,@
MN"P!X$J'4D#AJ%>(ZVP,MC*?-8K)X>L,@I,MCZW&51A8),*>OII*6<Q.RNJ2
M"*4Z200#^#[D!E#*5/`BG63LL:S1-$_P,I!^PBAZU.?DEU1T1\8?YAG\O'#_
M`#)Q-!O#KCI/^6GU5U+UWFLY2U.*ZG[&^2W2N?WOB-N8#-YS,4W]W,9BIYJZ
MGJW;,RP8O'25U#-DW2D,FJ/KVWM+#>;)=R`:"*Q1%)PC2H6`!)P!P/=@5!;'
M6,/,.U[)RYSYL,7-JK+M]GR]#!$S`K!+=V[2*BLS#0`:AOU"$4LAD(2O2+^1
MWPE[?V=7=CT'5NUH/E3_`#&_D])F]^?(/Y&T$=+@^B/AKU3O&!:JJVQL/>&\
MZ['[8VEN'/;>G>DQN3JIX<U3[5II):*EHEEI?(W>[7<Q%Q;K]1O4]6DDX1PH
MWDK$@`D8!/=HX`8Z2<P<G;K:/<)ML0W/G_<M4EU="BVUA#(*E(Y)"$1V7M1V
M(D$()14!6NK%OK:]/LK=^X-ITV[-J;YBV_D9L8=V;%K,GDMH9J:F"I4U&W\G
ME\1@ZS)XZ*IUQ)5"F6GJ=!D@>6!HY7`,L8BD,897H:56I!^PD"H^=,^6,]8T
MWMLMG=R6JRQ3"-J:XR3&U.)4LJDBN*TH:54E2"7/JG?5;U=VCUMV9C6D3(]=
M[^V=OJ@:%(Y)EK=H[BQVX*5HHY7BBDD$^/4JK,JD\$@<^[6\I@G2=>*.&_80
M>G-LO7VW<K?<8Z^);SQR#[4<,/YCK>AQ^Q,E6?-#=_3!2/\`N[MS^;[US\DT
M5:Z%HC2;T_ER=I=JR>;'B`&*E'8^PEEC!0Z\F7F!#H:@RJL3'<VMOP+N*R_[
MU;.W_'E_;GY]9GQV4C\WR[1_Q'CYJBN^/E)M4TW#T\6*H_IU/$:NM>G^:[@3
M2?$+^3_G'BG2=OBKN?8=>[,II8\MUW6;"I,QCX;+:2?&Y/-2I)(K/%*I1HRR
MV9@=S`E-NVUO/Z<K^:Z:C\B>H(]SH-'*O*DQ!K^['C/IJB,08?:"QJ>!Q3'5
M6GQLRFZ<1V53S[/[7ZXZFS%1C*JA^_[<IWKNN-V4L]31O+LO=^+KME[ZV5E<
M-E)88YW@W+1I@M=*KS2I*D-R"Q:19ZQR)&U.+_"?Z)&EE(/](:<9\NHUY>EN
M8MQ#6EU;VLI4BLXK$X)'Z<@,<D;*U`:3+X>`200.MO[^7+\<=Y8W>.$[-Q_Q
MWH?CIN#=&+?!93OWX2=V]4=S_"OOS%TM6\\6([;Z$R6^MX97;=!44TEEGP"T
M3Q/4R/!4XHL421]ELI%E$XA$+L*&2!T>&0>CQEB1_M:?(KUE9R!R_=QW:;C'
M8+M\\BZ6N=ON(;C;[D`UTSVQDD9`1YQ::5)5HJT!DJ\[#;^<F^:VC1TV(Z\^
M$7\OS._Z3TVUCX*3;^R,_P!@[SRVZ<+M2'#XVD=?OZS8>0FRJ4M-'%>-5TDE
M&C*T^%_675&*0VMF=5!A2Q)`H/Z.:#H0/]%_KM>-:@)8;-L3>-H%%C:61G5-
M('$QDO0`8X<*=3_FMW]LCY^_R=_E+VA\:Z/=.Z\'7[:R-,F-KL%)C=PQ'K#L
M3;69WA,V.6>KBJ:;'[?PL^062FFG62E`M^X&C6VZ7D6[\MW$]B&92IQ3/:P)
MQ]@KCRZ<YPWRSYX]J-RW+EX2RPM&10K1OT94:3%34!5+5!-1\\=5V?'7^3OB
M?FA\B]M_++OV>.N^*];\<OA76]=;>VYGZ0U'=.9VY\5>H=F[FQ>;KL1D!G=J
M;8VKN#:$]-7QA*:MKY)5CIYHO%.P)K/EM=SO5W"\S8&&'2`?C(B0$&F0`1G@
M3Y'CT`=A]IXN;]_CYHWPZN6FV_;S$J,*W#)901N&*G4B(R$,,,Q-%(HW6T9@
M<5UIT[M/;>R=NT>S.M-E8#'QX;:FV<<F'VIM_%XZA50F/PN,B^RHH(*<2`E(
ME^K:CRUR/$6"VC6)`J1`4`P`!Z`=9)0Q;=M-K'9P"&WLT72B#2BJ!Y*,``?+
MJ;_I!V%_SV^T/_0EPW_U;[WXT/\`&O[1U;Z^Q_W]%_O:_P"?I/=R=*]5_(+K
MW/=5]S;&P'86P=R0&'*;>W!1BII_*J.M/D<?4(8ZW$9F@,A>EK:22&KI9/7%
M(C<^Z7-K;WD)M[E`\+<0?]6#Z$9'3&[;/MF^V#[9N\*3V,@RK"H^1!XJP\F4
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M%4`DDV'L'`$F@X]02`6(515CU]`_`9RFI_YG?;&9<Q?PS+_.#X]]4T]>:B-:
M'^.[=_E2?)O>%6J5A'V\U:*K=$&.>C5O-%4:=1O(J>Y@1P-]D;\)NHT_,6DK
M?Y:4]>LZ()U7W&NI3_9OO-K`#7&I-EO)#GA6KA-/$'[:=5$?S=>GVJ_@>*:"
MAD?/_!'Y^=^]05Z3*?N\9U%\A<M6=T=>Y*=YPLYI9]J[NV11HZWCJ'.K42AL
M'.8K:NTTIWVEY(GV)(=:G]A0=17[J;47Y)TA3X^R;Y<P'U$%TQN(B?.A1[=?
M0G/EU3-\,=T;JR%6VVHJ?^7XFW-MF.H=_F=L[IK&4E<,ED*BIJ(UWC68*D[5
MW((GE(:-,A4&EI]$<(1%55#6V22$Z/\`$]"_[^"#C\Z:S^W'EU$G*-S<R/\`
M3@;%]/'G_'XX`#4DG]0J)G^S4:"@%`.MI3XO_)7XJ_$WI_MWY!;A_P"&S,;N
M?8FQJBKR.+^`D^\ZJJW)FZFF>/;VT*VHSU)XZ&MW7G_!14OF\J0M(Q,QC#R`
M>6%]M^WVTEX_T(=$R+?5D^0SPJ:`?X>LE.6^8>6>5]JNM]G_`*NK<P0DD;9X
MA+L1VH2PP7:BK6M*\:5/1JOB1U!V;TA\,=S=K[C[-ZIZI^:?S&W/0?(CM3L/
MNW&&LVKB<SO+<.(S$'760VW5[CVODFQFQ>L<BV%I<='7QPXW,5<LB?MMXV,-
MNMI[7;&N'DCCW.Y;Q'9Q@%B#II4&BJ=(%<$]";E;:MQV;E&3<[BYM;7F_=I!
M=32W`JBM(RL(BA=#2.$^&J!@$D8D8QT>_"?)CX5[4QT6U]N?('XN[:Q-))4P
MP[=PG:W4^'QU+-4U$LM9%%B:#/4U-!)45<SM(HC!>1F+78GV;+?;9&OAI-`J
MCR#H!^RO0UAYBY0M8Q;6]]ML<0KVK-"H%3GM#`9/'''HBG\PKXZ?&;?7P/W9
MDNO,7O&OZV^.E#O?M3!]??$#M["]6T5539#,5>XNQ4ISC-O;ZV--#C(JG)YB
M&DJ,-4I%/!)%3K")7]E.\65C+M+-"&,$(9PL+A?.K<`RXR:%3Z"G0*Y[V#EV
M]Y)EDL%F;;]O6298K&=8006+RTHLD>*O(%,9H00NFIZU"NI^D_Y>/R!JZO"[
M*S/S.V7O`Z/M,)N+='PKW!_$:NNE<T]-B:CLCMSXQU>YZFG2)_*E!3RS/<.R
M0+8-'5O:[->$K$;I9/0F$U^S4\5?R'[.L5MKV?D/?7,-F^[PW?DKOM[5)X!3
M+/9ER//2"?.@ZM3ZK_X3O]7=HF,?[,WV5LC[N`5&)&YME_'3/MG$94D08N/J
MGY2=E2R,T#-)^XL2A(VN0;`G]OR;;S_Z.Z>E5C-?LT2MU)FV>PNV;E_RT;B&
MHJNN.U;5_I?!O)?+.:<.KW.@/Y0'PYZ>V/CMM[FZFZYWUN6A^U2;>^(V]O#8
MN1RL=%$@IILO`>RMUU5=D8ZIIIO.U793,5C1$51[%EGRYMMM$$>-'<?B`*D_
M;W'/Y]37L?M5RGM-DMO<6MO-<+2LBK)&6IPU#Q7)-:FNKSP`.BI_S-/A]T#L
M_P"&7RDPO4G8N\<1VQUMMS8GRKV9U[FOD'O??&3ZLFZASM7"W8/7NT][;RS^
MX]@T>=PF3RV/DKJ!J>GEK#"L;!Z>.,%^^;;9Q[9<);NPN$5954R,Q70?B4,Q
M*U!(J*9IZ=!CW%Y4V.TY1W*':[B9-TMXX[V.)KJ20P^`Q_5B221GB#*74LM`
M6I3*@=$R[SZMS^YOC]U_\D^N/Y./4?=Y[4ZCZ[[3R_=_;WR5R79VZJQ]_P"S
ML'N"GR&Z]JY/<NV.R\_6F7,*KR#-R2K8(-"@%2R[MWDLTO8-MCE\2-7+O*6/
M<H-2"0QX_P`701WK;9[C8H.8=OY3M;SZFUBF:XGNS,Y\6-6!="Z3,>[CXA/E
MCK7X^#'5N0^27\Q?X][!@VE@MI+FN]-OY[<&T-M8[(#;VW]L]=UK;VWGC,?0
MY/*9;()1TFVMIUB7J:NH?5=I)'-[@_:K<WV]0PA0M902`,`+W,,D^0/$]07R
M7MLG,//]A8K$D6N]5FC0'2J1'Q)``68T"(W%C\R>MJ1<Q3+T;+\[UJYEV;-_
M.=@[^FW"HJA4R]&TV\*CX'4V5EG$WW,F(I]FU<M<D))ITBE=`H1BQ'VH?2_O
M:OZ7[S\2O]#5X%?LIGK)?Q5&S'G6I^D/-PN=6:_3ASMH:O'2(R6`X4)'#HR_
MSF^.F(WOVWV!U/N2:FPW5'\RCIF+I>NW)4P)+CME_,+H6FR6^_CUNC(M(EE_
MOGL^DK:5E0F:KFVA0TR%))(RR[=;)9;A[=\6]]%HKY+-'5HR?],*CYZ`.A%S
MGL$5YND^UW!";9S#:?3ER,1WUL#):N?^:D88>K&!%%"1UH./B\_T)W%E=O=A
M]=[<S>[.KMW[@VONKKKL2#+3[=7<^WJJOP-=C]P4V!SNWJVLAP^8A,HC%8M+
M/)`HF6:F:2*2)-+VER4F13)&Q!5JTJ,9H1P/SIZU&.L(3'/L>[-;W]O&]U;2
MLCQ2ABFM25(8*R$Z6S350D"M5J#>5USVKN_OO)8W%=V]X=2[X^!WPTV+C?EC
MWWT[\>NE=O\`3W26*WYMO*U^&ZR^.V+R$.Q=F5/86YNR-R3T&,:I8U.)F2IJ
MA25%2U.*DBJ&XDNV"W4L;[3;()9$C0(@8&BQ@Z5U%C05R,FA-*]3-M^YW6^2
M+%O%[:S<D[1`+VY@M;=8+=948K#:@^'&97E<JE<H:MI9M.KJO+8>'Z8^6>_,
MWN+?N/W5L;+YS/U-5FMT[G^;'06W<91/D9:K(&"APWR>BVSO#+40GJ?55R;H
MR#(Q;7K<FQ/"MKN,Q>8,C$Y)GC`SG`EH3]NL]`.RBVCFB^>XOEE@E=R6=]PM
MD`K4X6\T2,*GXC,U/.IZV%_Y<W\E_P"+U3D:KM>?MOJKY%TD*4=!DNK][[>Z
MA[HPF!HZQZ7(PY"?*=/]Z;KVS!E,I0>2""26694*O(D<BZ&88[+RS8$_4&2.
M8>:L$<#\T<BIZGCD#VBY;:0[FUU;;@HH##(L%PJ@T-=4%PZ`L*@$D^9`..KF
M\_\`RK?@KDMT[+WIM?HG;G4.Y=D[IQ&YJ?)=(--U*=P08H5`DVINNFV6<71Y
MO:.9\X%?2-&CU*HJF4(75Q*^P;4TBRQQ+&ZL#5.RM/(Z:54^8\^I;G]M.2Y+
MF&\MK*.TN(95<&W_`$-06O8XCH&1OQ+3-*5I6NES\Q_C2?Y:_P#,%W5L`T%:
M_5^ZYQO/I;*M-L%:2+8&\,G5KAJ7)U':W7O9FTL@VQLE3U.'KA64=.M3]GYI
M:BF@GUB,]RL?W)O#0T/@-W(>WX2<5UJP.DU!J,TK4`]8B<V<O?ZWO/<MCI;]
MVRGQ+=OTJ>%(3I!,T4R'PR#&VI1734LJM7K8'_EZ=R0B+:M=44#9W,TCTT\+
M]39O^2]'1T\,K-+68RJR?5G9NT=]TKU\3RI7:,12UDL$;%33SAFD%^SW/PDB
MK#^`V7[*HP;[<`_8>ITY$W84B=EURBA_0;8*#U!,,R2"N=5(PQ`_"U:[(='5
M0U]'2UU.Z24]93054$D<L%1&\-1$LT3I/2RSTTR,C@AXW>-ARK$6/L:@@@$<
M#UD"C!T#K\)`(X'C\Q4?LQUIJ?+GO/`;V^0O\Z#Y'861,MLC`?'K8W\O/861
MI%_W'[I[#[,W1LS$;@IZ&ND>"ER$V`RW6^>K/-$[0KCX(I+LLT/DC7<;I);S
M<[U<Q"%;=3Y%F*@_L*L?L^T=8E<T[S!>;]S?O\/=9QV$>UQ$<'EF>-6`.`=+
M12-4&FD`^8J3?^:#TYUIT'UKU!UYOGX1[MZI[9V[UKLK9NSOD_U5W^N^?CYW
MA6;2P&#P^YLE4XK*=?/#+D%J*2KJ9J*!MOYQ*N8357FIY(I)"S?K:"T@CAEM
M6CN%15$J2:HWH`#@K]IIVM7C4=!/W(VG;MCVZTL+W9Y;7=([>...\AN?$M;@
MHJJY(:+C4,2H\*34:M52"<G\J;K3>/473'?GS;P=`6[0WA+C_@]\)L9+_D]9
MN;Y*]^34.%K=QX6691&AZ[VW5"I\C!J>>%J]"RM3,/>^7X)+:VFW11^NWZ$`
M]99,5'^E&?V^G7O;+;KO:MHON<85_P!V4M-NV\<"]W<T4NO_`#20UKP(UCBI
MZW&/]D<Z\_V0/_9"?N$_N=_H'_T1?WA^Q'E_O#_!K_Z0OX?YM'\5_OQ_N=\7
MDT_=<7M[DG]U0_NC]T?Z%X6BOSI\7VZN[[>LL?ZF6']1_P"I%?\`%/HO`U4_
M%I_M:5^+Q/U*5^+H6_E-T'0?)7I#>75<N9GVGN*NCQ^X>N-_T$2OF.MNT]HY
M"FW)USV!A91IJ(:W:^Z\;33R"%XI*BE$U/K5)G]J+^T%]:M;UTN<JWFKC*L/
ML('VBH\^C3F78TYAV:;;"YBN&`:*4?%%,A#Q2KYU1P":4)6JUH3UIQ_S6_BO
MO'O[:.X?G'A-H4NW?D!TU/B>G_YCW3&(334[/[%VMCJ7$[?^0&UJ1@)<MU9V
M;MN&CJZ:KAU+_"I:*I!F*92:FC;F#;Y;R,[JBZ;R*B7*#R8"@D'JC"A!]*'/
M<1B=[G<LW>^6LG.<,0CWVT*P;K;KQCE0!5ND'XH9DTL&'X"C9I*5KY^2L\WQ
M>^+G4OPNH'%#V1V:=N?*7Y9K#.T>3QN<W!AI?]E_Z2SU.J03TAZ]ZWR?]X\A
M0U(<QYG<X#*KT:'V3WQ-A81[8N)Y*2S>H)'Z:'_2J=1!_$WRZ`G,)/+?+=KR
M@G;N%SHO+W.0S+_BUNPP1X41\5E/"2;U0=`;\/.UJCJ[L)JX]D9;K^BG--,W
MV._3L"GRM9#'5P4R/F:KHWOO"45522U*RK4UF*@2*-'"3+(R-&DVVX,$U=90
M?Z;37\_#D'[1T3<I[FVVW^OZAH$-.$OA!CD#N-M<J"*UJR"@!H:D$;C7P)^>
M6S9\[A=J;J^0'5M)MO)-!1P8;?7SO^,N^ZJ.MK):NE@3`X'&_''I'?V:R<LR
M*[1&IC>5WU,DEP9))VG=HBXCDFCT'R:>)OV`1HQ/Y]98\D<[6C3I:W-];"W:
M@TR;E:2&IJ!I46MO*Q^514YH?._U65U5T961E#*RD,K*PNK*PN"I!X/L7]3E
MQR.'5#7_``H!^%*?)+XC3=V[2QGW':GQ<3+[WA-+3&2LSW5-;%3'LO".8@'?
M^!TE!!GH7D+B&/&5,<:AJIF]A+F_:_K=N^JC'^,05;[4_$/R^+\CZ]0E[Y\G
MCF'E8[Q:K7<]MU2"@RT)IXR_[4`2"O`(P'Q=:V_\M_Y1=@4=3_<;.[DJ\SCL
M=4P1T<VZ>T_Y?^#EAH7$<=-B,)B_G!LS^*9J:FT@TZ8K=5(L0185A5"?8*V2
M_F!\)F)`]7MQ^0$ZU/Y./3K'WV_YDOD;Z*:0O&I%-<VV+CR51N,>IJ>6B9:<
M*4ZW*]S=][QJ/A?N'L;JC?74?3^_-AX;;L-7N[Y0[IZJW-U[MRCQ-9@WW'D=
M[5OQ>WOG]D4S9/;HJXL=#C*BF'WIB`I(XRJ&2GNY#MAGMWCCE0#,I0J*4KJ\
M)BN16E#Q\NLMKC>[MN49-PVR:UM+V!$J]X\+Q(%*ZS(;.1HQ5-04(1W4[0,=
M:TE5D.C=_=D[.A^,NTM@=+_$KHNMWKWQ\-NGODKC=U1[4_F/?(W!9;&T/9-;
M6;NW_N*FEJ*W'8<TN%VM3Y:OJ:F&:2C1:;Q55=24P()M9IU^@5(MOB+20I*#
M2YD![LL?(45*DGAC)`QX:39K[<8AR[%!9\KV1DN;""[#Z-UNU8"4EY7%2%TQ
MPAV)!*#31G5:D-G=6Y'^8O\`,.BZJ^*?5^1Z5VSV]NP[MK>M)]WUF^>O>GT*
MO)OG>4%91[;VLE%LC"15,TU%2O1?<4L=1'C(9IV:%I`[';MO6Y"WV^,Q)(U=
M-=2I_$>`[1Y"E1\-3CJ+;3;9.?\`FP;9RQ;-9VUU+K,)D,D4'^_)`0B4C6I*
MC3501&"V*[@GP'Z'V-V)OSK+<'6U!,OPI^`>-W9U#\5*RLIZ>./Y`_(*O-5@
M.^_E55K2Q08_+8NARDF2P^#J46II:C)5>2KZ62!@(ED?:+2*:5'@'^ZNS!2+
M_ADG"27YBM0IR"2Q%.LK.2-DLK^]MI]O4_U/V-7@LB0/\:NC5;F]-*!E!UQQ
MD5!=I'4KPZO)]BKJ9NO>_=>Z)%\E_CSO;([RP?R<^.$V*QWR'V-@I=M;@V;F
MZB#&;#^3?4_W$E=6]+=F5C4M2N/KJ>:6>HVKGWCE.!R=1()$DHJJJ3V5WUG*
MTHOK*@O$%"IPLJ?P-_SXWX3\B>@=S#L-Y)=IS'R^57?H4T-&Q`CO(*U-O,:&
MA&3#+0^$Y-049AUJX]^?RD-]_/ON#Y#?*_X]]\]4[=H\SV%N;<7<O3_R'3?W
M7W;_`,>=ZM!-E-W]?;^P>UME]A@R;?JX)ACZJ,)2Y''*DU*\T6F20!WG+LN[
MW,VX6<L:@N2Z2:E>-N)5@%;AY'@1D5ZQMWSVMO>>-VO^9]AO;6-'G=YX+KQ8
MI[63C)%*J1R_"0=)&'2A4D9)`-J?!.?JW.4NXMO?S$OY<66J726CJ$VE\N.Q
MMG96GI92AFDBS5'UYM2IA>:(-$/74QV=M<+<$$\>U&W?6EY9$_*9E/[=(_R_
M9T!;7DL[9,+B#?\`E]VX'1?2QL!_IA$A^7F,Y'5MO1OR,WWUA60/O#YX=6=A
M4[UU-/5S93^<-O'+34L"+$9?X?0;[^/.]Z&?_*HQ*8:DO%+&#!=!))(1%:WL
ML!_4NXW%?.\8_LU1M_/[.I2V;F"]VUP;O>[:==0K7?9&H/D)+60'.:'!&,5)
MZNPZ5_FA?$]MK0T';GRF^,N`RN,A@I*>M'R:V5V-FLVP,SSU65K<1U]UCAH4
M@C>***2.E$U05<RQHP$LXGM=^V_PZ7%Q`&'_``U6)^VBJ/Y?[,P[/[D<L&V"
M;IN>W)*H`!^KCE9OFQ6*%<8`(%3FH'$E\^1?\TSXG;+[AVKVW4?+KH[=_P`?
M-@]2]C8>LZ<ZDS.4[2[>[P[+WW)BX(-OYK;6+Q']R]M[(VYB=O0R45;7Y3Q5
M=?73)4BFBACDD1WN_P"WQ7*W!N8FLTC8:$)9W9J8(`H%`&"3DG-*=$._^Y7*
M]GNT6Z-NME+L4%K*I@@9II[B:331615\-(T5`59GHS,0VD`$Z>.X_GUN?*9K
M+Y;!?&OX.[8^]R^3K,:E)\-N@,DF*Q56U5'C\*F)S6R<EM6HAQ5'-$B3OCC4
MRR0++)(\C2,\;ON\C,62"U6I-/T8S0>E"M,?97K%&XYXN9)GE@V[9HZN2*6%
ML=*FM%TM&4.D4SHJ2*DDDU+?V;\@.WNWZ:EQ>^=X25.V\?6RY+&;(VYAMN[!
MZXP^2GC\,^1PO6NP<1MG8.&R$\("//2XV&5XP%+%0`$4]Y<W(TRMV`U"@!5!
M]0J@*#]@Z#VX[[NNZJ([V4FW4U$:*D42GS*PQ*D2D\*J@-.C)=$;7^;7SYPW
M6?PNZT;<':6RNL<[EMU[1Q^>6C_NSTQ0[BIXJ3<&2R>_J^D>KVAL6=*$2_PY
MZHTLE6A^RI7JY2DJZT3=-W6/;(*R11DD5X)7B2WDORK2O`5Z$.R6W.//$-MR
MAMWB7-G;.SH&IHMPXHQ,I%4C-*Z:T+?`I8T.R'\'OA3M1=N[C^)?Q,W)D,OL
M#)U4&(_F#?S!L`E;@9>Q9,16RBN^*'Q+S)5O-AI9HI*;/YVD>>BIJ"61WEGJ
MJFF@C&NU;7'H;;]N8F$XN+@8U4_T*(^GDS#`'J2!UD%R;R?:_3R<K\KR,]BQ
MT[GNBU7Q=)S963?P\1+(I*A222S,JC9UV=L_:W7NT]M[$V1@<9M;9VS\'C-M
M;7VYAJ6.BQ6#P6&HXJ#%XO'TL0"0TM%1P(B#ZV'))Y]CJ*..&-8H@%B4``#@
M`.`ZR,M+2VL+6.RLT6*TB0(B***JJ*``>@`ITI/=^E'7O?NO=>]^Z]T3CY`_
M#O`=L;MQW=/6&^-Q?'?Y.[<QZ8S`]Z=>TF.JJO.X2`2-3[([=V;E(VVYV]UU
M]RRR?PW)J*BE=`U%54C%RY;>;:EQ(+J!VAOE%`Z^8_A=3AU^1R/(CH)[[RG!
MNETN\;=-)8<QQK1;F(`EE'".>-NR>*N=#Y!'8RYKKY_-KX&=([ZR68S/S8Z7
MR_PO[3J*FIJ)/G!\4]IY7L[X==CU4\H)W!W+UQ1Q/N[IW-9*HJ"U0^1BQ\#5
M+2339RIB4:@?NFTVLK%MTB-M<?[_`(@6A;YNO%#ZUIGBY'4%<X\D[->R/-SA
M9OM&Y$D_O&R1IK"4G\4\0[X&).=845J3,P'5._97\E/YDX3"MOSH6+K;YC]1
MU"&HQ?8_QGW_`+>WM%5TLBK+312;5GK<?NB;*-!(K2P8ZGR<<1-O,W!(:GY8
MW)5\:TT7-MY-$P;^7&OV5ZB?</9_FV&'ZW9!;[MM1RLMI*LE1Y=A(?5ZA`X'
MKU7MO/XS_(_KBHGI>P>@.Z]C5--X_/#N_JS?.VY(A*XCA9US&"HRJ32$!&^C
MDBQ/LGEL;V$TFAE0_-&'^$=`2[Y=Y@V]BM]8WD+#CKAD3_CRCI$4G6?9&0J8
M:*@Z_P![UU94.(Z>DI-J9ZIJ9Y""0D,$-`\LKD#Z*"?;0@G)H$<G[#TB7;MP
M=@B03%SP`1B3^5.C6]1?RT?GQWE/3Q]=?%'N6KI:IJ<09O=&U*GKO;$JU*QO
M%)'NKL-MK;=EC\4RNQ2J;3&P8V!!)A;;'N]V?T;>6GJ1I'[6H/Y]"?:O;OG?
M>F`L-LNRII1G0Q)G^G+H3^?#JPWJW^4WT)UKNO&8+Y<_)>'M+M=]=33?#/X'
M8NM[Z[WS-11*DM5@]TY_%8RIPO73T<C*E;)64J40AUM'DHK++[.;?EZT@D"[
MC/XEQ_OF`>)(?D2!1?G44_I=#S;?:_8]NNEAYJW$7.Y\18;:#<W+$<5=E!6*
MGXBRZ:5I(./6Q3TC\!=]=B]=8GK+=O7F"^!OPX%3-4Y7XA=([GDRG<_>5))#
M'!'-\HOD9A*V++&DR=*ABK<'A:JKJJFCE^WK,N_BCCB&=KM$LT(@D06FV^<*
M&KO_`,U9!G/FJDDC!;J?-FY(O;^P3;KJW39.4ZU:QMWK<7`X?XY=*=5",-'&
MS$J=+RF@`N1V7LK:'7&U,!L38.V<'LW9FU<938;;>U]MXVDP^#PF+I%T4]#C
M<;0Q0TM+!&+FRJ+L2QN221)%%'#&(H5"Q**``4`'R'4LV=G:[?:QV5C&D-I$
MH5$0!551P``P!TI_;G2GKWOW7NO>_=>Z][]U[KWOW7NL51_F)O\`-?YJ3_@1
M_F/T-_GO^;7^J_PO[T>'6FX'AP\^M6G<?^B7_9E=]_W[_P!D[_CG\5B_@G_#
M1_\`L[/^SA>7^(U5O]('^RW_`/&/?[Y:-7B_O#^S]SJOZM'L!R?3_7/XOTVN
MN/I/'\;C^+P^VO\`IO/K&NX_=?\`6&?ZW]T^-J[?W)^\/KN)_M?I/TO$]/%Q
M6OG3HW76W^G;[R3_`$;_`/#\/\,UO]C_`*2?^&X_L_%]N^KQ_P"S7_[^[1;5
MI_B/[WDMIY\?LQ@^KK^A^]M/]+Z;_K+G]O0JV_\`?6O_`'7_`-=O#\O%_=5.
M'_+[^I_O>:_ET+&;_P!F^_A=7]]_P\3]IH3S?P3_`(8S_BFGRQZ?M/[N?[FM
M>NVKP>K1>_IU>U#?O+2:_O*GR^AK_+/1G-_6OPSK_K9I_H_U=K^6CN_9U75\
M@/[D_P!U\A_IL_X<H_COWC^+_ARO_9@O]E6\VAOLOXY_PWU_QCC[/RZ/+YO\
MG\/_``+_`&_)[)KSPM'^-?7:Z_\`$GQ/"_/Z?M_U9Z`6^_1_3-^^/ZP^/7_E
MK?5?1?+5^[/TJ>M<4^+%>K4/Y5'V/^AO-_PS_AN7^'_?T/V?_#=W]XO[K?;^
M&;Q_Z1_[V_[^?^]FGZ_?_P"5?K\GJO[/]@I],=/T5*_\1ZT_VU<U^W/4E>V6
MC]T/X?[@\/4*?NO7HIG^UU]^O_39XUZM.]GW4E]>]^Z]U[W[KW7O?NO=?__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>j06224092_ba004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j06224092_ba004.jpg
M_]C_X``02D9)1@`!`0$`2`!(``#_[0`L4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``2`````$``0!(`````0`!_]L`0P`!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M_]L`0P$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!_\``$0@`,P#"`P$B``(1`0,1`?_$
M`!\```$%`0$!`0$!```````````!`@,$!08'"`D*"__$`+40``(!`P,"!`,%
M!00$```!?0$"`P`$$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()
M"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T
M=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%
MQL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$`!\!``,!`0$!
M`0$!`0$````````!`@,$!08'"`D*"__$`+41``(!`@0$`P0'!00$``$"=P`!
M`@,1!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:
M)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#
MA(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3
MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:``P#`0`"$0,1`#\`_OXHI-R[
MMN1NP6VY&[:"`3CK@$@$],D"EH`****`"B@D`$D@`#))X``ZDGL!10`445YI
M\9_BYX&^`7PD^)7QN^)NKIH/P]^$_@CQ+\0/&6KN`YLO#WA72;K6-3DABW*;
MBZ>VM'BL[56$EU=R0V\>9)5!`-76?B7\.?#GC'PK\//$'C[P9H?C[QU#J=QX
M)\$:OXGT33?%OB^#18?M.L3>&/#EY>PZOKL6E6^9]1DTNSNDLX@9+@QH":[:
MOY?]9^&>M^./B]_P2X_:)^,WABUF_;._;?\`VS_#OQGN-4-A97VI_`3]E3X+
M?"#XN?%CPE\"O"4]U#)+X:TC1?"FJ>"=,^)]UHTEK+XO\?\`B7Q#JNLSWR2:
M=!!_4!0`4444`%%%?-7[3W[7/P&_9`\%V'C3XX^,O[#'B'5(_#W@7P;H6EZC
MXM^)7Q.\5W&W[+X1^&7P\\/6]_XK\<>)+@NC?V=H6FW7V2`M>ZC+96$<UU&`
M?2M%?,/[+'[0_BW]I#P=XA\7^*_V9?CW^S`VD^)I-$T;PQ^T'I7@_1/%?BK2
M/[.L=0M_%FFZ3X1\7^+Q8:1<&]:Q-MK5QI^K07]G>036"I&LK_3U`!1110`4
M5"US;I/%:O<0I<SI++!;-+&L\T<!C$\D4)822)"98A*Z*5C,D8<C>N9J`"BB
MB@`HKX<_X*#?MIVG["_P#7XK6?P\O/C'\0?$WCCPK\-/A1\'=+\26/A+5?B1
MXW\3W$]S)I5IXBU*QU*PT>VT+PII7B;QCK&HWMH]K;:/X<OC+)$SQN/H']GG
MXT>'/VCO@/\`!OX_^$+2^T_PO\:?AEX)^)^@:?J?DG4M/TKQOX=T_P`0V=A?
MFW>2W:\LH=06UN6@D>!YHG:)VC*D@'L5%%%`'X0?\%COV:/A+X&_9J_:)_:P
M\!1_$#PI^V!XNO/A-\//A5\7/#?QC^*VA>)/"7CGXD?$KX8?"7PM9^!K2S\;
M6OA?PM8O-?6%S>:59:/;Z%J%]'<ZGK-G>3W%U+)]B_L^?$_XR_L__$+PS^R1
M^U]XZC^).M^-6\0R_LP?M(7-AI^BW/QHT/PY9?VMJ/PP^)]EIT%CH^G?M!^#
M-!6?5)[C1K*ST7XI>%-.U'Q;HEC8ZIHGBO2[+RC_`(*RVMOXFD_X)Q?#35))
MV\._$3_@I[^S-!XCT^-D2WUBP\`Z3\1OBOINGW[-'*S6B^)_`GA_4#"J8N)K
M"&*1XHV:1=;_`(*^ZE<>!_@%\"/CAI,LD'B7X"_MS?L<>.=",#)#<WT/BSXU
M>'?@OXKT*.[92+6'7_`_Q4\3:3=LS)#-;W+P7#"&1Z`/U;HK\TOVTOC]^T-J
M'Q0\!_L1_L6OX?\`#W[17Q5\$:O\2_&WQT\9Z-%XG\$?LN?!'2]9B\-M\1]1
M\'RSVB>.?'7C'Q&;OPM\,/!LUW;:?=ZIIVM:[KLC:+H%W!<_+/\`P2'_`&I?
MBY\4?C;_`,%$?V;/B1^T7X@_:S\(_LC_`!,^$_AWX?\`[0_B_P`&>!?`VL^+
MV\7^"]8E^(^GQVWP_P!(T/PYJ_ACPY\0_"WB#3O#.N6MK<I+IT4EN=6U(6PN
M2`?M%\1/`OA_XH>`/&_PT\5IJ$GA?X@^$O$?@GQ''I6J7VB:H^A>*=(O-$U9
M-.UG2Y[;4M)OFL+Z<6FI:?<07MC.8[FUFCGB1UD\`^#;#X=^"/"7@+2M2\0Z
MQI?@WP[I'AG3=4\6ZY?>)O$]_8:)8PZ=9W.O^(M3DEU+7-6DM[>,WVK:A--?
M7\^^YNYI;B221OSC_9Q_X*N?`/\`:.\?_M[6NB1S>&O@5^P?/X0MO%/[0^OW
M<EKX'\<KJ7A;Q)XF\:ZSX=2XL+63_A&_"*Z`UM8:S;3ZG:^+;:>+5]%=["\T
M]KOL_P#@GO\`M_V/[<?P2^,OQOUSX8ZU\!=#^$WQZ^,/PFGTSQWJ42:F_A;X
M9?V;J-GXV\1PS6MB?"]SJ'A[5;:^UO0;P2MX?NH+RVEO9UB,@`/T6K\@_P#@
MK?<GXF:9^QA^Q-;WCPI^VA^V%\.?"OCRQ0EX]4^!7P2M-3_:`^,>DZA;`'[7
MHWB/2/A]I'@S5;>5EM9K;Q5]GNA-!,UO-Y[%_P`%D],^*VG_`+&+_LQ_!/7/
M'NI_MM?M7^,_A/\`"*W\6ZDFC0Z[^S-\%=7GMOCA^U6J:4E]<:)X2TVPL;R3
MP3INM".\UI[C2[F\B@6[^PCS?_@IW^T7H_[-W_!3O_@F#X]\<PSZQX6T?X/_
M`+>4W@3P3X7T^ZUGXC?$?XU:WX.^%GAGPC\/?">BVD5Q/J>J>+CJ4.D:-###
M&D-]-<7NH7=MIMK<S1@'U%H#/\<O^"OGB.YT]$?X=_\`!/W]E.Q\`QP>5NTZ
MV^//[66M:5XJU%=(6,+:VNH>%O@I\-_#5G?%=\\-CX_BM%6WBFE$WZR5\>_L
M/_`WQ!\%/@I]L^(^FZ39?'GXU^+_`!/\>_VBKC1KM]2L)_C'\3KT:SXBTG3=
M4FM[:YO/#W@BQ&D^`/"0GC#6WA?PMI%N"Q1I'T/V\_C)/^SS^Q/^UE\<+*X%
MIJ7PL_9X^+OC31K@W45F8]>T7P/K5UH!CN9V6..9M96Q2')W/,R1QJTC(I`/
MA#X4>)?C3_P43^)GQU^,.C_M0?%G]G?]B'X/_%3Q9\#_`(9>$?A%#X'\)>(O
MC9XA^"U]J6@?%CXS>)/BYK_A#6/%>C?#V;QL-2\*>&O#?AJ]TJ"X@\#7NN:G
MJICU)K&/T;_@E%\5_BS\5_`G[1-YXC\;_$#XP?L^^%/VB_%O@S]D?X]?%J70
MKKXD?&OX3Z!INDV?B/QA?ZIX:T?P]I'B7P7!\3D\8:-\,_%R:)97?B+P;8:?
M=7,FH+'!J5W^=G[`_P`/=4_X*`_L<_L]?L__``EUKQ!\,_\`@F)\'_!7@KPG
MX_\`B)IEW_9WQ/\`V_OB%X;6VNOC#X8LY`5U+P-\`=0^)/\`PE%C\3/$5P1X
MO^+^J2:OI.EOI7A9[W4-7_I7T#0-#\*:'I'AGPQH^F>'O#GA_3;+1M"T+1;&
MVTW2-'TG3K>.TL--TS3[..&ULK&RM8HK>UM;>*.&"&-(XT55``!P'QT^,W@7
M]G;X-?%#X[?$W4UT?P!\)/`_B/Q_XMU$@%X-%\-:9<:G=I`I(5[JY6`6MG&S
M*LMU-#&64,6'YW_L"?`OQ-\9[_3_`/@I'^UQX1LI?VE/C3HR:U\$/`^N6SWR
M_L?_`+/'B.Q@NO!GPE\)07LDUII?Q`U[1IX_$?QG\8Z;:6.J^(_$^K3:%),-
M!T'3;--#_@M;X(\2^._^"</QSL?#NG7NN67AO6/@[\1/'_AJQ-X9/%'PC^&W
MQH\`>.?B[H$\%BRW%[87OPYT'Q(^I:>N\7UA!<VOE2M*J-^G.BZUX>U#PSI/
MB+1=0TV7PI>Z%8ZUI.JVEQ!_8\GA^YT^*^L=0MKI&%L--?3GBN(;A7$'V4K(
M&$>#0!^>%A^VIX]E_P""MOB+_@G_`''@[3'^&=K^PUH'[3NF>-XK+4DUVW\9
M2_&'4_A_JFBWE\;U])N-"O=(?3IK&)=/M[ZVU33[W==W,-R(K;]$]=U6;2].
MOIM/L#K>M1Z=J-YH_AR&_P!.T^_\07=A;-.FFV-QJEQ:V4,MQ(8;<W5W/%9V
MAGCENYH8=SC^=7]AG]JRS_:*_P""RO[:OQEUZ*+2O@]+^Q3\/[']E;QOKDMI
MI>F:[^S_`/"CXZ_$?PK\3_B5I]Y=K:&7P=X^^*EKJ'B?0M<E>2TG\(Z9HFJF
MXCL;ZS>7)^&'[45W\>?^"UEY\</'OCS3/!?[)?P$_P"";WQ5^)WP&NM0DDT3
MPMK'@#QI\=-`\!^+?CGXJUW5;FWLF@\5GX:7^I>&U%K;Q:?X#B\,7DKF^U:]
M0`'Z?_%G]JS]M[P=%I<?PR_X)A?$CXL7]TQDU,2?M-_LV>"-)TRV\MRBQZC>
M>*M<OK^_,R%)+5=%MK5(GBF34979X(_*E_:I_P""L_B;3+?4/"O_``2L^'7@
MV=)KRWO](^+_`.WAX$L]2=H_*-G=:7_PKKX5>.]/FLIE:02F^O["Z21`J6[1
MGS:_*_\`9L_X*K_M!_$C_@J)^V7)XHL?&<WA!_@/\#?"/[#O["*W\>F^-_B!
MJOQ'U;6_%GA[XO\`BG09H]W@>'5O!.D_\+!^)/C7Q-:1VWPU^'?B_P`-Z/J;
MSZK;:?I6I_IA_P`$T_'W[1A^.7_!3WP)^TW\;;WXOW_P7^/GPMCTEHM-&E>$
M_`UIXQ_9T\"?$OQ'X8^'FB[[J[TOP7IFH>(&L=(L+J^O;RY_LZ36;QQJ>KWV
M\`_+;P+XO_X+:?MI_P#!0'Q#\>?`OPS_`&"_A(__``3[USXA?LB:MX5\7_$K
MXU>,?!^L>(OB[X9^&7Q!^)>K6^LZ#X(T74?&E[X7TI/`NEV[VT7A&RL-6LM7
MLX8M1CO7O8OZ/?V4[G]KZ7X>ZO:_MJ:9\!+7XJZ;XOU6STC5_P!G.^\;2^`/
M%'@@6FFW&B:W+I'C^(^(?#>OF[GU/3M3TB34=7M=MA;W]M>A+TVT'XJ_L>_M
M1VW[%/\`P1H\0_MS:[HD?Q!^+7[57QL^,OQY\">`([A=-U'XN_&_]J7X[^(-
M*^!_PYT^53<7?FZI83^"],E_UM[IN@:;?2F.-=.*1_K3\=?VU/`'[$W[+?@W
MX\?MLZSI?@GQ)?Z9X(\.:[X2^&FC^(?&-_XJ^-?B?28I)OAK\(O"UJ-2\3^+
M-1O=;BU.TT"SS+,UA9M?ZG>6UK#<W<8!]N45^87_``3R_P""F>C?\%`?%/[1
M7A"#]F[X[_LWZ_\`L]:E\-8M3T#X\Z9H>B>*=:T?XJ>&M0\3^&-0N_#^CZEJ
MDWA/5&L--FN+SPSK-RVJVEA>:3>W`B:_:UMN2^-7_!2_Q5/\4_&?P9_8G^`^
ME_M07WPKLU/QW_:#\0_&#PE\*/V3?V>];$Y-[X4^(/Q6O8-=N->\<:#I"G7?
M$?@GP7I.HZEH5E+9P:W>:3=W+10`'QI_P63\<VVH_M$?#'1;RRFU/2?V1OV.
M/VJOVO(='C!NHO$/QP^*^FV7[('[+GAU]/0C[5>:AXT^(OC/^SH)2@ENO+,)
M9XCM_;_]ESX7W/P1_9I_9\^#=\MBE_\`"KX*?"_X>:@-,A%OIQU#P=X*T70+
M]K*`!1%:O>6$SPI@$1LN0#FOYV/"L7A[_@J'_P`%L]6\9>&?&Z']E_\`9O\`
MV5/V8_&-U/H^BZ_9Z3^U/K7A3X]?%/QOX-O?">L:S:6MMK?P8\)_&?05U63Q
M%IZS:?XQU+P-H\6BW.IZ-<W>HK_4[0`4444`?BM_P6D\<Z/\'=%_X)W_`!X\
M3)XC_P"$1^#G_!2CX$^)?&EWX?\`"^M>,QHWA#5?`OQ<\,:_KVH^'?#MCJ&L
M7=MI-EK+3Q3V-O+/9W1BN88+N9([6;QKXY_M<_"S_@K;XO\`@]^R+^P[/??&
M[X:^$_VAO@1\;_VN?CJ_ACQ?X9^#_P`.OA?\%_B!H_Q2LOA_IGB;Q)H^AMXN
M^*OQ!\5>%O#^E:=X8\.Q7BZ5HJ:SJNM7=G%;A:_H&N;2TO42.\M;>[CCFAN8
MX[F&.=$N+>19;>=$E5U6:"55EAE4!XI%5T96`(9:6%CIZ21V%E:64<LC32I:
M6T-LDDK`!I9%A1`\C``,[`L0!D\4`?D?^T%^P/\`M+?$K]M?QY\;_A=^T-X:
M^%GP5_:%_9[^%G[/OQY%AH_B6/\`:!\+^%?A3XS^(7B]K;X!^+['4XO#'A:Z
M^(\7Q`O=`\1>)-:TVZUCPM;1RZOX8B;6?L=S:8?B'_@CKX3C^+GBW6O@_P#M
M&_%3]G_]FWXN>"/@_P##_P"/'[+GPNT+P;I.B_$KPI\#_#%UX-\'^&-,^*AT
M_P#X63\/?#&L>&[NXTSQYI_A74X=2\51W>I2G6M/N-3NIC^R]%`'Y!7/_!'7
MX*ZC^UKXS^/6I_$3Q\WP$\9Z1\$;K5?V)-+.GZ)^S[K/Q#^`?A>V\#_#OQ=X
MPTVP1+WQ?X?\->%M)T"/1/AQJ6SPC;Z]IIUS4K75V^QVECY'=_\`!+?]HCQ!
MXW_:D^!NL_'WPGH/_!/G]I;]H?QI^T_XT\-^#=,\3Z5^T9XSU?XH:;IY\;?L
M^^(/%-M?V/AS0_@K-XHTJ+6M2U70VF\7>*_#5RW@.X_L;3&U"]O_`-V:*`/Y
M9_@A_P`$*_VR?V&OC!\`/C[^RA^VE\/OCIXX^"O[/7BG]F'1O`_[8/P\\1:5
M\)O`'PRUC5=&UC3G^$.B?!G6;75-#U?[1I=P/$DVO7^K77B.\U*]U6^U5Y)E
MM8?0_P!L']DCXX_LT^,OV8_^"L?QU^-OC7]KKXW?LB?%JUG^+GAG0O!VE^#?
M@W\.OV6?BWI6H_#KXSW/P1^$>C0:MJNF7GPUA\0Z3\2+_P`7^)_$WBGQAK.A
M^$-1&JZG%:0P6]G_`$JU#<VUO>6\]I=P0W5I=0RVUU:W,23V]S;SHT4T$\,J
MM'-#-&S1RQ2*R2(S(ZE200#,\.>(]`\7Z!HOBKPKK.F>(O#/B32[#7-`U_1;
MVWU+2-9T?5+:.\T[4],U"TDEM;VQO;2:*XM;FWEDAFAD22-V5@:^$?\`@JK\
M!_B]^T[_`,$__P!I+X!_`O2O#VN_$GXH>%-$\-:9H?B?4+;2M(UG19/&GAF\
M\8Z3)J-X5L[.[U'P=::]9Z;-=20P+J$UL'G@!$R>7:S_`,$_OCK\$["[TG_@
MG3^U[?\`[+G@O4]9O=4D^!WQ2^%^C_M'?`KPD=4O+O4]4_X5)X>UO7?"?C3X
M7V]UJ=T]ROA?1?'5UX`LDFNDTGPAICR1RQ?8'[.'PJ^/OP]TG4-0_:+_`&E+
MW]H7Q]K-GI=M<2:1\-O"?PD^&WAM=/%PTP\'^"M";6-:CGU*>Y:34M2\4^,_
M$MY,D%I!9C3K:$P.`?$=W_P1;_9#M-2MM5^$.O\`[2_[)=E(8-3U/X??LC_M
M*?%#X$?"N[\3%_M%[XD;X<^$M73PC;:W>3%8[^[TS2["&_CMX#<V\LB&1NW\
M?_L._M;7U_9I\'?^"JO[3_PM\+V6EVUC#X=\3_"W]FGXR7WVFW0HU]-XQ\8?
M"RT\4Z@]P`CSC6-0U.Z>4.XO@KJB?I[10!Q/@SPOK.D_#SPUX-^('BE_BCKM
MAX2TWP[XQ\8ZSH6C:-)X^U&'2XM/UO7M4\-Z/!'H&G-XCF%Q>7ND:;;II=O]
MKDM;:%;940?G!9_\$HO`%M>ZAX0D_:<_:[D_9:DU+3M0T/\`8XM_BS;Z?\$M
M`L;6\-[>^!8]5L_#T?Q9U+X2Z@P2S'PJU#XBR^#+/1O.\/6^G?\`"/O%I<'Z
MJT4`?G;\=?\`@ES^R5^T-\<?@W\=_'GAWQ?8ZU\%_AW_`,*BTKP+X*\:ZQX+
M^$_C7X50:VOB73?AM\3/A[H#6FB^-/`FE^((X-4@\)WRQZ%>/;6]EK%CJ>EP
MI8CT/X\?\$]OV/?VF?B9\+?BY\;O@IH'CCQM\'=-CT/P7<W>H:_IVBMX>MM8
MMO$.G^&?%/A71]5T_P`,>.?#&D>(+2#7='\.^,M)US1M,U9#?6=E%-)(S?9]
M%`'F>D_!?X1:#\3/$?QGT3X8^`])^+GC#0=%\+>*?B7IWA71;3QSX@\-^'1(
MNA:%J_B>"S36+[2M*25DLK&>[>WAC6&-4V6\"Q_'&C?\$Z/`/A7]J3]HC]K3
M0/BG\:#XM^/45KK4OPOF\;SV/P<\-_$6T^$UG\'&^($/A71X--G\3:Y<^#M+
MTVQLX/&>I:_H_AJ1;Z]\,Z=I5_?RW:_HG10!_+E^S]_P1K_:\^+G[(O[)G@W
M]K/XV:1^SS\7?V'-2^'>H?LE^#?A9IFD?%OP#X*\4?"O6+^\3XN_&O1?$EY_
MPCOQ4\>_$5Y+2671+*[L=#\`:/:6]IH5[-JNJ^(KBY^]OVAO^"8/[0?[35S^
MR;XF^(G_``4%\:Z?\2_V9?&/Q3\9'X@^#O@'\(]$N-3U+XF>"M.\%17O@OPY
M=1:IX=\$^(O`NGIX@'@GQ;JEEXTUO1W\37=ZLKZK8V&H0_LO10!^`_\`P3X_
MX(:R?L:7WQAC^)/[:/QZ_:`\)?%#X\:Y\<+SP:UV_P`.(?&>M7JV%MI=S\>_
M%_A_5+OQ_P#&N\M;'3;9;S1-;\3Z=\/KR[EU&>Y\&W*ZA-&/HCX;_P#!$#_@
MGO\`#?Q)K>OI\/OB)X[TS7/B?XA^,=S\-OB?\:_BEXW^"T7Q%\4ZO=:[K7B)
M/@KJ?B<?"Z\NKG5;N2\4:QX4U-898[<Q[?L\.S]<**`/R<^.7A6?]F+_`(*$
M_`;]KZVT^;3?V?OB1\`-2_8P^-DGAW03)I/PWUK3?','Q#_9T\<>(;;2K667
M3/!+:QJ?CKX;7>JQ6T6F>&]2\5^&GU*6UTN[N+FV_6.FNB2*R.JNC##*ZAE8
M'J&4@@@^A&*=0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
80`4444`%%%%`!1110`4444`%%%%`'__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>j06224092_ba005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j06224092_ba005.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@!,0%*`P$1``(1`0,1`?_$`:(````&`@,!````````
M``````<(!@4$"0,*`@$`"P$```8#`0$!````````````!@4$`P<""`$)``H+
M$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M``P#`0`"$0,1`#\`WY<MEL5@<5D\[G<GC\+A,+CZS+9C,9:LIL=BL3BL=325
MF0R>3R%9)#24&/H*2%Y9II72.*-"S$*"??NO=$7C[X[X^348I/B7M)>M>J,C
M#9OEKWQM'-4E/F**>*%OO?C]\?<I+MG>W8+2PS/]IN3=3[;VP'$-;00;GHF:
M%O=>Z!'XZ_%#!;G[%^9N&[.[Y^9_9V4Z_P#DWM_;&)W-DOFG\GNNYGQN<^(G
MQ4[/RT,.S.C.T>J.J]N4=1OCL/+UD5%A<!C,?1I5"GIH(J>**)/=>Z-/_LC_
M`$Q_SVOR_P#_`$X1\^?_`+I;W[KW7O\`9'^F/^>U^7__`*<(^?/_`-TM[]U[
MKW^R/],?\]K\O_\`TX1\^?\`[I;W[KW1:N]?BKL':O:/PPP6W^S/F+C<3V7\
ME=T[)WS11?S`OG?*FX-K4'P\^5_8])B*AZCY'334\,.]>O\`#UX>!HI3)0JA
M8Q-(C^Z]T97_`&1_IC_GM?E__P"G"/GS_P#=+>_=>Z]_LC_3'_/:_+__`-.$
M?/G_`.Z6]^Z]U[_9'^F/^>U^7_\`Z<(^?/\`]TM[]U[KW^R/],?\]K\O_P#T
MX1\^?_NEO?NO=>_V1_IC_GM?E_\`^G"/GS_]TM[]U[HM6UOBKL&O^8?>O7%7
MV9\Q9ME;5^-7Q0WMM_`M_,"^=ZT^-W3V!VC\S\%O#+Q5"?(Y:Z6;-XGK3!PR
M))*\4:X]#&J,\I?W7NC*_P"R/],?\]K\O_\`TX1\^?\`[I;W[KW7O]D?Z8_Y
M[7Y?_P#IPCY\_P#W2WOW7NO?[(_TQ_SVOR__`/3A'SY_^Z6]^Z]U[_9'^F/^
M>U^7_P#Z<(^?/_W2WOW7NO?[(_TQ_P`]K\O_`/TX1\^?_NEO?NO=%J^*'Q5V
M#V!U=NG.[P[,^8N;RU!\E?F?LFDK9_Y@7SO@>':W6GS#[UZXV-B%2C^1U-"T
M.W]E;5Q]!&Y4RR1TRO*SRL[M[KW1E?\`9'^F/^>U^7__`*<(^?/_`-TM[]U[
MKW^R/],?\]K\O_\`TX1\^?\`[I;W[KW7O]D?Z8_Y[7Y?_P#IPCY\_P#W2WOW
M7NO?[(_TQ_SVOR__`/3A'SY_^Z6]^Z]T6KYG_%78/6GP\^5_8^QNS/F+M_>O
M7_QJ[UWML_/4_P#,"^=]1483=.U>KMTYW;^7@IZ[Y'55#/-C<M00S*DT4D3,
M@#JRD@^Z]T97_9'^F/\`GM?E_P#^G"/GS_\`=+>_=>Z]_LC_`$Q_SVOR_P#_
M`$X1\^?_`+I;W[KW7O\`9'^F/^>U^7__`*<(^?/_`-TM[]U[KW^R/],?\]K\
MO_\`TX1\^?\`[I;W[KW7O]D?Z8_Y[7Y?_P#IPCY\_P#W2WOW7NBU=Z_%78.U
M>T?AA@MO]F?,7&XGLOY*[IV3OFBB_F!?.^5-P;6H/AY\K^QZ3$5#U'R.FFIX
M8=Z]?X>O#P-%*9*%4+&)I$?W7NC*_P"R/],?\]K\O_\`TX1\^?\`[I;W[KW7
MO]D?Z8_Y[7Y?_P#IPCY\_P#W2WOW7NO?[(_TQ_SVOR__`/3A'SY_^Z6]^Z]U
M[_9'^F/^>U^7_P#Z<(^?/_W2WOW7NO?[(_TQ_P`]K\O_`/TX1\^?_NEO?NO=
M%JVM\5=@U_S#[UZXJ^S/F+-LK:OQJ^*&]MOX%OY@7SO6GQNZ>P.T?F?@MX9>
M*H3Y'+72S9O$]:8.&1))7BC7'H8U1GE+^Z]T97_9'^F/^>U^7_\`Z<(^?/\`
M]TM[]U[KW^R/],?\]K\O_P#TX1\^?_NEO?NO=>_V1_IC_GM?E_\`^G"/GS_]
MTM[]U[KW^R/],?\`/:_+_P#].$?/G_[I;W[KW7O]D?Z8_P">U^7_`/Z<(^?/
M_P!TM[]U[K7#_BG9/_>17R__`.XCS_9"_P#LL_Y8?]DG_P#/J?\`F<O_`*W?
M^/D_ZN'OW7NMGSY8?]DL_)7_`,0!W)_[[K<?OW7N@"H/EWMW$[>VATWT3L_-
M?)CY`8/86RZ3/=>=>5]#0[/ZNKZG:>%JZ-OD%W)D4FV)TO#]I7T]:V*J7K]Z
M5V,E-5B-OY4+H/NO=-'6OQQ^96W,MVOOW(_)OI_:&\.^.Q*'M;?>S]G_`![R
MN[ME[3W!C^K>M.GL9M[:FYMV]L8G<NXL?C=D]3XA*G)5='CVRF4^ZK(Z#&P5
M$6.I?=>Z%3_15\R?^\O.OO\`TE>B_P#MS^_=>Z]_HJ^9/_>7G7W_`*2O1?\`
MVY_?NO=>_P!%7S)_[R\Z^_\`25Z+_P"W/[]U[H/=Z?%_Y3[[W)U)NG-_+_:"
M9/I?L+)=E[/6A^,.-@I9=Q97JGLWIVI3,Q2=O3O6XT;2[8RC+%&T+BL6"365
MC:.3W7NA"_T5?,G_`+R\Z^_])7HO_MS^_=>Z]_HJ^9/_`'EYU]_Z2O1?_;G]
M^Z]U[_15\R?^\O.OO_25Z+_[<_OW7NO?Z*OF3_WEYU]_Z2O1?_;G]^Z]U[_1
M5\R?^\O.OO\`TE>B_P#MS^_=>Z#W&_%_Y3XKM;>G<5-\O]H'=N^^O>LNM,W%
M+\8<:^(3;O4^Y.V]T[7>AHQV\L\&2DR?=&8%7*TTB31+3JJ1F-FD]U[H0O\`
M15\R?^\O.OO_`$E>B_\`MS^_=>Z]_HJ^9/\`WEYU]_Z2O1?_`&Y_?NO=>_T5
M?,G_`+R\Z^_])7HO_MS^_=>Z]_HJ^9/_`'EYU]_Z2O1?_;G]^Z]U[_15\R?^
M\O.OO_25Z+_[<_OW7N@]ZR^+_P`I^I]MY+:VU_E_M"3&97L+MOLNI;*_&'&U
M=4-Q=T=K;T[BW@D4L/;U(B8V+=N^ZU:.(J7AHQ%&SR,ID;W7NA"_T5?,G_O+
MSK[_`-)7HO\`[<_OW7NO?Z*OF3_WEYU]_P"DKT7_`-N?W[KW7O\`15\R?^\O
M.OO_`$E>B_\`MS^_=>Z"WM[+]Y=";3_OOW!\]NH-B;=ER5%@L9/E_B_3/DMR
M;ERKF'";0V;M^A[BJ]P[VWMN&I'@QN$Q%+6Y7)5!$-+3RRLJ'W7NJL?FEW+_
M`#((OC7W!NK?63V)MWXJ]E=,_(3K%]N]I]'2]?\`R4[!&X?C%W?N'';HI=F;
M?[0W'CNC=LT3[7IZB"'<517;JK!,]+D<%@9HB9/=>ZV7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]T4'Y+?\SG_E[_`/BW^]?_`(`;YP>_=>Z-][]U[KWOW7NO>_=>
MZ][]U[KWOW7NB@[*_P"R^?DM_P"*@?!__P!_/_,(]^Z]T;[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=:@O_X7W[]U[K9\^6'_`&2S\E?_`!`'<G_ONMQ^_=>Z*Y\?
M_P"7!\-]C],=;8+8_566V1@6VCA,P,!LSMSNO:F!CRN?H(,UG*^#";?[%QV+
MIZK+Y>NFJJAXX5,T\KNUV8D^Z]T,7^R(?&;_`)Y?L#_T?_R$_P#MI^_=>ZI`
M[BWCL[J;MGY(;6?';'S,?3GS_P#C%\4.O>GYMW_,["[[[5V/\@>GOAWV-D*Y
M^Z9_EI5=<;/WQMBI^2>:EAJJ[`KBJBCVS'%+!!)6">/W7NA8W-3;)P':O=/3
M:;*Q<^Z:S^97U/\``CXZY*?M'Y;0XK#XO>GP-Z=^<^\]^=L4T/R5J9=\9C:N
MS=S[J@H:/&3;5ILE/B:&G>:F:JDGC]U[ID^4^-VW\58OE1US/A<;O/L;JSX8
MU7S'Z3WWG^R/E128/.X7:^^*KK_L78O:>RL!\C</'+5;>S%3AJN@R^+S6*6O
MI<X].V/B?$R5>2]U[IGR]=@=L;TPF$S>T<#5=7M\\MC_`!FI_D+C]V_,V+8G
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M(21I1^;&5M/)[KW2EW'O?XZ[[VC_`"^]T_'7KS-.ORS[&ZDC[:H>Q>Z_E'F:
M_I;K[?%1G]I[AV9D:#;W=^UIL+W=2=I83(8*EBR3?8I+M3<6N"::@$#>Z]T,
MF]\/\:]F?//J+XS5FR,LO4_8F)WCUA7;Y;Y.?("/=6+^6R[(Q/>^P.KZK;]1
MVI3_`&VV<Y\>\)G<FN24RK4Y>HH:&,>5F`]U[J+T;\?J+Y6=5YSY"=1TN/V=
MLZM[<[6VCU5U[N;LCY.[HK-U=:=/=R;BZDRFY=V;KIOD7MAL1OCLE=@Y/+8.
M.FIUQV!@R5#!D(<C)!4LWNO=(7I;8>W>SNX>QNN\J*'##:GS"[&Z"VSB(]I_
MS"QBMR;)ZZQ7]\\E)4=\CY5UW5>.["FV'C,I-%&:9HI*ZECB-)&)24]U[I:=
M.=2[<[&^).`[ERV!PM%V-F?E-ENEG..W]\M5V5!LW'?.#(_%N.K3;E3\K:G.
MON:3:E!_$FJ3F12_Q!K"E\(\9]U[KCMWXQ;SK/EWF/CMELCU'+A-H]%]!=[[
MBKL=4_-FCRF2Q_8'=G:.R.PMFX7+U/SGKZ2AK*/9G6,O\&RL^+G092K2:IHG
M@0TY]U[H).J\=MKM+/\`2G2C[6Q>*[9[L^1?\T':$^]<7V;\JZ7;&Q_CY_+I
M^5&]/C75[DQNR\M\E,]5;H[8WMDI-GH//EZ7$T4V:K:XT=3#CTQM;[KW1H^U
MOBOAND.B.Z<SG:3![P[8GW)!LCXMUM9W9\E>N]K;DSV]-M;/P'71[;I9.^MV
MS4\>$[.R64K-T5^*,$*;8QTU?#04R1/&ONO=`KE(>D>P/AW\0?E!T=LVJPE9
M\B^ZOBQUCN_;O8/<7R<WM%L6;N'N#;G3_;NT-&UOD7L@IOKJO=-?D\<TS551
M2+D<6ZO#(AX]U[I??/#K[H?XET?4&\,KM7LC9706?W1N+#]Z?(<;M^57<6#Z
M(BI\"M9U[DM^[5VAWAA<OM;K?>&YP]#E]V3)5X_"I''35`HVR,65Q_NO=&NZ
M.^&O0F\^ENHMW;I\.]MT;HZQV'G]S;RZ>^0_R'J^I=U[CR^UL77YW<?6%5)W
M=N66HZ]S65GEJ<,[Y&O=L=)"6J9S>1O=>Z%+_9$/C-_SR_8'_H__`)"?_;3]
M^Z]T"O1WQWZ<ZW^?W>E3MG9RSY'9OQ-^*N1V9F]WY[<_8NX]EU/9G:_S3Q/8
MHV;N7L+-;HS^TZ7?6.ZVV_%EZ?'5--!D%P])YT<P(1[KW0-_SOLMBJ3X=56(
MJLGCZ;+9O_3C_!<745M-#D<O_"OAQ\G,AD_X7122+4U_\-H$,\_B5_#""[V4
M7]^Z]U<;[]U[KWOW7NO>_=>Z][]U[KWOW7NB@_);_F<_\O?_`,6_WK_\`-\X
M/?NO=&^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW10=E?]E\_);_Q4#X/_`/OY_P"8
M1[]U[HWWOW7NO>_=>Z][]U[KWOW7NO>_=>ZU!?\`\+[]^Z]UL^?+#_LEGY*_
M^(`[D_\`?=;C]^Z]T`G5_P`DNY8.M.NX(_Y?ORZJXX=B[2BCJZ?>?P,6GJDC
MP&/1:B!:OYM4M4L,RC4HEBCD"D:E4W`]U[I.8[^8D<IN/L+:-/\`$#Y)0;DZ
MJW=2;%W[B<IV5_+^PE3@=TUVQ]F]CTV,_P!S/SBH(LHK[.[`Q-4:BB:HI4>I
M:G:05,%1#%[KW1&-^;7V9V74_(^AWCT[\\LIUY\K^[=C]Z=V]2+WA_*!H]D[
MDSVP.O>B^L,'M>AS%'\CX>T,!LV7:GQUVS'4QT6XX<G+-#/(*U34/[]U[I79
M1]D9C,]V[EK?CQ\U#N?N7Y-]>_+NAW'!WO\`RIZ7*].]V]8=/]5=$[5S74[4
M_P`LHZ6/#CK7I[%X^NQ^Y(MR4N3@GKHJI9J>MGA;W7NFCLN#;_=6V>_:#M;H
M[YGYW>_R+ZEQ'1.[^R\%W)_*EV_G-H]1X3)9S-TNQ^L,#5?+S/;-VW0UF>W-
MD,A75E?C\OEJ^JJE$]8]-18RFH?=>Z$;O[Y0;7WYN?XE4^_>A_F+MK<FQ/D)
M3[QZH;:W:O\`+`J%W[VCMWHSN@SXG?LM5\K-T8O&;?GZS;<];(\)P$+UL,,,
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MO=2NP<7L;LGJB'KK.]`_-&FWA1=^8'Y(XKY#8GMC^3S2]^8;LG:W>5-WSMZ3
M&[EG^1U7M&+!XK.T46#2E?!2>3:B'%2O)`[EO=>Z=.I.]\/U3OOL?IKJ_JGY
MFX':0R"=_;AZ1I^ROY7M+@=H2_(+L;LW<6;DV)V!%\M:#)X7:_9?8^U=V9"N
MPM%E*G(82KJ'>AEQ%%/CX#[KW3IL;=>1ZZSV\\KM?97\P6BQ._\`Y`5_R+W3
MM!>ZOY.$.#R&Z\MG\'GLQMA,K1?(&DWU1[#S*X"*@JZ.',I55&-EGIWJBLTA
M;W7NI&R]Y'8D3;2PG2'R]_T,Q]V;A[_H.HZCM7^5,U!C-\[C[=R'?-1@J3=T
M/S%AW>O6^.[?RDN>H\;]S_$(*A8Z+^(MAD_A9]U[H3*#O.FQ_P`D=T?)N+XU
M?+67=F[.F]E=(U^SYNZ_Y6YV#3;7V'O#?&]\+E:"GB^8T6\4W))F>PLB*B67
M-34DD#1JM,A34?=>Z+Y@\9MK:&)V+-LSI3YL8?LGJ_O?Y.=^[`[<K>X_Y2>4
MW;B,M\P.TM\=P=^=;9/&1_*G';/S_3^]MX;]J6?%SXX9&F2BQ\M/D8:W'TE7
M%[KW0VY#N6HW-NGK[=78'0OR[[`3862W7N$[,W+VQ_*=J^O-Q;IW1M:EV=39
M_(;>D^6LF1Q$VR\`*V#"PXK(4$4?\6K9*T5]14--[]U[HIFS/]%6\>O=_83K
M'K;Y_8+86:^=N;^4M!C,)VI_*"P=!UEWSTUWI-6[[V=UYA=U=X,M+UCD.]NN
MZ[(5T-;3Y1LG5S5-70Y$TM:)9?=>Z,C4=O=G?QZDW52XOY\UF=I_[VTE7!NG
MM+^3AF]IYO`;MQ6P,6VV,QL[%_)+;6'&+VS4;&DR>*GH10Y./*9FO-55UE!-
M_#Q[KW0H="_(/;WQQZ;ZYZ,ZX^'/R-@V1UAM?'[4V\N0[G_EI??2T="K,]55
MQX?YPX;"TU16U,LDSPT-%14$!?QTU/!`L<2>Z]T+G^SW9;_O#_Y`_P#HYOY<
M?_W>?OW7NBR4O:OR7[#^4O;F^.M-E]>?%S9W8GQ_^.'6=3VY\F^U>@>P\]MW
M*=5]@_+#<VXWZ]Z5^.W>_9%%O;,38_NC$BFGW%NC;&.HI1),T.4$344ONO=2
M?D_U#\:.L/AA\XM_/V9C.Z/D!G_AQ\F<+EN^NW-_;3WKW!EZ7(]0;R9]M;:J
M*&/$[;ZUV?55'CT[9V;B=O[>:91-]BU2\DTGNO=6H_Z5^K?^?E;`_P#0QV[_
M`/7'W[KW7O\`2OU;_P`_*V!_Z&.W?_KC[]U[KW^E?JW_`)^5L#_T,=N__7'W
M[KW7O]*_5O\`S\K8'_H8[=_^N/OW7NO?Z5^K?^?E;`_]#';O_P!<??NO=%'^
M2/9_6DW<G\O^2'L/8TL=)\N=YU%7)%NW`2)2T[?`[YLTBSU#+D"L,+555%$&
M:RF215O=@#[KW1N/]*_5O_/RM@?^ACMW_P"N/OW7NO?Z5^K?^?E;`_\`0QV[
M_P#7'W[KW7O]*_5O_/RM@?\`H8[=_P#KC[]U[KW^E?JW_GY6P/\`T,=N_P#U
MQ]^Z]U[_`$K]6_\`/RM@?^ACMW_ZX^_=>Z*/LSL_K1?GC\D:MNP]C+2S?$;X
M34\-2V[<`*>6HI>Y/Y@$E3!%,<AXY)J>.KB9U!+(LJ$@!A?W7NC<?Z5^K?\`
MGY6P/_0QV[_]<??NO=>_TK]6_P#/RM@?^ACMW_ZX^_=>Z]_I7ZM_Y^5L#_T,
M=N__`%Q]^Z]U[_2OU;_S\K8'_H8[=_\`KC[]U[KW^E?JW_GY6P/_`$,=N_\`
MUQ]^Z]UJ2?WLVM_STN`_[BV_[V?\7G'?\>M_STO_``)_XL'_`$V?\!O]K]^Z
M]UM.?+#_`+)9^2O_`(@#N3_WW6X_?NO=%/ZQZ[^5'R5ZTZ]7N#=-=\4ND9MC
M;5B7IOI/=Z57R$WYBOX!34_A[5^16`=:7J;&Y.E=7DQ'6CIG:2:..2'>IC>:
MB/NO=,7Q1^'_`,4\%V/\Z-K4'QQZ2?";6^5NS\5@Z?*=9[0SM324E3\&OAAG
M<@TN3S>)R.5KZ[,;AS-;DJ^JJ)Y:JOR=;4U=3)+4U$TK^Z]T<W_93_BS_P!X
MU=`?^B;ZZ_\`L<]^Z]U[_93_`(L_]XU=`?\`HF^NO_L<]^Z]U[_93_BS_P!X
MU=`?^B;ZZ_\`L<]^Z]T4SY&?&#XTT7</P'IJ/X\=&4E/E_EGO''Y6GINI=@P
M0Y.@B^"OS2RL=#D(HMOHE;1QY3&4U2L4@9!44\4@&N-"/=>Z-G_LI_Q9_P"\
M:N@/_1-]=?\`V.>_=>Z]_LI_Q9_[QJZ`_P#1-]=?_8Y[]U[KW^RG_%G_`+QJ
MZ`_]$WUU_P#8Y[]U[KW^RG_%G_O&KH#_`-$WUU_]CGOW7NO?[*?\6?\`O&KH
M#_T3?77_`-CGOW7NBF;.^,'QIE^=7R,Q4GQXZ,DQ=%\3/A;D*/&OU+L%Z"DK
M\GW#\^*;)5U-1MM\T\%9D*?$4D<\J*'E2EB5R1&@7W7NC9_[*?\`%G_O&KH#
M_P!$WUU_]CGOW7NO?[*?\6?^\:N@/_1-]=?_`&.>_=>Z]_LI_P`6?^\:N@/_
M`$3?77_V.>_=>Z]_LI_Q9_[QJZ`_]$WUU_\`8Y[]U[KW^RG_`!9_[QJZ`_\`
M1-]=?_8Y[]U[HIGPM^,'QIR?3V\:G)?'CHS(5$7RS^?&/CJ*[J78-7-'08CY
MU?(W%8JA26HV_(Z4>,Q=%#34\0.B&GB2-`J*H'NO=&S_`-E/^+/_`'C5T!_Z
M)OKK_P"QSW[KW7O]E/\`BS_WC5T!_P"B;ZZ_^QSW[KW7O]E/^+/_`'C5T!_Z
M)OKK_P"QSW[KW7O]E/\`BS_WC5T!_P"B;ZZ_^QSW[KW13/GQ\8/C3B/@K\TL
MKBOCQT9C,IC/B9\C,AC<EC^I=@T5?CZ^BZ>WC4T==0UE-M^*HI*RDJ(EDBEC
M97C=0RD$`^_=>Z-G_LI_Q9_[QJZ`_P#1-]=?_8Y[]U[KW^RG_%G_`+QJZ`_]
M$WUU_P#8Y[]U[KW^RG_%G_O&KH#_`-$WUU_]CGOW7NO?[*?\6?\`O&KH#_T3
M?77_`-CGOW7NO?[*?\6?^\:N@/\`T3?77_V.>_=>Z*9\C/C!\::+N'X#TU'\
M>.C*2GR_RSWCC\K3TW4NP8(<G01?!7YI96.AR$46WT2MHX\IC*:I6*0,@J*>
M*0#7&A'NO=&S_P!E/^+/_>-70'_HF^NO_L<]^Z]U[_93_BS_`-XU=`?^B;ZZ
M_P#L<]^Z]U[_`&4_XL_]XU=`?^B;ZZ_^QSW[KW7O]E/^+/\`WC5T!_Z)OKK_
M`.QSW[KW7O\`93_BS_WC5T!_Z)OKK_['/?NO=%,V=\8/C3+\ZOD9BI/CQT9)
MBZ+XF?"W(4>-?J78+T%)7Y/N'Y\4V2KJ:C;;YIX*S(4^(I(YY44/*E+$KDB-
M`ONO=&S_`-E/^+/_`'C5T!_Z)OKK_P"QSW[KW7O]E/\`BS_WC5T!_P"B;ZZ_
M^QSW[KW7O]E/^+/_`'C5T!_Z)OKK_P"QSW[KW7O]E/\`BS_WC5T!_P"B;ZZ_
M^QSW[KW7O]E/^+/_`'C5T!_Z)OKK_P"QSW[KW6J'_HGZL_Y]IL#_`+BN_P#1
M/_QYNW?^96?\^T_XMW_'@?\`5F_XMW_-GW[KW6UY\L/^R6?DK_X@#N3_`-]U
MN/W[KW1(-C?/O"=H[(V5L'X:S=;]H9#%;4V[M_=/R$[#WI2;3^+G7F5Q>+Q^
M-S5+C]P4]4NZ_D-NS!U$50G\'V1!-A?XC138W+[DV_4^M?=>Z;)NN^INC<+V
M#VMVQ_,M[1H]V]I[VQF]>T,YL3='2>S\!O#LVJVALOK'`X3J_J'`==;UW$C/
MM786$P6W]OTE3N#<->E#`L]5E<I-45E3[KW15OD/M+YX9SX\=]]_=4?)7Y9?
M%/J[I[H_MOMO;61[LJ.I-T?(KMK(]>]?;HW7@J).H9NJ$VMT%L?+Y/$T<TE1
MN:?-;NJ\>]115&WMNUGCK(_=>ZV&??NO=`U!\C?CU4[P/7M-WQTS4;^&XCM`
M['@[0V1+O`;L$0F.USMF/.-FAN(0L'^R\'W.DWT6]^Z]T$/;FY^G-[][?&G;
M*]^=-X;L;H[OO([]RG5N1W_M8=A9^7='QG^0/4>*VOC=IC,IG:?.5,O;L&5B
M22G)FH:&;0I+*1[KW0^P=P]25-!OK*4W:77-1C.KZZHQG9>1@WOMF6@Z[R5)
M31UM7C]]5<>3:GVE74M',DLD60:GD2)@Q`4@^_=>ZA;N[TZ1V!%A)]^=Q]5[
M)@W+BWSFW)MW=A;2VW%G\+&M.[Y?"29G+T297%HE7$340&2("5#J]0O[KW3K
MN'M;J[:.RJ/LG=G9.P=L==9&'"5&/W]N'>.W<+LJNI]S-2IMN>CW5DLC38*I
MAW`];"*%DG9:LS((B^M;^Z]TR4/?O164V1N7LS&=U=2Y'KC9;5:;Q[`H>Q]G
M5>R-IO0!&KEW+NNGS,F!P342R*9A55$1C##5:X]^Z]TTT_R;^-M7A=S;DI?D
M'T?4[=V5'@IMY9ZG[8V%-A=I1;HJ\A0;9EW-E(\^U#@8]Q5V)JH:%JJ2(5<M
M-*D6MHW`]U[I(U%#LWK3OO?/R%WKVAL';.U.Y^JOC3T;L^#<6X<5@%K]V=?[
M_P#DCN:BBQN6RU=2XW-56]5[XHJ;&4=*SU,TU')I5O)&/?NO="12][]'UVV=
M][UHNY>J:S9O5V2R^&[-W;2]A[1J-L]=9?;\<<N>Q6^\]%F'Q6T<EA(ID:K@
MR$M/+3*X,BJ"/?NO=,N3^3?QMPF;GVSF?D'T?B-R4W\*^YV_D^V-A4&;I_X]
M!!58/SXJJS\5?%_&::ICDI-48^XCD5H]08$^Z]U*B^1OQZGW-FME0=\=,S;R
MVVN??<6THNT-D2;FP*;4QHS.Z6S6!3.'*XM=M8@_=Y`SQ1BCIOW9M">KW[KW
M4ZA[ZZ,R>#V'N?&]S]3Y#;7:F8&WNL-PT/8NSZO!]CY]H:VH7![#RU/F)*#=
M^8:#&U+BFQ\E1,4IY#ILC$>Z]T*_OW7NB@_!_P#YDQO7_P`6_P#YA'_P?/R6
M]^Z]T;[W[KW7O?NO=>]^Z]U[W[KW10?YA'_9`WS@_P#%0/DM_P"^8WK[]U[H
MWWOW7NO>_=>Z][]U[KWOW7NO>_=>Z*#\EO\`F<_\O?\`\6_WK_\``#?.#W[K
MW1OO?NO=>]^Z]U[W[KW7O?NO=>]^Z]T4'97_`&7S\EO_`!4#X/\`_OY_YA'O
MW7NC?>_=>Z][]U[KWOW7NO>_=>Z][]U[K4%__"^_?NO=;/GRP_[)9^2O_B`.
MY/\`WW6X_?NO=(+JSXI_%VHZQZYGG^-O0<\\^P]H3333=/=>22S2R;?QSR2R
MR/MUGDDD=B68DDDW/OW7N@I[$Z-Z4ZZ^5GP>S77W3_5NQ,S)OKO&G?+;-Z_V
MGMC)O3O\>>P%>!Z_"8BAJFA=7(*E])!/'/OW7NE)_,KWYM#:OPC^3FT\YGZ&
MDWAW#T#W9U+U'LN$RY#>O:G:&^.L-T8#:77O6^SL;'6;FWSO+/9;(114^.Q=
M+553!BY01H[K[KW1[??NO=:]W<E%C=\?'K^<=T*G5V^NT>U.^OD=V?1_'G8V
MWMA;LK:[/=@Y[XP?'3974G9V`WG%A?X!L?`]?]R[?%;)O:2NI:+:]3@YJS[F
M.:D4'W7N@K[ZZT[TK>X>^*;?*9+M'HO:'9W\LO>7S`Q77&R-R3=W=C;?Z&VK
MCMRYSM'HG<T*YC^,X7J[O3;N`S6\\'A<!)NJJVU3Y"GQ62H,N:6GJ/=>Z.9B
M-PX?`;:_FH]896JFI=^?(;M[?6[>@]LOC<J,GW9MOMWX<=";*V=FNJ:<T(??
MV-3>>%R&+RTV,^YCP-5CJHY)J6*%I??NO=*[:N[MS="?(_\`F69KN,4>V]V]
MH[HZQWC\4>T-_P"%JJ[K?L+IG!?&[8>U=L=";5JZ3+8F/)[PV)W_`(+?E=5[
M.AR=+G*YMUC*4U,T->9![KW3/W\N]JO^4[T&N\.O8]D]@/3_`,N7,;HZGV3L
M?=^&38-=@>_?C?NW>>S,'U]E<EO#?&)Q_6&#PU>M325=36UE!0XJ>6I<"&5E
M]U[HJ'\P':&?[BG_`)FW='16PMZ#KC<7\E7Y4_'+?6XJ;8>Z]O1_)KY);SH,
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M99^+OQ]ZZZ![ZR66A&XZS?7Q9I.P$SVWMSQ;>Q>*J:"N*5M;E*G`XW<-$ONO
M='A^%?3N)ZU^2OR8ZDPE165'0'Q_WAB=^?$O9M3BO%M;K>?Y,[;KMY]VT&Q,
ML`,7G\'M/>%9D:#;RTB*^SL/N/(82.3[.I2"/W7NK7_?NO=%!^#_`/S)C>O_
M`(M__,(_^#Y^2WOW7NC?>_=>Z][]U[KWOW7NO>_=>Z*#_,(_[(&^<'_BH'R6
M_P#?,;U]^Z]T;[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%!^2W_,Y_Y>_P#XM_O7
M_P"`&^<'OW7NC?>_=>Z][]U[KWOW7NO>_=>Z][]U[HH.RO\`LOGY+?\`BH'P
M?_\`?S_S"/?NO=&^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6H+_^%]^_=>ZV?/EA
M_P!DL_)7_P`0!W)_[[K<?OW7NB[;"[&^<.!ZBV9EJ[X^_#?'[=PW7&W<C69S
M-_.7MW#4M#A<=MBCJ:C*Y>6;X`S4.*IZ:AA,U0SU#Q0*K$R%5U>_=>ZK/S7S
MP[O^57;.R\WU/M;KG9&`^,W;NZMNYCOCJ'K?Y\_S`MB;I@W_`/'G"5K9WJ.E
MZ=^#O6/76]H:?#=N4GV=57[SH(34T[58HZ_&24<N0]U[H[W36\_BCU'N7(=F
MY+;7SF[@[ZS^/DQFYOD#V_\``;YU[G[.R&,J)UJJO;NVWHOBOA]I=5;#FJXT
ME_NUL_%X#;WE1931M/JE;W7NC-_[/!TQ_P`\5\O_`/TWO\^?_N:??NO=>_V>
M#IC_`)XKY?\`_IO?Y\__`'-/OW7N@'[>_F&[*VYV#\6L/M?;ORGH<)O[O?<.
MTNQJ7)_`/YKTU;F=F4?QC^1F^J'&[>@S?QR@R61S$786RL#6/#B%FR*T%)4R
MN@H(JV1/=>Z'C_9X.F/^>*^7_P#Z;W^?/_W-/OW7NO?[/!TQ_P`\5\O_`/TW
MO\^?_N:??NO=>_V>#IC_`)XKY?\`_IO?Y\__`'-/OW7NO?[/!TQ_SQ7R_P#_
M`$WO\^?_`+FGW[KW7O\`9X.F/^>*^7__`*;W^?/_`-S3[]U[H!]O?S#=E5GR
M<[>V+7;=^4\O7NW.B/CGNW:^'@^`?S7?/T.\]Z]@_*7#[[R63Q]-\<FW938?
M*X38.W(J&:MA3'3S456M$[S0Y!8_=>Z'C_9X.F/^>*^7_P#Z;W^?/_W-/OW7
MNO?[/!TQ_P`\5\O_`/TWO\^?_N:??NO=>_V>#IC_`)XKY?\`_IO?Y\__`'-/
MOW7NO?[/!TQ_SQ7R_P#_`$WO\^?_`+FGW[KW7O\`9X.F/^>*^7__`*;W^?/_
M`-S3[]U[HJ7PT^9?4.&ZAWA25>S_`)6S2S?*WYX95'Q7P/\`G%G:44N=^<7R
M(S=%%+6X3X[Y"B@R4%%D(TK*-Y%K,=6++25<4-5#-#'[KW1K?]G@Z8_YXKY?
M_P#IO?Y\_P#W-/OW7NO?[/!TQ_SQ7R__`/3>_P`^?_N:??NO=>_V>#IC_GBO
ME_\`^F]_GS_]S3[]U[KW^SP=,?\`/%?+_P#]-[_/G_[FGW[KW14OGA\R^H<[
M\'?F7A*+9_RM@K<S\4OD1BJ2;,_`_P"<6W<1#59#J'>%)3RY7<&X/COC,#@L
M;'+,#/65U33T=+$&DFECC5G'NO=&M_V>#IC_`)XKY?\`_IO?Y\__`'-/OW7N
MO?[/!TQ_SQ7R_P#_`$WO\^?_`+FGW[KW7O\`9X.F/^>*^7__`*;W^?/_`-S3
M[]U[KW^SP=,?\\5\O_\`TWO\^?\`[FGW[KW7O]G@Z8_YXKY?_P#IO?Y\_P#W
M-/OW7NBI?(CYE]0Y#M[X'U=/L_Y6QQ8+Y6[PRM:E=\#_`)Q8RJGI9O@[\R\(
MD6&HLE\=Z2MW%DA6YF%VH\?'55B4:3U;1"EI:F:+W7NC6_[/!TQ_SQ7R_P#_
M`$WO\^?_`+FGW[KW7O\`9X.F/^>*^7__`*;W^?/_`-S3[]U[KW^SP=,?\\5\
MO_\`TWO\^?\`[FGW[KW7O]G@Z8_YXKY?_P#IO?Y\_P#W-/OW7NO?[/!TQ_SQ
M7R__`/3>_P`^?_N:??NO=%2V?\R^H8?G%\B,V^S_`)6FBR'Q2^&F*IX8O@?\
MXI\O'58;M[YX5=7+7;?A^.\F>QF-FBSL`I:RIIH:.OE2HCII99*2K2'W7NC6
M_P"SP=,?\\5\O_\`TWO\^?\`[FGW[KW7O]G@Z8_YXKY?_P#IO?Y\_P#W-/OW
M7NO?[/!TQ_SQ7R__`/3>_P`^?_N:??NO=>_V>#IC_GBOE_\`^F]_GS_]S3[]
MU[KW^SP=,?\`/%?+_P#]-[_/G_[FGW[KW6K'_IPV7_SI>W_^XIO_`$X?]D]]
M^_\`'E_\Z7_F6G_,W_\`OWO_`!_W_5F]^Z]UMN?+#_LEGY*_^(`[D_\`?=;C
M]^Z]T6'I_P"']3VKLCJG>/S*WY'\AZO';4V/FML=*4V!.T_BOL*NH<7A\C@Z
MZFZCJ,CG:GM?>&`J:6"6'/;XR&=--D(/O</0X)I#`ONO="Y\9T6/N7^8,B*J
M(GR]V2B(@"JBK\!?@\%55``55`L`.`/?NO='`]^Z]U[W[KW7O?NO=%!^2W_,
MY_Y>_P#XM_O7_P"`&^<'OW7NC?>_=>Z][]U[KWOW7NO>_=>Z][]U[HH.RO\`
MLOGY+?\`BH'P?_\`?S_S"/?NO=&^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW10?@_
M_P`R8WK_`.+?_P`PC_X/GY+>_=>Z-][]U[KWOW7NO>_=>Z][]U[HH/\`,(_[
M(&^<'_BH'R6_]\QO7W[KW1OO?NO=>]^Z]U[W[KW7O?NO=>]^Z]T4'Y+?\SG_
M`)>__BW^]?\`X`;YP>_=>Z-][]U[KWOW7NO>_=>Z][]U[KWOW7NB@[*_[+Y^
M2W_BH'P?_P#?S_S"/?NO=&^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6H+_\`A??O
MW7NMGSY8?]DL_)7_`,0!W)_[[K<?OW7NM.CY<?\`"HC(UFPL%TU\`-N939%+
MBMG[?V[F?D[VKU_E:W<<]50X6&AK9^FNH,OAJO&X^))XHVI\WO**9FTRQMMT
MJT-9[++K<1%V6X#R>M10?SJ?]6>H5YY]W$V56L>4X8-PW2E/$:>%;>,_/]57
ME8>:KI7_`(94%>M:_+_)3>^XMQ;FWCN3NWN_<6\-ZYE]Q[QW5F=X=MUV?W3G
MWH:'%G+9O(/4"6LJHL5BZ6CA!M'345+!30K'3P11(1-<;B[%C(17T8`?L!ZQ
MAO>;?=^^NGNI-SG1G:NF.[@C0?)424*`/D/F234]++K'=/>O=F\L7U]T_FOD
M+V'N[*,LKT.W\OW)5T>`PZU5)1U^[-VY*!IX=N[2PTM=#]U5R!W+RQP4\515
M304\KUNNZ7#Z5D8`<3JP/V$]"#E.T][N;K\VEENUU';I0RRM>!DC!K2HCD=B
MS4.E0N2#4@`L-K3X!?R[?B)TY_!NROF_\E.^ODIVDE.E3#U-A=B?,V@^..R:
MZ:!HY8JFBKMC8_<W=>2H_*ZI69V+'X9P4D7`Q5,,=3[$5O`T*][N[^I/^`>7
M^'Y]9=<I\KW/+EIIW#<K_<]Q8=\EQ*Q7[(XM11!CB=;\1KH:=7`_9_RGO^?1
MG_TG7Y)__:[]J.A=U#J<%_*/K9L=4UG2M)5U&(K'R.)J*GXV?(V>;%Y"7'UV
M)DKL=++UP\E%628O*5-,TL95S3U$L9.B1P?=>ZF?9_RGO^?1G_TG7Y)__:[]
M^Z]U[[/^4]_SZ,_^DZ_)/_[7?OW7NH>1E_E'XC'UV6RW65)B\7BZ.IR.2R61
M^/WR-HL?CL?10O4UE=75E3U_%3TE'24\322RR,J1HI9B`"??NO=(>D^)6V?E
MC!#)TK\9=L?$GX_Y:G6:#OKM#9/W?R4[!Q%5#Y*;(]*]`;O^_P`%T]BZZ*:.
M6FS_`&=1U>81H98)-C^*:FR:^Z]T;+^7QU!M+X]O\P>A^O:K=T_7O57REV]@
MMG4^]=[[K[`S=#1Y[X9?$'?F?\FX=XY;,Y9ES&]MWY3*20)+'1P5-?*M/#!#
MHB3W7NA/[F[7J^J>_P#J':6P>G]F[Q[1^2VW=U[9.[]P;YJ^OQ%@/C_BL[O_
M`!>`S^5QG7._\E7XVC;L/,28N-8M$-9D:C4$69Y/?NO=`S3_`,PY=P4VU,%M
M7I?*8_M^L^8&2^$W8_5/:.]\?LVMZJ[=H^H-P=ZXS)Y;<FR\!VMBMQ[#W?U=
MB:+-8;)8U9FJ\?G:!I(8)_O*>D]U[IXZ?_F!X/NS)?&RBVGUGE*&G[^WQ\H^
MM\A59W=%`L>S-V_$?=FY-D]F-AJ_;^*W#MKLS:>7S^TZS^`YG%9):')4OBE+
M0EI(XO=>Z$3=_P`N/[J[_FZBBV)1YSM;<W>C]']/[0H-Z>!-[38WI/;/?V\.
MP-W96MVM`O7NP]@=>[D$N6J(H<W/]XD5%1Q5E=74%-4^Z]T.76^].QMPY?>.
MW>R>KX>OLIM9MOS8W+8+=M1OO8^]<9GZ.LJ!D-K;GJ=I;+K3-AJVAFHLA0UV
M.HLA35$8E,!HJB@K*SW7NB1Q?S$Z[`]:R]]]E=%U6WOCWB_DSVK\7=Y]B[.[
M%H]ZYCK+<G5/RKWG\/,EV3V!LG,;2V'4P=0Y+MG9CR#(82LSN4H,-605U=CJ
M:*.L^T]U[J+6_.OKCI>BW]MYNN=C]8TN+^>>8^)&'RFX^PXME=493N'LWK^7
MY29OL'L/?*[%K(^N<7V#7[SGI(9GH,I497?.5IZ#AJ^.I/NO=#=_LUF[)=T]
M5=-1=*55!\D.T,3WCN]NM=P[V3&;.V3UIT-O_&]>Y[LW=O9.-VGG:Z/:N]LM
MN?`?W72CV_5Y'+_QV%VIJ>FI<C54?NO=83\K=ZMV)M'H$=(_9_(S=E'VONM=
MEY??\E+UQA^I^H,GLC`Y?MW)=IX_8V7K6VGO+</8^%H=M4T&WYLSDJBKF6HH
MZ+^&9G^&^Z]T&NR_YA^-W+\E]C?&7/=4UVS-S9W?W=/2F]LUE=X02T6R.^>G
M>L=F]XT77%#1-MNCJ=VTO<?1&^J/?.S<HC4:Y';%-725D%!7TC8Y_=>Z5&4^
M8V_5W/U!M3;W2NV<A6=[=]=]])=<9'.=P9#!X6MI^A]M]C;FK]]Y:JQ?4NZ*
MV@PNZZ3JK+QT$,%-5NS&DDUM3U)FB]U[I/\`<'R>ST]'U_U!N_X]=<[TI_D/
MTK\I-W[GP&>[UPD?6F3ZNZ4GVK@MT10;PK.OJK;6Y=L]N;'[*Q^1P\^4&#HS
MCZMTRK8[1(1[KW21ZQ_F>;8[,49!>H-V;*P&_P#X>=8_,OXQU.^,N,/G_D=L
M[L>/&8^LZ_VUMBGP%=5X;M#8.\]T[;P>7Q:RY&26KW=@Y<>:ZGR,4H]U[HYF
M]^QNW]J]6[;WI0].[?R>\IZ.7*;_`-FY#M7^$X+KW&4&R]Q[JS$\N]:#8>X*
MC<U1293#4V'ACHL1IJ*S()+KCI8Y)Q[KW16X/G-V(WQ^Z/[\JOC[@Z3%?(K.
M?$[%]7X__3///12T_P`N<OAL#M`[IRR=4+D<%F-D9'<F.?/TT&-KZ9*6J\E#
M5ULB/"/=>Z$S+?*S=.`W+U[U/D^J]OUW>?;N_.Q=J]:;9VIVM'N/K3*;6ZAV
MCA=R]H]H[F[*.Q<;N':>S]BYW,+M.O@;:U5F%W=+34:4;TM0:^+W7NN.9^4G
M8NSM^='=<[]Z(AVUG^[_`).Y[XU8/(P=D293:\LF"^*787RQ;LO;N5?8&.R&
MXMFU6V^IMQ;?5)J+&UL>X:.*)XEIY)JBF]U[HO\`W-\^-J]?X#L3M[LKX[Y+
M=&TOA_\`,:EZ8W/GMFY2??N\]A/E.FL)D=R?(/:.T(ME464R6%VAUAWC609N
MDHI3EH\,V4:G2J"K#/[KW0]=C_-K9^P:V/\`A^&Q_8F&WKB_C4O0F2V#N^DS
M<O=FZ_E3NK?.UNM<3AC_``B';N)VO##L&MS>0SPRE;24^VXY*]8W$31'W7ND
M/W9\]I?CEMKY)#M_JFGH.R?CW\2.Q_FO0[1VCOVKW%M/MKI7J*'(-V5!L7?V
M8Z_VG5P;\V55TM'35^-K\)34\<NX,.R5;PU<\M'[KW1EN\>^\7\>^JL?V!OO
M!563W'G-U=;=9[6Z_P!DUJ9K);Q[<[<WE@>N]A;$VSE,S2;9@EARV\=R4\<V
M4KH:"DQV-2?(5OV]+33O'[KW0"]C_/#;/QVSVY=H_*+:4?7.Z*+I_+=V;!BV
M#N2L[+V]V_M[`[]V-U5F]E;!S>>VCU=63]N8WLCM79^+.$JZ&FIYVWAB9(*Z
M97K10^Z]T*A[B[TP,U2^_P#X^8?`X>7J_?._<=GML=M5&]<;B-R;.@P%?2];
M=B..L<!)M/.;HQ>5K9J/(8X9[#"3"U4+U2RRX]:WW7NBV[)^7\^^-W]([IV-
MT3UKB=X?)OX-8#Y4YG>G8'<59LJEVWT]L3-;8K\5LC=FYL5TWN^HKIMHUGR3
MEK:=FBBQ\!J\HYDC]!J/=>Z6U%\W<SF^YLAT/M[IZCJNT]AXOXSYGN7K#*]J
M8C%]K;-P'R&S>W\9E]\[,V;3;:RV-[/ZOZ8I<Q52;@W#3Y:@I'JL-D*.E6:>
M`!_=>Z/_`._=>Z][]U[KWOW7NO>_=>ZU!?\`\+[]^Z]UL^?+#_LEGY*_^(`[
MD_\`?=;C]^Z]U\GW$?\`%JQG_:OHO_<:+W'[_&?M/7)^_P#]SIO^:S_\>/3A
M[KTDZV.?^$P?_9?7;?\`XI_V!_[^CX_>Q#L/^B_[7_G[K+7[K7_+=_Z@O^UO
MK>W]B'K+;KWOW7NO>_=>Z][]U[KWOW7N@`^6/_9+'R6_\5_[D_\`?=;C]^Z]
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M``*&FK<C5+4UU=B:BN/VLE<D-%[KW2NZY^%W?G4&*^+&.P>].N^RU^$>Z.Q=
MH]*R[ZS.Y]LY??WQFWWL+,;#VWLKLG/X39NXQ@>V.J<5%@*=-R4]#G(-TTV'
MG:LI**MR#5E-[KW2ZWA\/NR=S=H=3_*;';IV;MWY$]8=U;_[.DV<LN8R_4NZ
M-A]F]+[.Z$WATQ6[LEP=!N_'M7;3ZVV[F*?=$6)9Z7<>-\C8>>AD:B'NO=#%
M\<N@]R]:=F_*+N+>=-L?%;C^279&R=Z':VQJNOW!CMHX_9W3VP>MY*"3>65V
MQLFOW%49_/[7KLS+_N(HDAFR#`F:1I)6]U[HI"?`_NC?/Q\W7\1>S-Q]7[<Z
M0[&^5_R`^0W:FXMEY?=>[M_;XZ^[M^:W9OS(FZ-PV*S6S]DX/8'DJ]^4NV,M
MN5JS.RU>'I*QJ3'4-57P5&,]U[H0:GXF=KKC_DKM[+;2^-O</7'R9^6V=[?[
M+Z>[?DS>4V9OCH_.?'7:W4W^CW-5%;UGNJBQ6ZJ/L/KK`[@\YQ&5HY:..>B]
M$A2J]^Z]T'?0W\O7L3XKY/H3L;J+=>V=T[OZDV+\BND*WJOL?>>^)]B4?QU[
MP[\H.\^N>J-C]O9#;N^>R:-OBLF#H=N[<K\GBJ],[@_N8*BFQRG'+BO=>Z,Q
MNKH'M.;O_K3Y;[9JNO:KM[:W5O9_1V\.NLMD\YA-@[GZJ[%W1L/?6%Q]!V'2
M;4W)NC%[NZTWAUY!44V2."DI,Q2Y?*03T%,TF/GQONO=%_W_`/RZ=S=@=9=\
M9^/M#&["^7?<?RMZZ^:6U^X=M8>3*;?Z9[;Z:VGU?U7U7M;;-!D(:&IW/LV@
MZ(ZKAV=N"HKJ:&3<E+G,W5/1TB5Z4--[KW0I?(3X>2;YKOA=0[&V%T_O;KCX
MD[@W!D$ZP[GS&4CPFX\)4=";SZ.VIAHZMNN>SX?N-NP[MCR7W=51S2-)CUC"
MAYC/#[KW0(]V_P`MA/E#2=";*[MVKTSB^G^K^E?DSTF=@=95N=P[=6;<[8J^
MJ\9TM4]'96JV5"U#N;HS9O4E`D&6>/%-4929Y:>EHZ5%HS[KW0O9/XQ=\=A5
M'\OG</=.6Z7WSV)\.^\\UV)V#OVAH\GAF[7P$WQM[IZ'HLE@ML'9U51[(W)F
MMT=I8K>M=BHZJ3$TF7VI2Q4LQUTU3CO=>Z/3O_#9+<>Q=Y[>PPH3EL]M7<&%
MQO\`$ZJHHL<*W*XJKH*9JZKI:')5-/2I+4`NT=/,X4&R,>/?NO=5[;U^%>_]
MR?!SXB?%N>'J?=^<^.^4^&U9O*DWCD<TG7>_\?\`%;,[$S.4PZ:]B;EK/L^P
M?[C"G`JL7(E"E8SNE3X?'-[KW7O]D^[.PW8/1W>W7&U_COU7O+XY[@[WP'7_
M`$-LZJW!0]-YCI#Y/4NQ-Q=W[;RV_:#KG$YC;G9&X>\-C4>\:;-T&T9J&"*D
M.)DQ\K5U3E4]U[H2._?C3OSY';E^(^;[(P72^=V[T1\F\_WQO/K?/OD]T;;R
M.WLA\5>_OCCB]G8VJS.QI*3=^4H-P]ZONL9"OQ>*CC?%Q4"4^IER$7NO=(WJ
M?X=[RZDG[4I-LX/IW";5WY\WL;\F\'M+;.0RNW\'MK9$'5G777M?M>/&8_KN
M''+GJBOV$]?HAACI)/X@RM*&C+R^Z]T#=%_*GI=B9[?=1U+V>V$V3MWN;XY?
M(KXE=:;DQ;9?:OQYWOTYN[N+=>_>I,68V3('H7LV3N#.14-'%*U7M(;CK4QH
M6DH<91Q^Z]TK?D_\&NUOEE@OE'N3>64ZUV/V?VY\`N_O@/T_@L'G]R;LV;UW
MMWY*I23]I=E;MWG6;#VEN'=62R65VSMB6EP]/A:."CAVZ\8JY'R;S47NO=#+
MWCT!WE\GMK4&+W]4=5]2YCJ[L#I/N_I&IV;GMQ]MT?\`IJZ:[-Q?8]#E-_-N
M/8/5DZ;'RM%MV/;]1C<<IK9,9G,E,E;!618^6#W7N@7^4?\`+WW9\Z,U4;R[
MQW9MOJ#=6P^H\CL#XYQ=6U=9VG2]9=AY3O+H/Y%3]V[DRV[MI=82[SK*3L3X
MM[#AI=N)0T-/!CL=DE.1DERR-C?=>Z%+<7QN[F[.[RVIWUO_`!G2NW-R]??%
M+Y-?'S&XS:.X]U;BI=][L^0&X/COF,1O[*93-==;>K^OZ'K^CZ5S%#2T4:[E
MJ32[PJD2JC6.<5_NO=`#0?R\]W0K\2Z;?_6/QC^0VW_CY\!Y_AMN;9G:F>SE
M+@\_F<C+TQ%D]]X":MZ1["%#1OBNHY*<0-2Q53IF'7S(*?\`RGW7NE9WC\).
MX_DIG>N,]V]3_']>S^J>P.G.Q.G_`)5]=2[RV/WIT#-MY.N\KW5LSKW'0;7K
MI=T;+[+SN`S]#'0Y7=$.-J,+FX8LQ093[,Q5'NO=6M^_=>Z][]U[KWOW7NO>
M_=>ZU!?_`,+[]^Z]UL^?+#_LEGY*_P#B`.Y/_?=;C]^Z]UJ:;H_X3M?%[I_J
M+9'97</\PG>NPL5NC%;5I<+0U/4VU,IG-S;IW!B*>LQVRM@[4Q&4R.[^P=XY
M)BR4.'PU#796N*$0T[M<>RD[-9DUJ_[1_FZ@:7[NG($TK3.^XZW8DTF3B34_
MZ#T5KJ;^19O'M[<?>M+MBB^5:[<ZM[8Q'7^#?=FVOC+USO2JQN4Z-Z8[;IZ_
M=^R=S=P2Y+;>4R([2\]/22&.J@Q<E(E=3T>26MHJ;7[EL_5_VC_-TW_P.'M]
M_'N/_.9/^M/5D_PF_E3_`"Y^`O;><[DZ+QW:U5N;<?7.;ZRRM/OW'_%7<.-.
M"S6YMF[IEFHX<;WY@)*>NBR&RZ=0S-(#&["P/)66ME#9ZO"U=U*U/I7Y?/H?
M<C>V_+WM]]5^X6N6^K\/7XKJ_P#9>)ITZ42G]HU:UKCA3-I?]X/YK_\`SS1_
M]`7XV_\`W4?M7T/^O?W@_FO_`//-'_T!?C;_`/=1^_=>Z"7L;NC^;#L;>'0>
MV!MK'6[D[:S/6[??;!^/[U6G%]%=T]O?[AFH/DY+2PY+5U4-35K1TQH_.JL:
MAH$?W7NA:_O!_-?_`.>:/_H"_&W_`.ZC]^Z]U[^\'\U__GFC_P"@+\;?_NH_
M?NO=)/?N,_FD=C;&WIU[N#;E:F!WWM/<>S<V^.V9\::;()B-T8>LPF2:AJ)?
MD[41P5BT=<YB=HW57L2K`6/NO=+#HCJGL_IO*83?NY/AQW9WQWIAMOQ[:I.]
M.YN^/C5G]X[>P9HC056V^KL+C=V8G8_2NSZRCM#48W:F,Q29-(XY,F^0JU:J
M?W7NC=_Z=?DO_P!X/=@?^CM^/?\`]GWOW7NBI;/[J^1*?.+Y$5T?PSWU-DJG
MXI?#2DJ\(O<?1"5&.H:+M[YX38[*RUK[X7'U$.9J*^JACBBD::%J!VE55EA+
M^Z]T:W_3K\E_^\'NP/\`T=OQ[_\`L^]^Z]U[_3K\E_\`O![L#_T=OQ[_`/L^
M]^Z]U[_3K\E_^\'NP/\`T=OQ[_\`L^]^Z]U[_3K\E_\`O![L#_T=OQ[_`/L^
M]^Z]U[_3K\E_^\'NP/\`T=OQ[_\`L^]^Z]T5+X:=U?(FBZAWA#COAGOK,T[_
M`"M^>%7)5P=Q]$4:0UU?\XOD1793%-#7;X@G>;!9*IFH9)54PSR4[20L\3H[
M>Z]T:W_3K\E_^\'NP/\`T=OQ[_\`L^]^Z]U[_3K\E_\`O![L#_T=OQ[_`/L^
M]^Z]U[_3K\E_^\'NP/\`T=OQ[_\`L^]^Z]U[_3K\E_\`O![L#_T=OQ[_`/L^
M]^Z]T5+YX=U?(FO^#OS+H<I\,]]8+&UOQ2^1%)D<W4=Q]$5U/AJ&IZAWA#5Y
M6>BQV^*C(5D..IW:9HH(WFD5"J*S$`^Z]T:W_3K\E_\`O![L#_T=OQ[_`/L^
M]^Z]U[_3K\E_^\'NP/\`T=OQ[_\`L^]^Z]U[_3K\E_\`O![L#_T=OQ[_`/L^
M]^Z]U[_3K\E_^\'NP/\`T=OQ[_\`L^]^Z]U[_3K\E_\`O![L#_T=OQ[_`/L^
M]^Z]T5+Y$=U?(FI[>^!\U7\,]]8ZHH/E;O"KQ=)+W'T14/G:Y_@[\RZ&3%4\
MU+OB6"AFAQM;45QEJ6CA,=&T88RR1(WNO=&M_P!.OR7_`.\'NP/_`$=OQ[_^
MS[W[KW7O].OR7_[P>[`_]';\>_\`[/O?NO=>_P!.OR7_`.\'NP/_`$=OQ[_^
MS[W[KW7O].OR7_[P>[`_]';\>_\`[/O?NO=>_P!.OR7_`.\'NP/_`$=OQ[_^
MS[W[KW14MG]U?(E/G%\B*Z/X9[ZFR53\4OAI25>$7N/HA*C'4-%V]\\)L=E9
M:U]\+CZB',U%?50QQ12--"U`[2JJRPE_=>Z-;_IU^2__`'@]V!_Z.WX]_P#V
M?>_=>Z]_IU^2_P#W@]V!_P"CM^/?_P!GWOW7NO?Z=?DO_P!X/=@?^CM^/?\`
M]GWOW7NO?Z=?DO\`]X/=@?\`H[?CW_\`9][]U[KW^G7Y+_\`>#W8'_H[?CW_
M`/9][]U[K5C_`+]=E_\`/CMP?]Q3G]^O^/VZ]_YF7_SX[_B__P#'P?\`5[_X
M][_IJ]^Z]UMM_+#_`+)9^2O_`(@#N3_WW6X_?NO=!5\5/BGU;UA@MD]LUC;F
M[7[SS776!H<AWKW'EX-Z]FTF"S&'Q%97[/V75C'XO;/4O7M1/2P/)MO9V,V_
MM^:>!*B6B>IUS-[KW16>H?Y@?P+ZQ[Z_F`87LGYN?$3KW,UGRWVU5T>)WQ\D
M^FMIY.JI<3\*?AYL[*5--09[>=!53T^-W=M;)XJH=4*PY+'55,Y$U/*B5+*#
M0D5Z327EI$YCEEC5QQ!901Y\">C%_P##I?\`+'_[V,?!#_TKOX_?_;"]^UIZ
MC]O5?WA8?[_A_P![7_/U[_ATO^6/_P![&/@A_P"E=_'[_P"V%[]K3U'[>O?O
M"P_W_#_O:_Y^N$G\T_\`EAPHTDO\QSX&Q1H+O))\OOCXB*/ZLS=AA5'^O[\'
M4X!%>K)>V<C!(Y8F<\`&4D_D#T`G??SP^#^Y.T_@CF\!\Q_BSF,1MKY0[IW1
MN;(X_P"0'5%32[:VW7_"+YA[8H\[N.6+=C+@<34[FW3C,:D]7X8SD,C34U_-
M/$C6Z4]&M_X<*^`O_></P_\`_2E^E_\`[-??NO=>_P"'"O@+_P!YP_#_`/\`
M2E^E_P#[-??NO=>_X<*^`O\`WG#\/_\`TI?I?_[-??NO=>_X<*^`O_></P__
M`/2E^E__`+-??NO=>_X<*^`O_></P_\`_2E^E_\`[-??NO=%8VC\Z?A)3?-K
MY![KJ?F+\5Z?:V:^+'P[V]A]RS_(3J2+`9;/[8[:^<^2W+@\9F)-W+CJ_,;>
MQV[L345U-%(\U)#DZ1Y51:F$O[KW1I_^'"O@+_WG#\/_`/TI?I?_`.S7W[KW
M7O\`APKX"_\`></P_P#_`$I?I?\`^S7W[KW7O^'"O@+_`-YP_#__`-*7Z7_^
MS7W[KW7O^'"O@+_WG#\/_P#TI?I?_P"S7W[KW3IM?YV_"+?&]]I]9[(^8GQ;
MWKV/ORLK:#9'7^T._NJ=T;WW?68VAERF2I]L[4P6ZZ_/9R3&XV!ZBH^VIY/!
M`IDDTH+^_=>Z;/@__P`R8WK_`.+?_P`PC_X/GY+>_=>Z+Q\?OEUVWW#V#N':
M63[!Z%Q62P7RN^1_0L/74'3';5/N/+[1Z.WCV/@*?<5+V">W,QMBGW%5X#94
M>4GAEQ8I)'UTBO`\L4J>Z]T$_5_\S;L',_"WY`=E]A[%V+2?+KH]IL/0]3X!
MMR8W96_\CV5UI0]V_&O>V+H*ZOS^\:/K7=?4FYJ3)[EJ:>HR;88[>W,(I9AB
M)=/NO=.DGSO[@.]\!M7.;\Z!ZQH<I\#>A_E<<SG^CNW-^)6;S[7R_9N(SFV*
M>FVOW9A9L;MG"ML:FDIRXJ:R05;IJD95)]U[IM^0G\PKNSI/Y#=@=)XN/HO>
MN^=KXOX?5?6GQSQ>`WG)W?\`)#.=^Y_L_'=J;8ZPSL/8K)BX^KMJ]69'<K9F
MHVE78R@Q%-/+ES0TD$U?%[KW1CMQ=SYKY$[E^9'5&W<ET;M'HGXY5T'0/=VY
M^^=E9KL#;F^][;RZ8V=VQV%M>JQ=#VAU1A]N=<[1ZO[=V_39"LK:K('*5N2K
M8/%218\2UWNO=`_E?FC\@\IC^U1U]E/C+G,ALG^6=UE\SMLY[$T>Y^Q>MMT=
MJ;KJ>XJ/-[?QV]MG]ITM%N#J&IJ^IBN-R..$E5]OD!4>6J$0CF]U[IVPO\RO
M$U75M=W!OG`4_4)Z"VO\AZKYQ]%[CQM3N?M;HG?'QTZL?M#=^U<7G<;N'!83
M,8?)[<$68V[FEQM5C]U[:KZ#)431Q5:Z/=>Z&;:G=O>5+-\7=P=N;]^+.Q(?
MD3FJ.GEZ)KERFW.T:<;FZUW9O?%[-ZM[!W+V_'B^Y-_;&K,=1G+PT>T:$Y/#
MT>4KJ6GI3!'`WNO='Q]^Z]U[W[KW3%E]K[=W!D-K9;-X7&Y7)['SU1NC9]=7
M4L515;:W%5[8W'LNIS6&FD4O0Y*?:6[\ICFEC(<T>0GBOID8'W7NGWW[KW7O
M?NO=>]^Z]U[W[KW7O?NO=,5/M?;M)N?+[TIL+C8-V[@P.W-KYO<45+$F7RNW
M=H9#=.6VOA:ZN"B>HQN`R>^,Q/2Q,2D,N2J&4`RM?W7NGWW[KW7O?NO=>]^Z
M]U[W[KW7O?NO=:@O_P"%]^_=>ZV?/EA_V2S\E?\`Q`'<G_ONMQ^_=>Z^>!\P
M_P">9\YOF%LW&]487;^\?C?\>:/;6+VV_6W3V[MKP;K[!Q%'AH<2\G:G;O\`
M>[;^ZLQC,Q2B0S8+$4^#P[T]0U-7QY0(DWL/W>Z%ZQVSHB^I#5_X[0?SZQ/Y
M\][)MP:3;.4-SL;"V!*M-(EZ;@TP0H6S:.+TJ"[>:LO52E)F\A04T%%0]9;H
MHJ.FC6&FI*2?KNFIJ>)!9(H((=[I%%&H^BJ`![)"BL=32H2?]/\`]`]8UW&V
M6EU,US=;W8R7#FK,Z[@S,3Q+,;(DD^I->I']YLU_S[S>/_G;L#_[.?>O"3_?
MB?L?_H'IK]R;;_T>-N_WB_\`^V+I==7[6[8[M[*V%TYU9U-N'/=D=G;HQFS=
MDX;*[EZWV_CLEG\J["FIJO-UF]GH\;$8XG/DEM'<`%E!U!^VLQ<3")9$J?DW
ME]J@?SZ$O*/M_;\W;_#L5GN]CXLNHG3'=E@J*68J)+:%"0!P:1*^M<'<O_E_
M?RCNO_B;4;>[,[V_E]?+;Y7_`""Q,U#F*#.;TR_\O^BZ@Z\SE,(IX9^MNIJC
MYUY7'3Y/%UJ"2FSFX)LOEHID$U&<<&,"BFUL;>T'Z8K)_$>/^Q^76</)/MAR
MGR+$'VN#Q-S*T:YEHTQ]0IH!&I_AC"U%-18BO5_'^S+]T?\`>O7Y@?\`H:_`
M7_[N'VLZD/KW^S+]T?\`>O7Y@?\`H:_`7_[N'W[KW7O]F7[H_P"]>OS`_P#0
MU^`O_P!W#[]U[KW^S+]T?]Z]?F!_Z&OP%_\`NX??NO=>_P!F7[H_[UZ_,#_T
M-?@+_P#=P^_=>Z]_LR_='_>O7Y@?^AK\!?\`[N'W[KW7O]F7[H_[UZ_,#_T-
M?@+_`/=P^_=>Z]_LR_='_>O7Y@?^AK\!?_NX??NO=>_V9?NC_O7K\P/_`$-?
M@+_]W#[]U[KW^S+]T?\`>O7Y@?\`H:_`7_[N'W[KW03U'?\`\I.]NT-R_'[J
MGJ#(?$?,[.V'U[V)V5VC\C*GJKLO=N(VAVGN3LK;&T(NF>K>BNUNR]B;FW)E
M:GJ'<*R93=&Z<92[=J*:DF?!9^"I>"/W7ND5V+\6NKND]]_%7?%"-Q=B=S;L
M^6.Q<=OKO_MG+IO7N;>5##UIW77Q8:KW1)1T%!M39-)D:J:HHMJ[:HL'M'%3
M3R&@Q=*)&!]U[HQWP?\`^9,;U_\`%O\`^81_\'S\EO?NO=`5T7L[K#;^\-Q=
M<=6_.W8^Z<EG_D9W+W]G>K-JY/I[*[P.]]T=E[@['['V4B8K+9'>=#L_!;GS
M4U#D:-`N3CQ2O1558#+-(WNO=(VH^)_Q(K<#4=N5'R&V2V1Z_P#C#E/@/NSM
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MR.(29LA0XG/9#:N4@HJF6-8:J;&U21,S4\H3W7N@^K^^NC,5O`=>9/N?J?';
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MEJJ+/3;5K*:/=-)D9L&]12;HII,;*@G+1U\;4[`2J4'NO=3-S=A;`V5D=JXC
M>6^-G[2RV^LP^WMD8O<VYL+@<CO'/Q4DN0DP>U:+*UM)4[AS$=!3R3M34BS3
M"%&<KI!(]U[IK[`[>ZFZF@HJGM/M#KOK2FR5/E:O'5'8&]=M;-@KZ7!0T]1G
M*FBEW'D\;'54^&IZR)ZMT++3I*C2%0P)]U[I>4E72U]+35U#4T];0UM/#5T=
M9231U-+5TM3&LU/4TU1"SPST\\+AT="592""0??NO=2/?NO=>]^Z]U[W[KW7
MO?NO=:@O_P"%]^_=>ZV?/EA_V2S\E?\`Q`'<G_ONMQ^_=>Z^3[B/^+5C/^U?
M1?\`N-%[C]_C/VGKD_?_`.YTW_-9_P#CQZ</=>DG7O?NO='L_E=_]O(_@U_X
MLAL7_P"2'LRVC_<Y?L/^`]3+[!?]/.LO^:-Q_P!6'Z^H)[&'70;KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ^L_V[UAT?\`
M,GY2=@=N[[VSUYL^@^(OP6HWS>Z,I3XV"KRE;W3_`##$QF!P\$C?>9[<V;J$
M\&/Q=#'49#(U++#30RRNJ'W7NN"Y3N+Y;=A=+[HP_4F:Z3^//4?:.*[?HM[=
MW4U;MWM_N6>AV/O7;F*Q6S^AA'3[HZKVK-4;R6HJ<EOJ?"[EB>B:F&V/'41Y
M"/W7NA*^#_\`S)C>O_BW_P#,(_\`@^?DM[]U[JE;'[>[8W-O?J#%86BJ-]8?
M9/\`._[I[HEZ<P/3/8>W]^1]>;D^0O<>.3OFN^0LV8RVT<1U/LC;.]I-W21P
MXC%T^\<5#'@TR4J9+P5_NO=#!U=M[=6&[1Z/[@W)BLP_0O5'\R_^:3N3LLS8
M'(U-)LW*=P;H[:Q_Q\[_`,S1_;&JCZWI\3G,E01[ABAGQU'3[PILG++%C8ZB
MOIO=>Z@?(O;^\-T[O^6_<O74%8O27:?S/_D83=;Y4;;R^0V]OCLKX^?.+IK=
M_P`D/D#@,923XZJWAUGANE<=M6'(;BHY8,758S8%?/'6?:T3U8]U[H7=X_&C
M=70G>7PFI]A]BXW-[[[/^=7RV^2G9&_=P]:YC*]7[:W%W1\8NY\164^&Z^V]
MV!@IMD;)R&:R6,Q&+2LW///69_(":>JKJ^O=9?=>Z9^HY=ZYGKWY$_'C(8W;
M.^-Y_)/^8%\@\?N6#)8?>/6/66\^C8L;@-T]C5-17-A>X*K`;%[=VCA)MH4-
M2M16RUDF<DFH*AWI9'A]U[H&Z>O[2P_\O.E^(FYJ/(4?;?PI_F-_R]>E-L;B
MR6+WIV-MK<G1W4_\P[XH=N=4]G4&<JL9L#+=K[3ZF^.6/2BWOEHIL?(N2V1G
MYZV:@\<CQ>Z]UQH?CQ0=M_&'Y%?$KY.#<FR?D)W=\Y,YO'Y`;UPN+K\5L?);
MQWUA<=3]4_)SXGU,E#1XG'];X#:.U=HYC$Q)6Y#);6W5C9J;/5]5F4J:^L]U
M[I9;'S/R![/^1'\MKOSY:;(JNONTNK^RN_\`I/=V$3%RIM?;\W7?QA^077G=
M/?6-K(Z:,[<ZY^27?-!10[;:L*TE?@</MR6DD>;(%7]U[I38S/=G=?\`R]^/
M'S]J-FZ.K?F=E-P?'GM*#"Y??^9W_A^H=UXEM[?#[>?9G3F0ZEP%1U-)T'E-
MBS8?=,-1FZV/;V8[1W!-5A0G['NO=#M_+MDVGM;XA=)_&3OO#35/R<ZTW532
M]Z]>9G!9FIWCEOD/C.YJKL'=?R'IZ&NB>NW!L'>';4C[WH=Z023X2J@K(YDJ
MC(W@'NO=!]\$-P5>`:+";@WGG*PY#^8'_,WW#M7I>7HS(SY*FH>U/G1\OMU[
M([5Q_953B47";3R75NZIMP0Y26>GH\E@<TL=-/.U124U9[KW3Q\*Y,94_!_^
M6=\5LK222]T=(=4?&#KSOKJ?*X7()N#K')=%=&TNTNRX.S-OY&@CJML;?FSV
M`EH,969&&*@W`U92M025,%5%(WNO=&!Z)Q>+A^:O\P&MS.)I:?;T3?%#)X&O
MRV+6GP!?9?5.6I\AD,%7UU.F,F;:&1"1U$M*['&SZ4D,;V'OW7NJ[?@I%E.G
M,K_+N[6[WH\IM#IW#?RU,GT9MC=6[\5FL5MSI+Y"U?:6R<_V3MSLF7)0PT/5
M><[/V3MW#4U!D,U%0PS2[7J<<:J.IJ::EK/=>Z.9\L>N-L_*O9-5\+>M]CT:
M=?\`;V'[G[2[8I,UE][=*8?(TN2S>3HL3G]L;KQ?6.]:[&;TS/?6\1V+C*JC
M@I*FMK=K?Q)S)1Y..>K]U[HO&%^06\>TMA?R>>R>\,3N#&=I]/?-/M#:_P`H
M*JEV9NR3'T&[NM/Y?G\P7X^;L[AHJ.FV\E7#TWVEV?N;!U^V\R(?X;44.[\2
MBSL]0@/NO=/_`,U-UTW9&[Z'O3XW]P93J?NOK;IOLC:6W]M]Z=([JW=\7/FU
MU=G]TM3[R^.N<VY5XS%;R_OAF-]==QTVW:G;E30;KKS/)-C<?N'$RLC>Z]U;
M[U)7Y/*]4]993-;*JNM<SDNO=EU^6ZYKJT9*MV!DZS;>-J*_959D555KZK:M
M5(]#).`!*\!:W/OW7NA"]^Z]U[W[KW7O?NO=>]^Z]UJ"_P#X7W[]U[K9\^6'
M_9+/R5_\0!W)_P"^ZW'[]U[JBG+?RV_Y,NR,7L/KC#_$7=7?/R1S/76R=RGH
M;IGN+OW<'8--1[@Q%$U'NOL*HJN\L%L3I38N3K&D\.<W=D\#B:ET:&CDJ*C1
M3LG^DM/]]1_[R/\`-T$VY"Y%=BS;+M)8FI)L[<DD^9_3Z`?H;^1WUMVKOKY7
M#.]2_%OJ#^X/R!V[LW%=5Y>I^;WR1AV%BLC\5_C/V4N#Q/;F%^;GQ9&XZ6:O
M["J*RJ$^U(WARU56+#4S4?VHC]]':?[ZC_WD?YNM?U`Y$_Z,FT?]D=O_`-:^
MC(_]`\?3/_.J^(/_`*)+Y\__`'VKW[Z.T_WU'_O(_P`W7OZ@<B?]&3:/^R.W
M_P"M?3]M?^09U_L?<F"WELJN^+VS]W[7R4&9VUNO:_5/\PG;^Y-NYBEU?:Y7
M!9W$_P`W*DRF)R5-K/CGIY8Y4N;,+^[);V\;:HXT5O4*`?Y#I9M_*7*FTW2W
MVU[9M]M>J"!)%;0QN`10@.B!A4$@T.0:'HT'_#=7R2_[S*_]>C^;!_\`?GO;
MW0AZ+YW/\)?E'M'L?XD[?H?FGF(*;M+Y![DV)F(L9O?^:91T5;CL?\5/DUV;
M%3;AI\A_-^S-7E<.F7ZZI9D@H:G$U2Y"*FG:K>FAJ*&M]U[HP?\`PW5\DO\`
MO,K_`->C^;!_]^>]^Z]U[_ANKY)?]YE?^O1_-@_^_/>_=>Z]_P`-U?)+_O,K
M_P!>C^;!_P#?GO?NO=>_X;J^27_>97_KT?S8/_OSWOW7NO?\-U?)+_O,K_UZ
M/YL'_P!^>]^Z]T7S;?PE^4>0^5?<_64OS3S#XC:/Q\^,N^Z&CGWO_-,DP$&1
M[%['^6VW\K4XS%P_S?J;-4>8JZ;JVC6NGJ,K6TM3##2)3TE%)!4S5_NO=&#_
M`.&ZODE_WF5_Z]'\V#_[\][]U[KW_#=7R2_[S*_]>C^;!_\`?GO?NO=>_P"&
MZODE_P!YE?\`KT?S8/\`[\][]U[IRZZ_EW]Q=9=J?Z=,-VQ\5MU=V1;9I-EX
MSM_N7XU?+WY!=G[:V?1U6=KH]J[,W[WQ_-`['W3L?;LU;N:OEJ*+#U5#354E
M4[3)(3<>Z]T:W^Y7SY_[R6^('_I#_<__`-\(]^Z]T5+X:;/^<4W4.\'PGR(^
M*6/HA\K?GA%-3Y7X:=O9FJDR\'SB^1$.X*Z*KI/GA@HH<;D\]'4U-'2F!Y:"
MCFBII*BKDB>KF]U[HUO]ROGS_P!Y+?$#_P!(?[G_`/OA'OW7NO?W*^?/_>2W
MQ`_](?[G_P#OA'OW7NO?W*^?/_>2WQ`_](?[G_\`OA'OW7NO?W*^?/\`WDM\
M0/\`TA_N?_[X1[]U[H`OE=6_S#NH_BW\D^UL%\G?BE2YOK'H+N+L+#U6&^$O
M9=-EZ;*[+Z[W%N3'SXJIW/\`.3>>VZ?)0U>-1H'R&'RU"DH4ST=5$'@?W7NA
M]_N5\^?^\EOB!_Z0_P!S_P#WPCW[KW7O[E?/G_O);X@?^D/]S_\`WPCW[KW7
MO[E?/G_O);X@?^D/]S__`'PCW[KW7O[E?/G_`+R6^('_`*0_W/\`_?"/?NO=
M>_N5\^?^\EOB!_Z0_P!S_P#WPCW[KW0!=Q5O\P[9?8GQ1VWC_D[\4H:3MSOW
M<?7N=CH?A+V7%2U6*QOQ;^2?:T,&9CRWSDSM?4XU<WUC1RJF,JL+7"LC@=ZQ
MZ-*O'UWNO=#[_<KY\_\`>2WQ`_\`2'^Y_P#[X1[]U[KW]ROGS_WDM\0/_2'^
MY_\`[X1[]U[KW]ROGS_WDM\0/_2'^Y__`+X1[]U[KW]ROGS_`-Y+?$#_`-(?
M[G_^^$>_=>Z]_<KY\_\`>2WQ`_\`2'^Y_P#[X1[]U[H`MN5O\P[)?*3N+JF;
MY._%)L)LOH+XV=A8^EE^$O9;8B'*]G=B?*[;>8GH::G^<E+N2+)5-)U'0K5/
M5YBOH9(HJ<4E'0RI6SY'W7NA]_N5\^?^\EOB!_Z0_P!S_P#WPCW[KW7O[E?/
MG_O);X@?^D/]S_\`WPCW[KW7O[E?/G_O);X@?^D/]S__`'PCW[KW7O[E?/G_
M`+R6^('_`*0_W/\`_?"/?NO=>_N5\^?^\EOB!_Z0_P!S_P#WPCW[KW6K'_!>
M_?\`GY?4'_<4W_!?^9'[T_YG[_S\O_LH3_F4'_9C_P#%Z_[.SW[KW6VY\L/^
MR6?DK_X@#N3_`-]UN/W[KW2`Z:PWQM^&OQ8VYFH*;K3H#J?$;0V_O+>^XZV;
M%;4P]9N+<&*Q1R^[=Y[DR,L57N;>FZLO4(*C(Y"HJLKE:Z50\DT[J&]U[HN/
M1/=O:V/WS\K.QMK?";Y8[^ZX[V^0."[,ZNWA20?'+J^7<.S<+\8/C=TO/E*W
MKWY$_(OI7N#:K5F\.H\M)2Q9C;E!+4XYJ:J13'4)[]U[HQO^S+=S_P#>O?Y?
M_P#H:_`;_P"[@]^Z]U[_`&9;N?\`[U[_`"__`/0U^`W_`-W![]U[H`=T?S1-
MF[`[FZ^Z)[&^+_RAV=OK?V]NK=E5,%/4?%GLR+K0=R=@;;ZQV%O+N6@Z2^4/
M9^YNK>O<WO+=E#1P9C+8^"EJYY1#2FHG*Q'W7NA^^2W_`#.?^7O_`.+?[U_^
M`&^<'OW7NC?>_=>Z][]U[KWOW7NO>_=>Z][]U[HH.RO^R^?DM_XJ!\'_`/W\
M_P#,(]^Z]T;[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%!^#_`/S)C>O_`(M__,(_
M^#Y^2WOW7NC?>_=>Z][]U[KWOW7NO>_=>Z*#_,(_[(&^<'_BH'R6_P#?,;U]
M^Z]T;[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%!^2W_,Y_Y>_P#XM_O7_P"`&^<'
MOW7NC?>_=>Z][]U[KWOW7NO>_=>Z][]U[HH.RO\`LOGY+?\`BH'P?_\`?S_S
M"/?NO=&^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6H+_^%]^_=>ZV?/EA_P!DL_)7
M_P`0!W)_[[K<?OW7NJU^B?@K\O-/6G=?:GRU^-_?_9N&V_@\QUGF>WOA1V=E
M,!TE0UN&I3C\;TYUYM[YW;<ZZV/F,=BI5HY]S08IMW96%--=E*B()%'[KW1Y
M_P"Y7SZ_[R7^'_\`Z0]W1_\`?"O?NO=>_N5\^O\`O)?X?_\`I#W='_WPKW[K
MW0"[VQ/S'W7WKU=\9^QOE#L';^Q>S^I>\.V=R[L^,70.Y>D>VS0]+[Q^/NS6
MV%B]\=C_`"$^1=%MW$[W'?AFK,KBL9C]P4"8E5Q]=2S5'W,'NO=*;Y!=(]4=
M!_&O96R>H=D8?9.WYOFA_+^S646@%569G<VXZ[Y[_&),GNW>NZ,O4Y#=&^MZ
M9G[=&K\UF*RNRM?(H>HJ)7]7OW7NK#9:>GG>GDF@AFDHYFJ*226))'I:AJ>>
MD:>G=U+03-2U4L19;,8Y&6]F(/NO=5:=>?+SL_M?XX=1_-2B[$ZEZPZA[RW]
MUE5=6]>[QZ\W/G)<[TSV5VOM_:&P,3F.P,5O.CEQO?W=NV\G3?W>C3'KBL?N
M//T.!-!E:F+[ZL]U[KETS\LN^>SNW^R.N\ENCJ_"/M7Y@=D=!;6Q2_%+Y$/B
M-Q;,ZZQ/]\\A+5=[+VW5]64/8$FQ,9E)XXO!XI:VDCA-+$)B8_=>Z0?5_P#,
M"[LRN;[%^/O<.#ZOZY^36U?D)!MWJK<L&T]U573_`,F?C#)\R<7\7\QVUUIM
M:I[,3<F`[`ZXJ<JE!N_;D^X<FV"RD^,R&N?&YNCCC]U[H0.E/EIWIV;W)V'U
MYF=R]9XB/:GS$[%Z#VYAH/BO\AH\;N;8_7.+&\\HTO?A[5R756,[$GV%C,K-
M$II'A>OI8HFHXQ*='NO=!5\7/Y@O>O<WR2VGTAD?]#/8,C]T_P`P+8G=&VNN
M.M.QMB;EZ`ZG^+7R4[]Z`Z2[LW/N_=':_8&U]RTO<6X.G:##/A8**AJZC*YB
MKJZ.44F%KH/?NO=*3JGYK=V=G[GZ9Z?^WZEQ'<?>7R%_F=;(K=_8G9&XZ3`;
M-^.G\M_Y5[\^.#9VAVCE>P,[7;K[2W=ELAM01K49BEP^/GS^0KQ1U$5",;7>
MZ]U9'U[0=TT6,W]C>R-S;%SN4@W-44_6&Z<!LW)X*"HV:^S-JMCZS?6V'WKE
MQ7;FH][R9=*QJ"MQ=+74D4+004.O2GNO=4=;)_FF?+/<7PQW!\C4V]T'NW(T
M?\L#I3YQUF_-I=8=FT73O6'>/86`Q^Y,]\9=Z451W=GZW>&<.`R#Y*G3';@Q
MN6PU#2J^3I`N0QSS^Z]U9+L#Y89C?GS,K.B\'N;KW.=587XLT_<F<R\&Q-Z[
M;W?!OD=BILNI@7-Y_>382#:,E`DE6M/_``F:IA8A6K7"DM[KW33\+_F?E_E/
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MV;UQM?XFY+JK8^X=R;AV=7;_`,WOCN+L?JW`]W3X>?$1[KV=283K7:G7&_\`
M;+3?;S/ELW7Y.HCAK,2F.U9#W7NBV;M^6ORJVEWKV-T+N'<G2NT]P[!^%WP]
M[G&:H_BC\D.Y]N2]Y_(#>'RLZTWKA]T[DZU[BQV(V-U;B]X_'S'SXJ?*"CE^
MRRE4):R84<E0ONO=&/Z[[\[@W?N#^8[B,A/UK3P_%'O&#J[J*6CV5NA9*S$5
M7PN^,/R?CR'8XG[*G7<V2BW#WW5XP_PP8&)Z+'POH65W(]U[H(]V]Q?,E.S?
MBSUI#O3XLKB?E/MGMC(RG+?'CM//G:]/L?J7`[OH:>J"?*/!TV?ASN7R4XJH
M3!3K!1NM.KS/&U3-[KW23WG\Z.\MB=@=W]59#&=0YC>E-\POB7\/>AS2[;WE
MB,)2;@[_`.D.M^X=^;X[)JJC?N3JMVXWK[`YW<>2H,;C8MO2Y:/$4N.>III:
MQJ^#W7NCO?WD[.Z6HNW=^=Z[]V?NWIG9/6>.WKA\WM[8=7M;?&*RFVCOO*]H
MTFY(%WAF\1N+'UN$3`C;D6/HJ*I2:&MBJGJ))*:1O=>Z(A2_S!>WJW^69\Y/
MDQ)M[J?!?*_X/;,^6\?8>P$K,CV1U%3=G_'G9.=[7V52K6[=W'L[/9_8_:/5
M-3MK.4L\=;CJQ:+/(S*DD;1GW7NCA_,+N;M?X[_':;M#:6TLIV/FMN;DZYIN
MS:SKWK/<._\`-;6ZTR>[,-C.UNT-H]+X3<\F[]ZU&R=K5-5D8L/19"OK88HV
MJ!#DA3-1U/NO=*#X@]TP_(3I>@[9Q7;W3_>NT=U;DW34;`[-Z2H<AB=I9W8L
M&5E@V[1YC"9;<NZLI@NQ-NTZ'&[FHYZB%X<[250%)0KIHX/=>Z8/DM_S.?\`
ME[_^+?[U_P#@!OG![]U[HWWOW7NO>_=>Z][]U[KWOW7NO>_=>Z*#LK_LOGY+
M?^*@?!__`-_/_,(]^Z]T;[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:@O_P"%]^_=
M>ZV?/EA_V2S\E?\`Q`'<G_ONMQ^_=>Z[ZI[6ZNCZNZVCD[)V"CIL'9R.C[QV
MZKHZ[=QP964Y$%64BQ!Y!]^Z]TO?]+/5G_/R^O\`_P!#+;G_`-<O?NO=>_TL
M]6?\_+Z__P#0RVY_]<O?NO=5_?(#Y2=%]5_-KXOY[/;[H<]/EOBS\U=L;7VC
MUS29#M'L/>^[,EV[\!:_'[5V1U]U]2[CW?NK/5./Q-75O#1T<BTM!1U-94M#
M1TM1/%[KW0AC8?R1^5F2V=F^Z<=3_&/HK:O8G67:V$Z&Q]1M3?G?78.X.I.P
MMO\`:?7TG>'8-#)N/K;K#!X_>6TL75UFUMFR;@K*EZ10VZT@EJ,>WNO='/W+
MOW:>S\UU[M[<>5_AV8[5WA6["V%1_8Y*K_CV[,=L'?':%9BON*&CJJ7%^'8O
M6^:KO/6O3TS?9>%9#43012^Z]T37%_R^NNMO["V[TCMOL'L;!?'39_>W7'R'
MV?TO2MM"JQVS]Y]5_(O:?RGVCM/;.[LCM:LWA0]2TO<&SZ>L_@DU54U%-12O
MCJ*MH\9'345/[KW2RV-\/(^NL]O/*[7^1?R$HL3O_P"0%?\`(O=.T%DZ,AP>
M0W7EL_@\]F-L)E:+HVDWU1[#S*X"*@JZ.',I55&-EGIWJBLTA;W7NH>]O@CT
MUV5MCJ;!=@9'>F[<[T;\J,=\O>K>Q:VMVWA]_;1[1INYZSN;,XW'Y3:&UMLX
MMMC[OJ,QDMOY?&243K7;=R,L$CFH2"JA]U[J9L;X>1]=9[>>5VO\B_D)18G?
M_P`@*_Y%[IV@LG1D.#R&Z\MG\'GLQMA,K1=&TF^J/8>97`14%71PYE*JHQLL
M].]45FD+>Z]TB]G?R\>L=A9;KC=NUNT.Z,7V-UCW7\F>X\'V9!6=5Q[ORN,^
M7W;V^.]._.D=UQQ=3Q;6W'T?O#LO?!R46,GQAR>,JL1C*BCR,%51K.WNO=)3
M:WP[Z8P&Z,7UKL#NKMC&_(+X_P#9'<GR[P?8%;C=A9#=NU\3_,([L[ZW]V3L
MS)WZJQ76^Z^G^S^R,/N='PGVTF:QR8/'U`K:2JIL97>_=>Z/EM_:N6P^"RN.
MK]\[HS^<S,E355.ZL@F`2MQM;48VEQL;;<P\.%&V</C\:M&DE-2M1U$1FU2U
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M=15.V=P;LZD@2LFV]F<9CL/7TLF7R,,KST=9-3-[KW2-D^`OQ5^0^V/D#N+;
M.^NTEK^^.J9?A?VMV-MV7:^%W)+!\;]\[UZAW_7XS$;FZQFVI1]A97.[.I]O
M9S-KA9:7*X[9>$^R5::ECFJ/=>Z'[LSX1=6=S[,^36R^VL[NSL2F^4.UZ_8^
MX<[NC$]4UFYNMMDU_7-/UV=I=296+K&G7;^#H6;(9ZDCR467>EW'FLA61,HJ
M!$GNO=1]C_#H]8;QJ-^[`[][@QV[-W['Z\V5W5G,_C^I-QUO=]?U?@FVKM#M
M?>,;]98_&8SNBCVH(L5/EL334.-R./IJ:.NQE4:.B>G]U[J1E?AZLO;?87=.
MT_D;\A.O-Y]E]&=,?'_<#;>/0^Y**/:'0^6[MW!L7,TC=J=$]BY6;>#9WY`[
MCJ\A65E75Q5LLL(:$1PA&]U[KD_P_HL9GNX*_8_<?:6R<#\A9MM9#NK;U,VS
M]QU>Z-Q[8ZGV/T<F\L-O'=>ULSN_`;NW/U7UM@L/F:N2LKEGBQ4%11QT->:B
MLG]U[IX[QZTZIVQF^N/E9O[?&[NO]J_"O8O<6\!CMN46$K-F)L?)=?&BWS6[
MGP46Q=S[XRL.WMGX!I**FP=525&N/2L=0Q6,^Z]TC=X_`SK#?&:[UW+E]]=J
M0[D[L[DZ;^0./SV/K.O(,ETIV_T+M;9&T>M=Y].32]<5"4E1C<9L"A%72;C7
M<M!E(Y*NEK()J"LJ:23W7NA(W'\=\IV!@<#ANR>[.R-S+C-X=>[NS-+C\3UE
MA=L[L3K;=:;RQ&VLUM>IV%G*1-OYO.4-#/EFIY8LE4FA2*"KI:5Y:9_=>Z`_
MLG^7!U!V*_S1I*??_;'76U/G=\?*'X[=U[!ZW'4.$V?182BVGO/84G86QJ3*
M]19[*X;M3)[(WU68JKR-969&CJ*."C#4>JAI'B]U[H7LK\;]\Y3(8G-R_+CY
M'29W;N2PN3V]5S4GQ^IL70''4VXJ7.8W(;;V[T1MS![FQ._*?.00Y9<G#5U-
M-#C:=L-/B*EZFIG]U[I;="]![4Z`PF^:#;M9697+]H=H;M[F[#SM708'#+G>
MP][KC8\]DJ+!;7Q6%P.%Q_VN'I8(H8H&J)5A\];45E?-55M1[KW0:?);_F<_
M\O?_`,6_WK_\`-\X/?NO=&^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW10=E?]E\_)
M;_Q4#X/_`/OY_P"81[]U[HWWOW7NO>_=>Z][]U[KWOW7NO>_=>ZU!?\`\+[]
M^Z]UL^?+#_LEGY*_^(`[D_\`?=;C]^Z]U75M3*?&/?>T=I]>_$3X:=`?)WLC
M%;4VYB-W;\_T?=?[7^,W5V?IL'3PY6D[/[]CV/N2DSF[,1D:=Z>NVMLR@W9N
MNBK'B7*46+I96KXO=>Z"CXY?RZ:'=_9GS:;?G:V&V]NC!?*':V)R6/Z-^*'P
MHVWU8CUGPQ^(NZ0NT=J][_'7Y);[VSC:/^\GVHIY-U5D<YIS5.OW514R2^Z]
MT:W_`(:YV#_S_/L#_P!)G_E@_P#WOSW[KW2QV3_+^;K7)5.9ZY^5W>.P,Q6T
M+XRLRNR>COY;FU<E5XV2>GJI,?4UV"^!5!53T+U5)%(8G8QF2)&(NH(]U[H3
MO]EI[G_[V$?+_P#]`KX#?_</^_=>Z*E\B/COV]2=O?`^GJ/GA\K<G+D_E;O"
MAHJVNV?\'8ZK;M5'\'?F7DGS.&3&_#3'T4^2GHL?-CV7(0U]&*.OG98%JEIJ
MFG]U[HUO^RT]S_\`>PCY?_\`H%?`;_[A_P!^Z]U[_9:>Y_\`O81\O_\`T"O@
M-_\`</\`OW7NO?[+3W/_`-["/E__`.@5\!O_`+A_W[KW7O\`9:>Y_P#O81\O
M_P#T"O@-_P#</^_=>Z]_LM/<_P#WL(^7_P#Z!7P&_P#N'_?NO=%2V?\`'?MZ
M3YQ?(C&I\\/E;!6TGQ2^&E=4;@BV?\'3E\G2Y#M[YX4])AJZ&;X:38&/&X*7
M&3STK4U#3UCRY&H%3/41K21TONO=&M_V6GN?_O81\O\`_P!`KX#?_</^_=>Z
M]_LM/<__`'L(^7__`*!7P&_^X?\`?NO=>_V6GN?_`+V$?+__`-`KX#?_`'#_
M`+]U[KW^RT]S_P#>PCY?_P#H%?`;_P"X?]^Z]U[_`&6GN?\`[V$?+_\`]`KX
M#?\`W#_OW7NBI?#3X[]O9#J'>%12?/#Y6X**/Y6_/"A>BQ6S_@[-2SU6,^<7
MR(QM;F97S?PTS-:,EN*MI),A6*DR4:5E5*M)!2THAIHO=>Z-;_LM/<__`'L(
M^7__`*!7P&_^X?\`?NO=>_V6GN?_`+V$?+__`-`KX#?_`'#_`+]U[KW^RT]S
M_P#>PCY?_P#H%?`;_P"X?]^Z]U[_`&6GN?\`[V$?+_\`]`KX#?\`W#_OW7NB
MI?/#X[]O8SX._,O)5OSP^5NXJ+'_`!2^1%=5[?S.S_@[!B,[2TG4.\*BHPV5
MFV_\-,%GH<;DXHS!.U#74=8L3L89XI-,B^Z]T:W_`&6GN?\`[V$?+_\`]`KX
M#?\`W#_OW7NO?[+3W/\`]["/E_\`^@5\!O\`[A_W[KW7O]EI[G_[V$?+_P#]
M`KX#?_</^_=>Z]_LM/<__>PCY?\`_H%?`;_[A_W[KW7O]EI[G_[V$?+_`/\`
M0*^`W_W#_OW7NBI?(CX[]O4G;WP/IZCYX?*W)RY/Y6[PH:*MKMG_``=CJMNU
M4?P=^9>2?,X9,;\-,?13Y*>BQ\V/9<A#7T8HZ^=E@6J6FJ:?W7NC6_[+3W/_
M`-["/E__`.@5\!O_`+A_W[KW7O\`9:>Y_P#O81\O_P#T"O@-_P#</^_=>Z]_
MLM/<_P#WL(^7_P#Z!7P&_P#N'_?NO=>_V6GN?_O81\O_`/T"O@-_]P_[]U[K
MW^RT]S_]["/E_P#^@5\!O_N'_?NO=%2V?\=^WI/G%\B,:GSP^5L%;2?%+X:5
MU1N"+9_P=.7R=+D.WOGA3TF&KH9OAI-@8\;@I<9//2M34-/6/+D:@5,]1&M)
M'2^Z]T:W_9:>Y_\`O81\O_\`T"O@-_\`</\`OW7NO?[+3W/_`-["/E__`.@5
M\!O_`+A_W[KW7O\`9:>Y_P#O81\O_P#T"O@-_P#</^_=>Z]_LM/<_P#WL(^7
M_P#Z!7P&_P#N'_?NO=>_V6GN?_O81\O_`/T"O@-_]P_[]U[K5C_T:;T_[R$[
M?_[BF_\`1I_Q9>@O^/T_[R$_YD?_`,S?_P"F+_CP?^S:]^Z]UMN?+#_LEGY*
M_P#B`.Y/_?=;C]^Z]T"&\OE;\2_@1\6NHMS=[=C[#Z/V#0]<;,PNR]L4U&W\
M7SC8[:V+$6V>LNLMH8^NW/NJLHZ8J10X7&U+4\/K9$B4L*NZQJ7<@*/,])+^
M_L=KM'O]RFC@LHQ5GD8*JCYDD#_/P'6N9L7_`(4K=3===H_*;=."^)G<&YMJ
M=W][XCL_:-1F][[!VEN*CP.$^.W071ZP;@P-))NRBH,AD,GTY4Y&..+(5'CI
M*Z%)"DRRHI8V\V:L0-1'J!C^9'4*W?WB/;NUN7MXVO9T0TUQPC0WS76Z-3RJ
M5%?*HH2*_P#T%6=:_P#>%':'_HW-C_\`UA]U_?5GZ/\`L'^?I/\`\$?[??P;
MC_SA3_K=U[_H*LZU_P"\*.T/_1N;'_\`K#[]^^K/T?\`8/\`/U[_`((_V^_@
MW'_G"G_6[KC_`-!5_6S5./H8OA)VM4Y#,9*APN&QE%VIL^NRF:S63G6EQF%P
MN,H]NSU^7S.3JG6*FI*:.6HJ)6"1HS$#W>/=K>5M$:R,Q\@/]GHQVKWYY1WR
M]7;MGM-WN;Y^"1VZLU/,D"7"BN6-%'$D#JSK;?</SH^6D7Q8[RC_`)>^5Z#P
MW4_=.>[939'?_?VW]G=H;BP67^.OR"Z1@CJ-D8GKS<60V1,^2[AI*]*?.-0Y
M004<Z3T5.QA,AF#45(IU-$+M+$LCHT;L`2K:2RGT.AF6H\]+,/0GHY=7W!\O
MJ"EJ:ZN^)G7%%0T5/-5UE95_*W&4U+24M-&TU14U-1-TXD,%/!"A=W<A54$D
M@#WOISHL?37\S#=_;??/4/5U%\7LC5]2=L[XW9UK2?*K8?;.+WGT;2[\VSU%
MVQV_#MW:V:R^RMC5';\>3PW4.1IVRVSAG-OT%2PBJLA%4J:8^Z]U;%[]U[KW
MOW7NO>_=>Z+)M3:&YJ+YE=];]JL-60;.W+\9/B3M#`[@=4&/R>YMD=J?-?,[
MLPU,X<NU9@L7V#A9YP5`"9&&Q-S;W7NC-^_=>Z][]U[KWOW7NO>_=>Z][]U[
MHLGQ)VAN;9'5>Z\-NS#5F"RE;\F_FON^EHJY42:?;/8/S*[ZW[LO,H$=P:/<
M6SMRT&0IS>[4]4A(!)`]U[HS?OW7NO>_=>Z][]U[KWOW7NBR?-?:&YNP?AK\
MMMA;+PU9N+>.]_C)WUM#:>W\<J/D,[N;<O5>Z\-@<-0I(\:/69/*5L4$09E!
M=Q<CW[KW1F_?NO=>]^Z]U[W[KW7O?NO=>]^Z]T4'Y+?\SG_E[_\`BW^]?_@!
MOG![]U[HWWOW7NO>_=>Z][]U[KWOW7NO>_=>Z*#LK_LOGY+?^*@?!_\`]_/_
M`#"/?NO=&^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6H+_P#A??OW7NMGSY8?]DL_
M)7_Q`'<G_ONMQ^_=>Z^3MNG)]G=K[DD[,[-[Q[8[!W_G,1BJ*OW=O7)[8W5G
MQB*&EB3%[>HLGGMIY"KQNV,)"!%08RG>*@H8@$@BC4`>P7<7LEP_ZRJU#C+4
M_8&IUSDYN]RMTYIOV_K!:6ERL4C!%9[U46A(JL<=XD:L1Q8("?,],W]V<U_S
M\/>/_G%L#_[!O:?Q4_WVG[7_`.@N@C^^]M_Z,^W?[W?_`/;;U[^[.:_Y^'O'
M_P`XM@?_`&#>_>*G^^T_:_\`T%U[]][;_P!&?;O][O\`_MMZ]_=G-?\`/P]X
M_P#G%L#_`.P;W[Q4_P!]I^U_^@NO?OO;?^C/MW^]W_\`VV];UW\F?^4QU-M'
MXM_';YB]?=[]];&[[[YZ4V-OC=^]*?;'Q$WWDL%D-R;>ADS&)ZWRW</Q4[)W
M'UOM?(&4_<8[#UU+35;!7J%F=0P&EK#%#"OA*%J`33_/Q/YGKHUR3R]L6P;!
M;+LEI#:K-!&[Z`2S,RACJ=RTCT)(76[$#`-!U=G_`++1W1_WL*^8'_H%?`7_
M`.X>]J.A?T6O$?&Z'M'Y9]J=0?)ON+MSY:]7=6=#_&+MC9G7/=R]3XKKM-[]
MG]F_*S`[BR6\NN>BNJ>EM@=LT]%2=(X*7%4V[\9GH,36)+4TBQ3NLB>Z]T9#
MY(PQ4_<7\O"""*.""#Y>;RAAAA18XH8H_@%\X$CBBC0*D<<:*`J@``"P]^Z]
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M6.WMKXC%UG7U1L6B^[VSL>ACJJVJPU=5NSU#HR221/3^Z]T2^G[_`/E!A/Y<
M.!^6^3^2>_,WO3<>_.G-KY*B_P!%/2V3_A%#F_FUM?I;<E1M'"[3Z?IZW(UF
M;ZTS533-1S4>6J7KT@FHO#('BG]U[IW[X^?7:G6?8_S4FZ]S.YLQ@NL_CU_+
M6H^G-I=T]-[@Z[P^V^^?G'\O/DO\6Z[L#=.,S77G6_:6ZNO=M3;(VGE*B"&L
M2B>*FRL,-1%(^JC]U[JR^@VWOOJ3+UG86_\`Y*;JWGU!M?K'>]=OS'=E;8ZC
MQ;XO,XRJVIF\9ON@SG6?6/7]10XG`;8P^?2OI*@U4<QK8)$"F#GW7NJ]?C_\
MZ>R.V.F/Y@6"W)OC8\7>OQXVWNCNWKC,]<UFQ]S4V+Z/[FZYW%VMT)396&D;
M<>V<ENSJ'<V#W#UUG6FIY(LC7[*DKF#??@^_=>Z#WXT?,GY`]O=<?+_<V&[1
MW%NS:'2'PUZMW7+OCLGKO8?77;6ROF+N#IC<7<.]MM;?ZU7K_94^5Z1BV%F=
MH93%97<&UEI<C6UU6F+R69I%F_AWNO=':^$78':':&`V=NO?&_.^,X<E\?\`
MJC>FYL7VYU=U-M#:N6W;V=1-DH,QUEN#KK9&RLA)3X#^Z^3CKZ&M.00TV6QT
MBM"R-]Q[KW0#X7Y.]Q83YVT'Q_\`D!O3LSI"/=?=F_&Z$I*CK?KS-?%?Y3](
M1=0[V?:NP^O.Z*+963WCLOY,;0W334V>W!MW<6>Q]96?P*L_A=+5XNJC2'W7
MNI7P>[>[U[XI]O56]NW?D,^0;>WS(I<WDJ[J#H>@Z9S&U.FN^NP.AMF83`;L
MP_5^*SN-WU2)DL%FJ=YIZR#(2X#(I-3/`[JGNO=5W?'_`.:'\P3Y3_&FLW!\
M>>YMR;P[:VC_`"S/C)\JNSUWOU!U)LS=+_+3L?:VR>W<=TMTIL[)]5;<?<W2
M_?764&[L?3[GJ<-D\30YR+%?PC/5K09JDI_=>ZL=[(^5>ZNT/CM\E?EK\9>Y
M,U1=3];?`')]J=;^+:O7&4QV5[KW1T]E?D%MG.YD[@VMFLQ#EMC];U&UI*K&
MK/+AJM=SO&\8J:)[>Z]TKNENV^X?D9WIW#U-%VUNCK7:OQMZG^+\66SFT=M]
M85._.T>U>\>OLGVANO<NX*C?/6F[-HXO9>$VS-A:/%4F%QE%(^4?*M43-$E)
M!#[KW03[T[6^2VR?D1FNB=T]V]\;A78'P+Z2[,S.=Z`Z7Z)S=7N3N3)[X[NV
M%O3L#)87>'5VY&P>/WDO7-#7P86GG2AH:AYXHW\(#>_=>ZD;L^2_=W6GS'H.
MC^^>P.R.G=I;^[DZ5PWQ9[2H>K>O,_\`%3Y#[;JME['HNQ^CM\[_`*?:&YMZ
M=0?)C=?9&/WA_!\=D\M@Z/(4[8B'#R5DPJHY/=>ZN#]^Z]U[W[KW10?DM_S.
M?^7O_P"+?[U_^`&^<'OW7NC?>_=>Z][]U[KWOW7NO>_=>Z][]U[HH.RO^R^?
MDM_XJ!\'_P#W\_\`,(]^Z]T;[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:@O_`.%]
M^_=>ZV?/EA_V2S\E?_$`=R?^^ZW'[]U[KY;.$^//R0FPV(FA^,WR;GAEQE!)
M%-!\<^[)H9HGI8FCEAFBV(\<L4BD%64E6!N#;V"VV^]+$B-J5ZYP7OM1[BR7
MDKIM%V4:5B#1<@L:?BZ[H>CN_<I59FBQOQV^1V1K=N9*+#;AI*'X^=RU=5@L
MO/B,5N&'%9FGI]CR2XO)38#.T-<L$X25J.L@F"^.:-FK^[[W_?;=)O\`6F]R
M/^C/=_[RO_073E_LNOR5_P"\8?E!_P"DW=W_`/V!>_?N^]_WVW7O]:;W(_Z,
M]W_O*_\`077O]EU^2O\`WC#\H/\`TF[N_P#^P+W[]WWO^^VZ]_K3>Y'_`$9[
MO_>5_P"@NM^K^6/\I^H.H/Y>_P`.>K^S&[3V;V!L/X_=<[8WAM7,?'SY`QY3
M;^?Q6!IJ;(XJOCBZPFB2JI)T*N%9A<?7V,X@1&H/$*/\'717989;?9[2"8%9
MDMHE8'B&"*"#]A%.CKUW\P;XH8NJPU%DM^;OQU;N/)2X;;U)7=&]]TE5G<O!
MB,KN&;%8:GJ.L8Y<IDH<!@JZN:"`/*M'1SS%?'#(RWZ,^BLXOY.;AW%\S^\<
MQ\:^@^W.]*S>_P`9/B7LW!;ESVS]W]%=([8W!LCM/YLYC<LO9?;?:NU,0^.Q
M^%H>P<*\U%MG#[MW/(F1BD@Q$T"SS0>Z]T:[K[XW=AYKL'97>7RA[=JNR^R]
M@UV3SO6_6_75)6]>?'3IS/YW:.YMA9;,[6VH*VNWIV7O*JV1O3)XF?.;RR^5
M@$55+-B<5@C/+"?=>Z-]74SUE%64D=958^2JI:BFCKZ$TXK:%YXGB2LHS5T]
M72BJIF;7'Y8I8]:C4C"X/NO=%6V9\,.G]@;>^)^U-KU&]*';_P`)\'3[:^/.
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M2EZ-GIV]U[ITW?\`$/I;L7='=.Z>QL3EM\S?(/IG8'0G:>)SF5:#"YOK?JS.
M]E;HZ^HL=38*##56V,]M3<W<6Y\C1Y?&3TF4AK<MYEG#T>.-'[KW6:O^,.!S
MVRZG9&\.T>[-ZT4M'C,-!F,_OBFAW!3;8Q>>P6Y(]L5%?M_!8*'<6/R>2VW2
M)E*K,0Y+*YJB62CR-754<\\$GNO=8>R_B3U3VIV=E^W=QS[RH]Y;@Z%W?\:,
MY+@-SSXG%9?I_?&1.8SVW<CAXZ>6AK*X9;_**+)2*V1QCM**.:!*BI2;W7N@
M%Z@^-WQ^[@VED]Z;<Q'8&RZJAV7W=\`=UU=%O%J?(]B=.?'KN3M'H;&8??4-
M)3'"[EDP53M;+56V<O/2_P`?PM+G*M(ZQ7JZLR^Z]T9CJ?XX[-Z>JMLU.W]R
M]F9N'977[=8;/Q>\=^YG<.%VWLUY-KR/C\?B)FAH9JPKLO&QK6U*5%;'%3E$
ME59IQ)[KW2?I_B;UVNZL3N+)[B[(W+B=M]N;I[[VCL+=.[FS^S-H]R[NJ-VU
M&1WQ@H\A02[F6.@;?.3.-P53DZG:^*FG6II,9#5PP5$?NO=-/77PVZWZLHL%
MBMG[Q[BI,%MC=W8&_P#!;;J^Q\G7;;H]\=F9#?6<W/N2IP-1`V+S<PW1V-E,
MQ1T>0BJ\90Y9J>J@IDDHZ0P>Z]UCZN^$G1?3,_Q\KNN:+=6W,I\9>E:#XW]:
M9:FW5D&KJGH+#4V"I-N]3[_+@TW96V=JQ;<I7Q,N<CK<EBZDU%33545365<T
M_NO=(?MSI#XY_&3X$_*?8>"ZXJL/T!0=3?*3LGL'KS8N2_@>5W#@M\8_?_97
M:^W,!FZD3RX!MQP9G(8W&M$T8PM"]/3T1IH:2F$/NO="P/BML7';TPG9&S=S
M]A=>=@4.P=H=5[GW5L[.8J"H[.ZYV%-E:C:&V.RL+F]OYW:NX9MMS9_(_P`-
MS$>/IMPXM,C5QT5?3QU,Z/[KW4'+_$3KFO["K.T,5NKMS9^\:_JO:O2]5E-H
M]E9W%U%1U[LS,;KW'@L;5U<QK<C7YB+<.^,M739BHGFS%54UK-+5/HB$?NO=
M-]#\+NIJ)L9C)LUV9F.O\1V)L#MRAZGW'OJOW%L"F[,ZIR&T<UUKNRDCS,%;
MNS&_W.W)L7%9B#%TF6I\%4YRE_B=90U.0EFJ9/=>Z-O[]U[KWOW7NB@_);_F
M<_\`+W_\6_WK_P#`#?.#W[KW1OO?NO=>]^Z]U[W[KW7O?NO=>]^Z]T4'97_9
M?/R6_P#%0/@__P"_G_F$>_=>Z-][]U[KWOW7NO>_=>Z][]U[KWOW7NM07_\`
M"^_?NO=;/GRP_P"R6?DK_P"(`[D_]]UN/W[KW15>L^Q/E5\A>N=B8;I+9=9\
M7>JDV9MS%UG?O?.TUJ>X=S4:;<I*;^*]&_&_)2QOMF.5P32YOLTXV>CJ(T=]
MGY:CD#GW7N@Q^,_PIZ:R7:/SHI-]Y;N7L[<.#^5.S\95[\WGWOVY#NW<LM3\
M'OAKN"NRF?\`[F[NVCMI:JIR^<J6BIZ#&T..QU*8J&@IJ3'TM)20>Z]T;G_9
M$_C1_P`\QV!_Z/[Y"?\`VTO?NO=>_P!D3^-'_/,=@?\`H_OD)_\`;2]^Z]U[
M_9$_C1_SS'8'_H_OD)_]M+W[KW14OD1\*?CMCNWO@?1TFW-])3Y_Y6[PQ.46
M7O/O>I>6AA^#OS+SL<=/-5=ES3X^89+"T[&:F:*9HU:(N8I94?W7NC6_[(G\
M:/\`GF.P/_1_?(3_`.VE[]U[KW^R)_&C_GF.P/\`T?WR$_\`MI>_=>Z]_LB?
MQH_YYCL#_P!']\A/_MI>_=>Z]_LB?QH_YYCL#_T?WR$_^VE[]U[KW^R)_&C_
M`)YCL#_T?WR$_P#MI>_=>Z*EL_X4_':;YQ?(C!2;<WT<;COBE\-,M21+WGWN
ME0E=FNWOGA1Y&26O3LM<A4PR4^`I1'#+*\,#([1(C2S&3W7NC6_[(G\:/^>8
M[`_]']\A/_MI>_=>Z]_LB?QH_P">8[`_]']\A/\`[:7OW7NO?[(G\:/^>8[`
M_P#1_?(3_P"VE[]U[KW^R)_&C_GF.P/_`$?WR$_^VE[]U[KW^R)_&C_GF.P/
M_1_?(3_[:7OW7NBI?#3X4_';-=0[PK,CMS?4E1#\K?GAB8V@[S[WH4%#@/G%
M\B,%BXVAH>RZ:!YHL;CH5DF93-42!I9GDE=W;W7NC6_[(G\:/^>8[`_]']\A
M/_MI>_=>Z]_LB?QH_P">8[`_]']\A/\`[:7OW7NO?[(G\:/^>8[`_P#1_?(3
M_P"VE[]U[I([:^*7PLWID-UXG9U?DMV978>>?:N^<9MKY1=UYW(;,W/%30UD
MFW-UT>+[?JJG;N>CI*B.5J.L6&H$<BL4TL"?=>Z*W\H?C?\``G>GQQ[NV#MK
MN?K7:6[^T>O>]ND^O<_OWYG]E4NSH>W(-H;CVI783,M5=LYN.LFV-N.91G\>
ME#7U5%'#*D]([`Q-[KW0O9;K/^6C@<9M_-9SN'9>%PV[://9':N6RWS9[%QV
M,W-C]K9%L1N>NV_7UG>4-+F:/;F64TM?+3/(E'4`QRE']/OW7NEH?C7\%1-L
M2F.Y+5':7E_T94Y^6/<(F[&\&/?+3?W$B_TR>3=_AQ<;5+?P\5&FG4R'T`GW
M[KW3/+T;_+UI]X'KR?L##P[_`%S%-MX[&E^8?:D>\!GZQH%H\&=LOW6N:&8J
MFJHA'3>#S.9%TJ=0O[KW0A1?#'XF3YVNVO#1;JFW+B\3BL]DMNQ?)#OB3.X[
M!9VLS./P>:KL0G;!R%)B<SD-N9""DJ9(UAJ)J"H2-F:"0+[KW3+M/XJ_"K?L
MFX8MC9'(;TEVEG*G;&ZX]I_*3NK<<FV=RT2JU9M[<*8?N"L;"YRD5P9:2I$5
M1&"-2"_OW7NBY_(_XH?"7:O9/QDFW?V;LOJD;"[/W5VQNS`]K?+[M;:.XMS=
M:Q]!=X=4S5>R*/<7:1JI:C%=B]G;?FJZM)*&&+'QU,;U1:1:2J]U[H8MS]'_
M`,O/9--M>MWGV'A=HT>^*&3)[+J]S_,7M/`TV[\;#!#52Y#:\^5[KI(MP4,5
M-4QR-+2&:-4D5B;,"?=>ZS;=Z'_E][OS^#VIM+?F+W1NG<^VZO>6VMM;=^8'
M:V;S^X=H4%:<;7;JP>&QG=-3D<MMNBR(-/+74\<E+',-#.&X]^Z]U[%]#_R^
M\WF\?MK"[\Q>7W'E]P;GVGBL!B_F!VM7YO)[JV0RIO/;./Q5)W3+75NX-HLP
M&4HHXVJ:`D>=(_?NO=84Z/\`Y><F[CL"/L/"OOQ<M58%MDI\Q>TVW<,[0FH%
M=A3ML=UG,C+49I)?+3>'S1^-]2C2;>Z]U!VMU'_+AWSFZ3;.RNT]K[PW)7U&
M6I*';^UOFAV7N#-UM5@8,A59RFI,5B>[ZNOJ*C#4V(JY*M$C+4\=+*T@41N1
M[KW0;]2?#_X:]C_(SNCL'KG?^U^SMG5G2'QOVG'@NN/EIVYO#=^U]P;=WU\H
M\WE<WO`;=[/JWQ^U]WXO>..AP+35TRSU6'ROC@@\<DE3[KW1L/\`9$_C1_SS
M'8'_`*/[Y"?_`&TO?NO=>_V1/XT?\\QV!_Z/[Y"?_;2]^Z]U[_9$_C1_SS'8
M'_H_OD)_]M+W[KW7O]D3^-'_`#S'8'_H_OD)_P#;2]^Z]U[_`&1/XT?\\QV!
M_P"C^^0G_P!M+W[KW6K'_H)ZT_YUFX/^XIS_`$$_\?\`]A?\RT_YUG_'T_\`
M'P?]G!_Q\/\`TW>_=>ZVV_EA_P!DL_)7_P`0!W)_[[K<?OW7NJW_`)-_SEOA
M?\"^K=D[1W5O"?M[ONFZWVJ:/X^]/2X[<F]J&M&UL6](.Q\P]9!M+J/&3/41
M/JSU939&II3)+CZ'(-$T7MB>Z@MEU3,!\O,_8.@MS1SIRUR;:?5\P74<-1VI
M\4LG^DC6KMG!:FE?Q,!GK6NV]_PHV^8VSNP>_=\;(Z4^-&"QO?7;&/[6J=J;
MKQ_:._:_:%3B^G.I.E:'`P[QP_8?6=-N*$;>Z?H:J:I.$H#)6U4Y6)(O&BDS
M;\H8Z8B5^;4_E0_X>L>KK[T5JERZ66RR26@8Z&>Z$;L/(LBV\@4_(2-3UZ7/
M_03Y\^?^?1_$#_T`.Y__`+?_`+U^_O\`A7_&O^A>D_\`P4O_`$@O^SW_`+=.
MO?\`03Y\^?\`GT?Q`_\`0`[G_P#M_P#OW[^_X5_QK_H7KW_!2_\`2"_[/?\`
MMTZ]_P!!/GSY_P"?1_$#_P!`#N?_`.W_`._?O[_A7_&O^A>O?\%+_P!(+_L]
M_P"W3I+M_/T_F.?)7N'X][=ZZ^/70?8W;'6'9>9[7V#UIU;T_P!X;MW/NJMR
M'4':O1N1;*X3']XU]=2[0Q6&[HJJNJR3-1T=!4P4\E5514XE#/P;K/<MIA@)
M^>K`^TZ>A3RO[X\R\XW?TG+_`"Q)-0T9_K-,4?GWR&T"+C(%=3?A4G'6T[\<
MC_.%["V'2[I^2.>^!OQOW=D'DEI^KMM=%]R]]9G%8^18#3#=^[<7\P^O=HXK
M<4#K*L]%AY=Q4!5HWCR3$-'[.5U%1J`#?(U_G0?X.LA;5KI[9'O4CCNRHUJC
MF1%/F%=DC+#YF-:^G1@_[E?/G_O);X@?^D/]S_\`WPCWOI1U[^Y7SY_[R6^(
M'_I#_<__`-\(]^Z]U[^Y7SY_[R6^('_I#_<__P!\(]^Z]U[^Y7SY_P"\EOB!
M_P"D/]S_`/WPCW[KW08XKX\_.+$]R[][JA^4WQ2DSW8'674G5V2Q4OP@[>_A
M%%B.G]U=U[LPF0H0G\P%:T9+)UO>.0CJO)*\7BI*?QHC>0O[KW0G?W*^?/\`
MWDM\0/\`TA_N?_[X1[]U[KW]ROGS_P!Y+?$#_P!(?[G_`/OA'OW7NO?W*^?/
M_>2WQ`_](?[G_P#OA'OW7NO?W*^?/_>2WQ`_](?[G_\`OA'OW7NO?W*^?/\`
MWDM\0/\`TA_N?_[X1[]U[H,>I/CS\XNG]JY7:>$^4WQ2R=%ENS>Z^T9JG*_"
M#MXU4>7[Q[EW[W5N#'Q?:?S`::+^&XC/=@5-)1W4R_9PQ>1WDUNWNO=/V_JW
MY?=5;0SG8'9OS(^#'7VQMLT;9#<.[]Y_#SM7;6V\+1*RI]QD\SE_YB-)CZ.-
MI'5%UR#6[!5NQ`/NO=$U'RP_F,/FNO>PMOX_X_;F^*M=WE\9>M=U]F=B_%ON
M[XU;T[#V_P!]?(+JWIJMR7Q_Z_W+\K>T=[U,.&HNP):@9G>F#VOCY7C@J,9!
MG*.0R>_=>ZNX]^Z]U1%O':'=?6/S][X[R^,F)KLK2_+_`']A/B-WQ68N@@K*
M/JC<NP_C)UIN+H/YB93'UD28_+[9Z?J,9V%M3/+(6_B]=48?'^6,8Z54]U[H
M!NG=K-U=L[X#[<VGD-P=9;=ZK_F;_P`X7))GGV+F=YG9O56Z>V/YA4O5>X\S
MC*F@GD3:^_\`:?8.VI,/E:G33Y&FSM#44\DJU,+/[KW1Q6W_`('"?)'^7OOS
M.5^>RV`VCT+\Y]J]A]HP]0[DV9B]U=DUVZOC5C-P=@56SL7@7JMJTO<?86S]
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M--NY=R;X_F#=N-M3$46QMW5<N=PN^<YL;!X?>&.K5PRXFKV3`TDM5599*AJ*
M"BI*B7R'Q%??NO=*GOC=.$V1_,@^)^\]TIEH=GX7X-?S`=K9W-T.V=Q[BQN,
MW!O[O?\`ELY796W\FVW\3EOM<MO+%]8[CFQE+(HER$>$K?"K_;RZ?=>ZK(ZC
MV!V%U+V3\9MPSTN\/CGU9GOEQ_,I[@Z:VMF>KLQD*WHOX]]MXG&2=?X'<_6U
M1C;]14?9>\3E]P8S;];!CZC"Q9Y,?+2TM93U%)![KW1Q.]<9OK:^QOAO\[^A
M]@;H[H[@^.N[-R=2=K[9VYL.'K#=7R1Z:^0&Z*3K+OW*X_:N0HJ%\+1Y3O\`
MV_MCMVCJI`4DQV#J)E61<@Y;W7NG[MWJC>VP^V_@+L79F5I7[(QVR?FU69SL
M:GP=52[9'>7:O5$N9R/8VX8:2&JI-NP]@]T9VOR4<$K*)ZF>2&`.RZ??NO=+
MSX"97J>E^'WQ#Z'W3M>NQ?='1_7/4."[$ZGW+A<JW9W5G=VQ=J4=-V)O?>+Y
M`/DJ&EJMW1YBIEWI/5/B=VK7R/2U^2_BL25GNO=$[^,>6P6)^.F>V?W1F.PM
M\['RF6_F54]9\=-L]`;HJ-_XZGWQW7WYOB@[`VYOK&X9,WB&R/0Z;EIL741S
M0/FCN^DHZ%YZNJHJ:I]U[HR7\NU.UMG=I]I=3[A['V_\K>I=I]+]+4?4OS`3
M8PV)VTFU<%N/M&@V]\6_D8V)IJ/9.\>V.H*')SY%J[&T>$RT,.;=L[B**KJZ
M>6K]U[JV_P!^Z]U[W[KW7O?NO=>]^Z]U[W[KW6H+_P#A??OW7NMGSY8?]DL_
M)7_Q`'<G_ONMQ^_=>Z^25A^OMJ+CJ:9*"K26NC7(UDD><ST;560KU%575M04
MR:^6KK*F5I)9&NSNQ9B2?8&DNIV<EFJ:^8!_R=<R-XYUYEO=SFFO+@33>(PU
M210NU`2`-31DT`P,XZ<_[A;8_P"57(?^A!N'_P"NONGU$OJ/V#_-T6?UJWO^
M.'_LGM_^M77O[A;8_P"57(?^A!N'_P"NOOWU$OJ/V#_-U[^M6]_QP_\`9/;_
M`/6KKW]PML?\JN0_]"#</_UU]^^HE]1^P?YNO?UJWO\`CA_[)[?_`*U=>_N%
MMC_E5R'_`*$&X?\`ZZ^_?42^H_8/\W7OZU;W_'#_`-D]O_UJZWL_Y`/P(^*&
MZ/Y:W37=>3ZNJ:;M?LS<WR&H>PM^[=[#[2VAN'>E'L#Y4=Z;*V53[EK-I[VP
MG\7BVQM3#4U#1B8/X8(@%Y+$C*QS:1G%2H/IUT2]M2'Y#VJ?2BR2V43MI54!
M=E!9M*@+5CDT&3U==_LB'QF_YY?L#_T?_P`A/_MI^U70XZ]_LB'QF_YY?L#_
M`-'_`/(3_P"VG[]U[KW^R(?&;_GE^P/_`$?_`,A/_MI^_=>Z]_LB'QF_YY?L
M#_T?_P`A/_MI^_=>Z]_LB'QF_P">7[`_]'_\A/\`[:?OW7NO?[(A\9O^>7[`
M_P#1_P#R$_\`MI^_=>Z]_LB'QF_YY?L#_P!'_P#(3_[:?OW7NO?[(A\9O^>7
M[`_]'_\`(3_[:?OW7NO?[(A\9O\`GE^P/_1__(3_`.VG[]U[KW^R(?&;_GE^
MP/\`T?\`\A/_`+:?OW7NO?[(A\9O^>7[`_\`1_\`R$_^VG[]U[KW^R(?&;_G
ME^P/_1__`"$_^VG[]U[HO>$^*_0^S?GYU@V.V/)FO[J_&_L3L+:2;_W9O;M*
M+9^_Z7LWKG;5-OC9\'9>Y-VP[4WA!MW,UE`F3QRTU:M'5S0B3QRNK>Z]T.WS
MNR>-QW3?7<60R%#0297YG?R\\9C(ZRK@I7R62D^>7QQJTQ]`D\B-65STM'-*
M(H]4ACB=K65B/=>Z.;[]U[HC7R&^7>4Z-^0WQLZU&SZ7+]6=E[ZP'7'=W8TL
MU7!4=/[F[NAW7MSXJ-'3_M466QO;7;^QZS:M4T9FFQN1R6)\L:1U\<OOW7ND
M'G?FAO?K+YJY7XW=Q;>VKM[I[M!=H;5^-?R#H,?EX<)0]];BV[D<Y!\?^YZ"
MLW)4TR;FWKCJ%Z[9V4IJC$4FX)Z2KPWA@R2T+9'W7NF'8_R/^4_:?8_4O6VU
M<W\?]MY#??P7V/\`*?)Y3<'4G8N?HFWINC<=#@JC:M#3XWOC`SXC:X&05DFD
M;(5<.DD^:X4>Z]T];=^;^\-\?R[N_/EAC=C[=V5W3\?MH_+?"[\ZTS5;D=Z;
M,P7>_P`.]P]G;![%VQ!F<;-L[*;FV+E=\=6U3XRO0X^KGQ%93S2Q05'DIT]U
M[J13?)KOG8/='Q6ZL[;CZEW+MOYJ;9WWBNJ>Q-@;/W?L^LZY[MV/T]E^\4V7
MOO8&X.R=\C>>S=R==;1W#6T^8H,[AZFFK,0M#+1$5B5T/NO=!M-\^NXJ/^6#
M\9OFIC.JMO\`97=W=GQ\Z5^2&;Z@V72YS'8C^YF7ZOPWR([YQFTZ>JS6>SO\
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M86V-NYK</2]#\9NWMX=T=?\`578^\MG[3^*/R#W-V_LG-=V;CZ#VQO;<'9%4
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MG[>[HK^RZC9>[MW8??E5MW%Y2MEVOC,?54,F0JJ:.-XZ:*3W7N@_^`'S.W!\
MP(,SE*S>?4M=5[0V;MG'=Q]-8SK[?W47R!^-??\`4559)NSJON;KGL??FY-Q
M4F-IZ$"/#Y7^'T-+F6H:JII9)J5X&/NO=64^_=>Z][]U[KWOW7NO>_=>Z][]
MU[K4%_\`POOW[KW6SY\L/^R6?DK_`.(`[D_]]UN/W[KW7S[=L?R)_P":KE=M
M;>R=!\6#/0Y'!XFOHI_]-_QQB\U)64%/44\OBF[?CFC\D,@.EU5A>Q`/'L+M
MLEV6)U1\?4_]`]81W7W:^>IKF29;O:=+NS"LMQ6A).?\5Z`P_P`M;YA4^\>R
MM@9C9/5NU]X=2[PHMC;XP.\/E9\1]IY#&[AR&Q-E=CTT--39_O7'RY*C.V-_
MXYFJ8!)`M2TU.6$]/,B:_<=W_%'^T_\`0/3'_`S\]_\`*7M'_.6X_P"V7IP_
MX;(^77_.HZ!_]+6^%'_W0OOW[CN_XH_VG_H'KW_`S\]_\I>T?\Y;C_MEZ]_P
MV1\NO^=1T#_Z6M\*/_NA??OW'=_Q1_M/_0/7O^!GY[_Y2]H_YRW'_;+U[_AL
MCY=?\ZCH'_TM;X4?_="^_?N.[_BC_:?^@>O?\#/SW_RE[1_SEN/^V7K9\_EC
M_,?'_P`OCX4?&3XD=W]/[@S?9C=F?(/;]+E.LODK_+JW3LBJK]]=H_(GY*85
MY,YD?FYMZNP^/3KF-TFJ<E1T4`RP6B1Y)9J?S"*VC:&W2)J:E4#'#K+_`)/V
M>YY?Y6V_9+QHVN[2TCB<H24+(H!*EE4D5X54'Y#JSK_AT;8/_/C.P/\`TIC^
M6#_]\#]O]"3KW_#HVP?^?&=@?^E,?RP?_O@?OW7NO?\`#HVP?^?&=@?^E,?R
MP?\`[X'[]U[KW_#HVP?^?&=@?^E,?RP?_O@?OW7NO?\`#HVP?^?&=@?^E,?R
MP?\`[X'[]U[I*T?\W?J>NWON'K^#HOM+^\.V-J[.WCE#+\@OY:4.(.&WUE]]
M83`BASLOS[7$Y')"NZ[R7W5)!*]111&GDG1$JJ=I/=>Z57_#HVP?^?&=@?\`
MI3'\L'_[X'[]U[KW_#HVP?\`GQG8'_I3'\L'_P"^!^_=>Z]_PZ-L'_GQG8'_
M`*4Q_+!_^^!^_=>Z]_PZ-L'_`)\9V!_Z4Q_+!_\`O@?OW7NO?\.C;!_Y\9V!
M_P"E,?RP?_O@?OW7NDKL[^;OU/OK$5F;P/1?:0H:'=6^MG3_`,5^07\M+"U7
M\9Z[WON'K_<9BH\I\^Z6IFQIW#MBJ-'5JIIZ^C\553O)!-'(WNO=`GN3YE[U
M[`^3^UM_=1[<Z2Z:HDZ)W?UAE>R?E=\I?B;D-H;0K<]V%L?=$6:QW77QH^2G
M;N^>S\E3T&W91%AI:_9]%5,;29NCLNOW7NC1=64WPJVAO&@[B[6^7O4GR,^0
MU%3U4%%W'VKW!U/*^R8,C!%3Y+#]*]>8;,4'7O2.WZN")89A@:"#+Y2!$_C&
M1RDZ_<-[KW1L_P#9L/BS_P!Y*]`?^CDZZ_\`LC]^Z]U7WWAU'\"_D+L#Y#;9
M[)^4WQPR6_>]=P-G,'WC!N'H6/MCI`X_';1QFR#U/N2?)U,^&RG6(V71UN!K
M)#(T.74UE2E5(\JR^Z]TJ.YMQ_`W<O4'R6I_E+\K>A.S.I>Q.K\54]J4M%N_
M:-+GL;1]4[4DJI-[[/AV%NG+;K@WQCY\9_&L8V"I/XM0YJGIY<4$GBA4^Z]T
MR[?VE\;=D[DZUW1L'^8SU]M7,=;?%'9GQ'HLTV^OCYN7/Y/9NSZFBKX]\5E5
MNJHS&%;L:LR5"E1YY,=-BE<6DH)D+*WNO=+J'!_`_!?#K?7POV-\INH-L[#[
M`Z[[;V%G]W5W=O6^YM]Y&O[VDW97=K]D9?*Y+<,=/F^R-Y;DWUE\W55U1$U/
M)F*UIGIWBO`?=>ZA[<H_BC2]@]9=L;\^<_5'9N^NB=A[HV/T/39[L?I+#[`Z
MQJMX8#'[8W#OZFVCMK)XK([C[$S&W<>,5-D,AEIHZ?#SU-+CX:`UV0EJ_=>Z
M1_3G6?P4ZTV+\?\`J_>7RF^-'>?7?QE^,FQ?C+U/M?M;-]"Y^FQ.,V'08#!0
M]AU<E1EYUJ-^;KVSM'#T69>)(**7^&1/14]#Y*I*CW7ND/T5TC\1?C5#U1G.
MH?GUU)1]C=,]7[HZ!VIN#=>_>J<]LS.?'3+;[J.PMC])[[Z]Q.]]KIE=M]%9
MFMFI]C5V)R>#S.'Q;?95%76TTM9'5^Z]T*6PMV?"OX^U72&VX?FKT]D*C*]Z
M_*[>L,.4WAL+-1;U[/\`E=O+NKY5=K4536[>S:8[K_:.)KLON,X-LBQAAIH:
M/'SUE;7RP_>>Z]TB]D]"?RY^I,/3X_I?Y3=3=:5FSOE%N;Y8])U%!W5UAEL5
MTMO3>W6J=5;VZZVM@,EG6HZCHG=NS\AF*&HVM(Z4^/H\RRXB7&3X[#5..]U[
MI?1+\?Z+?&X>\<5_,%Z8QGR)WGN#KRLWEOJ'>'44^P\[U_U3M;L[`;#Z$'6U
M7O:?)T'2>(S?;V>W$].FX6W++N#)3U(S:)]O#3>Z]TF7ZT^$,'QOW-\=\%\P
M.BMKT6^?D%2?)?=VX-O[]Z@QU&>QT[_P/R0R%%M+9T&YDP>U-FUF^]MTU(M%
M>KJAB3+YJNHR<\N4;W7NA@[6RWPU[B[=ZR[/WC\J?C]7XOK_`*M[TZCR?7U1
MV5UE5;;WUM3Y"TNPZ+?U-N&:?=QK8U6DZZH8J-(2J)'/5K.*CRQ&G]U[I,]=
M97I'KSJ.AZ%I?YC?6E;UGLS8\O7O5V13L3J/'=N8#;%-M.OVCM6@WKV5#NZ:
MFWW)L.BGHY<;6T^'PF5JY\9`^6J\H\E6U3[KW3;U5O[X=X'Y0;H[4WK\TNAN
MQ?D/M_X\[%ZQR&XZ+*=:=<4N1Z?W)OG=>8V[EMZ9;$9F;;78/966W=UUDC5&
M@JJ.AP=+"GVN#Q$63:7)>Z]T=+_9L/BS_P!Y*]`?^CDZZ_\`LC]^Z]U[_9L/
MBS_WDKT!_P"CDZZ_^R/W[KW7O]FP^+/_`'DKT!_Z.3KK_P"R/W[KW7O]FP^+
M/_>2O0'_`*.3KK_[(_?NO=>_V;#XL_\`>2O0'_HY.NO_`+(_?NO=:H?^ECJS
M_GY>P/\`N*[_`-+'_'Y;=_YE9_S\O_BX_P#'@?\`5Y_XMW_-[W[KW6UY\L/^
MR6?DK_X@#N3_`-]UN/W[KW12^L=L?)[Y3=;;!AWU6;F^('QZDV-M.GAV+LK<
MV/'RI[8QB83'**C>O9NUZS)87XZ[2S=+K'\*VE5U^]&A:&<[BP52*C&+[KW3
MC\./CST1U]OOYT[&V;T_UQ@=I[7^6>TJ+!X6DV?@WIZ**M^#'PMS>3F,M313
MU57D,SGLK5Y"OJIY)*JOR-7/55$DM1/+(_NO='B_T4=6_P#/M=@?^@=MW_ZW
M>_=>Z]_HHZM_Y]KL#_T#MN__`%N]^Z]U[_11U;_S[78'_H';=_\`K=[]U[HH
M_P`D>L.M(>Y/Y?\`'#UYL:*.K^7.\Z>KCBVE@(TJJ=?@=\V:M8*A5QX6:%:J
MEBE"M=1)&K6NH(]U[HW'^BCJW_GVNP/_`$#MN_\`UN]^Z]U[_11U;_S[78'_
M`*!VW?\`ZW>_=>Z]_HHZM_Y]KL#_`-`[;O\`];O?NO=>_P!%'5O_`#[78'_H
M';=_^MWOW7NO?Z*.K?\`GVNP/_0.V[_];O?NO=%'V9UAUHWSQ^2-(W7FQFI8
M?B-\)JB&F;:6`-/%457<G\P".IGBA./\<<U1'21*[`!G6)`20HM[KW1N/]%'
M5O\`S[78'_H';=_^MWOW7NO?Z*.K?^?:[`_]`[;O_P!;O?NO=>_T4=6_\^UV
M!_Z!VW?_`*W>_=>Z]_HHZM_Y]KL#_P!`[;O_`-;O?NO=>_T4=6_\^UV!_P"@
M=MW_`.MWOW7NBC_";K#K2JZ;WG)4]>;&J)%^7/\`,`IUDGVE@)76GI/GC\D:
M2D@5I,>S"&EI84BC7]*1HJ@``#W[KW1N/]%'5O\`S[78'_H';=_^MWOW7NO?
MZ*.K?^?:[`_]`[;O_P!;O?NO=>_T4=6_\^UV!_Z!VW?_`*W>_=>Z]_HHZM_Y
M]KL#_P!`[;O_`-;O?NO=%'_F`=8=:4GP.^;-72=>;&I:JE^(WR1J*:II]I8"
M&HIZB'IO><D,\$T>/62*:*10RLI#*P!!O[]U[HW'^BCJW_GVNP/_`$#MN_\`
MUN]^Z]U[_11U;_S[78'_`*!VW?\`ZW>_=>Z]_HHZM_Y]KL#_`-`[;O\`];O?
MNO=>_P!%'5O_`#[78'_H';=_^MWOW7NO?Z*.K?\`GVNP/_0.V[_];O?NO=%'
M^2/6'6D/<G\O^.'KS8T4=7\N=YT]7'%M+`1I54Z_`[YLU:P5"KCPLT*U5+%*
M%:ZB2-6M=01[KW1N/]%'5O\`S[78'_H';=_^MWOW7NO?Z*.K?^?:[`_]`[;O
M_P!;O?NO=>_T4=6_\^UV!_Z!VW?_`*W>_=>Z]_HHZM_Y]KL#_P!`[;O_`-;O
M?NO=>_T4=6_\^UV!_P"@=MW_`.MWOW7NBC[,ZPZT;YX_)&D;KS8S4L/Q&^$U
M1#3-M+`&GBJ*KN3^8!'4SQ0G'^..:HCI(E=@`SK$@)(46]U[HW'^BCJW_GVN
MP/\`T#MN_P#UN]^Z]U[_`$4=6_\`/M=@?^@=MW_ZW>_=>Z]_HHZM_P"?:[`_
M]`[;O_UN]^Z]U[_11U;_`,^UV!_Z!VW?_K=[]U[KW^BCJW_GVNP/_0.V[_\`
M6[W[KW6I)_=/:W_/-8#_`+BV_P"Z?_%FQW_'K?\`/-?\!O\`BP?],?\`P&_V
MCW[KW6TY\L/^R6?DK_X@#N3_`-]UN/W[KW55&T/YMO37:&T]K=>_&WOSXG]:
MT.W-L;7V_N?Y%_+'MW9.R]H8W(X_#T%%FJ/J_P"/57V!LCNOM_,8FKB>,U&6
M?8NU:E"*G'YK*(I@?W7NE'M#*?RY=NU&\-P9?^;A1;CW[V7NB/?/9V\J/Y_]
M4==)O+>46U=K[&@R_P#<KJK<>R=@[>I\=LW96(Q-)38_&P*E#C8!*T\_EJ)?
M=>Z6G^D/^7'_`-[71_Z<UQ/_`-LWW[KW7O\`2'_+C_[VNC_TYKB?_MF^_=>Z
M]_I#_EQ_][71_P"G-<3_`/;-]^Z]TF\YD_Y7NY<GLW-9[^:)19/*=?;DJMW[
M+K:G^9GC&FV[N:MVANK8-5F<>5[04)63[.WOEL>Q8,/MZ^46N01[KW2D_P!(
M?\N/_O:Z/_3FN)_^V;[]U[KW^D/^7'_WM='_`*<UQ/\`]LWW[KW7O](?\N/_
M`+VNC_TYKB?_`+9OOW7NO?Z0_P"7'_WM='_IS7$__;-]^Z]U[_2'_+C_`.]K
MH_\`3FN)_P#MF^_=>Z3=+D_Y7M%N_.;^I?YHE%!O'<NV]J[0SVX$_F9XP5^3
MVSLC)[RS6T\-4N>T#&U'@LIV#FIX`%!#Y&6Y-P![KW2D_P!(?\N/_O:Z/_3F
MN)_^V;[]U[KW^D/^7'_WM='_`*<UQ/\`]LWW[KW7O](?\N/_`+VNC_TYKB?_
M`+9OOW7NO?Z0_P"7'_WM='_IS7$__;-]^Z]U[_2'_+C_`.]KH_\`3FN)_P#M
MF^_=>Z3>U<G_`"O=D8RJPNT_YHE%@L76[DWEN^JHJ'^9GC%AGW-V#N_.;^WI
MF7#]H.36;BWCN6OR%0;V-15.0`"`/=>Z4G^D/^7'_P![71_Z<UQ/_P!LWW[K
MW7O](?\`+C_[VNC_`-.:XG_[9OOW7NO?Z0_Y<?\`WM='_IS7$_\`VS??NO=>
M_P!(?\N/_O:Z/_3FN)_^V;[]U[I-[RR?\KWL':&ZM@[T_FB46XMG;WVWG-H;
MLV_D/YF>,>@SNV=RXRJPN>PU<D?:$<C4>3Q=;+!*%924<V(^OOW7NE)_I#_E
MQ_\`>UT?^G-<3_\`;-]^Z]U[_2'_`"X_^]KH_P#3FN)_^V;[]U[KW^D/^7'_
M`-[71_Z<UQ/_`-LWW[KW7O\`2'_+C_[VNC_TYKB?_MF^_=>Z]_I#_EQ_][71
M_P"G-<3_`/;-]^Z]TF\YD_Y7NY<GLW-9[^:)19/*=?;DJMW[+K:G^9GC&FV[
MN:MVANK8-5F<>5[04)63[.WOEL>Q8,/MZ^46N01[KW2D_P!(?\N/_O:Z/_3F
MN)_^V;[]U[KW^D/^7'_WM='_`*<UQ/\`]LWW[KW7O](?\N/_`+VNC_TYKB?_
M`+9OOW7NO?Z0_P"7'_WM='_IS7$__;-]^Z]U[_2'_+C_`.]KH_\`3FN)_P#M
MF^_=>Z3=+D_Y7M%N_.;^I?YHE%!O'<NV]J[0SVX$_F9XP5^3VSLC)[RS6T\-
M4N>T#&U'@LIV#FIX`%!#Y&6Y-P![KW6;+]E?"RIF@P'37S.^3ORN[,R4,D^"
MZ<^)WS`W)WIV1DX8JBDI)<EDZ;:N_&VMUWM6GJJZ&*?<.[LKM[;=+-+''/D(
MI)(U?W7ND)N+H;Y?]<U'6GR,WU\D^Y>J,/BODK\2=F8?XN;>[XW?W?BMQ;7[
M>^6?1?5>Y?\`9@NS^P:1*#<M=4[(WAD(TP.T</AJ'$UTS>3-[@@$3)[KW5Z_
MOW7NO>_=>Z][]U[K4%__``OOW[KW6SY\L/\`LEGY*_\`B`.Y/_?=;C]^Z]TO
MNIO^96=:?^(_V;_[SF-]^Z]T('OW7NO>_=>Z][]U[KWOW7NJZ_YJ5!F<%\#?
MF7W=M'L+M;8'8'1/PJ^76_.N,EUMVAOGKJGQV_,)TWF-V[5WAEJ796<P8W+E
MMGYO9L$F-CR#5-%"M35!X)/-Z?=>Z#7Y>[0W!U7OGX"[,ZTW5\@-PXKN3YU[
MUVYO/9K?*'N/!Y'<NSX_Y=/S#WTVR?\`2%6[Y_O32[3QV_.D,%NB*DGR$PCR
ME).(6CBJY86]U[HO7R,['[<^*6[/B!\A,;O+N#"]7=(T?R.S_P`Z>D=Z=V;C
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MF.N\%UW_`"U^ZL1/C>W][U'9'7.]NZ/G?D.A-]==8GM;/[YI=ZK@^]NM-FN:
M/&Y/.PT5!4T&1FBDBCK&,'NO=&(^'WR)WUC?CM\R.YMR5F^,]2[5^3_9>Q>E
MOC9V3F]V[_[XZ3S.`QW7O66"^._;&[33;OW1G-V=D=X/4;CQ'VU1N>CH]L[U
MQ7\,RF4Q8HI1[KW1;*SY'=QXK^5K_-GZWW=VYVI7?*#X,=(?+3.[4[MS.#W_
M`-)=N[LV/E.F]^][_%7O>/!YFAVMNO;=91TP?;,SB..EK<YL?)Z$:C=4;W7N
MAY^.^*[`^3.2_F6]+5G:WR*^/>T\7N+973W7'7N>[?W;E_EA\;-]0=>Y',9G
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MV\=Z9OY)[GZEVYN3;N,[\Z7W?LC>.`J<W+!49+)X+$[8EEBQ=50U=9(/=>Z!
MKY+=W=T;1ZR_GC?W97Y)9"3J3NW$X_JOM#:?<-!BMO=&8ZH_E\?"#MN?#;>I
M\UW3MO?.WZ&@[%[-SN>J(,'A:JGD&8\4?E$8IH/=>ZL?^>F7W!M/KKX]-M3=
M>\MK3UWS6^%NQ\E6[:WENG`9'+[0WG\@MA[/W9MS-Y/$Y>CR&;Q.X]MY2HI:
MR&KEF6=)2SW>S#W7NJX^\>]N[/B)'\PZ[M'L?L;<OP_[NW-W'L?J+M+^]N\)
M-\_"[Y+1;<CI.N]D9G?M)E3O*CZ)[TW544E/MK)-6^/:>\G3$RE,7F*%:'W7
MNAX[9W[OWXT?+WNKJ&LW]V-GL!\].B=N2_#B#='9>^\SCNM_DCL;+T'3/9_7
M>TTK<[6UVU\+D<3VMM+L)I\9+!D(*+$;GK(U>'')X?=>ZC]A[=[&Q7S$WOTC
MM"?Y)=N[2V'_`"^>BLYA<'0?,#MKK;.KO:J[1^1&RZO?>6S5!O;%-NC?6[<3
ML_'I6UTR32R34:RE&=K-[KW3'O;?O:G5'RHP.3[4S?<6^_BCW#\AOC=MWXZ?
M*GI#O/<&6VEU1NW(X_K'J.C^-/REZ&Q6X,+M^NVCWAVYCJ[[3?%%09VDJLKO
MBGILB,<*>A<^Z]T+W2O49/S.^2_4E7W%\G,MM'ICIOX1;DV7%G/D[WIFY_XW
MNO)?(J'?]?G(LIONKQ6<D[#HM@XZ#)K/2M'&J-)0K1SZ)D]U[JM[`?++Y,;'
M_E^_)SXHY[M7L+*?+K8OQEW-\CNK._LOG*C(=@UWPV[/Z+W?WG@>])=UU\,N
M5KMS=6[QP>=Z?3)K%+546YZ3`UU3(17"H/NO='%S]1VGN7Y09;8V"B[\[,P=
M#_+<^./8-)M/:7RQ[6ZA:@[!W-O_`+_V]D]X"HQ>^,=_&MT;DQ^V*"&>IF%1
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M`(I_V7_[^CJ;W[KW2`^8':&RMX9;KOXO;+RLF]^^JGY!_#7M/,=<[-QV2W1E
M]A]8]9_+#IOMG=?87:E3A:2LQ75.T!LK864EQM;N*HQD6<K*?[+&FKK'2`^Z
M]T?[W[KW7O?NO=>]^Z]UJ"__`(7W[]U[K9\^6'_9+/R5_P#$`=R?^^ZW'[]U
M[HL6W]P?,/KWHO;6^=Z=M_"/8NP-J]9;=SF?W=OC:/:.W=O;9V[0;;H9ZC+;
MEW'E>X<=A<50T-*NJHJ9I(8$`+$J/?NO=%NVE\SOY@6^)=SY79_1&&WAUS3[
M@IZ+K;LS;_QS[2Q6"[5VJVUMM9*IWMA<%V?W[UIO3$X==V9+)XJD>HQK4V4I
ML7'E**HGH:ZF<^Z]TL/]F<_F.?\`>.(_])^RG_W7WOW7NO?[,Y_,<_[QQ'_I
M/V4_^Z^]^Z]U[_9G/YCG_>.(_P#2?LI_]U][]U[HJ797SA^5/<V\\U\-<E\8
MML]V2[JPN7PWR.ZX@Z%W1F<-L#JO/;.S]2M-VXV%^4N5VWCE[&R$=#AZ?:^=
MK\55;AQ.2K*F"*LHZ*LB;W7NA1W[N7YA=HT^PZ;L+X?T6[EZORDN=Z_FS/1N
M[*FMVIN"?:^6V3-N/%9#_9SUKXMR2[.W!D<6V0:1JUL?DZV`R^*LJ5E]U[IE
MH#\HL;CY\/2?"/;BX:LVSV#LW(X:;X^[AJ\-F-L=LY)\OV=A\YB:OYE3X[.T
MN_\`)E)\O]Y'.]?)!`9B_P!O!X_=>ZZW*/E!O%NR/[T?"';6;B[AZSP_2_:%
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M[H;-Z0?)KL3-]G;CWO\`!S:VYLUW3UO1].]M5^4^/&>FD[%ZFH&R;4O6>[XQ
M\R$@S>PXSG<C?$SJU"PR=<&C(K:KS>Z]TL<?OOYHXO?M-VG0?$/&4_95/LG'
M];R;]'0.?DW=D]A8G(9'+XC:.X-P3?,>3)[EP.(R^8JZRDI\A)51TU752S1!
M99'<^Z]U.V!V=\X.K:'.XW8'Q-HMLT.YMV;CWWN"FH>@]P2)E]Y[PR<^:W9N
MBM^[^8]2TV<W/FJJ6MR%23Y:RLEDFE+RNS'W7NDSNK._+W>>]O\`2/GOA]2-
MOF;;L&S<ON;$=([PVUDMV[)I:JNKJ78V_I-M?-'$1]A[%I:S*5<L6%SJY#%Q
MR5<[+`#/+K]U[I#=G]_=Z=)=9]R9[MCXW=?===6]MUD,?<<^Y^DLKA]O]A9?
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MPV>V=VI49JJ[#VON+X^9S<6!W9/N.+PYV3*XK-_,6OHY/XI&`)@J*K:%X]"V
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MQC]D4N/KML5WS#J<`U#%LS$4F(\2TRQG&4D-*08(HT7W7NB^-\N/D5NCO#J;
MI[87Q1VKV%V%\9:ZHCJ(]K=%;PGH_BCAINL,[A*$Y',8+Y5Y':&V=];CQ%7C
ML##M?(Y#&YZNVSG:BLCAGQL50DWNO="VL_RJ3>U?V$OPNQ']YLMO*C['R[-T
M3NM\#F>R<;28S'XCLG,[.;YGG9^6[&P6/PM'3X[/5%!+E\?3TD,=-41)$BK[
MKW0Y?[,Y_,<_[QQ'_I/V4_\`NOO?NO=>_P!F<_F.?]XXC_TG[*?_`'7WOW7N
MO?[,Y_,<_P"\<1_Z3]E/_NOO?NO=1ZOY3_S$:"EJ:ZN^/5-145%3S5=965?0
MM?34M)2TT;35%34U$WS`2&"G@A0N[N0JJ"20![]U[H%.F?YC'SI[^EW'G^J/
MC[1;SZDQ=/A*;;7;V%Z#W3+M'L'<4]7N-=STNQ<A6?*"AP>]=G[>QU%B9:?<
MV"R.7PF5GR<]-#,LN/G#>Z]UGS_^SI=M=U8/L;L_:_R2ZOVKCNK]P]8;AP_Q
M>Z.V5L_L;=^#S^[]J[MJ,;3=J=A?)/?51UUCZJ3;'VM968+&P;B^WJ"V-RF)
MJHTJA[KW1V>H>P]F="[138_4/P&^4FQ]NM75.8R,6,V/UG497<FXL@(SEMV[
MSW)D^ZZ[<N^-[9Z6,2Y+-YBKKLMDJB\U5432LSGW7NA2_P!FNW'_`-X??+[_
M`-`OJS_[<GOW7NO?[-=N/_O#[Y??^@7U9_\`;D]^Z]T'_9W\P/;'2VSLCV!V
MS\=_DMUYLO%24M/5[CW;@^G\-COOLA.E'BL3225?=$;Y'.9JOE2FH*"G66LK
MJJ1(*>*25T0^Z]UKI_>=W?\`>%GS?_[?6_\`#PO_`&31OK_LD#_E2_S/_90'
M_?O/^/H_Z9??NO=;5?RP_P"R6?DK_P"(`[D_]]UN/W[KW5873'Q3^;6Y:3K#
MMGY%S?%GY*;OVYB-L[@ZJP&[=X=M;:Z1Z8,&/IYMN9/K;HVAZWSFWD[`Q..,
M*C=NXZW<^ZZ6H-2,;DL?154E"/=>Z/\`?Q+Y\?\`/&_$'_T9?<__`-J;W[KW
M7OXE\^/^>-^(/_HR^Y__`+4WOW7NO?Q+Y\?\\;\0?_1E]S__`&IO?NO=$G[&
M_P"'(_D5W-O7HJCW5\?NI.L^J]L]?YSLW%=7=C]P;5W_`-KOV6^YJC%8&E[J
MINNYMV];;1H:':%1'D%VU28?<L\L\;TN>I(UDAE]U[HRW5_7/RMZ4V;C^ONI
M>E/@YU[LS&35M73;?VKO;MW%44F2RE5)7YG-Y#[?J-9\ON+/Y.>2KR.1JWFK
MLC6RR5%3++-(\C>Z]T(7\2^?'_/&_$'_`-&7W/\`_:F]^Z]U[^)?/C_GC?B#
M_P"C+[G_`/M3>_=>Z]_$OGQ_SQOQ!_\`1E]S_P#VIO?NO=>_B7SX_P">-^(/
M_HR^Y_\`[4WOW7NJZ=A]8?.3YL[=VUWC\@T^,/9'46\*>GW'U[\69=\=O[0Z
M.P6,2J1J)NWMJXSK[-U?R'W0M70"60;HKZO:<4D<,U#M^BJD:HD]U[JQ"GJ?
MGA24\%)2;&^'=+2TL,5/34U/V/W'#3T]/"BQPP00Q]2K'%#%&H554!54``6]
M^Z]UF_B7SX_YXWX@_P#HR^Y__M3>_=>Z]_$OGQ_SQOQ!_P#1E]S_`/VIO?NO
M=>_B7SX_YXWX@_\`HR^Y_P#[4WOW7N@7[][?_F!=2]<KN;';'^'+YC.]B=+]
M3X"HK=]=UYG&XG<G>W<VP>D-M[BS&&@V#MJJS6#VSGNPJ?(UU%#D:&HJZ2ED
MABJ(9'61?=>Z##K#XJ_,K;.]L9W1V_2?&'Y(?(?%QURX;MSM+L/M-J;KB+*Q
M3P93#]"];8GIZFV#T=@ZJDJGHYY\/2?WDS&/2&+.YC,20)./=>Z-O_$OGQ_S
MQOQ!_P#1E]S_`/VIO?NO=>_B7SX_YXWX@_\`HR^Y_P#[4WOW7NO?Q+Y\?\\;
M\0?_`$9?<_\`]J;W[KW7OXE\^/\`GC?B#_Z,ON?_`.U-[]U[HK'>V]_YF6XN
MP>O?C=UMDOBCTUNCM+KSMKL^N[7Q&:["WMN';VS.GMU=([2W%A=E4.\NK:K:
M&$WYGZWO2@FH,KE\+N;%T<&/J5EQ<\DT,D/NO=++I7H'Y.]!QY^KV%U;\2Y]
MX;TFHZSL7M/>7<O?V^NW>S<E01/#0UW8/9FZ^LLKN_<RXR*5XL?1S57\-P]*
M12XZFI*1(X$]U[H=?XE\^/\`GC?B#_Z,ON?_`.U-[]U[KW\2^?'_`#QOQ!_]
M&7W/_P#:F]^Z]U[^)?/C_GC?B#_Z,ON?_P"U-[]U[KW\2^?'_/&_$'_T9?<_
M_P!J;W[KW1%MSX[^8W\L>R.X^N*[=7076G2O1/8.*ZHW_P!?]5]G]V=?;S[B
MW#F^FNFN[_N,UWM@]BOV%M7KZ#!=NT=!_#MIKM7-S5E)4FHR]10S_9^_=>Z-
M?UML/Y9].;,PO775'2OP8ZYV)MV&2#";2V9N_M;;V`QRSS2555)!C<9T_3TW
MW5=63//43,IFJ)Y'EE9Y'9C[KW2Z_B7SX_YXWX@_^C+[G_\`M3>_=>Z]_$OG
MQ_SQOQ!_]&7W/_\`:F]^Z]U[^)?/C_GC?B#_`.C+[G_^U-[]U[KW\2^?'_/&
M_$'_`-&7W/\`_:F]^Z]U7+UCU7\WOFSL7K#Y&_(RG^+O;'6/;.P^N>X.LOB[
MD=Z]N;3Z$V+AMY;;PV]MNP]C["QW7N>D[^WYBH\E3_=56[\EE]MPY&DBK</A
M,14)Y&]U[JQ:*L^><$44$&R/A[#!#&D4,,79'<L<444:A(XHHTZE"1QQH`%4
M```6'OW7NLG\2^?'_/&_$'_T9?<__P!J;W[KW7OXE\^/^>-^(/\`Z,ON?_[4
MWOW7NO?Q+Y\?\\;\0?\`T9?<_P#]J;W[KW00]X=M_/7JK8U#N$[2^(='/N'L
MWH_J3'Y8;J[FW?%MS+]\]U]?='87=M9M#^ZO7[[MQNT,MV'!DZK%)G<++DJ:
MD>FCKJ1Y%GC]U[H9^L/B-M+:V\\;W'VYNO<WR1^06,6K_@_;7:\>)DAZ[CR,
M-335^+Z,ZVPE%CNNNDL3445;)1SU.%H$W%F*!8HLWELN\*3#W7NC:>_=>Z`'
MY8?]DL_)7_Q`'<G_`+[K<?OW7NE_U1_S*WK7_P`,#9W_`+SN.]^Z]TO_`'[K
MW7O?NO=>]^Z]T4+JO_LLCY=_^(_^+/\`[@]S>_=>Z-[[]U[KWOW7NO>_=>Z]
M[]U[KWOW7NBA?`7_`+(W^/?_`(C^C_\`<ZO]^Z]T;WW[KW7O?NO=>]^Z]U[W
M[KW10?G!_P`R8V5_XM__`"]__@^?C3[]U[HWWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z*#O7_LOGXT_^*@?.#_W\_P#+W]^Z]T;[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=%!^-/_,Y_YA'_`(M_LK_X`;X/^_=>Z-][]U[KWOW7NO>_=>Z][]U[KWOW
M7NB@_P`O?_L@;X/_`/BH'QI_]\QLKW[KW1OO?NO=>]^Z]U[W[KW7O?NO=%!^
M<'_,F-E?^+?_`,O?_P"#Y^-/OW7NC?>_=>Z][]U[JL/L+^9/M78NR][=E9OJ
MRLR_4J4_S&PW6>8Q6Z:?)[A[.WA\+ZG>V-[,VSD=H-MM*';6$W:O5^ZLC@,M
M3Y/-4M3M["O7UJ4/GBIS[KW1CNF_D[!W#2;9H]O[!R&/W%4=B?('8N\L)/D7
M7&[&P?QQ[L[(^/\`N/?AS$N$HSDMM[ZW[UV?[GPO2T-9G\;5M61Q1P4&1>E]
MU[HUWOW7NO>_=>Z)-\OOF/C_`(PYGH[8V-Q?6^;[([]WI6;4V/BNW>WGZ&V'
M4G'+BZ2>D_TF3]?]B8O^_&9S^Y<308';\E+#5Y^:IG%)(TE*\3^Z]TG<!\[-
MEUO>7>?5>3ZVW5@UZIH=U^#=-/`^1S&^,KL#+]6[8FVJFV4Q5%44FXM\;H[E
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M&L=C!4F:G]U[I)=#?/\`Q??VT]TY?;W4NZ,/NF+='7VV>NMG9C)212[QJ.TM
MD4F^]NQ;CR;;?B;8^8V;@365V]:&.ES$NV\70M41-D998:5_=>ZL,]^Z]U[W
M[KW7O?NO=$[[3^17;G5O??4.QZ[H'&YOHGMKL7%].4?;>)[9#]F8OL3-;!W3
MV!1Y9>BVZ\.+RG4./H]J3T.2S:[RASE#5I+-_`9<;`^0/NO=`#6_S)=KT.$V
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MMG8NZ<QM^AJ\M4TO9G:#].;"Q^&Q5!693+Y?<W8<.R>Q:G`4-+1T3(DB8:L4
MSR1^8P4_FJ8?=>Z)IN+Y\0)O/X5=4R=7;5VIVG\L]C;*[3RG5WR"[8H^H-U=
M8T&7AV_FI]G86(;$WW@NV.\MJ.,Q,=K8VMI*MCMFJG2=(@DP]U[I\ZO^?N#[
M/S?=.V:'JK=V.W'UK58_';+PM15%JWM#.YWY'?*_XRX':E.E3B*!=K[I7>7Q
M(S66S,$QJJ;;NV<C29*OJ(H8ZW[;W7NCX>;/_P#.MQ'_`!:/-_Q?*W_B_P#_
M`#K?^/>_XM'_`$W?Y[_ID]^Z]T1GK3X6U6RNQ.O:C*[CP&6ZHZ1[0^5?<75.
M!BP\B;FGW=\LMT[VW!F<;NB5U7$TNW^J\1VGNO"XL4HF?-8_+4C5:T]1C))<
MG[KW28^0?P2W+W'L.#";1[6/56[<EC^UL?ELOMW%)_#-I3;\Z7W=U)U9GNM*
M.DBQPP.8^*L^X:?+[+6..EIY,C%6U<JTV1R<U?'[KW5DGOW7NO>_=>Z*O\H.
MF-^?(?:6X^C9YNKCT#V]USO+KSN&/<V$W+D.Q<=!N.E2@I\SUY/0Y:GVV^2A
MQT]0*9ZV*&7%9-:;(1R5/@-')[KW3UW%T$>V3N^.DW+)UW5YCKS<N$V[O#9U
M%34V\,+V;N';&X]EX+M6OKEBI:G,9CJ7`9J1ML02U1I8*S(54\L1GI\?/3>Z
M]U#^*W16X.@-B;CVMG]VT^XWW!O>KW=C,+B*22AVCU_CZC:^T]NR;2V51S!)
MH,'7Y;;=5N"H#HA_BV<K39@1(_NO=&:]^Z]U[W[KW6*H:H6GG:DBAFJEAE:F
MAJ)WI:>6H",88IZF.GJY*>&22P9UBE9%)(1B+'W7NJXNK/A7OOJ3I+X0;:PV
M[=E9WMWX48W*[>QF7R%#F,9LOLO;6Y.MMR]:;BQ%>T<67SNS%K&RN,SJ24\>
M1E6LP<=$6,%5+/'[KW0Q]5_$G;O6?5W0G4<E=C=QX7J?;..HMZ[H?`4.$W)V
MGN##Y*CW7$,DE,M:^%V5G^SIJG=-?B*6M6)J^EHZ1C/0/603^Z]TU_$#XN;R
M^-HWS_>SMS)=F'=.-V-BE-52/2#*YG9C[O.<[?W*'D<U':W;:;FI!N293)'*
M<)2%97^B>Z]T=/W[KW7O?NO=%G^772.X?D1TG5]6[8S>%V[E*KL;H_?`R^>A
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M[97!8_";!W)U5V'N#LC`T$X4]DYW`;MHNV=O[+I=^[XHWDQ5-DZK`5O\%PUX
M*:.]7DVR'NO=(GH[X32]7[EZK3<F:VQNGKSXW]0=Z]%='[9CPK)-E-@]Z;ZZ
M^W/-_I%CKH:FACR&P=D]7XC:5(E%YX,M3OD<E6:9*V"@Q_NO=-':_P`&MU]@
M5_6.:V]V_4['RV!H]S3;\&)Q@6@J-[[E[,^,^^,-V9L.FC\<."W)TWLWX^5>
MR-F1RQL,?MG=%4D\\[).E=[KW5CGOW7NO>_=>ZZ<L%8H%9PI**[%%9K'2&<)
M(44GZD*Q`_!]^Z]U7WUIU3\]=E5?;FZMS]H_$G?&\]ZU$&5V]+3]/]P;7,T]
M-N_%5&,VGN?<53W/NZ:@V1M'K9<GA\'3XK&0K2Y7(',UD5?529%,C[KW0I;/
M^,E-M3KC<>U:.HV]A]T]B=L[S[?W?N7:>*FPD&S=T]FY.HJ]_97J&FGDR%=M
M3<U?B:NHI8<M'4051RE?59F0&>:2DD]U[I&]8?$/.]:?*'<W=N/[*D3KVNQ^
M]\5MSK#'8J/&TN*VWN7KSXF;&V=L"=(6&'BV9T_6?'/.Y+`QTE/`ZR;YJ8P(
M6AKI\U[KW1Y??NO=>]^Z]TC.P8]Z3;1RD/7^-V9F=T2R8N.GQ'8-9E<?M'*X
MI\O0+N;&Y2OPF*SN0H9*[;!K(J69:&LCBK&B:6":(/&WNO=$.V3\$)^E6Z[W
MIT?7;$VUV!L7L_Y3]@4^T,AB<E3]/XW"?+S-2;HWYU_M/&87[?(;:P>UMZ8O
M`9Q)**GI1GZ[$5JO#BSFY)L?[KW0V]5?$O:?576_QMZBHJBES>T?CYUML;9=
M1G*W$XVCWAV-D^LJ/!KLNJW34T5$*9-O1;GI*K<]5CJ8Q1-N)**6/1!!-#4>
MZ]TQ_"OXM[R^+FS\SMO>7;F2[7K<EA>H\++E*RD:C.9S/6/4NU.MMR]K[@26
M2>:H[-[OS6W9-P;FG#O&]=,BAYI$DJ9_=>Z.G[]U[KWOW7N@E[BVWNG>.W:7
M:F'V=U)O_:VXZRHPW96T>XER,VW<KLNOQ=?#,:6@I=O;HQV<K*3+&EEDQM?2
M)29"E66$U-*[).ONO=%*PGPPW)A.HOC[\2I<]L+<GQAZ%V3\8*?$9O<.)W75
M=Y-OWXP;RVSNO;^0QE=+GZK;&*QN7J-C8:2BK(##7;=,%1%3I4":FEH?=>Z%
M3OOXPU'<^W>V\=BMT4W7F<W=M'([?V1F,#BXFAQ&<SU#C*?=F]=UTE.F-GS^
M>W?BL;%MFJD:9JJEVLM33T=53G)UJGW7NB#_`/#6';__`'E-FO\`MX/_`+.S
M_P``G_YD5_WK$_X"_P#9''^T_P"9_P"K)[]U[J[/W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]T2_$_/KX^;AQ\&8VWB/E#N?!U;3C'[@VO\$?G)N7;N6BIZF:E>LPNX<'\
M=*_"YO&R30-XJJDGFIIT`>-W0AC[KW3E_L\'3'_/%?+_`/\`3>_SY_\`N:??
MNO=>_P!G@Z8_YXKY?_\`IO?Y\_\`W-/OW7NO?[/!TQ_SQ7R__P#3>_SY_P#N
M:??NO=>_V>#IC_GBOE__`.F]_GS_`/<T^_=>Z]_L\'3'_/%?+_\`]-[_`#Y_
M^YI]^Z]U[_9X.F/^>*^7_P#Z;W^?/_W-/OW7NO?[/!TQ_P`\5\O_`/TWO\^?
M_N:??NO=>_V>#IC_`)XKY?\`_IO?Y\__`'-/OW7NO?[/!TQ_SQ7R_P#_`$WO
M\^?_`+FGW[KW46N^=O1F-HJS(Y#:?RYHZ#'TM16UM74?R^OGO%3TM)2Q//4U
M,\C?&H+'#!#&S,QX"@GW[KW1J=I[IP6^-K;:WKM:N_BFV=X;?PVZ=NY/[6LH
MOXC@MP8ZFRV(KOL\C3TF0I/N\?5QR>*>**:/5I=%8$#W7NG_`-^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:N_P`JOYJ?;G\LWX8_RY8^
MI>J>N.S:[O39W9T&7/8N:W-B*3!4W6W]SJFF;&_W:1YJF?)2;T<2>6RHL`MR
M3[2W=TMI%XK`D5ICH$<_\[VO(&Q#?+R"2XB-PD6E"%-7#&M6Q0:/Y]"#\,OY
MU7>_R9^!O\RGY6;LZ:ZDVAOCX*=:;P[(VSM?;N5WCF=J;]BV=TIN7N&3#9V?
M)56-R^*DRPVRV.6HIW<4OW`G,4WC,,F[2Y6[A\900*D9^73O(G.5MSWL"[_:
M0R00M*Z:'(8U0@$U7&:]'.W#_,/W_A>@?YE_:NUL=U1W+C/@=T?N+MW8G>_7
M29T=`=\;FVAU3V!V5OOI>D6+=>Y9,5OSJ^MV##BMR38O<>=H\>^XJ!G*UT%?
MBJ=3T,NEWV/\V-S]7=-][]NXO?O2WR2VMT_DNAZ'<6[/CYUYOO<-/U7AM^]@
MP8CN??F_=C[3[-[6S.^\#TGU+EZ7>DN/V_D8,G5T5+4P3+11%*Y/=>Z3N^?F
M'WYCOBYN[Y6]9[T^)/;'4V%K,;5]?=@=?TVZ]\;4[KVGNC=6P]K8+-8.7`]L
M)!L>HP5;N#*09:">NS$OW^/^WC5$O4-[KW2H^2?RT[5^+^X^BMJ]L=H?%7KG
M&]GU'?,F=[@["PVZ=K]=8S%]5[.H=Z[8D;'Y;M[&S;?R&XX:IZ"J@?*Y5H98
MO/3_`'&H4WOW7NLVWOG'V'68;X);O[)ZLAZ%QOR8Z>[3[6[HV-V)C]Q3[WZ=
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MNWOUQN?-;X%5B\[UCMO/9'&[CH=PW-3A9:2HQ4`FAJ6]U[HXWQ/_`.R6?C5_
MX@#IO_WW6W/?NO=#][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>ZUN^ROY=WQJ_F5?#OX+XSM7Y.9_I3,=`[2WPV+_`-'NXNJ!D*Z7L"7`
MT6<Q^XJ#L#!;F2$T)V;3F(11P2HSN')%@&9[>*Y3PYA5*UXTZ#G-'*FR<X[:
M-HW^-I;$2K)0.R'4H8`U0@\&.*TZ%#XY?RH/BU\8_B#\W_B1LGYBY;=.,^<V
MQ-S]?;[W]V'E^H\AG-G8;=O6.;ZFRD^U,1LVFV+B9:^GVSN&IEIFJ_,D=<(Y
M)%EB5H)/001V\?A1"B5^WJ_+/+&S\H[6-FV*-HK!79PI=G.ILDZF)/Y5Z,MV
MA\3^IM^;1^:^P=N_*'877VR/GWTSN_K_`+YVAB(-NY#;6/[0[`Z^RG5.^>_N
MK\;5=AP-LW>V\]A5]/!EJ.HDRE!7U^(H:^134_?M7O="#H=LO%OK.5YW%/\`
M-KIC;VY<=4;0;`Q;(Z_P>'V;4T."SF0RNXL9O[;^X.Z]W;@WK1[KQ]6N.58L
MWBQB:9ZB:B$5=.M7#[KW0(S?$OH9?C_\C^E<'WQU/LZN^4G=L7??8V6V=C=L
MX/8F%WLT75=+E%Z[ZP3?\\>U<;N*/J.AKLDLF7K9:[/Y'*92:1YZYPONO=#%
M\@.I.A_DAO;J;.]C]J]0YW96PMK]R[-WEUGG#M_-;?[/VSWEL:+K_>N%RLTF
M]J5L7CY,")%B3Q59#2G6S``>_=>Z#/:_QUV%CI_C31;Z^6NT.W-M?&7!]O[$
MP$/8(VYE=X=@=9]H[138-'MOL_>']_Q#NG<&VMFP144V:..BGS1B\];$]1)-
M++[KW0J?'C:&%^/VQ-@=+4/RPV)NCI3I_#X':'5^*R2;?@[4INO]GXR+#;+V
M5O\`[1E[!R6-WS2;=Q--3TIKX-O8C+9""CA-;55$SUDU9[KW679NQ.N=G93Y
MG9>G^0G6];5?+_LY.TJI)I,%%!L',0?&_IKXR4V/IT3?;2;EQJ[,Z*PM=)J>
MAE?*3UK!T@F@@I?=>Z!;'_'S'?[+'/\`%'._,;J2?K:G^(F9^(N'GVULO`;=
MSU7@*[K_`!?6&%WUOG)9'N'=$FZ=R;1VI3Y`T%)0_P`$Q)K\Q4U$]--HIHX/
M=>ZF[HZCZYJ6P';?</R.V!V;N;XZ]*]J;2Z+VOMC^[G7O7VSLCO+KJ79>Y>Q
MJO`U6]]^;HW-VGE-F0U&#BK:C-#%46*R-9'2XR&>JGJ9/=>Z.+\3_P#LEGXU
M?^(`Z;_]]UMSW[KW0_>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NM$GMG_F:?9?\`XD#>7_O1Y+W[KW0?^_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZWM^J/^96]:_^&!L[_P!YW'>_=>Z7
M_OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
5>Z][]U[KWOW7NO>_=>Z][]U[K__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
